
<html lang="en"     class="pb-page"  data-request-id="11ef7829-9c84-4192-8a3d-3721991bdcda"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-4;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01463;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma" /></meta><meta name="dc.Creator" content="Yuting  Kuang" /></meta><meta name="dc.Creator" content="Mario  Sechi" /></meta><meta name="dc.Creator" content="Salvatore  Nurra" /></meta><meta name="dc.Creator" content="Mats  Ljungman" /></meta><meta name="dc.Creator" content="Nouri  Neamati" /></meta><meta name="dc.Description" content="Altering redox homeostasis provides distinctive therapeutic opportunities for the treatment of pancreatic cancer. Quinazolinediones (QDs) are novel redox modulators that we previously showed to ind..." /></meta><meta name="Description" content="Altering redox homeostasis provides distinctive therapeutic opportunities for the treatment of pancreatic cancer. Quinazolinediones (QDs) are novel redox modulators that we previously showed to ind..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 2, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01463" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01463" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01463" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01463" /></link>
        
    
    

<title>Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01463" /></meta><meta property="og:title" content="Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0015.jpeg" /></meta><meta property="og:description" content="Altering redox homeostasis provides distinctive therapeutic opportunities for the treatment of pancreatic cancer. Quinazolinediones (QDs) are novel redox modulators that we previously showed to induce potent growth inhibition in pancreatic ductal adenocarcinoma (PDAC) cell lines. Our lead optimization campaign yielded QD325 as the most potent redox modulator candidate inducing substantial reactive oxygen species (ROS) in PDAC cells. Nascent RNA sequencing following treatments with the QD compounds revealed induction of stress responses in nucleus, endoplasmic reticulum, and mitochondria of pancreatic cancer cells. Furthermore, the QD compounds induced Nrf2-mediated oxidative stress and unfolded protein responses as demonstrated by dose-dependent increases in RNA synthesis of representative genes such as NQO1, HMOX1, DDIT3, and HSPA5. At higher concentrations, the QDs blocked mitochondrial function by inhibiting mtDNA transcription and downregulating the mtDNA-encoded OXPHOS enzymes. Importantly, treatments with QD325 were well tolerated in vivo and significantly delayed tumor growth in mice. Our study supports the development of QD325 as a new therapeutic in the treatment of PDAC." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01463"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01463">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01463&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01463&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01463&amp;href=/doi/10.1021/acs.jmedchem.7b01463" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1576-1594</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01465" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01710" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuting++Kuang">Yuting Kuang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mario++Sechi">Mario Sechi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-2983-6090" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Salvatore++Nurra">Salvatore Nurra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mats++Ljungman">Mats Ljungman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nouri++Neamati">Nouri Neamati</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3291-7131" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, California 90033, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">¶</span> <span class="aff-text">Department of Chemistry and Pharmacy, University of Sassari, Via Vienna 2, 07100 Sassari, Italy</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Radiation Oncology, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span></div><div class="corresp-info"><strong>*</strong>M.S. Phone: +39 079-228-753. Fax: +39 079-229-559. E-mail: <a href="/cdn-cgi/l/email-protection#a3cec2d1cacc8dd0c6c0cbcae3d6cdcad0d08dcad7"><span class="__cf_email__" data-cfemail="a0cdc1d2c9cf8ed3c5c3c8c9e0d5cec9d3d38ec9d4">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>N.N. Phone: 734-647-2732. Fax: 734-763-8152. E-mail: <a href="/cdn-cgi/l/email-protection#3f515a5e525e4b567f4a52565c57115a5b4a"><span class="__cf_email__" data-cfemail="9af4fffbf7fbeef3daeff7f3f9f2b4fffeef">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01463&amp;href=/doi/10.1021%2Facs.jmedchem.7b01463" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1576–1594</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 12, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 October 2017</li><li><span class="item_label"><b>Published</b> online</span>2 February 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 February 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01463" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01463</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1576%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYuting%2BKuang%252C%2BMario%2BSechi%252C%2BSalvatore%2BNurra%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D4%26contentID%3Dacs.jmedchem.7b01463%26title%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BReactive%2BOxygen%2BSpecies%2BInducers%2Bfor%2Bthe%2BTreatment%2Bof%2BPancreatic%2BDuctal%2BAdenocarcinoma%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1594%26publicationDate%3DFebruary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01463"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2144</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01463" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yuting&quot;,&quot;last_name&quot;:&quot;Kuang&quot;},{&quot;first_name&quot;:&quot;Mario&quot;,&quot;last_name&quot;:&quot;Sechi&quot;},{&quot;first_name&quot;:&quot;Salvatore&quot;,&quot;last_name&quot;:&quot;Nurra&quot;},{&quot;first_name&quot;:&quot;Mats&quot;,&quot;last_name&quot;:&quot;Ljungman&quot;},{&quot;first_name&quot;:&quot;Nouri&quot;,&quot;last_name&quot;:&quot;Neamati&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;1576-1594&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01463&quot;},&quot;abstract&quot;:&quot;Altering redox homeostasis provides distinctive therapeutic opportunities for the treatment of pancreatic cancer. Quinazolinediones (QDs) are novel redox modulators that we previously showed to induce potent growth inhibition in pancreatic ductal adenocarcinoma (PDAC) cell lines. Our lead optimization campaign yielded QD325 as the most potent redox modulator candidate inducing substantial reactive oxygen species (ROS) in PDAC cells. Nascent RNA sequencing following treatments with the QD compounds revealed induction of stress responses in nucleus, endoplasmic reticulum, and mitochondria of pancreatic cancer cells. Furthermore, the QD compounds induced Nrf2-mediated oxidative stress and unfolded protein responses as demonstrated by dose-dependent increases in RNA synthesis of representative genes such as NQO1, HMOX1, DDIT3, and HSPA5. At higher concentrations, the QDs blocked mitochondrial function by inhibiting mtDNA transcription and downregulating the mtDNA-encoded OXPHOS enzymes. Importantly, treatments wi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01463&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01463" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01463&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01463" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01463&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01463" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01463&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01463&amp;href=/doi/10.1021/acs.jmedchem.7b01463" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01463" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01463" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01463%26sid%3Dliteratum%253Aachs%26pmid%3D29328656%26genre%3Darticle%26aulast%3DKuang%26date%3D2018%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BReactive%2BOxygen%2BSpecies%2BInducers%2Bfor%2Bthe%2BTreatment%2Bof%2BPancreatic%2BDuctal%2BAdenocarcinoma%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D4%26spage%3D1576%26epage%3D1594%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/jmcmar.2018.61.issue-4/20180222/jmcmar.2018.61.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Altering redox homeostasis provides distinctive therapeutic opportunities for the treatment of pancreatic cancer. Quinazolinediones (QDs) are novel redox modulators that we previously showed to induce potent growth inhibition in pancreatic ductal adenocarcinoma (PDAC) cell lines. Our lead optimization campaign yielded <b>QD325</b> as the most potent redox modulator candidate inducing substantial reactive oxygen species (ROS) in PDAC cells. Nascent RNA sequencing following treatments with the QD compounds revealed induction of stress responses in nucleus, endoplasmic reticulum, and mitochondria of pancreatic cancer cells. Furthermore, the QD compounds induced Nrf2-mediated oxidative stress and unfolded protein responses as demonstrated by dose-dependent increases in RNA synthesis of representative genes such as <i>NQO1, HMOX1, DDIT3</i>, and <i>HSPA5</i>. At higher concentrations, the QDs blocked mitochondrial function by inhibiting mtDNA transcription and downregulating the mtDNA-encoded OXPHOS enzymes. Importantly, treatments with <b>QD325</b> were well tolerated <i>in vivo</i> and significantly delayed tumor growth in mice. Our study supports the development of <b>QD325</b> as a new therapeutic in the treatment of PDAC.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pancreatic cancer is the fourth leading cause of cancer-related death in both genders in the United States, estimated to claim over 40 000 lives in 2017.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Given its asymptomatic and metastatic nature, over 50% of pancreatic cancer cases are diagnosed at late stages, when the tumor has metastasized and is often unresectable.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Therefore, treatment of pancreatic cancer is largely dependent on systemic chemotherapy. Ever since its approval by the FDA in 1996, gemcitabine-based regimes have been the standard of care for pancreatic cancer.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> However, limited by late-stage diagnosis and inherent/acquired resistance to available chemotherapy, the overall five-year survival rate of pancreatic cancer is only 6.7%, one of the lowest among all types of cancers. Recently, two combination regimens with modest clinical activity have been added as an option for pancreatic cancer patients. The combination of nab-paclitaxel (albumin-bound paclitaxel) with gemcitabine has increased median overall survival from 6.7 to 8.5 months.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The combination cocktail including oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) was approved for the treatment of metastatic pancreatic cancer by improving median overall survival from 6.8 months in the gemcitabine group to 11.1 months in the FOLFIRINOX group,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> but increased toxicity is the major concern for these new treatment options.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Therefore, novel therapeutics are urgently needed to enhance the survival and quality of life of patients with this devastating disease.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a></div><div class="NLM_p">Modulation of redox homeostasis in cancer cells provides a new opportunity for tumor intervention.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17 ref18">(12-18)</a> Reactive oxygen species (ROS), natural byproducts from mitochondrial respiration and other cellular processes, play important roles as second messengers in cell signaling.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> However, when present at high concentrations, ROS can be detrimental to cells by inducing oxidative damage to DNA, lipids, and proteins.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Cells eliminate excess intracellular ROS via expression of antioxidant genes regulated by the ROS-detoxifying machinery. In tumor cells, antioxidant enzymes are often induced as a result of elevated levels of intrinsic ROS.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Expression of mutant oncogenic Kras<sup>G12D</sup>, commonly present in pancreatic ductal adenocarcinoma (PDAC), keeps the master transcription factor NRF2 elevated at basal state to mount an antioxidant response.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a> A shift in the redox homeostasis is expected to make tumor cells more susceptible to induced oxidative stress, overwhelming their adaptive antioxidant capacity and promoting ROS-mediated cell death.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a></div><div class="NLM_p">Among various classes of small-molecule drugs tested in our laboratory to induce ROS, the quinone containing compounds showed great promise due to their significant increase in oxygen consumption rate in treated cells. Many quinones inhibit multiple biochemical assays due to their redox, metal-chelation, color, and in some cases, reactivity toward nucleophiles through Michael addition. Therefore, they are classified as pan assay inhibitors in high throughput screening campaigns. However, over two-dozen drugs containing a quinone moiety have been approved by the FDA or are under clinical investigations not only in oncology but also for other diseases. For example, doxorubicin and dozen of its analogues, mitoxantrone, and mitomycin C are some of the most commonly used FDA approved chemotherapeutic agents for numerous cancers that contain a quinone group. In addition, there are many other agents that are approved for various indications or are in late stage clinical development that broadly fall under the quinone class of drugs (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>).</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Select Examples of Drugs Containing Quinone or a Michael Acceptor That Are FDA-Approved or under Clinical Investigations for Various Diseases</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previously, we showed that the quinazolinedione <b>QD232</b> (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>) exerts ROS-mediated cytotoxicity in pancreatic cancer models.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> In this study, we performed a lead optimization campaign and identified <b>QD325</b> as a lead compound for in-depth preclinical and mechanistic studies. Several major modifications on <b>QD232</b> were made by varying the substituents at the nitrogen atom on position 6 of the quinazoline-5,8-dione backbone.</div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Structure of Lead Compound <b>QD232</b> and Design of Title Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Specifically, mono/poly substitution on the phenyl ring with various functionalities and/or bulky aromatic system was mainly explored to modulate lipophilicity and steric effects (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>). Furthermore, to evaluate a potential synergistic effect in terms of ROS modulation, we sought to conjugate the quinazoline-5,8-dione scaffold to a highly lipophilic triphenylphosphonium cation for mitochondrial targeting.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Disruption of mitochondrial-mediated cell redox modulation represents a promising avenue for future therapy in cancer. Because our compounds increase ROS production, we tested their ability to interfere with mitochondrial processes.</div><div class="NLM_p last">Our results show that <b>QD325</b> caused selective inhibition of transcription of the mitochondrial genome potentially by abrogating the mitochondrial D-loop, critical for mtDNA transcription. We propose that such targeting could be efficacious and should be further explored as an innovative therapeutic approach to target cancers that heavily depend on mitochondrial function. Importantly, <b>QD325</b> was found to be well tolerated and showed tumor-suppressing activities in a pancreatic cancer xenograft model.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The synthesis of compounds <b>QD324</b>–<b>338</b>, <b>353</b>–<b>357</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) was carried out using Bracher’s methodology, according to our previously reported procedure with some modifications. <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> illustrates the synthesis of the key synthone <b>QD323</b> from the readily available dimethoxybenzaldehyde (<b>1)</b>. Nitration of compound <b>1</b> with concentrated nitric acid in the presence of acetic anhydride under simple magnetic stirring afforded the 3,6-dimethoxy-2-nitrobenzaldehyde (<b>2</b>) in good yield. This regioisomer was converted to the diformamido-derivative <b>3</b> under gaseous HCl. Compound <b>3</b> was then cyclized to dimethoxyquinazoline <b>4</b> by treatment with zinc powder and acetic acid. Final oxidation by cerium ammonium nitrate resulted in the production of quinazoline-5,8-dione <b>QD323</b>. Regioselective addition of appropriate aminobenzenes to 6 position of <b>QD323</b> in the presence of Ce(III) ions gave <b>QD324</b>–<b>338</b>, <b>353</b>–<b>357</b> (<a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for the Preparation of the Key Intermediate <b>QD323</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) conc. HNO<sub>3</sub>, (CH<sub>3</sub>CO)<sub>2</sub>O, 0 °C, 1.5 h; (<i>ii</i>) H<sub>2</sub>NCHO, HCl<sub>(g)</sub> from 40 to 80 °C, 1h; (<i>iii</i>) glacial CH<sub>3</sub>COOH, Zn, 0 °C for 2 h, rt for 4 h; (<i>iv</i>) (NH<sub>4</sub>)<sub>2</sub>Ce(NO<sub>3</sub>)<sub>6</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O, 0 °C, 20 min.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compounds <b>QD324</b>–<b>338</b>, <b>353</b>–<b>355</b>, <b>357</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) CeCl<sub>3</sub>·7H<sub>2</sub>O, abs EtOH, rt, 1–6 h.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of <b>QD356</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) CeCl<sub>3</sub>·7H<sub>2</sub>O, abs EtOH, rt, 2 h.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure and Cytotoxicity of QD Compounds in MIA PaCa-2, Panc-1, and BxPC-3 Cells by MTT Assay<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">substitution group</th><th class="rowsep1 colsep0" colspan="3" align="center">IC <sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">MIA PaCa-2</th><th class="colsep0 rowsep0" align="center">Panc-1</th><th class="colsep0 rowsep0" align="center">BxPC-3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>232</b></td><td class="colsep0 rowsep0" align="left">COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">5.2 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>325</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>335</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-Et-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>336</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-OCH<sub>3</sub>–Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.5</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.3</td><td class="colsep0 rowsep0" align="left">3.5 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>337</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-NH<sub>2</sub>–Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">3.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">3.5 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>334</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.5 ± 1.0</td><td class="colsep0 rowsep0" align="left">3.2 ± 0.8</td><td class="colsep0 rowsep0" align="left">4.4 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>338</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>–Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4.6 ± 1.1</td><td class="colsep0 rowsep0" align="left">4.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">5.0 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>326</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.6 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>353</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1.8 ± 0.3</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>354</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>355</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.3</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>357</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">7.7 ± 2.0</td><td class="colsep0 rowsep0" align="left">7.2 ± 0.8</td><td class="colsep0 rowsep0" align="left">16.3 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>327</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>324</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O-Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.7 ± 0.7</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">3.6 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>328</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>333</b></td><td class="colsep0 rowsep0" align="left">B(OH)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">9.0 ± 1.0</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>331</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.4</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.4</td><td class="colsep0 rowsep0" align="left">5.8 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>329</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.5 ± 1.3</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.2</td><td class="colsep0 rowsep0" align="left">5.7 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>332</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.5 ± 1.5</td><td class="colsep0 rowsep0" align="left">1.6 ± 0.3</td><td class="colsep0 rowsep0" align="left">5.9 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>330</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.0 ± 0.9</td><td class="colsep0 rowsep0" align="left">6.3 ± 0.3</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>323</b><a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">9.4 ± 0.9</td><td class="colsep0 rowsep0" align="left">18.0 ± 2.5</td><td class="colsep0 rowsep0" align="left">19.4 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>356</b><a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>339</b><a class="ref internalNav" href="#t1fn4" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>358</b><a class="ref internalNav" href="#t1fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>331</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.4</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.4</td><td class="colsep0 rowsep0" align="left">5.8 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>340</b></td><td class="colsep0 rowsep0" colspan="2" align="left">H CONH(CH<sub>2</sub>)<sub>3</sub>(TPP)<sup>+</sup>Br<sup>–</sup><a class="ref internalNav" href="#t1fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">15.3 ± 2.5</td><td class="colsep0 rowsep0" align="left">11.7 ± 1.5</td><td class="colsep0 rowsep0" align="left">21.5 ± 2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>232</b></td><td class="colsep0 rowsep0" align="left">COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">5.2 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>359</b></td><td class="colsep0 rowsep0" colspan="2" align="left">CONH(CH<sub>2</sub>)<sub>3</sub>(TPP)<sup>+</sup>Br<sup>–</sup><a class="ref internalNav" href="#t1fn6" aria-label="g">g</a> H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">16.3 ± 3.5</td><td class="colsep0 rowsep0" align="left">14.3 ± 1.5</td><td class="colsep0 rowsep0" align="left">21.3 ± 2.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">QD compounds are grouped by structure.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">Data is presented as mean ± SD from three independent experiments.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">Structure of intermediate <b>QD323</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</p></div><div class="footnote" id="t1fn3"><sup>d</sup><p class="last">Structure of <b>QD356</b> is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</p></div><div class="footnote" id="t1fn4"><sup>e</sup><p class="last">Structure of intermediate <b>QD339</b> is shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</p></div><div class="footnote" id="t1fn5"><sup>f</sup><p class="last">Structure of intermediate <b>QD358</b> is shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>.</p></div><div class="footnote" id="t1fn6"><sup>g</sup><p class="last">TPP stands for triphenylphosphonium.</p></div></div></div><div class="NLM_p">Then, we wanted to obtain triphenylphosphonium-based model derivatives of compound <b>QD331</b> and <b>QD232</b>. Compounds <b>QD340</b> and <b>QD359</b> were therefore generated by adapting a phosphine conjugation method, as we previously described.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> The synthesis of triphenylphosphonium-based compounds <b>QD340</b> and <b>QD359</b> is illustrated in <a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a> and <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Initially, 3-bromopropylamine hydrobromide (<b>5</b>) was reacted with triphenylphosphine in refluxing acetonitrile for 16 h, and the resulting triphenylphosphonium intermediate (<b>6</b>) was isolated after treatment with <i>n</i>-hexane/diethyl ether/isopropanol. Next, the 4- and 3-aminobenzamido-propyl-triphenylphosphonium bromides <b>QD339</b> and <b>QD358</b> were prepared by conjugating <b>6</b> with 4- or 3-aminobenzoic acid, respectively, via a standard coupling protocol using DIPEA, HBtU, DMAP, in CH<sub>2</sub>Cl<sub>2</sub>. Finally, <b>QD340</b> and <b>QD359</b> were obtained by nucleophilic addition of appropriate triphenylphosphonium salts (<b>QD339</b> or <b>QD358</b>) to <b>QD323</b> in the presence of Ce(III), according to the above-mentioned procedure.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <b>QD339</b>, <b>340</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) MeCN, reflux, 16 h; (<i>ii</i>) 4-aminobenzoic acid, DIPEA, HBtU, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h; (<i>iii</i>) CeCl<sub>3</sub>·7H<sub>2</sub>O, abs EtOH, rt, 2 h.</p></p></figure><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of <b>QD358, 359</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) MeCN, reflux, 16 h; (<i>ii</i>) 3-aminobenzoic acid, DIPEA, HBtU, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h; (<i>iii</i>) CeCl<sub>3</sub>·7H<sub>2</sub>O, abs EtOH, rt, 1.5 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> QD Compounds Inhibit Proliferation of Pancreatic Cancer Cells</h3><div class="NLM_p">We designed and synthesized 25 new analogues of our previous lead compound, <b>QD232</b>, to better elucidate their mechanisms of action. Nine of these novel analogues showed improved cytotoxicity compared to <b>QD232</b> in at least two PDAC cell lines in MTT assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). <b>QD325</b> was found to be the most potent analogue with IC<sub>50</sub> values <1 μM in the three PDAC cell lines (MIA PaCa-2, Panc-1, and BxPC-3).</div><div class="NLM_p"><b>QD325</b> (as well as <b>QD232</b>) showed similar dose-dependent cytotoxicity in MIA PaCa-2 and a gemcitabine-resistant derivative cell line MIA PaCa-2-GR<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). In HPV16-E6E7 immortalized pancreatic cell line HPDE,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> gemcitabine produced similar IC<sub>50</sub> values as MIA PaCa-2 cells, while the most potent <b>QD325</b> compound showed a 3-fold higher sensitivity for MIA PaCa-2 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Cytotoxicity of QD Compounds in Gemcitabine Resistant MIA PaCa-2 cells and Normal Pancreatic Cells by MTT Assay</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC <sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">MIA PaCa-2</th><th class="colsep0 rowsep0" align="center">MIA PaCa-2-GR</th><th class="colsep0 rowsep0" align="center">HPDE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>232</b></td><td class="colsep0 rowsep0" align="left">2.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">3.6 ± 0.6</td><td class="colsep0 rowsep0" align="left">4.5 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>325</b></td><td class="colsep0 rowsep0" align="left">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.3</td><td class="colsep0 rowsep0" align="left">2.7 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>326</b></td><td class="colsep0 rowsep0" align="left">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">3.2 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>340</b></td><td class="colsep0 rowsep0" align="left">15.3 ± 2.5</td><td class="colsep0 rowsep0" align="left">17.7 ± 1.8</td><td class="colsep0 rowsep0" align="left">18.3 ± 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>359</b></td><td class="colsep0 rowsep0" align="left">16.3 ± 3.5</td><td class="colsep0 rowsep0" align="left">16.2 ± 1.9</td><td class="colsep0 rowsep0" align="left">24.3 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">gemcitabine</td><td class="colsep0 rowsep0" align="left">0.11 ± 0.07</td><td class="colsep0 rowsep0" align="left">3.3 ± 0.6</td><td class="colsep0 rowsep0" align="left">0.14 ± 0.05</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data is presented as mean ± SD from three independent experiments.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cytotoxicity of QD Compounds Correlates with Increased ROS Production</h3><div class="NLM_p">Treatment with the QD compounds elicited significant ROS accumulation in MIA PaCa-2 cells as shown in the H2DCFDA reactivity assay (<a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a class="ref internalNav" href="#notes-1" aria-label="S2">S2</a>). To validate ROS induction as the mechanism for cytotoxicity, the effect of QD compounds was evaluated in the presence and absence of the antioxidant N-acetyl-cysteine (NAC). For the lead compound <b>QD232</b> and the two active analogues <b>QD325</b> and <b>QD326</b>, we observed a time- and dose-dependent accumulation of ROS (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). While H<sub>2</sub>O<sub>2</sub> treatment lead to an immediate conversion of H2DCFDA to fluorescent DCF, treatment with the QD compounds resulted in a gradual induction of the fluorescent signal, which reached peak levels after 4–6 h, implying a progressive ROS accumulation.</div><figure id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cytotoxicity of the QD compounds is reduced by NAC in MIA PaCa-2 cells. (A) The parental compound <b>QD232</b> induces ROS accumulation in a dose- and time-dependent manner. The new analogues <b>QD325</b> and <b>QD326</b> induced a stronger and more rapid ROS accumulation in MIA PaCa-2 cells than the parental <b>QD232</b> compound. Compounds were tested at 10, 3.3, or 1.1 μM. DMSO was used as a negative control to determine the basal signal of the assay (DMSO). Cells without preloaded H2DCFDA were treated with compounds at 10 μM at the same conditions to determine the endogenous fluorescence of the compounds (no stain). Data points represent mean ± SD from duplicates. Graphs are representatives of three independent experiments. (B) ROS induction by <b>QD232</b>, <b>325</b>, and <b>326</b> was inhibited by NAC pretreatment (5 mM for 30 min). Data points represent mean ± SD from duplicates. Graphs are representatives of three independent experiments. (C) Presence of NAC at 5 mM decreased the cytotoxicity of the <b>QD232</b>, <b>QD325</b>, and <b>QD326</b> compounds. Cytotoxicity was determined by the MTT assay after a 72 h treatment. Data points represent mean ± SD from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When cells were pretreated with 5 mM NAC, ROS induction by H<sub>2</sub>O<sub>2</sub> and the QD compounds was blocked (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). In the MTT cell proliferation assay, NAC attenuated the proliferation inhibitory effect of H<sub>2</sub>O<sub>2</sub>, <b>QD232</b>, <b>QD325</b>, and <b>QD326</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C). Importantly, we did not observe any colloidal behavior or aggregation for QD compounds in our assays. These results demonstrate that ROS accumulation is a major mechanism for cytotoxicity of the QD compounds. However, NAC treatment did not completely block the effect of the QD compounds and H<sub>2</sub>O<sub>2</sub>, suggesting these compounds may induce additional cellular effects responsible for the inhibition of cell proliferation. Testing many analogues in the presence of NAC and GSH at 1 to 5 mM we discovered that these antioxidants could protect toxicity anywhere from 10 to 80% depending on the analogue. In most cases, NAC addition never fully protects the cells even at 1000-fold excess of antioxidant. These studies suggest that the compounds not only produce ROS but also bind to unique targets. It is also possible that the QD-NAC conjugate is partially responsible for the ROS induction and cytotoxicity.</div><div class="NLM_p">The faster induction of oxidative stress by the optimized compounds is perhaps due to improved membrane permeability (predicted cLogP values for <b>QD232</b> and <b>QD325</b> are 1.99 and 3.89, respectively). We expected that better in vitro antiproliferative activity of <b>QD325</b> should translate to better <i>in vivo</i> efficacy. Therefore, we selected <b>QD325</b> for extensive mechanistic and <i>in vivo</i> studies.</div><div class="NLM_p last">In order to selectively target these compounds to the mitochondria, we synthesized two derivatives containing a triphenylphosphine group. To our surprise, <b>QD340</b> and <b>QD359</b> did not show better ROS induction and cytotoxicity than <b>QD325</b> and were not further explored. A possible explanation of this unexpected behavior could be attributed to their redox properties, because we previously showed that triphenylphosphoniums decreased cellular oxygen consumption rate (OCR). Furthermore, the QD compounds without the triphenylphosphonium group cause a remarkable increase in cellular OCR.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> QD Compounds Induce Oxidative Stress and the Unfolded Protein Response</h3><div class="NLM_p">We used the recently established bromouridine labeled RNA sequencing (Bru-seq) technique to better characterize transcriptional effects of the QD compounds. Bru-seq captures nascent RNA and provides information on ongoing transcription genome-wide without interference by pre-existing RNA.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> We observed that the transcription signatures induced by 4-h treatments with <b>QD232</b> or <b>QD325</b> were similar according to Ingenuity Pathway Analysis (IPA) or Gene Set Enrichment Analysis (GSEA) of the expressed genes (<a class="ref internalNav" href="#fig2" aria-label="Figures 2">Figures 2</a> and <a class="ref internalNav" href="#notes-1" aria-label="S3–S6">S3–S6</a>). This implies that the two compounds have similar mechanisms of action. IPA profiling of all genes with >1.5-fold change in expression upon treatment of MIA PaCa-2 cells with <b>QD232</b> or <b>QD325</b> identified the “NRF2-mediated oxidative stress response” and “unfolded protein response” (UPR) as key pathways activated by these compounds (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A).</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. QD compounds induce oxidative stress and the unfolded protein response. (A) Top 15 canonical pathways induced by <b>QD232</b> or <b>QD325</b> treatment as revealed by IPA analysis of Bru-seq data. MIA PaCa-2 cells were treated with <b>QD232</b> (at 1, 2, or 3 times IC<sub>50</sub>) or <b>QD325</b> (at 1, 2, or 5 times IC<sub>50</sub>) for 4 h. Nascent RNA was labeled with 2 mM bromouridine during the last 30 min of treatment, immunocaptured, converted to cDNA libraries and deep sequenced. (B) Transcription of oxidative stress responsive genes <i>NQO1</i> and <i>HMOX1</i> was upregulated by <b>QD232</b> or <b>QD325</b> treatment in MIA PaCa-2 cells in a dose-dependent manner. (C) Transcription of unfolded protein response target genes <i>DDIT3</i> and <i>HSPA5</i> was upregulated by <b>QD232</b> or <b>QD325</b> treatment in MIA PaCa-2 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">NRF2 is a transcription factor that is rapidly activated in response to oxidative and electrophilic exposure, and it promotes the transcription of genes encoding various detoxifying enzymes.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Upon oxidative challenge, KEAP1 inactivation allows nascent NRF2 proteins to translocate to the nucleus<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> and activate transcription of antioxidant genes containing AREs (antioxidant response element) or MAREs (MAF recognition element) in <i>cis</i>-acting enhancer elements.</div><div class="NLM_p"><i>NQO1</i> and <i>HMOX1</i> are two target genes of NRF2 that counteract the effects of oxidative stress.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a><i>NQO1</i> encodes the flavoprotein NAD(P)H:quinone oxidoreductase 1 that catalyzes a two-electron reduction of quinones to hydroquinones and exhibits chemo-protective effects.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a><i>HMOX1</i> encodes heme oxygenase 1 (HO-1), whose antioxidant properties arise from degradation of the pro-oxidant heme and production of antioxidant bilirubin from biliverdin.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> As revealed by Bru-seq, synthesis of <i>NQO1</i> and <i>HMOX1</i> RNAs was upregulated in a dose-dependent manner by treatments with either <b>QD232</b> or <b>QD325</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B).</div><div class="NLM_p">The unfolded protein response (UPR) comprises three pathways regulated by the ER trans-membrane proteins inositol-requiring enzyme 1a (IRE1a), activating transcription factor 6 (ATF6), and protein kinase RNA-like endoplasmic reticulum kinase (PERK), respectively.<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46-48)</a> Misfolded proteins in the ER lumen trigger the competitive binding of the ER chaperone GRP78, leading to the activation of IRE1a, ATF6 and PERK and downstream responses to UPR.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Depending on the severity and duration of the ER stress, the UPR can function as a pro-survival mechanism and restore homeostasis, or trigger apoptosis if the stress burden is beyond the capacity of this adaptive response.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a></div><div class="NLM_p"><i>DDIT3</i> and <i>HSPA5</i> are genes that are induced as a result of UPR signaling. <i>HSPA5</i> encodes GRP78, the key regulatory protein of ER stress. <i>DDIT3</i> is a downstream target gene that transcriptionally responds to all three arms of the UPR. As a transcription factor, the <i>DDIT3</i> gene product CHOP promotes apoptosis under prolong ER stress by inducing transcription of pro-apoptotic genes including PUMA and BIM.<a onclick="showRef(event, 'ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54">(52-54)</a> Transcription of the two stress-responsive genes <i>DDIT3</i> and <i>HSPA5</i> is significantly increased by <b>QD232</b> or <b>QD325</b> treatment in a dose-dependent manner (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C).</div><div class="NLM_p">Upregulation of mRNA synthesis detected by Bru-seq was found to also result in increased protein levels of the major stress responsive genes. We observed time-dependent increased protein levels of CHOP and GRP78 in MIA PaCa-2, Panc-1, and BxPC-3 cells treated with the QD compounds (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A–C). For the oxidative stress responsive genes, <i>HO-1</i> was upregulated by QD treatments in MIA PaCa-2 and BxPC-3 cells, while no significant change was detected in Panc-1 cells. Of note, the <i>NQO1</i> gene is known to be deleted in Panc-1 cells, and as expected, no transcription of the gene was observed in this cell line using Bru-seq In MIA PaCa-2 and BxPC-3, <i>NQO1</i> showed high basal expression levels with no further induction following treatment. These results suggest that MIA PaCa-2 and BxPC-3 cells have a high intrinsic oxidative stress burden and that this may make them sensitive to exogenous agents inducing oxidative stress. Indeed, IPA analysis showed significant activation of apoptosis signaling at higher concentration of <b>QD232</b> (3 times IC<sub>50</sub>) or <b>QD325</b> (5 times IC<sub>50</sub>) after 4 h treatment (<a class="ref internalNav" href="#notes-1" aria-label="Figure S3">Figure S3</a>), suggesting that apoptosis is a mode of death following exposure to the QD compounds.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. QD compounds induce protein expression of target genes for oxidative stress and unfolded protein response. Expression levels of oxidative stress responsive proteins NQO1, HO-1, and unfolded protein response target proteins CHOP and GRP78 were regulated to different extents by <b>QD232</b> or <b>QD325</b> treatment time dependently in (A) MIA PaCa-2, (B) Panc-1, and (C) BxPC-3 cells. Protein levels were quantified by ImageJ and normalized to respective loading controls. Data on quantification plots represent mean ± SD from three independent experiments. <i>p</i> values were calculated using student’s <i>t</i> test. *, <i>p</i> < 0.05; **, <i>p</i> < 0.01, ***, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Previously, it was shown that ROS-inducing compounds such as phenethylisothiocyanate and curcumin efficiently downregulate specificity protein (Sp) transcription factors Sp1, Sp3, and Sp4 in pancreatic cancer cells;<a onclick="showRef(event, 'ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57">(55-57)</a> however, we did not observe selective downregulation of these transcription factor genes in our Bru-seq studies and these factors were not in our top 100 affected genes.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> QD Compounds Inhibit Transcription of mtDNA from the D-Loop</h3><div class="NLM_p">Mitochondria play an important role in regulating redox homeostasis in mammalian cells. Deregulation of the expression of mitochondrial genes can lead to interruption of the oxidative phosphorylation pathway, resulting in the accumulation of ROS. Mitochondrial DNA (mtDNA) harbors 13 genes that encode proteins with important functions in the electron transport chain. The double-stranded circular mitochondrial genome comprises the guanine-rich heavy strand and the cytidine-rich light strand. Using Bru-seq, we observed significant inhibition of mtDNA transcription after a 4-h treatment with QD compounds at higher concentrations (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A; <a class="ref internalNav" href="#notes-1" aria-label="Figure S7">Figure S7</a>). Both compounds decreased COX III protein levels, which correlated to a reduced rate of transcription of the gene (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). These results strongly suggest that the QD compounds disrupt mitochondrial function.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. QD compounds show selective inhibition of transcription from the mitochondrial genome. (A) Nascent mitochondrial RNA synthesis was inhibited following a 4-h treatment with <b>QD232</b> (at 6.9 μM) or <b>QD325</b> (at 5.0 μM) in MIA PaCa-2 cells. Top forward arrows represent transcripts from the heavy strand. While the shorter arrow represents the shorter rRNA transcript regulated by the HSP1 promoter, the longer arrow represents transcript regulated by the HSP2 promoter that covers the full length of the heavy strand of the mitochondrial genome. Bottom reverse arrow represents the light strand transcript regulated by the LSP promoter. Transcription signals from DMSO-treated control cells are shown in yellow, while transcription signals from the <b>QD232</b>-treated cells are shown in blue, and signals from the <b>QD325</b>-treated cells are shown in red. The full-length transcripts from both heavy and light strands are further processed into functional tRNA, rRNA and mRNA molecules, whose corresponding genes are shown at the bottom of the panel. (B) Protein (COXIII) expression levels of the mitochondrial gene <i>COIII</i> were decreased by treatment of the QD compounds in MIA PaCa-2 cells. Protein levels were quantified by ImageJ and normalized to respective loading controls. Data on quantification plots represent mean ± SD from three independent experiments. <i>p</i> values were calculated using student’s <i>t</i> test. *, <i>p</i> < 0.05; **, <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The D-loop (displacement loop) is a noncoding area of the mtDNA genome composed of a short three-stranded structure required for the regulation of initiation of mtDNA replication and transcription. This region contains two promoters on the heavy strand HSP1 and HSP2, one on the light strand, LSP, and also the mtDNA replication origin O<sub>H</sub>. The D-loop region has been reported to be frequently mutated in lung, hepatocellular, colorectal and cervical cancers<a onclick="showRef(event, 'ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref60 ref61">(58-61)</a> and these D-loop mutations are linked to a poor prognosis of the disease.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a></div><div class="NLM_p last">Using Bru-seq, we found that the QD compounds inhibited the transcription of mtDNA from both the heavy strand promoter HSP2 (top long arrow in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A) and the light strand promoter LSP (bottom arrow), thus inhibiting the expression of mitochondrial genes that are essential for mitochondrial oxidative phosphorylation. However, the activity of the heavy strand promoter HSP1 (top short arrow, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A), which regulates transcription of 12s rRNA and 16s rRNA, was less affected by the QDs. This pattern of transcriptional inhibition was not observed following treatments with UV light, camptothecin, or with 40 FDA-approved and other novel drugs developed in our laboratory (data not shown). Thus, the Bru-seq data showing selective transcriptional inhibition of the mitochondrial genome suggest that this mechanism may be linked to the toxicity induced by the <b>QD232</b> and <b>QD325</b> compounds.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <b>QD325</b> Delays Tumor Growth without Systemic Toxicity</h3><div class="NLM_p">In NOD/SCID mice, MIA PaCa-2-derived xenograft showed significantly delayed growth following treatment with <b>QD325</b> (5 mg/kg). On day 44, the xenografts treated with <b>QD325</b> had only reached a size of 308 ± 72 mm<sup>3</sup> (<i>p</i> =  2.1E6) compared to 1291 ± 168 mm<sup>3</sup> for the xenografts in the control group (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A).</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>QD325</b> inhibits tumor growth of MIA PaCa-2 xenograft without systemic toxicity. (A) MIA PaCa-2 engrafted NOD/SCID mice were randomized into vehicle control (<i>n</i> = 5) or <b>QD325</b> treatment (<i>n</i> = 5) group when tumor size reached 65 mm<sup>3</sup>. <b>QD325</b> was given at 5 mg/kg five times a week until day 44. (B) Body weight of engrafted mice was not affected by <b>QD325</b> treatment at 5 mg/kg five times a week until day 44. Data points represent mean ± SEM. (C) Representative micrographs of hematoxylin and eosin (H&E)-stained organ sections. Images were taken with an Olympus IX83 inverted microscope at 20× magnification. Histopathology inspection showed no major microscopic changes in major organs after <b>QD325</b> treatment at 5 mg/kg five times a week until day 44. (D) Representative immunohistochemistry images for Ki67 staining of MIA PaCa-2 xenograft sections. <b>QD325</b> decreased Ki67 index (percentage of Ki67 positive cells in the field) of treated tumors. Data represents mean ± SD (<i>n</i> = 9, 3 tumors from each group, 3 images of each tumor section). <i>p</i> values were calculated using student’s <i>t</i> test. (E) NQO1, HO-1, CHOP, GRP78 protein levels in vehicle or <b>QD325</b>-treated MIA PaCa-2 xenografts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">No symptoms of gross toxicity such as weakness, weight loss, or lethargy were observed in any treatment group for the duration of the treatments (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). H&E-stained organ sections did not reveal any major histopathological changes, further confirming the <i>in vivo</i> tolerability of <b>QD325</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C). Following the 44-day treatment, two mice from each group were used to evaluate efficacy and safety of <b>QD325</b> at higher doses. While tumors in the control group exhibited rapid growth, <b>QD325</b> treatment was able to delay growth of the tumors without any overt systemic toxicity observed even at doses as high as 20 mg/kg (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A,B).</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>QD325</b> inhibits tumor growth of MIA PaCa-2 xenograft. (A) <b>QD325</b> treatment at 5 mg/kg inhibits growth of MIA PaCa-2 xenograft in NOD/SCID mice. MIA PaCa-2 engrafted mice were randomized into vehicle control (<i>n</i> = 5) or <b>QD325</b> treatment (<i>n</i> = 5) group when tumor size reached 65 mm<sup>3</sup>. <b>QD325</b> was given at 5 mg/kg five times a week until day 44. Three mice from each group were euthanized for tissue analysis. Two mice remained in each group after day 44 and <b>QD325</b> dose was increased from 5 mg/kg to 20 mg/kg until day 67. (B) Body weight of engrafted mice was not affected by <b>QD325</b> treatment from 5 to 20 mg/kg. Error bars indicate mean ± SEM. (C) Gemcitabine treatment at 15 mg/kg inhibits growth of MIA PaCa-2 xenograft in NOD/SCID mice. MIA PaCa-2 engrafted mice were randomized into vehicle control (<i>n</i> = 4), gemcitabine treatment 1 (<i>n</i> = 3), gemcitabine treatment 2 (<i>n</i> = 4) groups when tumor size reached 75 mm<sup>3</sup>. In treatment 1, gemcitabine was given at 15 mg/kg once a week for 48 days; in treatment 2, gemcitabine was given at 15 mg/kg twice a week for 15 days. Data points represent mean ± SEM. (D) Body weight of engrafted mice is not affected by gemcitabine treatment in either dosing frequency. (E) <b>QD325</b> treatment at 5 mg/kg inhibits growth of MIA PaCa-2 xenograft in NOD/SCID mice. MIA PaCa-2 engrafted mice were randomized into vehicle control (<i>n</i> = 4), gemcitabine treatment (<i>n</i> = 3), <b>QD325</b> treatment (<i>n</i> = 3) and combination treatment groups (<i>n</i> = 3) when tumor size reached 75 mm<sup>3</sup>. <b>QD325</b> was given at 5 mg/kg five times a week and gemcitabine was given at 15 mg/kg once a week. Data points represent mean ± SEM. (F) Body weight of engrafted mice was not affected by gemcitabine or <b>QD325</b> treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In line with the tumor growth inhibition, <b>QD325</b> treatment decreased the staining for the proliferation marker Ki67 in tumor tissues, suggesting inhibition of cell proliferation (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>D). To further evaluate the mechanisms of action of <b>QD325</b><i>in vivo</i>, we examined the protein levels of stress response markers in tumor lysates. NQO1, HO-1, CHOP, and GRP78 protein levels were significantly upregulated in <b>QD325</b>-treated tumors compared with tumors treated with vehicle, further confirming induction of oxidative stress and UPR as major mechanisms of action for <b>QD325</b> in these pancreatic cancer models (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>E).</div><div class="NLM_p last">Gemcitabine is currently used as the standard of care for treatment of pancreatic cancer patients. Unfortunately, inherent or acquired resistance to gemcitabine represents a major challenge for successful treatment of this disease. Here we sought to explore the potential efficacy of administering <b>QD325</b> in combination with gemcitabine. In mice studies, gemcitabine is usually given at high doses (40–160 mg/kg) twice weekly. Considering its low tolerance in NOD/SCID mice, we compared antitumor activity of two different gemcitabine treatment schedules in a MIA PaCa-2 xenograft model in this mouse strain: (1) 15 mg/kg once a week for 48 days; (2) 15 mg/kg twice a week for the first 15 days. Similar antitumor activity was achieved by either schedule (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). In both cases, gemcitabine was well tolerated and no weight loss was observed (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D). Therefore, schedule 1 was used for comparison of efficacy with <b>QD325</b> at 5 mg/kg and the combination of gemcitabine and <b>QD325</b>. <b>QD325</b> was given at 5 mg/kg five times a week and gemcitabine was given at 15 mg/kg once a week (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>E). At the end of the 48-day treatment period, average tumor size was 1503 ± 189 mm<sup>3</sup> for the control group, 387 ± 74 mm<sup>3</sup> (<i>p</i> = 0.0049) for the gemcitabine group, 248 ± 72 mm<sup>3</sup> (<i>p</i> = 0.0030) for the <b>QD325</b> group, and 163 ± 83 mm<sup>3</sup> (<i>p</i> = 0.0023) for the combination of gemcitabine and <b>QD325</b> group (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>E). Single agent treatment with <b>QD325</b> at 5 mg/kg showed similar antitumor activity as gemcitabine. In this experiment, both gemcitabine and <b>QD325</b> greatly inhibited tumor growth as single agents. Importantly, the combination was well tolerated. and no weight loss was observed in any of the treatment groups, suggesting a reasonable safety profile of the drug combination (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>F).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Altered redox homeostasis has been observed in various types of cancers including PDAC. ROS levels are increased as a result of elevated energy demands in cancer cells. To adapt to changes in the microenvironment, cancer cells hijack the intracellular antioxidant machinery to reach a new redox state that can facilitate their proliferation. Such dependency on an altered redox state provides novel therapeutic opportunities. Previously, we provided proof of concept that generation of additional ROS using the tool compound <b>QD232</b> can lead to the selective killing of cancer cells when they are challenged beyond their antioxidant capacity.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> In order to expand upon our previous observations and to select a compound for future clinical development, we performed a lead optimization campaign and identified <b>QD325</b>, which showed a stronger induction of ROS and more potent cytotoxicity in PDAC cells (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><div class="NLM_p">As revealed by nascent RNA Bru-seq analysis, the NRF2-mediated oxidative stress response is induced within 4 h of treatment with the QD compounds (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The cytoprotective NRF2 signaling pathway has been found to be cancer preventive under certain circumstances but oncogenic under other conditions.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a> Activating mutations in NRF2 and KEAP1 are often seen in cancers as an adaptation to elevated intrinsic ROS levels.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In PDAC, where such mutations are not very common, the redox state alteration can be supported through other pathways. The Kras<sup>G12D</sup> mutation found in >90% of PDAC cases, activates the Nrf2 signaling through the MAPK pathway, thus modifying the antioxidant program of PDAC cells to promote tumor progression.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This subtle balance is crucial for cancer cells as knockdown of NRF2 in PDAC cell lines results in decreased cell viability,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> showing dependency of cell proliferation on the antioxidant pathway.</div><div class="NLM_p">The NRF2 inhibitor, trig, can significantly sensitize PDAC cells to etoposide or TRAIL-induced apoptosis, and also enhances the antitumor response to etoposide in xenograft models.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> However, trig was not cytotoxic as a single agent, and the sensitization of cells was dependent on the proteasome degradation pathway. An alternative strategy to target the altered redox balance in cancer cells would be to trigger ROS accumulation. ROS inducing-agents such as <b>QD232</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> piperlongumine,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> and imexon<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> have shown single agent antitumor activities in pancreatic cancer models. Induction of ROS by the QD compounds alters this delicate balance and cells respond by upregulating the NRF2 pathway in an effort to counter the insult. However, excessive ROS overwhelms the system to the point of no return leading to cell death. A phase I trial of imexon and gemcitabine in patients with advanced pancreatic cancer demonstrated feasibility and antitumor responses<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> encouraging clinical testing of more potent compounds such as <b>QD325</b>. These results support the notion that manipulating redox homeostasis by inducing ROS could be an efficacious therapeutic strategy.</div><div class="NLM_p">Another significant pathway upregulated following 4 h of QD treatment is the unfolded protein response (UPR) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In the ER, where an oxidizing environment is required for formation of disulfide bonds, the luminal redox state is under stringent regulation. UPR is triggered when there is imbalance between protein-folding demands and protein folding capacity, as well as any homeostatic perturbation that can cause protein misfolding, such as nutrition deprivation or redox insults.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Furthermore, UPR serves as a sensitive cytoprotective response to integrated stresses including oxidative stress. The activation of the NRF2-mediated oxidative stress response and UPR both imply that <b>QD232</b> and <b>QD325</b> treatments induce oxidative stress. While the activation of NRF2 protects cells against ROS, activation of UPR is considered to be both an adaptive response and a major executor of cell death in response to oxidative stress. UPR regulates cell survival on the basis of the severity and the duration of the ER stress. The proapoptotic path of UPR is adopted through several mechanisms including induction of CHOP and its transcription targets to activate apoptosis.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Upregulation of CHOP is observed following treatment with the QD compounds (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), suggesting that ER-mediated apoptosis is a major mechanism of cytotoxicity of the QD compounds.</div><div class="NLM_p">For the mitochondrial genome, we observed substantial inhibition of transcription from the HSP2 and LSP promoters (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), with only modest change in the transcription from the HSP1 promoter (<a class="ref internalNav" href="#notes-1" aria-label="Figure S6">Figure S6</a>). This suggests selectivity in QD-mediated inhibition of transcription. The displacement loop (D-loop) is a noncoding control region in the mitochondrial genome where promoters for transcription of the H and L strands (HSP and LSP), as well as the origin of replication (O<sub>H</sub>) are located.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> There are two promoters for the H-strand, while transcripts from HSP1 terminates right after the two rRNAs, transcripts from HSP2 cover the full strand and are subjected to subsequent processing into individual mRNA, tRNA and rRNA molecules.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74, 75)</a> The selective transcriptional inhibition of two out of the three promoters implies that mechanisms other than universal oxidative damaging contribute to such suppressed transcription, and might serve as a pharmacologically induced model to further elucidate regulation of transcription from the mitochondrial genome. We hypothesize that blockage of transcription initiation of selective promoters in the D-loop is a unique feature of the mechanism of action of the QD compounds.</div><div class="NLM_p">In our <i>in vivo</i> xenograft model for pancreatic cancer, <b>QD325</b> showed substantial antitumor efficacy with a favorable safety profile. Our original lead compound <b>QD232</b> significantly delayed tumor growth at 20 mg/kg in a similar MIA PaCa-2 xenograft model as reported earlier,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> suppressing growth of tumor by 65% in the 31-day study. <b>QD325</b>, the most potent compound in this lead optimization campaign, showed improved potency by achieving comparable tumor inhibitory effect at a dose of only 5 mg/kg. <b>QD325</b> did not show any toxicity following repetitive treatments with doses as high as 20 mg/kg, suggesting that it is well tolerated and that it has a favorable therapeutic window. We repeated the experiments with two independent experiments under the same conditions (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A and <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>E), and observed similar results (76% vs 83% inhibition of tumor growth) for <b>QD325</b>-treated animals.</div><div class="NLM_p last">Gemcitabine is the standard of care treatment for pancreatic cancer patients. In our studies, <b>QD325</b> showed similar antitumor effect as gemcitabine, supporting the application of <b>QD325</b> as a novel therapeutic option with a distinct new mechanism, especially for patients with gemcitabine resistance. Due to its remarkable ROS-induction in tumor cells, we expect <b>QD325</b> to be less toxic than gemcitabine. In general, drug combinations demonstrate survival advantages over single-agent therapy as long as they have manageable safety profiles. Our studies show that combination with gemcitabine is tolerable without additional toxicity burden to mice. However, to perform clinically relevant synergy studies, both drugs need to be evaluated at optimal doses and in additional cell lines and mice models. These findings warrant the development of <b>QD325</b> as a novel treatment for PDAC as a single agent and in combination with standard of care drugs.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study, we successfully optimized the anticancer ROS modulator <b>QD232</b>, leading to the discovery of <b>QD325</b> that shows significant ROS dependent anticancer activity in PDAC models. Bru-seq analysis predicted cellular responses in the nucleus, ER, and mitochondrial for the ROS-mediated cytotoxicity in pancreatic cancer cells, providing in-depth understanding of the unique mechanisms of this active class of anticancer compounds. Significant antitumor efficacy and the favorable safety profile of <b>QD325</b> in vivo provides strong rationale for further developing these QD drugs to target mitochondria as a novel approach to treat PDAC.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Methods</h4><div class="NLM_p last">The reference compound <b>QD232</b> and the intermediate <b>6</b> were prepared as previously described by us (see refs <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a> and <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>, respectively). All solvents, including anhydrous solvents, and chemicals were purchased from Aldrich Co., Alfa Aesar, or Carlo Erba and were used without further purification. All reactions involving air- or moisture-sensitive compounds were performed under a nitrogen atmosphere using oven-dried glassware and syringes to transfer solutions. Analytical thin-layer chromatography (TLC) was carried out on Merck silica gel F-254 plates. Flash chromatography purifications were performed on Merck Silica gel 60 (230–400 mesh ASTM) as a stationary phase. Melting points (mp) were determined using an Electrothermal melting point or a Köfler apparatus and are uncorrected. Nuclear magnetic resonance (<sup>1</sup>H NMR, <sup>13</sup>C NMR) spectra were recorded in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> on 400 MHz Bruker Avance III. Chemical shifts (δ) are reported in parts per million (ppm) downfield from tetramethylsilane (TMS), used as an internal standard. Splitting patterns are designated as follow: s, singlet; d, doublet; t, triplet; q, quadruplet; m, multiplet; brs, broad singlet; dd, double doublet. The assignment of exchangeable protons (OH and NH) was confirmed by the addition of D<sub>2</sub>O. Mass spectra were obtained on a Hewlett-Packard 5989 mass engine spectrometer, or a MALDI micro MX (Waters, Micromass) equipped with a reflectron analyzer. Elemental analyses were performed on a PerkinElmer Elemental Analyzer 2400-CHN at Laboratory of Microanalysis, Department of Chemistry and Pharmacy, University of Sassari (Italy), and were within ±0.4% of the theoretical values (<a class="ref internalNav" href="#notes-1" aria-label="Table S8">Table S8</a>), thus confirming ≥95% purity.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Method A: Preparation of Compounds <b>QD324–327</b>, <b>329</b>, <b>331</b>, <b>332</b>, <b>334</b>–<b>336</b>, <b>338</b>, <b>353</b>–<b>357</b></h4><div class="NLM_p last">A solution of quinazoline-5,8-dione, cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 equiv) and (3,4,5)-substituted aniline (1.1 equiv) in absolute ethanol was stirred at room temperature for 1–2 h. Next, most of the ethanol was removed under vacuum, and water was added, followed by the extraction with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness. Then, the crude product was purified by flash chromatography to give the expected product.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Method B: Preparation of the Compounds <b>QD328</b>, <b>330</b>, <b>333</b>, <b>337</b></h4><div class="NLM_p">A solution of quinazoline-5,8-dione, cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 equiv) and (3,4,5)-substituted aniline (1.1 equiv) in absolute ethanol was stirred at room temperature for 2–6 h. Next, most of the ethanol was removed under vacuum, and water was added, followed by the extraction with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were dried over sodium sulfate (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to dryness. Then, the crude residue was treated with water, and the solid residue that precipitated was filtered and triturated with petroleum ether to give the desired product.</div><div id="sec5_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 3,6-Dimethoxy-2-nitrobenzaldehyde (<b>2</b>)</h5><div class="NLM_p last">Nitric acid (8.0 mL; 179.02 mmol), acetic anhydride (8.0 mL, 84.24 mmol), and 2,5-dimethoxybenzaldehyde (<b>1</b>, 4.0 g, 24.07 mmol) were added at 0 °C with stirring, respectively. After 1.5 h of stirring, the mixture was poured onto 20 mL ice/water. The resultant yellow solid was filtered, washed with cold water, and then purified by flash chromatography on silica gel using ethyl acetate-petroleum ether (1:1) to give first the regioisomer 2,5-dimethoxy-4-nitrobenzaldehyde, and then (by further elution with only ethyl acetate) the desired compound <b>2</b>. Yield: 68%. <i>R<sub>f</sub></i> = 0.10 (ethyl acetate-petroleum ether 5:5); mp: 167 °C. <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 10.25 (s, 1H), 7.70 (d, 1H), 7.48 (d, 1H), 3.95 (s, 3H), 3.86 (s, 3H). <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 10.39 (s, 1H), 7.30 (d, 1H), 7.12 (d, 1H), 3.97 (s, 3H), 3.89 (s, 3H). MS: <i>m</i>/<i>z</i> 211 [M]<sup>+</sup>.</div></div><div id="sec5_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> <i>N</i>,<i>N</i>′-[(3,6-Dimethoxy-2-nitrophenyl)methanediyl)diformamide (<b>3</b>)</h5><div class="NLM_p last">A solution of 3,6-dimethoxy-2-nitrobenzaldehyde (<b>2</b>, 11.90 g, 56.35 mmol) in formamide (66.5 eq., 150 mL), heated at 40 °C, was exposed to dry HCl gas (1 h) until the temperature reached 80 °C. Then, the solution was cooled to room temperature, and water/ice was added. Pale yellow colored precipitate was formed, which was filtered, dried and triturated with ethyl acetate and petroleum ether to yield the desired compound. Yield: 90%. <i>R<sub>f</sub></i> = 0.26 (dichloromethane-methanol 9.5:0.5); mp: 255 °C. <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 8.67 (d, 2H), 7.92 (s, 2H), 7.28 (s, 2H), 6.77 (t, 1H), 3.88 (s, 3H), 3.82 (s, 3H). MS: <i>m</i>/<i>z</i> 283 [M<sup>+</sup>].</div></div><div id="sec5_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 5,8-Dimethoxyquinazoline (<b>4</b>)</h5><div class="NLM_p last">Zinc powder (22.9 g) was added to a suspension of <i>N</i>,<i>N</i>′-[(3,6-dimethoxy-2-nitrophenyl)methanediyl)]diformamide (<b>3</b>, 7.0 g, 24.71 mmol) in triturated ice (92 g) and glacial acetic acid (32 mL), under constant magnetic stirring. The reaction mixture was stirred for 2 h in an ice bath and for 4 h at room temperature. After filtration of the reaction mixture through filter paper, the resulting solution was dropped on cooled 50% NaOH (120 mL), and the yellow colored suspension thus formed was left without stirring for 1 h. Next, the suspension was filtered and the solid dried (at 30–40 °C) to give a yellow powder. The solid was then solubilized in ethyl acetate, filtered, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness yielding the desired compound. Yield: 79%. <i>R<sub>f</sub></i> = 0.46 (dichloromethane-methanol 9.5:0.5); mp: 106 °C. <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 9.64 (s, 1H), 9.28 (s, 1H), 7.39 (d, 1H), 7.10 (d, 1H), 3.98 (s, 3H), 3.94 (s, 3H). MS: <i>m</i>/<i>z</i> 190 [M]<sup>+</sup></div></div><div id="sec5_1_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> (3-Aminopropyl)triphenylphosphonium bromide hydrobromide (<b>6</b>)</h5><div class="NLM_p last">To a 50 mL round-bottom flask equipped with a magnetic stirring bar, triphenylphosphine (1.0 eq., 1.0 g, 3.82 mmol), 3-bromopropylamine hydrobromide (<b>5</b>, 1.0 eq., 0.84 g, 3.82 mmol), and acetonitrile (7 mL), were added. The resulting suspension was heated to reflux, and the mixture was stirred for 16 h. The reaction was cooled to room temperature, then <i>n</i>-hexane was added, and the resulting solid was filtered, washed with <i>n</i>-hexane, dissolved in 100 mL isopropanol and precipitated with cold diethyl ether, to give a white powder. Yield: 50%; <i>R<sub>f</sub></i> = 0.28 (dichlorometane-methanol 9:1); mp: 200 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 7.95–7.92 (m, 3H), 7.84–7.74 (m, 15 H), 3.74 (m, 2H), 3.00–2.98 (m, 2H), 1.85 (m, 2H).</div></div><div id="sec5_1_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Quinazoline-5,8-dione (<b>QD323</b>)</h5><div class="NLM_p last">A solution of 5,8-dimethoxyquinazoline (<b>4</b>, 0.35 g, 1.84 mmol) in (7:3) acetonitrile:water (10 mL) was cooled at 0 °C in an ice bath, and a solution of ceric ammonium nitrate (2.7 eq., 2.72 g, 4.97 mmol) in (9:1) acetonitrile:water (10 mL) was added dropwise. The reaction mixture was stirred for 20 min, then poured into ice/water and extracted (8–10 times) with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed (5–6 times) with water, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to dryness to give a brown powder. Yield: 69%. <i>R<sub>f</sub></i> = 0.62 (dichloromethane-methanol 9.5:0.5); mp: > 320 °C. <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 9.69 (s, 1H), 9.43 (s, 1H), 7.28 (d, 1H), 7.18 (d, 1H). <sup>13</sup>C NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 184.07, 182.88, 162.08, 156.27, 152.61, 139.46, 137.74, 124.61. MS: <i>m</i>/<i>z</i> 160 [M]<sup>+</sup></div></div><div id="sec5_1_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 6-((4-Phenoxyphenyl)amino)quinazoline-5,8-dione (<b>QD324</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.10 g, 0.62 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.26 g, 0.69 mmol), 4-phenoxyaniline (1.1 eq., 0.13 g, 0.69 mmol), and absolute ethanol (11 mL). Flash chromatography (ethyl acetate-petroleum ether 6:4) gave compound <b>QD324</b> as a violet powder. Yield: 65%. <i>R<sub>f</sub></i> = 0.30 (ethyl acetate-petroleum ether 6:4); mp: 169–171 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.66 (s, 1H), 9.49 (s, 1H), 7.51 (s, 1H), 7.39 (t, 2H), 7.25 (d, 2H), 7.20–7.15 (m, 1H), 7.09–7.04 (m, 4H), 6.53 (s, 1H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.65, 180.39, 163.76, 156.48, 156.31, 154.40, 145.15, 130.90, 130.01, 125.25, 124.04, 123.34, 119.76, 119.28, 104.65. MS: <i>m</i>/<i>z</i> 343 [M]<sup>+</sup></div></div><div id="sec5_1_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 6-([1,1′-Biphenyl]-4-ylamino)quinazoline-5,8-dione (<b>QD325</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.16 g, 1.01 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.41 g, 1.11 mmol), 4-aminobiphenyl (1.1 eq., 0.19 g, 1.11 mmol), and absolute ethanol (19 mL). Flash chromatography (ethyl acetate-petroleum ether 7:3) gave compound <b>QD325</b> as a violet powder. Yield: 58%. <i>R<sub>f</sub></i>  = 0.48 (ethyl acetate-petroleum ether 8:2); mp: 230 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.68 (s, 1H), 9.51 (s, 1H), 7.68 (d, 2H), 7.65 (s, 1H), 7.60 (d, 2H), 7.48 (t, 2H), 7.42–7.36 (m, 3H), 6.73 (s, 1H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.67, 180.52, 163.78, 156.39, 154.32, 144.33, 139.71, 135.44, 128.99, 128.53, 127.53, 127.00, 123.26, 105.20. MS: <i>m</i>/<i>z</i> 327 [M]<sup>+</sup></div></div><div id="sec5_1_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 6-((3,4,5-Trimethoxyphenyl)amino)quinazoline-5,8-dione (<b>QD326</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.07 g, 0.44 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.18 g, 0.48 mmol), 3,4,5-trimethoxyaniline (1.1 eq., 0.09 g, 0.48 mmol), and absolute ethanol (8 mL). Flash chromatography (ethyl acetate-petroleum ether from 7:3 to 8:2) gave compound <b>QD326</b> as a violet powder. Yield: 88%. <i>R<sub>f</sub></i> = 0.18 (ethyl acetate-petroleum ether 8:2); mp: 161–162 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.67 (s, 1H), 9.49 (s, 1H), 7.51 (s, 1H), 6.59 (s, 1H), 6.50 (s, 2H), 3.88 (s, 9H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.61, 180.40, 163.77, 156.33, 154.15, 144.90, 136.96, 131.87, 123.30, 105.00, 101.20, 61.07, 56.39. MS: <i>m</i>/<i>z</i> 341 [M]<sup>+</sup></div></div><div id="sec5_1_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 6-((4-(Trifluoromethoxy)phenyl)amino)quinazoline-5,8-dione (<b>QD327</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.31 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.13 g, 0.34 mmol), 4-(trifluoromethoxy)aniline (1.1 eq., 0.046 mL, 0.34 mmol), and absolute ethanol (6 mL). Flash chromatography (dichloromethane-methanol 9.7:0.3) gave compound <b>QD327</b> as a dark red powder. Yield: 67%. <i>R<sub>f</sub></i> = 0.53 (dichloromethane-methanol 9.5:0.5); mp: 114 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.68 (s, 1H), 9.51 (s, 1H), 7.55 (s, 1H), 7.33 (s, 4H), 6.58 (s, 1H). MS: <i>m</i>/<i>z</i> 335 [M]<sup>+</sup></div></div><div id="sec5_1_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 4-((5,8-Dioxo-5,8-dihydroquinazolin-6-yl)amino)benzenesulfonamide (<b>QD328</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.31 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.13 g, 0.34 mmol), sulfanilamide (1.1 eq., 0.06 g, 0.34 mmol), and absolute ethanol (6 mL). The precipitate was filtered and triturated with petroleum ether gave compound <b>QD328</b> as a red powder. Yield: 59%. <i>R<sub>f</sub></i> = 0.16 (ethyl acetate-petroleum ether 8:2); mp: > 320 °C. <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 9.72 (s, 1H), 9.64 (s, 1H), 9.44 (s, 1H), 7.88 (d, 2H), 7.60 (d, 2H), 7.38 (s, 2H), 6.46 (s, 1H). <sup>13</sup>C NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 180.50, 180.32, 162.58, 155.78, 153.46, 145.33, 140.91, 140.20, 127.38, 127.05, 124.19, 123.17, 112.38, 105.11. MS: <i>m</i>/<i>z</i> 331 [M+1]<sup>+</sup></div></div><div id="sec5_1_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 6-((4-(Hydroxymethyl)phenyl)amino)quinazoline-5,8-dione (<b>QD329</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.31 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.13 g, 0.34 mmol), 4-aminobenzyl alcohol (1.1 eq., 0.04 g, 0.34 mmol), and absolute ethanol (6 mL). Flash chromatography (dichloromethane-methanol 9.7:0.3) gave compound QD329 as a brown-red powder. Yield: 27%. <i>R<sub>f</sub></i> = 0.30 (dichloromethane-methanol 9.5:0.5); mp: 203 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.67 (s, 1H), 9.50 (s, 1H), 7.59 (s, 1H), 7.47 (d, 2H), 7.29 (d, 2H), 6.64 (s, 1H), 4.75 (s, 2H). MS: <i>m</i>/<i>z</i> 303 [M + Na]<sup>+</sup></div></div><div id="sec5_1_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 4-((5,8-Dioxo-5,8-dihydroquinazolin-6-yl)amino)benzamide (<b>QD330</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.31 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.13 g, 0.34 mmol), 4-aminobenzamide (1.1 eq., 0.05 g, 0.34 mmol), and absolute ethanol (6 mL). The precipitate was filtered and triturated with petroleum ether gave compound <b>QD330</b> as a brown powder. Yield: 24%. <i>R<sub>f</sub></i> = 0.58 (dichloromethane-methanol 9.5:0.5); mp: > 320 °C. <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 9.65 (s, 1H), 9.63 (s, 1H), 9.43 (s, 1H), 7.95 (d, 2H), 7.49 (d, 2H), 7.38 (s, 2H), 6.42 (s, 1H). MS: <i>m</i>/<i>z</i> 295 [M+1]<sup>+</sup></div></div><div id="sec5_1_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> Methyl 4-((5,8-Dioxo-5,8-dihydroquinazolin-6-yl)amino)benzoate (<b>QD331</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.06 g, 0.37 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.15 g, 0.41 mmol), methyl 4-aminobenzoate (1.1 eq., 0.06 g, 0.41 mmol), and absolute ethanol (7.2 mL). Flash chromatography (ethyl acetate-petroleum ether from 6:4 to 7:3) gave compound <b>QD331</b> as a red powder. Yield: 42%. <i>R<sub>f</sub></i> = 0.35 (ethyl acetate-petroleum ether 7:3); mp: 226–230 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.69 (s, 1H), 9.52 (s, 1H), 8.14 (d, 2H), 7.72 (s, 1H), 7.36 (d, 2H), 6.81 (s, 1H), 3.95 (s, 3H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.75, 180.40, 165.96, 163.85, 156.57, 153.96, 143.34, 140.64, 131.51, 127.69, 123.27, 121.66, 121.55, 106.35, 52.35. MS: <i>m</i>/<i>z</i> 309 [M]<sup>+</sup></div></div><div id="sec5_1_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Ethyl 4-((5,8-Dioxo-5,8-dihydroquinazolin-6-yl)amino)benzoate (<b>QD332</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.13 g, 0.81 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.33 g, 0.89 mmol), ethyl 4-aminobenzoate (1.1 eq., 0.15 g, 0.89 mmol), and absolute ethanol (16 mL). Flash chromatography (ethyl acetate-petroleum ether 6.5:3.5) gave compound <b>QD332</b> as a red powder. Yield: 39%. <i>R<sub>f</sub></i> = 0.36 (ethyl acetate-petroleum ether 7:3); mp: 206–207 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.69 (s, 1H), 9.52 (s, 1H), 8.14 (d, 2H), 7.72 (s, 1H), 7.36 (d, 2H), 6.80 (s, 1H), 4.43–4.38 (q, 2H), 1.42 (t, 3H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.74, 180.42, 165.49, 163.85, 156.56, 153.98, 143.38, 140.53, 131.47, 128.08, 123.27, 121.65, 106.31, 61.31, 14.34. MS: <i>m</i>/<i>z</i> 323 [M]<sup>+</sup></div></div><div id="sec5_1_3_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (3-((5,8-Dioxo-5,8-dihydroquinazolin-6-yl)amino)phenyl)boronic acid (<b>QD333</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.31 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.13 g, 0.34 mmol), 3-aminophenylboronic acid (1.1 eq., 0.05 g, 0.34 mmol), and absolute ethanol (6 mL). The precipitate was filtered and triturated with petroleum ether gave compound <b>QD333</b> as a red powder. Yield: 48%. <i>R<sub>f</sub></i> = 0.37 (dichloromethane-methanol 9.5:0.5); mp: 208–210 °C. <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 9.61 (s, 1H), 9.52 (s, 1H), 9.41 (s, 1H), 8.20 (s, 2H), 7.77–7.70 (m, 2H), 7.43 (m, 2H), 6.23 (s, 1H). MS: <i>m</i>/<i>z</i> 318 [M + Na]<sup>+</sup></div></div><div id="sec5_1_3_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 6-((4′-Fluoro-[1,1′-biphenyl]-4-yl)amino)quinazoline-5,8-dione (<b>QD334</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.31 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.13 g, 0.34 mmol), 4-amino-4′-fluorobiphenyl (1.1 eq., 0.06 g, 0.34 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate-petroleum ether from 7:3 to 8:2) gave compound <b>QD334</b> as a violet powder. Yield: 29%. <i>R<sub>f</sub></i> = 0.32 (ethyl acetate-petroleum ether 7:3); mp: 285–289 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.68 (s, 1H), 9.51 (s, 1H), 7.63 (d, 2H), 7.55 (t, 2H), 7.53 (s, 1H), 7.37 (d, 2H), 7.16 (t, 2H), 6.72 (s, 1H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.64, 180.53, 163.97, 163.79, 161.51, 156.39, 154.30, 144.33, 138.70, 135.98, 135.47, 128.65, 128.39, 123.33, 116.03, 115.82, 105.21. MS: <i>m</i>/<i>z</i> 345 [M]<sup>+</sup></div></div><div id="sec5_1_3_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 6-((4′-Ethyl-[1,1′-biphenyl]-4-yl)amino)quinazoline-5,8-dione (<b>QD335</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.34 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.14 g, 0.37 mmol), 4-amino-4′-ethylbiphenyl (1.1 eq., 0.07 g, 0.37 mmol), and absolute ethanol (6.5 mL). Flash chromatography (ethyl acetate-petroleum ether from 6:4 to 7:3) gave compound <b>QD335</b> as a red-violet powder. Yield: 60%. <i>R<sub>f</sub></i> = 0.36 (ethyl acetate-petroleum ether 7:3); mp: 232 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.66 (s, 1H), 9.49 (s, 1H), 7.68 (s, 1H), 7.66 (d, 2H), 7.51 (d, 2H), 7.34 (d, 2H), 7.30 (d, 2H), 6.71 (s, 1H), 2.74–2.68 (q, 2H), 1.29 (t, 3H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.67, 180.48, 163.73, 156.35, 154.34, 144.35, 144.09, 139.64, 137.03, 135.15, 128.53, 128.46, 126.89, 123.35, 123.24, 105.11, 28.54, 15.55. MS: <i>m</i>/<i>z</i> 356 [M+1]<sup>+</sup></div></div><div id="sec5_1_3_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 6-((4′-Methoxy[1,1′-biphenyl]-4-yl)amino)quinazoline-5,8-dione (<b>QD336</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.34 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.14 g, 0.37 mmol), 4′-methoxy-biphenyl-4-ylamine (1.1 eq., 0.07 g, 0.37 mmol), and absolute ethanol (6.5 mL). Flash chromatography (ethyl acetate-petroleum ether from 7:3 to 10:0) gave compound <b>QD336</b> as a dark violet powder. Yield: 69%. <i>R<sub>f</sub></i> = 0.29 (ethyl acetate-petroleum ether 7:3); mp: 270–272 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.67 (s, 1H), 9.51 (s, 1H), 7.63 (d, 2H), 7.61 (s, 1H), 7.53 (d, 2H), 7.32 (d, 2H), 7.01 (d, 2H), 6.71 (s, 1H), 3.87 (s, 3H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.67, 180.47, 163.77, 159.58, 156.36, 154.37, 144.38, 139.38, 134.81, 132.20, 128.05, 128.01, 123.29, 123.19, 114.44, 105.09, 55.40. MS: <i>m</i>/<i>z</i> 357 [M]<sup>+</sup></div></div><div id="sec5_1_3_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 6-((4′-Amino-[1,1′-biphenyl]-4-yl)amino)quinazoline-5,8-dione (<b>QD337</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.34 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.14 g, 0.37 mmol), benzidine (1.1 eq., 0.07 g, 0.37 mmol), and absolute ethanol (6.5 mL). The precipitate was filtered and triturated with petroleum ether gave compound <b>QD337</b> as a dark violet powder. Yield: 16%. <i>R<sub>f</sub></i> = 0.71 (dichlorometane-methanol 9.5:0.5); mp: > 320 °C. <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 9.66 (s, 1H), 9.63 (s, 1H), 9.44 (s, 1H), 7.83 (d, 2H), 7.64 (d, 1H), 7.53 (d, 2H), 7.40 (d, 2H), 6.65 (d, 1H), 6.40 (s, 1H), 5.27 (s, 2H). MS: <i>m</i>/<i>z</i> 342 [M]<sup>+</sup></div></div><div id="sec5_1_3_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 6-((2-Fluoro-4′-methyl-[1,1′-biphenyl]-4-yl)amino)quinazoline-5,8-dione (<b>QD338</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.06 g, 0.35 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.14 g, 0.38 mmol), 2-fluoro-4′-methyl-biphenyl-4-ylamine (1.1 eq., 0.08 g, 0.38 mmol), and absolute ethanol (6.7 mL). Flash chromatography (ethyl acetate-petroleum ether, from 6:4 to 8:2) gave compound <b>QD338</b> as a violet powder. Yield: 60%. <i>R<sub>f</sub></i> = 0.26 (ethyl acetate-petroleum ether 7:3); mp: 282–283 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.69 (s, 1H), 9.52 (s, 1H), 7.62 (s, 1H), 7.52 (t, 1H), 7.45 (d, 2H), 7.29 (d, 2H), 7.14 (t, 2H), 6.75 (s, 1H), 2.42 (s, 3H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.61, 180.47, 163.83, 156.49, 143.93, 138.14, 131.79, 129.40, 128.89, 128.71, 123.31, 118.67, 110.85, 110.58, 105.75, 21.24. MS: <i>m</i>/<i>z</i> 359 [M]<sup>+</sup></div></div><div id="sec5_1_3_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (3-(4-Aminobenzamido)propyl)triphenylphosphonium bromide (<b>QD339</b>)</h5><div class="NLM_p last">To a solution of 4-aminobenzoic acid (1.0 eq., 0.076 g, 0.55 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL), <i>N,N</i>-diisopropylethylamine (DIPEA, 5 eq 0.48 mL, 2.75 mmol), and HBtU (1.0 eq., 0.206 g, 0.55 mmol) were added. The reaction mixture was stirred for 15 min, and (3-aminopropyl)triphenylphosphonium bromide (<b>6</b>, 3 eq 0.80 g, 1.66 mmol) and DMAP (0.04 eq., 2.7 μg, 0.02 mmol) were added. The resulting mixture was stirred at room temperature for 5 h, filtered, washed with CH<sub>2</sub>Cl<sub>2</sub>, and concentrated to dryness. The crude product was purified by flash chromatography on silica gel using dichloromethane-isopropanol (9.5:0.5) to give <b>QD339</b> as a beige powder. Yield: 70%; <i>R<sub>f</sub></i> = 0.27 (dichlorometane-methanol 9:1); mp: 203–205 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 8.91 (t, 1H), 8.10 (d, 2H), 7.77–7.72 (m, 9H), 7.61–7.58 (m, 6H), 6.70 (d, 2H), 3.94–3.90 (m, 2H), 3.72–3.71 (m, 2H), 1.95 (m, 2H). MS: <i>m</i>/<i>z</i> 439.</div></div><div id="sec5_1_3_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (3-(4-((5,8-Dioxo-5,8-dihydroquinazolin-6-yl)amino)benzamido)propyl) triphenylphosphonium bromide (<b>QD340</b>)</h5><div class="NLM_p last">A solution of quinazoline-5,8-dione (<b>5</b>, 1.0 eq., 0.04 g, 0.25 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.102 g, 0.27 mmol) and (3-(4-aminobenzamido)propyl)triphenylphosphonium bromide (<b>QD339</b>, 1.1 eq., 0.143 g, 0.27 mmol) in absolute ethanol (5 mL) was stirred at room temperature for 2 h. Then, most of the ethanol was removed under vacuum, and water was added, followed by the extraction with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were washed with water, brine, dried over anhydrous sodium sulfate, and concentrated to dryness. The crude product was triturated with petroleum ether to give <b>QD340</b> as a red powder. Yield: 42%; <i>R<sub>f</sub></i> = 0.45 (dichlorometane-methanol 9:1); mp: 205 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.90 (t, 1H), 9.67 (s, 1H), 9.50 (s, 1H), 8.46 (d, 2H), 7.79–7.72 (m, 10H), 7.65–7.62 (m, 6H), 7.37 (d, 2H), 6.74 (s, 1H), 3.97–3.93 (m, 2H), 3.75–3.74 (m, 2H), 2.00 (m, 2H). MS: <i>m</i>/<i>z</i> 597.</div></div><div id="sec5_1_3_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 6-((3-Methoxyphenyl)amino)quinazoline-5,8-dione (<b>QD353</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.05 g, 0.31 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.13 g, 0.34 mmol), <i>m</i>-anisidine (1.1 eq., 0.38 mL, 0.34 mmol), and absolute ethanol (6 mL). Flash chromatography (ethyl acetate-petroleum ether 6:4) gave compound <b>QD353</b> as a dark violet powder. Yield: 43%. <i>R<sub>f</sub></i> = 0.30 (ethyl acetate-petroleum ether 7:3); mp: 142 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.67 (s, 1H), 9.50 (s, 1H), 7.56 (s, 1H), 7.36 (t, 1H), 6.88 (d, 2H), 6.83 (d, 2H), 6.82 (s, 1H), 6.69 (s, 1H), 3.84 (s, 3H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.65, 180.56, 163.76, 160.81, 156.36, 154.28, 144.45, 137.40, 130.75, 123.33, 115.25, 112.07, 109.17, 105.34, 55,53. MS: <i>m</i>/<i>z</i> 281 [M]<sup>+</sup></div></div><div id="sec5_1_3_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 6-((4-Methoxyphenyl)amino)quinazoline-5,8-dione (<b>QD354</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.06 g, 0.37 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.15 g, 0.41 mmol), <i>p</i>-anisidine (1.1 eq., 0.05 g, 0.41 mmol), and absolute ethanol (7.2 mL). Flash chromatography (ethyl acetate-petroleum ether from 6.5:3.5 to 8:2) gave compound <b>QD354</b> as a dark powder. Yield: 41%. <i>R<sub>f</sub></i> = 0.32 (ethyl acetate-petroleum ether 7:3); mp: 238 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.66 (s, 1H), 9.48 (s, 1H), 7.49 (s, 1H), 7.21 (d, 2H), 6.98 (d, 2H), 6.48 (s, 1H), 3.85 (s, 3H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.76, 180.28, 163.73, 156.24, 154.52, 145.34, 128.75, 125.18, 123.36, 115.16, 104.34, 55,62. MS: <i>m</i>/<i>z</i> 281 [M]<sup>+</sup></div></div><div id="sec5_1_3_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 6-((3,4-Dimethoxyphenyl)amino)quinazoline-5,8-dione (<b>QD355</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.06 g, 0.40 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.16 g, 0.44 mmol), 3,4-dimethoxyaniline (1.1 eq., 0.067 g, 0.44 mmol), and absolute ethanol (7.6 mL). Flash chromatography (ethyl acetate-petroleum ether from 7:3 to 10:0) gave compound <b>QD355</b> as a dark powder. Yield: 70%. <i>R<sub>f</sub></i> = 0.23 (ethyl acetate-petroleum ether 8:2); mp: 241–242 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.66 (s, 1H), 9.49 (s, 1H), 7.50 (s, 1H), 6.92 (d, 2H), 6.86 (d, 2H), 6.78 (s, 1H), 6.53 (s, 1H), 3.92 (s, 3H), 3.90 (s, 3H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.73, 180.31, 163.75, 156.75, 156.26, 154.48, 149.97, 148.10, 145.21, 129.02, 123.34, 116.10, 111.74, 107.50, 104.54, 56,18. MS: <i>m</i>/<i>z</i> 334 [M + Na]<sup>+</sup></div></div><div id="sec5_1_3_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 6-((4-Fluorobenzyl)amino)quinazoline-5,8-dione (<b>QD356</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.06 g, 0.40 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.16 g, 0.44 mmol), 4-fluorobenzylamine (1.1 eq., 0.05 mL, 0.44 mmol), and absolute ethanol (7.6 mL). Flash chromatography (ethyl acetate-petroleum ether from 7:3 to 8:2) gave compound <b>QD356</b> as an orange powder. Yield: 35%. <i>R<sub>f</sub></i> = 0.30 (ethyl acetate-petroleum ether 8:2); mp: 203 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.64 (s, 1H), 9.43 (s, 1H), 7.30 (t, 2H), 7.09 (t, 2H), 6.28 (s, 1H), 6.05 (s, 1H), 4.40 (d, 2H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 180.33, 179.62, 163.93, 163.67, 161.47, 156.16, 154.57, 146.96, 130.68, 129.43, 123.35, 116.14, 103.76, 46.30. MS: <i>m</i>/<i>z</i> 283 [M]<sup>+</sup></div></div><div id="sec5_1_3_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 6-((3,5-Dimethoxyphenyl)amino)quinazoline-5,8-dione (<b>QD357</b>)</h5><div class="NLM_p last">The reaction mixture consisted of quinazoline-5,8-dione (<b>QD323</b>, 0.06 g, 0.40 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.16 g, 0.44 mmol), 3,5-dimethoxyaniline (1.0 eq., 0.07 g, 0.44 mmol), and absolute ethanol (7.6 mL). Flash chromatography (ethyl acetate-petroleum ether from 6:4 to 7:3) gave compound <b>QD357</b> as a violet powder. Yield: 70%. <i>R<sub>f</sub></i> = 0.45 (ethyl acetate-petroleum ether 8:2); mp: 204–206 °C. <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>): δ 9.66 (s, 1H), 9.43 (s, 1H), 7.05 (s, 1H), 5.97 (s, 2H), 5.72 (s, 2H), 3.62 (s, 6H). <sup>13</sup>C NMR 400 MHz (CDCl<sub>3</sub>): δ 183.14, 182.27, 162.43, 159.30, 157.54, 152.64, 150.43, 145.40, 138.54, 125.32, 100.99, 91.24, 55,74. MS: <i>m</i>/<i>z</i> 312 [M+1]<sup>+</sup><b>\</b></div></div><div id="sec5_1_3_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (3-(3-Aminobenzamido)propyl)triphenylphosphonium bromide (<b>QD358</b>)</h5><div class="NLM_p last">To a solution of 3-aminobenzoic acid (1.0 eq., 0.076 g, 0.55 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL), <i>N,N</i>-diisopropylethylamine (DIPEA, 5 eq 0.48 mL, 2.75 mmol), and HBtU (1.0 eq., 0.206 g, 0.55 mmol) were added. The reaction mixture was stirred for 15 min before (3-aminopropyl)triphenylphosphonium bromide (<b>6</b>, 3 eq., 0.80 g, 1.66 mmol) and DMAP (0.04 eq., 2.7 μg, 0.02 mmol) were added. The resulting mixture was stirred at room temperature for 5 h, filtered, washed with CH<sub>2</sub>Cl<sub>2</sub>, and concentrated to dryness. The crude product was purified by flash chromatography on silica gel using dichloromethane-isopropanol (9.5:0.5) to give an orange powder. Yield: 59%; <i>R<sub>f</sub></i> = 0.45 (dichlorometane-methanol 9:1); mp: 223 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 8.97 (t, 1H), 7.77–7.73 (m, 10H), 7.62–7.60 (m, 6H), 7.55 (d, 1H), 7.21 (t, 1H), 6.78 (d, 1H), 3.92–3.88 (m, 2H), 3.73–3.72 (m, 2H), 1.97 (m, 2H). MS: <i>m</i>/<i>z</i> 439.</div></div><div id="sec5_1_3_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (3-(3-((5,8-Dioxo-5,8-dihydroquinazolin-6-yl)amino)benzamido)propyl) triphenylphosphonium bromide (<b>QD359</b>)</h5><div class="NLM_p last">A solution of quinazoline-5,8-dione (1.0 eq., 0.04 g, 0.25 mmol), cerium(III) chloride heptahydrate (CeCl<sub>3</sub>·7 H<sub>2</sub>O, 1.1 eq., 0.102 g, 0.27 mmol) and (3-(3-aminobenzamido)propyl)triphenyl phosphonium bromide (<b>QD358</b>, 1.0 eq., 0.130 g, 0.25 mmol) in absolute ethanol (5 mL) was stirred at room temperature for 1.5 h. Then, most of the ethanol was removed under vacuum, and water was added, followed by the extraction with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were washed with water, dried over anhydrous sodium sulfate and concentrated to dryness. The crude product was purified by flash chromatography on silica gel using dichloromethane-methanol (9.4:0.4) to give a red powder. Yield: 30%; <i>R<sub>f</sub></i> = 0.21 (dichlorometane-methanol 9:1); mp: 108–110 °C. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>): δ 9.78 (t, 1H), 9.64 (s, 1H), 9.47 (s, 1H), 8.34 (d, 2H), 8.19 (d, 2H), 7.77–7.73 (m, 10H), 7.64–7.62 (m, 6H), 7.54 (t, 1H), 7.45 (d, 1H), 6.63 (s, 1H), 3.92–3.88 (m, 2H), 3.74–3.73 (m, 2H), 2.05–2.00 (m, 2H). MS: <i>m</i>/<i>z</i> 597.</div></div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Biology</h4><div id="sec5_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> Cell Culture</h5><div class="NLM_p last">MIA PaCa-2, Panc-1 and BxPC-3 pancreatic cancer cell lines were obtained from the ATCC. Normal pancreatic cells HPDE and HPNE were kindly provided by Dr. Diane Simeone (Translational Oncology Program, University of Michigan, Ann Arbor, MI). Gemcitabine resistant cell line MIA PaCa-2-GR (gemcitabine resistant) was kindly provided by Dr. Sarkar (Department of Pathology, Wayne State University, Detroit, MI) All cell lines were cultured as monolayer and maintained in RPMI1640 supplemented with 10% fetal bovine serum (FBS) in a humidified atmosphere with 5% CO<sub>2</sub> at 37 °C. MIA PaCa-2-GR culture was supplemented with 200 nM gemcitabine.</div></div><div id="sec5_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> MTT Assay</h5><div class="NLM_p last">Cytotoxicity of compounds was evaluated with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells were placed in 96-well plate at 3000–8000 cells/well. After the cells were allowed to attach overnight, compounds were added to the wells at sequential dilutions (30 nM–10 μM for most cell lines). After 72 h of treatment, MTT was added into the media to a final concentration of 300 μg/mL. Cells were incubated for 3 h at 37 °C, and the insoluble formazan converted by viable cells were dissolved in 150 μL of DMSO. Absorbance at 570 nm was read by microplate reader (Molecular devices, Sunnyvale, CA), and inhibition of cell proliferation was calculated using the following formula: Inhibition of cell proliferation (%) = (1 – OD<sub>treatment</sub> /OD<sub>control</sub>) × 100%</div></div><div id="sec5_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> ROS Detection Assay</h5><div class="NLM_p last">Cells were detached by 0.05% trypsin-EDTA, neutralized, centrifuged (1200 rpm, 5 min) and resuspended in cell culture media. Suspension were then treated with 20 μM cell permeable H2DCFDA for 30 min at 37 °C. Cells were then centrifuged (1200 rpm, 5 min) and washed with cell culture media to remove excess probe. After the cells were washed, they were placed in black-wall 384-well plate at 20 000 cells/well, incubated for 30 min, and treated by compounds at designated conditions. Fluorescent signal were then read at 493 nm/523 nm on BioTek H1 plate reader for ROS detection.</div></div><div id="sec5_1_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Bru-seq Analysis for Nascent RNA Synthesis</h5><div class="NLM_p last">Bru-seq analysis was performed as previously reported.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Briefly, 4 × 10<sup>6</sup> MIA PaCa-2 cells were placed in 10 cm dishes on Day 1. On Day 2, cells were treated with DMSO, <b>QD232</b> or <b>QD325</b> for 4 h. Bromouridine was added into the media to label newly synthesized nascent RNA during the last 30 min of treatment to a final concentration of 2 mM. Cells were then collected in TRIZOL, and total RNA was isolated. Bromouridine-containing RNA was immunocaptured from total RNA, converted into cDNA libraries and deep sequenced at the University of Michigan Sequencing Core. Sequencing reads were mapped to the HG19 reference genome. Preranked gene lists were generated for each treatment through ranking genes by fold changes in RNA synthesis levels compared with control, and analyzed with GSEA (Broad Institute, MA)<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76, 77)</a></div></div><div id="sec5_1_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Western Blotting</h5><div class="NLM_p last">Cells (4 × 10<sup>5</sup>) were cultured in 60 mm tissue dishes and treated with QD compounds at designated concentrations. After treatment, cells were lysed with cell lysis buffer at 4 °C for 30 min and centrifuged (12000 rpm, 10 min, 4 °C). Protein concentrations of supernatants were measured with BCA assay (Thermo Fisher Scientific). Next, 40 μg protein per sample was subjected to SDS-PAGE analysis. Proteins were then electrotransferred to methanol activated immobilon-FL PVDF membranes (EMD Millipore, Billerica, MA). Membranes were blocked with 5% skim milk in TBST buffer and incubated with primary antibodies (anti-NQO1, anti-HO-1, anti-CHOP, and anti-GAPDH from Cell Signaling, anti-COXIII, anti-ACTIN and anti-GRP78 from Santa Cruz Biotechnology) 1:1000 dilutions overnight at 4 °C. Membranes were then washed with TBST (10 min × 3), incubated with Dylight 800-conjugated secondary antibodies (Thermo Fisher Scientific, Rockford, IL) 1:5000 dilutions in 5% milk for 1 h at room temperature, and washed with TBST (10 min × 2) and TBS (10 min). The fluorescent signal was then scanned by Odyssey Imaging Systems (LI-COR Biosciences, Lincoln, NE).</div></div><div id="sec5_1_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Xenograft Studies</h5><div class="NLM_p last">MIA PaCa-2 cells (2.0 × 10<sup>6</sup>) in a 100 μL suspension of RPMI1640 was injected subcutaneously into dorsal flank of 6-week NOD/SCID mice. Tumor size was monitored twice a week through caliper measurement using the following equation: <i>V</i> = <i>d</i><sup>2</sup> × <i>D</i>/2, where <i>d</i> represents width and <i>D</i> represents length of the tumor. In study 1, mice were randomly grouped (<i>n</i> = 5 per group) when average tumor size reached 65 mm<sup>3</sup>. Daily treatment was given at 5 days on 2 days off cycles. <b>QD325</b> was given at 5 mg/kg in 100 μL vehicle (5% DMSO, 60% Propylene glycol, 35% Saline) by intraperitoneal injection. Study was concluded on Day 44 when average tumor size in the group reached 1200 mm<sup>3</sup>. An unpaired <i>t</i> test was performed for data analysis, and <i>p</i> < 0.05 was considered significant. For a tolerance test, two mice remained on each group beyond day 44, and <b>QD325</b> dose was gradually increased to 20 mg/kg until day 67. Procedures for study 2 with gemcitabine treatment are detailed in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_1_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> Histochemical Analysis</h5><div class="NLM_p last">At the time of necropsy, tumors, hearts, kidneys, livers, lungs, spleens and pancreases were collected, fixed in 10% neutral buffered formalin, embedded in paraffin, and sectioned. Sections (5 μM) were stained with hematoxylin and eosin to facilitate histologic examination. For Ki67 expression level, immunohistochemistry staining was performed on sections with Ki67 antibody. Embedding, sectioning and staining of samples were performed by ULAM pathology core for animal research at the University of Michigan. Representative images were taken on Olympus IX83 microscope with 20× magnification.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01463">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01463" class="ext-link">10.1021/acs.jmedchem.7b01463</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Correlation of cytotoxicity of QD compounds and ROS induction (Figure S2); list of top 30 canonical pathways affected by QD compound treatments (Figures S3 and S4); list of top 50 gene sets up regulated by QD compound treatments (Figure S5); list of top 50 gene sets down regulated by QD compound treatments (Figure S6); panels showing <b>QD232</b> or <b>QD325</b> treatment that selectively inhibits synthesis of mtDNA transcripts (Figure S7); and elemental analyses for tested compounds (Table S8) <a href="/doi/suppl/10.1021/acs.jmedchem.7b01463/suppl_file/jm7b01463_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Additional compound data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01463/suppl_file/jm7b01463_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01463/suppl_file/jm7b01463_si_001.pdf">jm7b01463_si_001.pdf (4.42 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01463/suppl_file/jm7b01463_si_002.csv">jm7b01463_si_002.csv (1.92 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01463" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mario Sechi</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, University of
Sassari, Via Vienna 2, 07100 Sassari, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2983-6090" title="Orcid link">http://orcid.org/0000-0003-2983-6090</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#375a56455e58194452545f5e7742595e4444195e43"><span class="__cf_email__" data-cfemail="533e32213a3c7d2036303b3a13263d3a20207d3a27">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nouri Neamati</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, College
of Pharmacy, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3291-7131" title="Orcid link">http://orcid.org/0000-0003-3291-7131</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c3ada6a2aea2b7aa83b6aeaaa0abeda6a7b6"><span class="__cf_email__" data-cfemail="274942464a46534e67524a4e444f09424352">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuting Kuang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, College
of Pharmacy, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, California 90033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salvatore Nurra</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Pharmacy, University of
Sassari, Via Vienna 2, 07100 Sassari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mats Ljungman</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiation Oncology, University of Michigan, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Certain aspects of the reported compounds are included in patent applications.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4143-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by NIH grant R01 CA188252 and a grant from the University of Michigan Forbes Institute for Cancer Discovery. M.S. gratefully acknowledges the Regione Autonoma della Sardegna (within the frame of Legge regionale n. 7/2007), and the Fondazione Banco di Sardegna for its partial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i64" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i64"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i65" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i65"> Abbreviations Used</h2><tr><td class="NLM_term">Bru-seq</td><td class="NLM_def"><p class="first last">bromouridine labeled RNA sequencing</p></td></tr><tr><td class="NLM_term">D-loop</td><td class="NLM_def"><p class="first last">displacement loop</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">GSEA</td><td class="NLM_def"><p class="first last">Gene Set Enrichment Analysis</p></td></tr><tr><td class="NLM_term">HSP</td><td class="NLM_def"><p class="first last">heavy strand promoter</p></td></tr><tr><td class="NLM_term">LSP</td><td class="NLM_def"><p class="first last">light strand promoter</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">HPDE</td><td class="NLM_def"><p class="first last">human pancreatic ductal epithelial</p></td></tr><tr><td class="NLM_term">H2DCFDA</td><td class="NLM_def"><p class="first last">2′,7′-Dichlorodihydrofluorescein diacetate</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">(2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">ingenuity pathway analysis</p></td></tr><tr><td class="NLM_term">IC50</td><td class="NLM_def"><p class="first last">half-maximum inhibitory concentration</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">mtDNA</td><td class="NLM_def"><p class="first last">mitochondrial DNA</p></td></tr><tr><td class="NLM_term">NAC</td><td class="NLM_def"><p class="first last"><i>N</i>-acetyl-cysteine</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">PDAC</td><td class="NLM_def"><p class="first last">pancreatic ductal adenocarcinoma</p></td></tr><tr><td class="NLM_term">QDs</td><td class="NLM_def"><p class="first last">quinazolinediones</p></td></tr><tr><td class="NLM_term">UPR</td><td class="NLM_def"><p class="first last">unfolded protein response</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 77 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Siegel, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer statistics, 2017</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.3322/caac.21387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.3322%2Fcaac.21387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28055103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC1c7isFWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2017&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2017&doi=10.3322%2Fcaac.21387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Statistics, 2017</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2017, 1,688,780 new cancer cases and 600,920 cancer deaths are projected to occur in the United States.  For all sites combined, the cancer incidence rate is 20% higher in men than in women, while the cancer death rate is 40% higher.  However, sex disparities vary by cancer type.  For example, thyroid cancer incidence rates are 3-fold higher in women than in men (21 vs 7 per 100,000 population), despite equivalent death rates (0.5 per 100,000 population), largely reflecting sex differences in the "epidemic of diagnosis." Over the past decade of available data, the overall cancer incidence rate (2004-2013) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2005-2014) declined by about 1.5% annually in both men and women.  From 1991 to 2014, the overall cancer death rate dropped 25%, translating to approximately 2,143,200 fewer cancer deaths than would have been expected if death rates had remained at their peak.  Although the cancer death rate was 15% higher in blacks than in whites in 2014, increasing access to care as a result of the Patient Protection and Affordable Care Act may expedite the narrowing racial gap; from 2010 to 2015, the proportion of blacks who were uninsured halved, from 21% to 11%, as it did for Hispanics (31% to 16%).  Gains in coverage for traditionally underserved Americans will facilitate the broader application of existing cancer control knowledge across every segment of the population.  CA Cancer J Clin 2017;67:7-30. © 2017 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB4oj7vNRTIb5oR8RchjrrfW6udTcc2ea5f-c2w8WGobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7isFWgtA%253D%253D&md5=e439f3424d5a773e4ae289c392236ad6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21387%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202017%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2017%26volume%3D67%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Sohal, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangu, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khorana, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uronis, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engebretson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggiero, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copur, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laheru, D.</span><span> </span><span class="NLM_article-title">Metastatic pancreatic cancer: American Society of Clinical Oncology clinical practice guideline</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2784</span><span class="NLM_x">–</span> <span class="NLM_lpage">2796</span><span class="refDoi"> DOI: 10.1200/JCO.2016.67.1412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1200%2FJCO.2016.67.1412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27247222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fltl2qtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=2784-2796&author=D.+P.+Sohalauthor=P.+B.+Manguauthor=A.+A.+Khoranaauthor=M.+A.+Shahauthor=P.+A.+Philipauthor=E.+M.+O%E2%80%99Reillyauthor=H.+E.+Uronisauthor=R.+K.+Ramanathanauthor=C.+H.+Craneauthor=A.+Engebretsonauthor=J.+T.+Ruggieroauthor=M.+S.+Copurauthor=M.+Lauauthor=S.+Urbaauthor=D.+Laheru&title=Metastatic+pancreatic+cancer%3A+American+Society+of+Clinical+Oncology+clinical+practice+guideline&doi=10.1200%2FJCO.2016.67.1412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline</span></div><div class="casAuthors">Sohal Davendra P S; Mangu Pamela B; Khorana Alok A; Shah Manish A; Philip Philip A; O'Reilly Eileen M; Uronis Hope E; Ramanathan Ramesh K; Crane Christopher H; Engebretson Anitra; Ruggiero Joseph T; Copur Mehmet S; Lau Michelle; Urba Susan; Laheru Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2784-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To provide evidence-based recommendations to oncologists and others for the treatment of patients with metastatic pancreatic cancer.  METHODS:  American Society of Clinical Oncology convened an Expert Panel of medical oncology, radiation oncology, surgical oncology, gastroenterology, palliative care, and advocacy experts to conduct a systematic review of the literature from April 2004 to June 2015.  Outcomes were overall survival, disease-free survival, progression-free survival, and adverse events.  RESULTS:  Twenty-four randomized controlled trials met the systematic review criteria.  RECOMMENDATIONS:  A multiphase computed tomography scan of the chest, abdomen, and pelvis should be performed.  Baseline performance status and comorbidity profile should be evaluated.  Goals of care, patient preferences, treatment response, psychological status, support systems, and symptom burden should guide decisions for treatments.  A palliative care referral should occur at first visit.  FOLFIRINOX (leucovorin, fluorouracil, irinotecan, and oxaliplatin; favorable comorbidity profile) or gemcitabine plus nanoparticle albumin-bound (NAB) -paclitaxel (adequate comorbidity profile) should be offered to patients with Eastern Cooperative Oncology Group performance status (ECOG PS) 0 to 1 based on patient preference and support system available.  Gemcitabine alone is recommended for patients with ECOG PS 2 or with a comorbidity profile that precludes other regimens; the addition of capecitabine or erlotinib may be offered.  Patients with an ECOG PS ≥ 3 and poorly controlled comorbid conditions should be offered cancer-directed therapy only on a case-by-case basis; supportive care should be emphasized.  For second-line therapy, gemcitabine plus NAB-paclitaxel should be offered to patients with first-line treatment with FOLFIRINOX, an ECOG PS 0 to 1, and a favorable comorbidity profile; fluorouracil plus oxaliplatin, irinotecan, or nanoliposomal irinotecan should be offered to patients with first-line treatment with gemcitabine plus NAB-paclitaxel, ECOG PS 0 to 1, and favorable comorbidity profile, and gemcitabine or fluorouracil should be offered to patients with either an ECOG PS 2 or a comorbidity profile that precludes other regimens.  Additional information is available at www.asco.org/guidelines/MetPC and www.asco.org/guidelineswiki.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJv2riehYPOZQHPYJuLg8TfW6udTcc2ea5f-c2w8WGobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fltl2qtg%253D%253D&md5=ac8fe5f540eff233a3010d69d93960bd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2016.67.1412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2016.67.1412%26sid%3Dliteratum%253Aachs%26aulast%3DSohal%26aufirst%3DD.%2BP.%26aulast%3DMangu%26aufirst%3DP.%2BB.%26aulast%3DKhorana%26aufirst%3DA.%2BA.%26aulast%3DShah%26aufirst%3DM.%2BA.%26aulast%3DPhilip%26aufirst%3DP.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DE.%2BM.%26aulast%3DUronis%26aufirst%3DH.%2BE.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DCrane%26aufirst%3DC.%2BH.%26aulast%3DEngebretson%26aufirst%3DA.%26aulast%3DRuggiero%26aufirst%3DJ.%2BT.%26aulast%3DCopur%26aufirst%3DM.%2BS.%26aulast%3DLau%26aufirst%3DM.%26aulast%3DUrba%26aufirst%3DS.%26aulast%3DLaheru%26aufirst%3DD.%26atitle%3DMetastatic%2520pancreatic%2520cancer%253A%2520American%2520Society%2520of%2520Clinical%2520Oncology%2520clinical%2520practice%2520guideline%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D34%26spage%3D2784%26epage%3D2796%26doi%3D10.1200%2FJCO.2016.67.1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ryan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardeesy, N.</span><span> </span><span class="NLM_article-title">Pancreatic adenocarcinoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1049</span><span class="refDoi"> DOI: 10.1056/NEJMra1404198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1056%2FNEJMra1404198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25207767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Olt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=1039-1049&author=D.+P.+Ryanauthor=T.+S.+Hongauthor=N.+Bardeesy&title=Pancreatic+adenocarcinoma&doi=10.1056%2FNEJMra1404198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic adenocarcinoma</span></div><div class="casAuthors">Ryan, David P.; Hong, Theodore S.; Bardeesy, Nabeel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1049, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ1-TPh2I8RbVg90H21EOLACvtfcHk0liRKG5xvd2jVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Olt7rK&md5=c916814b3ce1e14f3a93b9a0b05cd286</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1404198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1404198%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DD.%2BP.%26aulast%3DHong%26aufirst%3DT.%2BS.%26aulast%3DBardeesy%26aufirst%3DN.%26atitle%3DPancreatic%2520adenocarcinoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D1039%26epage%3D1049%26doi%3D10.1056%2FNEJMra1404198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ervin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arena, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiorean, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjulandin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleh, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowden, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laheru, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahary, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cutsem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iglesias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renschler, M. F.</span><span> </span><span class="NLM_article-title">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">–</span> <span class="NLM_lpage">1703</span><span class="refDoi"> DOI: 10.1056/NEJMoa1304369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1056%2FNEJMoa1304369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=24131140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=1691-1703&author=D.+D.+Von+Hoffauthor=T.+Ervinauthor=F.+P.+Arenaauthor=E.+G.+Chioreanauthor=J.+Infanteauthor=M.+Mooreauthor=T.+Seayauthor=S.+A.+Tjulandinauthor=W.+W.+Maauthor=M.+N.+Salehauthor=M.+Harrisauthor=M.+Reniauthor=S.+Dowdenauthor=D.+Laheruauthor=N.+Baharyauthor=R.+K.+Ramanathanauthor=J.+Taberneroauthor=M.+Hidalgoauthor=D.+Goldsteinauthor=E.+Van+Cutsemauthor=X.+Weiauthor=J.+Iglesiasauthor=M.+F.+Renschler&title=Increased+survival+in+pancreatic+cancer+with+nab-paclitaxel+plus+gemcitabine&doi=10.1056%2FNEJMoa1304369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span></div><div class="casAuthors">Von Hoff, Daniel D.; Ervin, Thomas; Arena, Francis P.; Chiorean, E. Gabriela; Infante, Jeffrey; Moore, Malcolm; Seay, Thomas; Tjulandin, Sergei A.; Ma, Wen Wee; Saleh, Mansoor N.; Harris, Marion; Reni, Michele; Dowden, Scot; Laheru, Daniel; Bahary, Nathan; Ramanathan, Ramesh K.; Tabernero, Josep; Hidalgo, Manuel; Goldstein, David; Van Cutsem, Eric; Wei, Xinyu; Iglesias, Jose; Renschler, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: In a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clin. activity was noted in patients with advanced pancreatic cancer.  We conducted a phase 3 study of the efficacy and safety of the combination vs. gemcitabine monotherapy in patients with metastatic pancreatic cancer.  METHODS: We randomly assigned patients with a Karnofsky performance-status score of 70 or more (on a scale from 0 to 100, with higher scores indicating better performance status) to nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 wk or gemcitabine monotherapy (1000 mg per square meter) weekly for 7 of 8 wk (cycle 1) and then on days 1, 8, and 15 every 4 wk (cycle 2 and subsequent cycles).  Patients received the study treatment until disease progression.  The primary end point was overall survival; secondary end points were progression-free survival and overall response rate.  RESULTS: A total of 861 patients were randomly assigned to nab-paclitaxel plus gemcitabine (431 patients) or gemcitabine (430).  The median overall survival was 8.5 mo in the nab-paclitaxel-gemcitabine group as compared with 6.7 mo in the gemcitabine group (hazard ratio for death, 0.72; 95% confidence interval [CI], 0.62 to 0.83; P<0.001).  The survival rate was 35% in the nab-paclitaxel-gemcitabine group vs. 22% in the gemcitabine group at 1 yr, and 9% vs. 4% at 2 years.  The median progression-free survival was 5.5 mo in the nab-paclitaxel-gemcitabine group, as compared with 3.7 mo in the gemcitabine group (hazard ratio for disease progression or death, 0.69; 95% CI, 0.58 to 0.82; P<0.001); the response rate according to independent review was 23% vs. 7% in the two groups (P<0.001).  The most common adverse events of grade 3 or higher were neutropenia (38% in the nab-paclitaxel-gemcitabine group vs. 27% in the gemcitabine group), fatigue (17% vs. 7%), and neuropathy (17% vs. 1%).  Febrile neutropenia occurred in 3% vs. 1% of the patients in the two groups.  In the nab-paclitaxel-gemcitabine group, neuropathy of grade 3 or higher improved to grade 1 or lower in a median of 29 days.  CONCLUSIONS: In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCXpODbQZ6dLVg90H21EOLACvtfcHk0liRKG5xvd2jVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I&md5=b1169c7e9879c08061dd9e9389dc36fe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1304369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1304369%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DArena%26aufirst%3DF.%2BP.%26aulast%3DChiorean%26aufirst%3DE.%2BG.%26aulast%3DInfante%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DSeay%26aufirst%3DT.%26aulast%3DTjulandin%26aufirst%3DS.%2BA.%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DSaleh%26aufirst%3DM.%2BN.%26aulast%3DHarris%26aufirst%3DM.%26aulast%3DReni%26aufirst%3DM.%26aulast%3DDowden%26aufirst%3DS.%26aulast%3DLaheru%26aufirst%3DD.%26aulast%3DBahary%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DIglesias%26aufirst%3DJ.%26aulast%3DRenschler%26aufirst%3DM.%2BF.%26atitle%3DIncreased%2520survival%2520in%2520pancreatic%2520cancer%2520with%2520nab-paclitaxel%2520plus%2520gemcitabine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1304369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Conroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desseigne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ychou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouche, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimbaud, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becouarn, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adenis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raoul, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourgou-Bourgade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Fouchardiere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennouna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachet, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khemissa-Akouz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pere-Verge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbaldo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assenat, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauffert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoto-Grillot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducreux, M.</span><span> </span><span class="NLM_article-title">Groupe Tumeurs Digestives of, U.; Intergroup, P. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1825</span><span class="refDoi"> DOI: 10.1056/NEJMoa1011923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1056%2FNEJMoa1011923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=21561347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1817-1825&author=T.+Conroyauthor=F.+Desseigneauthor=M.+Ychouauthor=O.+Boucheauthor=R.+Guimbaudauthor=Y.+Becouarnauthor=A.+Adenisauthor=J.+L.+Raoulauthor=S.+Gourgou-Bourgadeauthor=C.+de+la+Fouchardiereauthor=J.+Bennounaauthor=J.+B.+Bachetauthor=F.+Khemissa-Akouzauthor=D.+Pere-Vergeauthor=C.+Delbaldoauthor=E.+Assenatauthor=B.+Chauffertauthor=P.+Michelauthor=C.+Montoto-Grillotauthor=M.+Ducreux&title=Groupe+Tumeurs+Digestives+of%2C+U.%3B+Intergroup%2C+P.+FOLFIRINOX+versus+gemcitabine+for+metastatic+pancreatic+cancer&doi=10.1056%2FNEJMoa1011923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FOLFIRINOX versus gemcitabine or metastatic pancreatic cancer</span></div><div class="casAuthors">Conroy, Thierry; Desseigne, Francoise; Ychou, Marc; Bouche, Olivier; Guimbaud, Rosine; Becouarn, Yves; Adenis, Antoine; Raoul, Jean-Luc; Gourgou-Bourgade, Sophie; de la Fouchardiere, Christelle; Bennouna, Jaafar; Bachet, Jean-Baptiste; Khemissa-Akouz, Faiza; Pere-Verge, Denis; Delbaldo, Catherine; Assenat, Eric; Chauffert, Bruno; Michel, Pierre; Montoto-Grillot, Christine; Ducreux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1817-1825</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.  METHODS We randomly assigned 342 patients with an Eastern Cooperative Oncol. Group performance status score of 0 or 1 (on a scale of 0 to 5, with higher scores indicating a greater severity of illness) to receive FOLFIRINOX (oxaliplatin, 85 mg per square meter of body-surface area; irinotecan, 180 mg per square meter; leucovorin, 400 mg per square meter; and fluorouracil, 400 mg per square meter given as a bolus followed by 2400 mg per square meter given as a 46-h continuous infusion, every 2 wk) or gemcitabine at a dose of 1000 mg per square meter weekly for 7 of 8 wk and then weekly for 3 of 4 wk.  Six months of chemotherapy were recommended in both groups in patients who had a response.  The primary end point was overall survival.  RESULTS The median overall survival was 11.1 mo in the FOLFIRINOX group as compared with 6.8 mo in the gemcitabine group (hazard ratio for death, 0.57; 95% confidence interval [CI], 0.45 to 0.73; P < 0.001).  Median progression-free survival was 6.4 mo in the FOLFIRINOX group and 3.3 mo in the gemcitabine group (hazard ratio for disease progression, 0.47; 95% CI, 0.37 to 0.59; P < 0.001).  The objective response rate was 31.60% in the FOLFIRINOX group vs. 9.4% in the gemcitabine group (P < 0.001).  More adverse events were noted in the FOLFIRINOX group; 5.4% of patients in this group had febrile neutropenia.  At 6 mo, 31% of the patients in the FOLFIRINOX group had a definitive degrdn. of the quality of life vs. 66% in the gemcitabine group (hazard ratio, 0.47; 95% CI, 0.30 to 0.70; P < 0.001).  CONCLUSIONS As compared with gemcitabine, FOLFIRINOX was assocd. with a survival advantage and had increased toxicity.  FOLFIRINOX is an option for the treatment of patients with metastatic pancreatic cancer and good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyDR85GUgOrVg90H21EOLACvtfcHk0liXTg-C9N_D1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D&md5=a1a7135a6c97c4dc47233465ce0defd5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1011923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1011923%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DDesseigne%26aufirst%3DF.%26aulast%3DYchou%26aufirst%3DM.%26aulast%3DBouche%26aufirst%3DO.%26aulast%3DGuimbaud%26aufirst%3DR.%26aulast%3DBecouarn%26aufirst%3DY.%26aulast%3DAdenis%26aufirst%3DA.%26aulast%3DRaoul%26aufirst%3DJ.%2BL.%26aulast%3DGourgou-Bourgade%26aufirst%3DS.%26aulast%3Dde%2Bla%2BFouchardiere%26aufirst%3DC.%26aulast%3DBennouna%26aufirst%3DJ.%26aulast%3DBachet%26aufirst%3DJ.%2BB.%26aulast%3DKhemissa-Akouz%26aufirst%3DF.%26aulast%3DPere-Verge%26aufirst%3DD.%26aulast%3DDelbaldo%26aufirst%3DC.%26aulast%3DAssenat%26aufirst%3DE.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DP.%26aulast%3DMontoto-Grillot%26aufirst%3DC.%26aulast%3DDucreux%26aufirst%3DM.%26atitle%3DGroupe%2520Tumeurs%2520Digestives%2520of%252C%2520U.%253B%2520Intergroup%252C%2520P.%2520FOLFIRINOX%2520versus%2520gemcitabine%2520for%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1817%26epage%3D1825%26doi%3D10.1056%2FNEJMoa1011923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kamisawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaori, K.</span><span> </span><span class="NLM_article-title">Pancreatic cancer</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1016/S0140-6736(16)00141-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS0140-6736%2816%2900141-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=26830752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=73-85&author=T.+Kamisawaauthor=L.+D.+Woodauthor=T.+Itoiauthor=K.+Takaori&title=Pancreatic+cancer&doi=10.1016%2FS0140-6736%2816%2900141-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer</span></div><div class="casAuthors">Kamisawa, Terumi; Wood, Laura D.; Itoi, Takao; Takaori, Kyoichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10039</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence.  Most patients with pancreatic cancer remain asymptomatic until the disease reaches an advanced stage.  There is no std. program for screening patients at high risk of pancreatic cancer (eg, those with a family history of pancreatic cancer and chronic pancreatitis).  Most pancreatic cancers arise from microscopic non-invasive epithelial proliferations within the pancreatic ducts, referred to as pancreatic intraepithelial neoplasias.  There are four major driver genes for pancreatic cancer: KRAS, CDKN2A, TP53, and SMAD4.  KRAS mutation and alterations in CDKN2A are early events in pancreatic tumorigenesis.  Endoscopic ultrasonog. and endoscopic ultrasonog.-guided fine-needle aspiration offer high diagnostic ability for pancreatic cancer.  Surgical resection is regarded as the only potentially curative treatment, and adjuvant chemotherapy with gemcitabine or S-1, an oral fluoropyrimidine deriv., is given after surgery.  FOLFIRINOX (fluorouracil, folinic acid [leucovorin], irinotecan, and oxaliplatin) and gemcitabine plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) are the treatments of choice for patients who are not surgical candidates but have good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowv4Kc18l117Vg90H21EOLACvtfcHk0liXTg-C9N_D1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D&md5=008fad5f1be8c3c6f3534c5bc3c3ea3a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2900141-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252900141-0%26sid%3Dliteratum%253Aachs%26aulast%3DKamisawa%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DL.%2BD.%26aulast%3DItoi%26aufirst%3DT.%26aulast%3DTakaori%26aufirst%3DK.%26atitle%3DPancreatic%2520cancer%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D73%26epage%3D85%26doi%3D10.1016%2FS0140-6736%2816%2900141-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Suker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beumer, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marthey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faris, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellon, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Rayes, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang-Gillam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosein, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorcraft, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taieb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shridhar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eijck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerkamp, B. G.</span><span> </span><span class="NLM_article-title">FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span><span class="refDoi"> DOI: 10.1016/S1470-2045(16)00172-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS1470-2045%2816%2900172-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27160474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVChtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=801-810&author=M.+Sukerauthor=B.+R.+Beumerauthor=E.+Sadotauthor=L.+Martheyauthor=J.+E.+Farisauthor=E.+A.+Mellonauthor=B.+F.+El-Rayesauthor=A.+Wang-Gillamauthor=J.+Lacyauthor=P.+J.+Hoseinauthor=S.+Y.+Moorcraftauthor=T.+Conroyauthor=F.+Hohlaauthor=P.+Allenauthor=J.+Taiebauthor=T.+S.+Hongauthor=R.+Shridharauthor=I.+Chauauthor=C.+H.+van+Eijckauthor=B.+G.+Koerkamp&title=FOLFIRINOX+for+locally+advanced+pancreatic+cancer%3A+a+systematic+review+and+patient-level+meta-analysis&doi=10.1016%2FS1470-2045%2816%2900172-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis</span></div><div class="casAuthors">Suker, Mustafa; Beumer, Berend R.; Sadot, Eran; Marthey, Lysiane; Faris, Jason E.; Mellon, Eric A.; El-Rayes, Bassel F.; Wang-Gillam, Andrea; Lacy, Jill; Hosein, Peter J.; Moorcraft, Sing Yu; Conroy, Thierry; Hohla, Florian; Allen, Peter; Taieb, Julien; Hong, Theodore S.; Shridhar, Ravi; Chau, Ian; van Eijck, Casper H.; Koerkamp, Bas Groot</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">801-810</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">35% Of patients with pancreatic cancer have unresectable locally advanced disease at diagnosis.  Several studies have examd. systemic chemotherapy with FOLFIRINOX (leucovorin and fluorouracil plus irinotecan and oxaliplatin) in patients with locally advanced pancreatic cancer.  We aimed to assess the effectiveness of FOLFIRINOX as first-line treatment in this patient population.  We systematically searched Embase, MEDLINE (OvidSP), Web of Science, Scopus, PubMed Publisher, Cochrane, and Google Scholar from July 1, 1994, to July 2, 2015, for studies of treatment-naive patients of any age who received FOLFIRINOX as first-line treatment of locally advanced pancreatic cancer.  Our primary outcome was overall survival.  Secondary outcomes were progression-free survival; rates of grade 3 or 4 adverse events; and the proportion of patients who underwent radiotherapy or chemoradiotherapy, surgical resection after FOLFIRINOX, and R0 resection.  We evaluated survival outcomes with the Kaplan-Meier method with patient-level data.  Grade 3 or 4 adverse events, and the proportion of patients who underwent subsequent radiotherapy or chemoradiotherapy or resection, were pooled in a random-effects model.  We included 13 studies comprising 689 patients, of whom 355 (52%) patients had locally advanced pancreatic cancer. 11 studies, comprising 315 patients with locally advanced disease, reported survival outcomes and were eligible for patient-level meta-anal.  Median overall survival from the start of FOLFIRINOX ranged from 10·0 mo (95% CI 4·0-16·0) to 32·7 mo (23·1-42·3) across studies with a pooled patient-level median overall survival of 24·2 mo (95% CI 21·7-26·8).  Median progression-free survival ranged from 3·0 mo (95% CI not calculable) to 20·4 mo (6·5-34·3) across studies with a patient-level median progression-free survival of 15·0 mo (95% 13·8-16·2).  In ten studies comprising 490 patients, 296 grade 3 or 4 adverse events were reported (60·4 events per 100 patients).  No deaths were attributed to FOLFIRINOX toxicity.  The proportion of patients who underwent radiotherapy or chemoradiotherapy ranged from 31% to 100% across studies.  In eight studies, 154 (57%) of 271 patients received radiotherapy or chemoradiotherapy after FOLFIRINOX.  The pooled proportion of patients who received any radiotherapy treatment was 63·5% (95% CI 43·3-81·6, I2 90%).  The proportion of patients who underwent surgical resection for locally advanced pancreatic cancer ranged from 0% to 43%.  The proportion of patients who had R0 resection of those who underwent resection ranged from 50% to 100% across studies.  In 12 studies, 91 (28%) of 325 patients underwent resection after FOLFIRINOX.  The pooled proportion of patients who had resection was 25·9% (95% CI 20·2-31·9, I2 24%).  R0 resection was reported in 60 (74%) of 81 patients.  The pooled proportion of patients who had R0 resection was 78·4% (95% CI 60·2-92·2, I2 64%).  Patients with locally advanced pancreatic cancer treated with FOLFIRINOX had a median overall survival of 24·2 mo-longer than that reported with gemcitabine (6-13 mo).  Future research should assess these promising results in a randomized controlled trial, and should establish which patients might benefit from radiotherapy or chemoradiotherapy or resection after FOLFIRINOX.None.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDWNhn2_V6LbVg90H21EOLACvtfcHk0ljFIrnGEZprxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVChtbc%253D&md5=65d6114f17bcebe3d620379281b2ecbb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2816%2900172-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252816%252900172-8%26sid%3Dliteratum%253Aachs%26aulast%3DSuker%26aufirst%3DM.%26aulast%3DBeumer%26aufirst%3DB.%2BR.%26aulast%3DSadot%26aufirst%3DE.%26aulast%3DMarthey%26aufirst%3DL.%26aulast%3DFaris%26aufirst%3DJ.%2BE.%26aulast%3DMellon%26aufirst%3DE.%2BA.%26aulast%3DEl-Rayes%26aufirst%3DB.%2BF.%26aulast%3DWang-Gillam%26aufirst%3DA.%26aulast%3DLacy%26aufirst%3DJ.%26aulast%3DHosein%26aufirst%3DP.%2BJ.%26aulast%3DMoorcraft%26aufirst%3DS.%2BY.%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DHohla%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DP.%26aulast%3DTaieb%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DT.%2BS.%26aulast%3DShridhar%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DI.%26aulast%3Dvan%2BEijck%26aufirst%3DC.%2BH.%26aulast%3DKoerkamp%26aufirst%3DB.%2BG.%26atitle%3DFOLFIRINOX%2520for%2520locally%2520advanced%2520pancreatic%2520cancer%253A%2520a%2520systematic%2520review%2520and%2520patient-level%2520meta-analysis%26jtitle%3DLancet%2520Oncol.%26date%3D2016%26volume%3D17%26spage%3D801%26epage%3D810%26doi%3D10.1016%2FS1470-2045%2816%2900172-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Conroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachet, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huguet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caramella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laethem, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducreux, M.</span><span> </span><span class="NLM_article-title">Current standards and new innovative approaches for treatment of pancreatic cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.ejca.2015.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.ejca.2015.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=26851397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC28not1aiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=10-22&author=T.+Conroyauthor=J.+B.+Bachetauthor=A.+Ayavauthor=F.+Huguetauthor=A.+Lambertauthor=C.+Caramellaauthor=R.+Marechalauthor=J.+L.+Van+Laethemauthor=M.+Ducreux&title=Current+standards+and+new+innovative+approaches+for+treatment+of+pancreatic+cancer&doi=10.1016%2Fj.ejca.2015.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Current standards and new innovative approaches for treatment of pancreatic cancer</span></div><div class="casAuthors">Conroy Thierry; Bachet Jean-Baptiste; Ayav Ahmet; Huguet Florence; Lambert Aurelien; Caramella Caroline; Ducreux Michel; Marechal Raphael; Van Laethem Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cancer (Oxford, England : 1990)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic adenocarcinoma remains a devastating disease with a 5-year survival rate not exceeding 6%.  Treatment of this disease remains a major challenge.  This article reviews the state-of-the-art in the management of this disease and the new innovative approaches that may help to accelerate progress in treating its victims.  After careful pre-therapeutic evaluation, only 15-20% of patients diagnosed with a pancreatic cancer (PC) are eligible for upfront radical surgery.  After R0 or R1 resection in such patients, evidence suggests a significantly positive impact on survival of adjuvant chemotherapy comprising 6 months of gemcitabine or fluorouracil/folinic acid.  Delayed adjuvant chemoradiation is considered as an option in cases of positive margins.  Borderline resectable pancreatic cancer (BRPC) is defined as a tumour involving the mesenteric vasculature to a limited extend.  Resection of these tumours is technically feasible, yet runs the high risk of a R1 resection.  Neoadjuvant treatment probably offers the best chance of achieving successful R0 resection and long-term survival, but the best treatment options should be determined in prospective randomised studies.  Gemcitabine has for 15 years been the only validated therapy for advanced PC.  Following decades of negative phase III studies, increasing evidence now suggests that further significant improvements to overall survival can be achieved via either Folfirinox or gemcitabine + nab-paclitaxel regimens.  Progress in systemic therapy may improve the chances of resection in borderline resectable pancreatic cancer (BRPC) or locally advanced PC.  This requires first enhancing knowledge of the genetic events driving carcinogenesis, which may then be translated into clinical studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREoImV5nSKf_6BottYdIAWfW6udTcc2eaKuY9JSbZ1hLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28not1aiuw%253D%253D&md5=d336a90b16ee93020e64a1481858df55</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2015.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2015.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DBachet%26aufirst%3DJ.%2BB.%26aulast%3DAyav%26aufirst%3DA.%26aulast%3DHuguet%26aufirst%3DF.%26aulast%3DLambert%26aufirst%3DA.%26aulast%3DCaramella%26aufirst%3DC.%26aulast%3DMarechal%26aufirst%3DR.%26aulast%3DVan%2BLaethem%26aufirst%3DJ.%2BL.%26aulast%3DDucreux%26aufirst%3DM.%26atitle%3DCurrent%2520standards%2520and%2520new%2520innovative%2520approaches%2520for%2520treatment%2520of%2520pancreatic%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2016%26volume%3D57%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.ejca.2015.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Fogel, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandrasegaran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easler, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagleson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zyromski, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">House, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Hajj, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakeeb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, S.</span><span> </span><span class="NLM_article-title">A multidisciplinary approach to pancreas cancer in 2016: A review</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span><span class="refDoi"> DOI: 10.1038/ajg.2016.610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fajg.2016.610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28139655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC1c3gvFGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2017&pages=537-554&author=E.+L.+Fogelauthor=S.+Shahdaauthor=K.+Sandrasegaranauthor=J.+DeWittauthor=J.+J.+Easlerauthor=D.+M.+Agarwalauthor=M.+Eaglesonauthor=N.+J.+Zyromskiauthor=M.+G.+Houseauthor=S.+Ellsworthauthor=I.+El+Hajjauthor=B.+H.+O%E2%80%99Neilauthor=A.+Nakeebauthor=S.+Sherman&title=A+multidisciplinary+approach+to+pancreas+cancer+in+2016%3A+A+review&doi=10.1038%2Fajg.2016.610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review</span></div><div class="casAuthors">Fogel Evan L; Shahda Safi; DeWitt John; Easler Jeffrey J; Ellsworth Susannah; El Hajj Ihab; O'Neil Bert H; Sherman Stuart; Sandrasegaran Kumar; Agarwal David M; Eagleson Mackenzie; Zyromski Nicholas J; House Michael G; Nakeeb Attila</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">537-554</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In this article, we review our multidisciplinary approach for patients with pancreatic cancer.  Specifically, we review the epidemiology, diagnosis and staging, biliary drainage techniques, selection of patients for surgery, chemotherapy, radiation therapy, and discuss other palliative interventions.  The areas of active research investigation and where our knowledge is limited are emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRH3FF2fu0tB0wlCcfExbvbfW6udTcc2eZU9GygpfaI67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3gvFGktg%253D%253D&md5=fa28cd98c222f298baf369bd7f261cee</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fajg.2016.610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2016.610%26sid%3Dliteratum%253Aachs%26aulast%3DFogel%26aufirst%3DE.%2BL.%26aulast%3DShahda%26aufirst%3DS.%26aulast%3DSandrasegaran%26aufirst%3DK.%26aulast%3DDeWitt%26aufirst%3DJ.%26aulast%3DEasler%26aufirst%3DJ.%2BJ.%26aulast%3DAgarwal%26aufirst%3DD.%2BM.%26aulast%3DEagleson%26aufirst%3DM.%26aulast%3DZyromski%26aufirst%3DN.%2BJ.%26aulast%3DHouse%26aufirst%3DM.%2BG.%26aulast%3DEllsworth%26aufirst%3DS.%26aulast%3DEl%2BHajj%26aufirst%3DI.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%2BH.%26aulast%3DNakeeb%26aufirst%3DA.%26aulast%3DSherman%26aufirst%3DS.%26atitle%3DA%2520multidisciplinary%2520approach%2520to%2520pancreas%2520cancer%2520in%25202016%253A%2520A%2520review%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2017%26volume%3D112%26spage%3D537%26epage%3D554%26doi%3D10.1038%2Fajg.2016.610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Falasca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casari, I.</span><span> </span><span class="NLM_article-title">Pancreatic cancer: Current research and future directions</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1865</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1016/j.bbcan.2016.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.bbcan.2016.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=26794394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1865&publication_year=2016&pages=123-132&author=M.+Falascaauthor=M.+Kimauthor=I.+Casari&title=Pancreatic+cancer%3A+Current+research+and+future+directions&doi=10.1016%2Fj.bbcan.2016.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer: Current research and future directions</span></div><div class="casAuthors">Falasca, Marco; Kim, Minkyoung; Casari, Ilaria</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1865</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-132</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite the survival rate advancements in different types of cancer in the last 40 years, the perspective for pancreatic cancer patients has seen no substantial changes.  Indeed, the five year survival rate remains around 5%.  Nevertheless, in the last decade we have witnessed an increased interest in pancreatic cancer biol. and this has produced a substantial increment in our knowledge on pancreatic cancer progression.  The big challenge is now to translate this knowledge in better outcomes for patients.  The aim of this review is to describe the latest discoveries and advancements in pancreatic cancer research and to discuss future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8OJHrOiLVYbVg90H21EOLACvtfcHk0lhnEQ87ClqM2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVajsw%253D%253D&md5=8632fdedacfb4992e4a59fb712899790</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2016.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2016.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DFalasca%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DCasari%26aufirst%3DI.%26atitle%3DPancreatic%2520cancer%253A%2520Current%2520research%2520and%2520future%2520directions%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2016%26volume%3D1865%26spage%3D123%26epage%3D132%26doi%3D10.1016%2Fj.bbcan.2016.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mukherjee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parianos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer</span> <span class="citation_source-journal">Cancer Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span><span class="refDoi"> DOI: 10.1016/j.cancergen.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.cancergen.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27613576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC2szptFygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2016&pages=582-591&author=I.+Mukherjeeauthor=B.+Powellauthor=M.+Parianosauthor=D.+Downsauthor=S.+B.+Ross&title=Available+technologies+and+clinical+applications+of+targeted+chemotherapy+in+pancreatic+cancer&doi=10.1016%2Fj.cancergen.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer</span></div><div class="casAuthors">Mukherjee Indraneil; Powell Brett; Parianos Mary; Downs Darrell; Ross Sharona B</div><div class="citationInfo"><span class="NLM_cas:title">Cancer genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">582-591</span>
        ISSN:<span class="NLM_cas:issn">2210-7762</span>.
    </div><div class="casAbstract">The incidence of pancreatic cancer, the fourth leading cause of cancer death in United States, is increasing worldwide.  Even though the cure rate has doubled in 40 years, it is abysmally poor at 6-7%.  As surgical resection remains the only curative treatment and less than 20% of the newly diagnosed cancers are resectable, the major burden of disease management lies in early diagnosis, good prognostication, and proper neo-adjuvant and/or adjuvant therapy.  With advancing technologies and their ease of availability, researchers have better tools to understand pancreatic cancer.  In the post-genetic era, proteomic, phosphoproteomic, metabolomic, and more have brought us to a multi-omics era.  These newer avenues bring promises of better screening modalities, less invasive diagnostics and monitoring, subtyping of pancreatic cancer, and fine tuning the treatment modalities not only to the right stage of tumor but also to the right tumor biology.  As the multitudes of technologies are generating extensive amounts of incongruous data, they are giving clinicians a lot of non-actionable information.  In this paper, we wish to encompass the newer technologies, sub-classifications, and future treatment modalities in personalized care of patients with pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReZY61VS1T9nRxY89Cm6SyfW6udTcc2ea50_HsWkxLX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szptFygtg%253D%253D&md5=716782d8540d2770e57d084edcb5b301</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cancergen.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cancergen.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DParianos%26aufirst%3DM.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DAvailable%2520technologies%2520and%2520clinical%2520applications%2520of%2520targeted%2520chemotherapy%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Genet.%26date%3D2016%26volume%3D209%26spage%3D582%26epage%3D591%26doi%3D10.1016%2Fj.cancergen.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Martinez-Useros, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabeza-Morales, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Foncillas, J.</span><span> </span><span class="NLM_article-title">Oxidative stress: A new target for pancreatic cancer prognosis and treatment</span> <span class="citation_source-journal">J. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="refDoi"> DOI: 10.3390/jcm6030029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.3390%2Fjcm6030029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKgs7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=29&author=J.+Martinez-Userosauthor=W.+Liauthor=M.+Cabeza-Moralesauthor=J.+Garcia-Foncillas&title=Oxidative+stress%3A+A+new+target+for+pancreatic+cancer+prognosis+and+treatment&doi=10.3390%2Fjcm6030029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress: a new target for pancreatic cancer prognosis and treatment</span></div><div class="casAuthors">Martinez-Useros, Javier; Li, Weiyao; Cabeza-Morales, Marticela; Garcia-Foncillas, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">29/1-29/16</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of tumors, and its incidence is rising worldwide.  Survival can be improved when tumors are detected at an early stage; however, this cancer is usually asymptomatic, and the disease only becomes apparent after metastasis.  Several risk factors are assocd. to this disease.  Chronic pancreatitis, diabetes, and some infectious disease are the most relevant risk factors.  Incidence of PDAC has increased in the last decades.  It is hypothesized it could be due to other acquired risk habits, like smoking, high alc. intake, and obesity.  Indeed, adipose tissue is a dynamic endocrine organ that secretes different pro-inflammatory cytokines, enzymes, and other factors that activate oxidative stress.  Reactive oxygen species caused by oxidative stress, damage DNA, proteins, and lipids, and produce several toxic and high mutagenic metabolites that could modify tumor behavior, turning it into a malignant phenotype.  Anti-oxidant compds., like vitamins, are considered protective factors against cancer.  Here, we review the literature on oxidative stress, the mol. pathways that activate or counteract oxidative stress, and potential treatment strategies that target reactive oxygen species suitable for this kind of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMFm6vrD8mZLVg90H21EOLACvtfcHk0ljGMd9KPTB5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKgs7zN&md5=164c1c2f59446cde147e0da0e308de42</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fjcm6030029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm6030029%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Useros%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DCabeza-Morales%26aufirst%3DM.%26aulast%3DGarcia-Foncillas%26aufirst%3DJ.%26atitle%3DOxidative%2520stress%253A%2520A%2520new%2520target%2520for%2520pancreatic%2520cancer%2520prognosis%2520and%2520treatment%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2017%26volume%3D6%26spage%3D29%26doi%3D10.3390%2Fjcm6030029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Trachootham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span> </span><span class="NLM_article-title">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span><span class="refDoi"> DOI: 10.1038/nrd2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fnrd2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=19478820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=579-591&author=D.+Trachoothamauthor=J.+Alexandreauthor=P.+Huang&title=Targeting+cancer+cells+by+ROS-mediated+mechanisms%3A+a+radical+therapeutic+approach%3F&doi=10.1038%2Fnrd2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span></div><div class="casAuthors">Trachootham, Dunyaporn; Alexandre, Jerome; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increased generation of reactive oxygen species (ROS) and an altered redox status have long been obsd. in cancer cells, and recent studies suggest that this biochem. property of cancer cells can be exploited for therapeutic benefits.  Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacol. ROS insults.  However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance.  Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications.  We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgIa2fgBPBrVg90H21EOLACvtfcHk0ljGMd9KPTB5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D&md5=d50931b8de8bcab62d376becc768a71c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2803%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DAlexandre%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DTargeting%2520cancer%2520cells%2520by%2520ROS-mediated%2520mechanisms%253A%2520a%2520radical%2520therapeutic%2520approach%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D579%26epage%3D591%26doi%3D10.1038%2Fnrd2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Moloney, J. N.; Cotter, T. G.</span><span> </span><span class="NLM_article-title">ROS signalling in the biology of cancer</span>.  <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span>. DOI: <span class="refDoi"> DOI: 10.1016/j.semcdb.2017.05.023</span> . Published Online: June 3, 2017.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.semcdb.2017.05.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+N.+Moloney&author=T.+G.+Cotter&title=ROS+signalling+in+the+biology+of+cancer&doi=10.1016%2Fj.semcdb.2017.05.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2017.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2017.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DMoloney%26aufirst%3DJ.%2BN.%26atitle%3DROS%2520signalling%2520in%2520the%2520biology%2520of%2520cancer%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2017%26doi%3D10.1016%2Fj.semcdb.2017.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Idelchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melendez, J. A.</span><span> </span><span class="NLM_article-title">Mitochondrial ROS control of cancer</span> <span class="citation_source-journal">Semin. Cancer Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1016/j.semcancer.2017.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.semcancer.2017.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28445781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFCnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=57-66&author=M.+Idelchikauthor=U.+Begleyauthor=T.+J.+Begleyauthor=J.+A.+Melendez&title=Mitochondrial+ROS+control+of+cancer&doi=10.1016%2Fj.semcancer.2017.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial ROS control of cancer</span></div><div class="casAuthors">Idelchik, Maria del Pilar Sosa; Begley, Ulrike; Begley, Thomas J.; Melendez, J. Andres</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-66</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mitochondria serves a primary role in energy maintenance but also function to govern levels of mitochondria-derived reactive oxygen species (mROS).  ROS have long been established to play a crit. role in tumorigenesis and are now considered to be integral to the regulation of diverse signaling networks that drive proliferation, tumor cell survival and malignant progression. mROS can damage DNA, activate oncogenes, block the function of tumor suppressors and drive migratory signaling.  The mitochondrion's oxidant scavenging systems including SOD2, Grx2, GPrx, Trx and TrxR are key of the cellular redox tone.  These mitochondrial antioxidant systems serve to tightly control the levels of the primary ROS signaling species, H2O2.  The coordinated control of mROS levels is also coupled to the activity of the primary H2O2 consuming enzymes of the mitochondria which are reliant on the epitranscriptomic control of selenocysteine incorporation.  This review highlights the interplay between these many oncogenic signaling networks, mROS and the H2O2 emitting and consuming capacity of the mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobMZDqsgiyr7Vg90H21EOLACvtfcHk0lh2vt67H-fHLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFCnsb0%253D&md5=faf124b5a300a215c8d85a41f1c8a904</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DIdelchik%26aufirst%3DM.%26aulast%3DBegley%26aufirst%3DU.%26aulast%3DBegley%26aufirst%3DT.%2BJ.%26aulast%3DMelendez%26aufirst%3DJ.%2BA.%26atitle%3DMitochondrial%2520ROS%2520control%2520of%2520cancer%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D47%26spage%3D57%26epage%3D66%26doi%3D10.1016%2Fj.semcancer.2017.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Dharmaraja, A. T.</span><span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3221</span><span class="NLM_x">–</span> <span class="NLM_lpage">3240</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3221-3240&author=A.+T.+Dharmaraja&title=Role+of+reactive+oxygen+species+%28ROS%29+in+therapeutics+and+drug+resistance+in+cancer+and+bacteria&doi=10.1021%2Facs.jmedchem.6b01243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria</span></div><div class="casAuthors">Dharmaraja, Allimuthu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3221-3240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Evading persistent drug resistance in cancer and bacteria to most of the com. used drugs is necessary to restore the human health settings.  A distinct property of cancer phenotype is enhanced glucose metab. and oxidative stress from normal cells.  Reactive oxygen species (ROS) are metabolic byproducts of aerobic respiration and are responsible for maintaining redox homeostasis in cells.  Maintaining the redox balance in cancerous cells are found to be crit. for their survival, which is modulated by reduced thiols and reducing cofactors NAD(P)H.  Thus altering the levels reducing equiv. were found to enhance intracellular ROS and sensitize cancer cells to therapeutics.  Similarly, Escherichia coli and life threatening infectious pathogens such as Staphylococcus aureus and Mycobacterium tuberculosis were found to be more sensitive to modulation of intracellular oxidative environment.  Combination drug strategies were successfully employed in attenuating the effects of drug resistant cancer and bacterial.  Here, a collection of some ROS modulation based cancer and bacterial therapeutics is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoshDBtCrwl5LVg90H21EOLACvtfcHk0lh2vt67H-fHLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D&md5=71bfb8f37ab75364fedcb07de262fc2c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01243%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520therapeutics%2520and%2520drug%2520resistance%2520in%2520cancer%2520and%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3221%26epage%3D3240%26doi%3D10.1021%2Facs.jmedchem.6b01243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Panieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M. M.</span><span> </span><span class="NLM_article-title">ROS homeostasis and metabolism: a dangerous liason in cancer cells</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2253</span><span class="refDoi"> DOI: 10.1038/cddis.2016.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fcddis.2016.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27277675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFChsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=e2253&author=E.+Panieriauthor=M.+M.+Santoro&title=ROS+homeostasis+and+metabolism%3A+a+dangerous+liason+in+cancer+cells&doi=10.1038%2Fcddis.2016.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">ROS homeostasis and metabolism: a dangerous liason in cancer cells</span></div><div class="casAuthors">Panieri, E.; Santoro, M. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e2253</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor cells harbor genetic alterations that promote a continuous and elevated prodn. of reactive oxygen species.  Whereas such oxidative stress conditions would be harmful to normal cells, they facilitate tumor growth in multiple ways by causing DNA damage and genomic instability, and ultimately, by reprogramming cancer cell metab.  This review outlines the metabolic-dependent mechanisms that tumors engage in when faced with oxidative stress conditions that are crit. for cancer progression by producing redox cofactors.  In particular, we describe how the mitochondria has a key role in regulating the interplay between redox homeostasis and metab. within tumor cells.  Last, we will discuss the potential therapeutic use of agents that directly or indirectly block metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRB6mlouZWDrVg90H21EOLACvtfcHk0li4vC2JFxCToQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFChsLo%253D&md5=44483b7ad16d4c5212b9329d0c7811f9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.105%26sid%3Dliteratum%253Aachs%26aulast%3DPanieri%26aufirst%3DE.%26aulast%3DSantoro%26aufirst%3DM.%2BM.%26atitle%3DROS%2520homeostasis%2520and%2520metabolism%253A%2520a%2520dangerous%2520liason%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2016%26volume%3D7%26spage%3De2253%26doi%3D10.1038%2Fcddis.2016.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Diebold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandel, N. S.</span><span> </span><span class="NLM_article-title">Mitochondrial ROS regulation of proliferating cells</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2016.04.198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.freeradbiomed.2016.04.198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27154978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvV2rsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2016&pages=86-93&author=L.+Dieboldauthor=N.+S.+Chandel&title=Mitochondrial+ROS+regulation+of+proliferating+cells&doi=10.1016%2Fj.freeradbiomed.2016.04.198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial ROS regulation of proliferating cells</span></div><div class="casAuthors">Diebold, Lauren; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86-93</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Once thought of exclusively as damaging mols., reactive oxygen species (ROS) are becoming increasingly appreciated for the role they play in cellular signaling through redox biol.  Notably, mitochondria are a major source of ROS within a cell (mROS).  Mounting evidence now clearly shows that mROS are crit. for intracellular redox signaling by which they contribute to a plethora of cellular processes such as proliferation. mROS are essential for physiol. cell proliferation, particularly by the regulation of hypoxia inducible factors (HIFs) under hypoxia. mROS are also vital mediators of growth factor signaling cascades such as angiotensin II (Ang II) and T-cell receptor (TCR) signaling.  Pathol. proliferative diseases such as cancer utilize mROS to their advantage, aberrantly activating growth factor signaling cascades and perpetuating angiogenesis under hypoxia.  This review discusses how mROS pos. regulate mitogenic cellular signaling through redox biol., which is crit. for both physiol. and pathol. proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjlm-SYjhpnbVg90H21EOLACvtfcHk0li4vC2JFxCToQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvV2rsbc%253D&md5=eb952b7d486db48c650cbe13bed2ae14</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2016.04.198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2016.04.198%26sid%3Dliteratum%253Aachs%26aulast%3DDiebold%26aufirst%3DL.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DMitochondrial%2520ROS%2520regulation%2520of%2520proliferating%2520cells%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2016%26volume%3D100%26spage%3D86%26epage%3D93%26doi%3D10.1016%2Fj.freeradbiomed.2016.04.198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. F.</span><span> </span><span class="NLM_article-title">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span> <span class="citation_source-journal">J. Hematol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="refDoi"> DOI: 10.1186/1756-8722-6-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1186%2F1756-8722-6-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23442817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=19&author=X.+Liauthor=P.+Fangauthor=J.+Maiauthor=E.+T.+Choiauthor=H.+Wangauthor=X.+F.+Yang&title=Targeting+mitochondrial+reactive+oxygen+species+as+novel+therapy+for+inflammatory+diseases+and+cancers&doi=10.1186%2F1756-8722-6-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span></div><div class="casAuthors">Li, Xinyuan; Fang, Pu; Mai, Jietang; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  There are multiple sources of reactive oxygen species (ROS) in the cell.  As a major site of ROS prodn., mitochondria have drawn considerable interest because it was recently discovered that mitochondrial ROS (mtROS) directly stimulate the prodn. of proinflammatory cytokines and pathol. conditions as diverse as malignancies, autoimmune diseases, and cardiovascular diseases all share common phenotype of increased mtROS prodn. above basal levels.  Several excellent reviews on this topic have been published, but ever-changing new discoveries mandated a more up-to-date and comprehensive review on this topic.  Therefore, we update recent understanding of how mitochondria generate and regulate the prodn. of mtROS and the function of mtROS both in physiol. and pathol. conditions.  In addn., we describe newly developed methods to probe or scavenge mtROS and compare these methods in detail.  Thorough understanding of this topic and the application of mtROS-targeting drugs in the research is significant towards development of better therapies to combat inflammatory diseases and inflammatory malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdw7mjnRfUbVg90H21EOLACvtfcHk0li4vC2JFxCToQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D&md5=d041a496a1ede846460023f0cc54885a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-19%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%2BF.%26atitle%3DTargeting%2520mitochondrial%2520reactive%2520oxygen%2520species%2520as%2520novel%2520therapy%2520for%2520inflammatory%2520diseases%2520and%2520cancers%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D19%26doi%3D10.1186%2F1756-8722-6-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Chio, I. I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span> </span><span class="NLM_article-title">ROS in cancer: The burning question</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span><span class="refDoi"> DOI: 10.1016/j.molmed.2017.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.molmed.2017.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28427863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1WiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=411-429&author=I.+I.+C.+Chioauthor=D.+A.+Tuveson&title=ROS+in+cancer%3A+The+burning+question&doi=10.1016%2Fj.molmed.2017.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ROS in Cancer: The Burning Question</span></div><div class="casAuthors">Chio, Iok In Christine; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-429</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An unanswered question in human health is whether antioxidn. prevents or promotes cancer.  Antioxidn. has historically been viewed as chemopreventive, but emerging evidence suggests that antioxidants may be supportive of neoplasia.  We posit this contention to be rooted in the fact that ROS do not operate as one single biochem. entity, but as diverse secondary messengers in cancer cells.  This cautions against therapeutic strategies to increase ROS at a global level.  To leverage redox alterations towards the development of effective therapies necessitates the application of biophys. and biochem. approaches to define redox dynamics and to functionally elucidate specific oxidative modifications in cancer vs. normal cells.  An improved understanding of the sophisticated workings of redox biol. is imperative to defeating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0BkT0gWhumrVg90H21EOLACvtfcHk0lhez4NLTMwxew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1WiurY%253D&md5=74ce7fb3d8db3718d6c97b9030deb0da</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2017.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2017.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DI.%2BI.%2BC.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DROS%2520in%2520cancer%253A%2520The%2520burning%2520question%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D411%26epage%3D429%26doi%3D10.1016%2Fj.molmed.2017.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Fruehauf, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyskens, F. L.,  Jr.</span><span> </span><span class="NLM_article-title">Reactive oxygen species: a breath of life or death?</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1158%2F1078-0432.CCR-06-2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=17289868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=789-794&author=J.+P.+Fruehaufauthor=F.+L.+Meyskens&title=Reactive+oxygen+species%3A+a+breath+of+life+or+death%3F&doi=10.1158%2F1078-0432.CCR-06-2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species: A Breath of Life or Death?</span></div><div class="casAuthors">Fruehauf, John P.; Meyskens, Frank L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-794</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  New insights into cancer cell-specific biol. pathways are urgently needed to promote development of rationally targeted therapeutics.  Reactive oxygen species (ROS) and their role in cancer cell response to growth factor signaling and hypoxia are emerging as verdant areas of exploration on the road to discovering cancer's Achilles heel.  One of the distinguishing and near-universal hallmarks of cancer growth is hypoxia.  Unregulated cellular proliferation leads to formation of cellular masses that extend beyond the resting vasculature, resulting in oxygen and nutrient deprivation.  The resulting hypoxia triggers a no. of crit. adaptations that enable cancer cell survival, including apoptosis suppression, altered glucose metab., and an angiogenic phenotype.  Ironically, recent investigations suggest that oxygen depletion stimulates mitochondria to elaborate increased ROS, with subsequent activation of signaling pathways, such as hypoxia inducible factor 1α, that promote cancer cell survival and tumor growth.  Because mitochondria are key organelles involved in chemotherapy-induced apoptosis induction, the relationship between mitochondria, ROS signaling, and activation of survival pathways under hypoxic conditions has been the subject of increased study.  Insights into mechanisms involved in ROS signaling may offer novel avenues to facilitate discovery of cancer-specific therapies.  Preclin. and clin. evaluation of agents that modify ROS signaling in cancer offers a novel avenue for intervention.  This review will cover recent work in ROS-mediated signaling in cancer cells and its potential as a target for developmental therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquetAH3cZLGrVg90H21EOLACvtfcHk0lh9-D5Exb_Vpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyrsrs%253D&md5=1a31e4373a08496e74a631af5f532b0b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2082%26sid%3Dliteratum%253Aachs%26aulast%3DFruehauf%26aufirst%3DJ.%2BP.%26aulast%3DMeyskens%26aufirst%3DF.%2BL.%26atitle%3DReactive%2520oxygen%2520species%253A%2520a%2520breath%2520of%2520life%2520or%2520death%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D789%26epage%3D794%26doi%3D10.1158%2F1078-0432.CCR-06-2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">DeNicola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karreth, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humpton, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopinathan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frese, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calhoun, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrimieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruban, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacobuzio-Donahue, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span> </span><span class="NLM_article-title">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">475</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span><span class="refDoi"> DOI: 10.1038/nature10189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fnature10189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=21734707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=106-109&author=G.+M.+DeNicolaauthor=F.+A.+Karrethauthor=T.+J.+Humptonauthor=A.+Gopinathanauthor=C.+Weiauthor=K.+Freseauthor=D.+Mangalauthor=K.+H.+Yuauthor=C.+J.+Yeoauthor=E.+S.+Calhounauthor=F.+Scrimieriauthor=J.+M.+Winterauthor=R.+H.+Hrubanauthor=C.+Iacobuzio-Donahueauthor=S.+E.+Kernauthor=I.+A.+Blairauthor=D.+A.+Tuveson&title=Oncogene-induced+Nrf2+transcription+promotes+ROS+detoxification+and+tumorigenesis&doi=10.1038%2Fnature10189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span></div><div class="casAuthors">DeNicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Wei, Cong; Frese, Kristopher; Mangal, Dipti; Yu, Kenneth H.; Yeo, Charles J.; Calhoun, Eric S.; Scrimieri, Francesca; Winter, Jordan M.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.; Blair, Ian A.; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">106-109</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer.  Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly regulated by the transcription factor Nrf2 (also known as Nfe2l2) and its repressor protein Keap1 (refs. 2-5).  In contrast to the acute physiol. regulation of Nrf2, in neoplasia there is evidence for increased basal activation of Nrf2.  Indeed, somatic mutations that disrupt the Nrf2-Keap1 interaction to stabilize Nrf2 and increase the constitutive transcription of Nrf2 target genes were recently identified, indicating that enhanced ROS detoxification and addnl. Nrf2 functions may in fact be pro-tumorigenic.  Here, we investigated ROS metab. in primary murine cells following the expression of endogenous oncogenic alleles of Kras, Braf and Myc, and found that ROS are actively suppressed by these oncogenes.  K-RasG12D, B-RafV619E and MycERT2 each increased the transcription of Nrf2 to stably elevate the basal Nrf2 antioxidant program and thereby lower intracellular ROS and confer a more reduced intracellular environment.  Oncogene-directed increased expression of Nrf2 is a new mechanism for the activation of the Nrf2 antioxidant program, and is evident in primary cells and tissues of mice expressing K-RasG12D and B-RafV619E, and in human pancreatic cancer.  Furthermore, genetic targeting of the Nrf2 pathway impairs K-RasG12D-induced proliferation and tumorigenesis in vivo.  Thus, the Nrf2 antioxidant and cellular detoxification program represents a previously unappreciated mediator of oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFpMbvjw2msLVg90H21EOLACvtfcHk0lh9-D5Exb_Vpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D&md5=54d0e0b5940672a96bde0f8cfd9e7ff9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnature10189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10189%26sid%3Dliteratum%253Aachs%26aulast%3DDeNicola%26aufirst%3DG.%2BM.%26aulast%3DKarreth%26aufirst%3DF.%2BA.%26aulast%3DHumpton%26aufirst%3DT.%2BJ.%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DFrese%26aufirst%3DK.%26aulast%3DMangal%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DCalhoun%26aufirst%3DE.%2BS.%26aulast%3DScrimieri%26aufirst%3DF.%26aulast%3DWinter%26aufirst%3DJ.%2BM.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DBlair%26aufirst%3DI.%2BA.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DOncogene-induced%2520Nrf2%2520transcription%2520promotes%2520ROS%2520detoxification%2520and%2520tumorigenesis%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D106%26epage%3D109%26doi%3D10.1038%2Fnature10189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erkan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalski, C. W.</span><span> </span><span class="NLM_article-title">Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels</span> <span class="citation_source-journal">Front. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="refDoi"> DOI: 10.3389/fphys.2013.00246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.3389%2Ffphys.2013.00246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=24062691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC2cflt1ylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=246&author=B.+Kongauthor=C.+Qiaauthor=M.+Erkanauthor=J.+Kleeffauthor=C.+W.+Michalski&title=Overview+on+how+oncogenic+Kras+promotes+pancreatic+carcinogenesis+by+inducing+low+intracellular+ROS+levels&doi=10.3389%2Ffphys.2013.00246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels</span></div><div class="casAuthors">Kong Bo; Qia Chengjia; Erkan Mert; Kleeff Jorg; Michalski Christoph W</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">246</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease without clearly known disease causes.  Recent epidemiological and animal studies suggest that the supplementation of dietary antioxidants (e.g., vitamins C and E) decreases cancer risk, implying that increased reactive oxygen species (ROS) may play a role in pancreatic carcinogenesis.  However, oncogenic Kras mutations (e.g., Kras(G12D)), which are present in more than 90% of PDAC, have been proven to foster low intracellular ROS levels.  Here, oncogenic Kras activates expression of a series of anti-oxidant genes via Nrf2 (nuclear factor, erythroid derived 2, like 2) and also mediates an unusual metabolic pathway of glutamine to generate NADPH.  This can then be used as the reducing power for ROS detoxification, leading collectively to low ROS levels in pancreatic pre-neoplastic cells and in cancer cells.  In adult stem cells and cancer stem cells, low ROS levels have been associated with the formation of a proliferation-permissive intracellular environment and with perseverance of self-renewal capacities.  Therefore, it is conceivable that low intracellular ROS levels may contribute significantly to oncogenic Kras-mediated PDAC formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4U-tZwxXjRY2y4bB4mnvYfW6udTcc2ea62ZgKuHZkRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflt1ylsg%253D%253D&md5=02f78da404b5d0367cb3776c32f91bf2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2013.00246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2013.00246%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DB.%26aulast%3DQia%26aufirst%3DC.%26aulast%3DErkan%26aufirst%3DM.%26aulast%3DKleeff%26aufirst%3DJ.%26aulast%3DMichalski%26aufirst%3DC.%2BW.%26atitle%3DOverview%2520on%2520how%2520oncogenic%2520Kras%2520promotes%2520pancreatic%2520carcinogenesis%2520by%2520inducing%2520low%2520intracellular%2520ROS%2520levels%26jtitle%3DFront.%2520Physiol.%26date%3D2013%26volume%3D4%26spage%3D246%26doi%3D10.3389%2Ffphys.2013.00246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">KRas, ROS and the initiation of pancreatic cancer</span> <span class="citation_source-journal">Small GTPases</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1080/21541248.2016.1192714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1080%2F21541248.2016.1192714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27215184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtValtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=38-42&author=P.+Storz&title=KRas%2C+ROS+and+the+initiation+of+pancreatic+cancer&doi=10.1080%2F21541248.2016.1192714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">KRas, ROS and the initiation of pancreatic cancer</span></div><div class="casAuthors">Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Small GTPases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-42</span>CODEN:
                <span class="NLM_cas:coden">SGMTBK</span>;
        ISSN:<span class="NLM_cas:issn">2154-1256</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Oncogenic mutations of KRAS are the most frequent driver mutations in pancreatic cancer.  Expression of an oncogenic allele of KRAS leads to metabolic changes and altered cellular signaling that both can increase the prodn. of intracellular reactive oxygen species (ROS).  Increases in ROS have been shown to drive the formation and progression of pancreatic precancerous lesions by upregulating survival and growth factor signaling.  A key issue for precancerous and cancer cells is to keep ROS at levels where they are beneficial for tumor development and progression, but below the threshold that leads to induction of senescence or cell death.  In KRas-driven neoplasia aberrantly increased ROS levels are therefore balanced by an upregulation of antioxidant genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeeejFcCf6r7Vg90H21EOLACvtfcHk0ljAhT69pnDabg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtValtL3J&md5=d1fa43521389b67fe2c99e966391f930</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1080%2F21541248.2016.1192714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21541248.2016.1192714%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DKRas%252C%2520ROS%2520and%2520the%2520initiation%2520of%2520pancreatic%2520cancer%26jtitle%3DSmall%2520GTPases%26date%3D2017%26volume%3D8%26spage%3D38%26epage%3D42%26doi%3D10.1080%2F21541248.2016.1192714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span> </span><span class="NLM_article-title">The relevance of Nrf2 pathway and autophagy in pancreatic cancer cells upon stimulation of reactive oxygen species</span> <span class="citation_source-journal">Oxid. Med. Cell. Longevity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">3897250</span><span class="refDoi"> DOI: 10.1155/2016/3897250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1155%2F2016%2F3897250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=26682003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC28risl2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=3897250&author=L.+Zhangauthor=J.+Liauthor=J.+Maauthor=X.+Chenauthor=K.+Chenauthor=Z.+Jiangauthor=L.+Zongauthor=S.+Yuauthor=X.+Liauthor=Q.+Xuauthor=J.+Leiauthor=W.+Duanauthor=W.+Liauthor=T.+Shanauthor=Q.+Maauthor=X.+Shen&title=The+relevance+of+Nrf2+pathway+and+autophagy+in+pancreatic+cancer+cells+upon+stimulation+of+reactive+oxygen+species&doi=10.1155%2F2016%2F3897250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species</span></div><div class="casAuthors">Zhang Lun; Li Jiahui; Chen Xin; Chen Ke; Jiang Zhengdong; Zong Liang; Xu Qinhong; Lei Jianjun; Duan Wanxing; Li Wei; Ma Qingyong; Ma Jiguang; Yu Shuo; Shan Tao; Li Xuqi; Shen Xin</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3897250</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nrf2 (NF-E2-related factor 2) pathway and autophagy both can respond to oxidative stress to promote cancer cells to survive in the tumor microenvironment.  We, therefore, explored the relevance between Nrf2 pathway and autophagy in pancreatic cancer cells upon stimulation of reactive oxygen species (ROS).  Pancreatic cancer cells were cultured under controlled ROS stressing condition or basal condition.  Different inhibitors were used to prevent autophagy at particular stages.  Nrf2 siRNA was used to inhibit Nrf2 pathway activation.  Ad-mRFP-GFP-LC3 infection was used to monitor autophagic flux.  The result shows that a small amount of exogenous hydrogen peroxide (H2O2) can significantly improve the level of intracellular ROS.  Moreover, our findings indicate that ROS promotes the activation of both Nrf2 pathway and autophagy in pancreatic cancer cells.  Moreover, our data demonstrate that suppression of autophagic activity at particular stages results in an increased promotion of Nrf2 pathway activation upon ROS stimulation.  Furthermore, we found that silencing of Nrf2 promotes autophagy upon ROS stimulation.  In addition, Nrf2 interference effectively promotes autophagic flux upon ROS stimulation.  In summary, our findings suggest that Nrf2 pathway and autophagy have a negative interaction with each other upon ROS stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyYNpHHtF1I_69nzq6467DfW6udTcc2ea62ZgKuHZkRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28risl2lsA%253D%253D&md5=f277f5c57372b27af3cb2e9ff006d707</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1155%2F2016%2F3897250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F3897250%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DZong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DShan%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DX.%26atitle%3DThe%2520relevance%2520of%2520Nrf2%2520pathway%2520and%2520autophagy%2520in%2520pancreatic%2520cancer%2520cells%2520upon%2520stimulation%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D3897250%26doi%3D10.1155%2F2016%2F3897250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Pelicano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span> </span><span class="NLM_article-title">ROS stress in cancer cells and therapeutic implications</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1016/j.drup.2004.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.drup.2004.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15158766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Wquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=97-110&author=H.+Pelicanoauthor=D.+Carneyauthor=P.+Huang&title=ROS+stress+in+cancer+cells+and+therapeutic+implications&doi=10.1016%2Fj.drup.2004.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ROS stress in cancer cells and therapeutic implications</span></div><div class="casAuthors">Pelicano, Helene; Carney, Dennis; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-110</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are constantly generated and eliminated in the biol. system, and play important roles in a variety of normal biochem. functions and abnormal pathol. processes.  Growing evidence suggests that cancer cells exhibit increased intrinsic ROS stress, due in part to oncogenic stimulation, increased metabolic activity, and mitochondrial malfunction.  Since the mitochondrial respiratory chain (electron transport complexes) is a major source of ROS generation in the cells, the vulnerability of the mitochondrial DNA to ROS-mediated damage appears to be a mechanism to amplify ROS stress in cancer cells.  The escalated ROS generation in cancer cells serves as an endogenous source of DNA-damaging agents that promote genetic instability and development of drug resistance.  Malfunction of mitochondria also alters cellular apoptotic response to anticancer agents.  Despite the neg. impacts of increased ROS in cancer cells, it is possible to exploit this biochem. feature and develop novel therapeutic strategies to preferentially kill cancer cells through ROS-mediated mechanisms.  This article reviews ROS stress in cancer cells, its underlying mechanisms and relationship with mitochondrial malfunction and alteration in drug sensitivity, and suggests new therapeutic strategies that take advantage of increased ROS in cancer cells to enhance therapeutic activity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2pkSeKlxObVg90H21EOLACvtfcHk0lgj-q0c4Pa6uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Wquro%253D&md5=80f41fc45cd1e43971bb118a238e2196</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2004.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2004.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPelicano%26aufirst%3DH.%26aulast%3DCarney%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DROS%2520stress%2520in%2520cancer%2520cells%2520and%2520therapeutic%2520implications%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2004%26volume%3D7%26spage%3D97%26epage%3D110%26doi%3D10.1016%2Fj.drup.2004.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sabharwal, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacker, P. T.</span><span> </span><span class="NLM_article-title">Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span><span class="refDoi"> DOI: 10.1038/nrc3803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fnrc3803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25342630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSmtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=709-721&author=S.+S.+Sabharwalauthor=P.+T.+Schumacker&title=Mitochondrial+ROS+in+cancer%3A+initiators%2C+amplifiers+or+an+Achilles%E2%80%99+heel%3F&doi=10.1038%2Fnrc3803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?</span></div><div class="casAuthors">Sabharwal, Simran S.; Schumacker, Paul T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">709-721</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mitochondria cooperate with their host cells by contributing to bioenergetics, metab., biosynthesis, and cell death or survival functions.  Reactive oxygen species (ROS) generated by mitochondria participate in stress signalling in normal cells but also contribute to the initiation of nuclear or mitochondrial DNA mutations that promote neoplastic transformation.  In cancer cells, mitochondrial ROS amplify the tumorigenic phenotype and accelerate the accumulation of addnl. mutations that lead to metastatic behavior.  As mitochondria carry out important functions in normal cells, disabling their function is not a feasible therapy for cancer.  However, ROS signalling contributes to proliferation and survival in many cancers, so the targeted disruption of mitochondria-to-cell redox communication represents a promising avenue for future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNrCJgdvCMg7Vg90H21EOLACvtfcHk0lgj-q0c4Pa6uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSmtLbO&md5=96707798e33043d755b569fd089d8617</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrc3803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3803%26sid%3Dliteratum%253Aachs%26aulast%3DSabharwal%26aufirst%3DS.%2BS.%26aulast%3DSchumacker%26aufirst%3DP.%2BT.%26atitle%3DMitochondrial%2520ROS%2520in%2520cancer%253A%2520initiators%252C%2520amplifiers%2520or%2520an%2520Achilles%25E2%2580%2599%2520heel%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D709%26epage%3D721%26doi%3D10.1038%2Fnrc3803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Durand, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">Targeting reactive oxygen species in development and progression of pancreatic cancer</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1080/14737140.2017.1261017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1080%2F14737140.2017.1261017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27841037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCgtbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=19-31&author=N.+Durandauthor=P.+Storz&title=Targeting+reactive+oxygen+species+in+development+and+progression+of+pancreatic+cancer&doi=10.1080%2F14737140.2017.1261017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting reactive oxygen species in development and progression of pancreatic cancer</span></div><div class="casAuthors">Durand, Nisha; Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-31</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDA) is characterized by expression of oncogenic KRas which drives all aspects of tumorigenesis.  Oncogenic KRas induces the formation of reactive oxygen species (ROS) which have been implicated in initiation and progression of PDA.  To facilitate tumor promoting levels and to avoid oncogene-induced senescence or cytotoxicity, ROS homeostasis in PDA cells is balanced by addnl. up-regulation of antioxidant systems.  We examine the sources of ROS in PDA, the mechanisms by which ROS homeostasis is maintained, and the biol. consequences of ROS in PDA.  Addnl., we discuss the potential mechanisms for targeting ROS homoeostasis as a point of therapeutic intervention.  An extensive review of the relevant literature as it relates to the topic was conducted using PubMed. Even though oncogenic mutations in the KRAS gene have been detected in over 95% of human pancreatic adenocarcinoma, targeting its gene product, KRas, has been difficult.  The dependency of PDA cells on balancing ROS homeostasis could be an angle for new prevention or treatment strategies.  These include use of antioxidants to prevent formation or progression of precancerous lesions, or methods to increase ROS in tumor cells to toxic levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGcAyB4qAqGbVg90H21EOLACvtfcHk0lgj-q0c4Pa6uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCgtbfO&md5=dd51ffe392d672754074fc7afa8ec44e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F14737140.2017.1261017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14737140.2017.1261017%26sid%3Dliteratum%253Aachs%26aulast%3DDurand%26aufirst%3DN.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DTargeting%2520reactive%2520oxygen%2520species%2520in%2520development%2520and%2520progression%2520of%2520pancreatic%2520cancer%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2017%26volume%3D17%26spage%3D19%26epage%3D31%26doi%3D10.1080%2F14737140.2017.1261017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pathania, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1111/bph.12855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1111%2Fbph.12855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25047070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWlsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=50-63&author=D.+Pathaniaauthor=Y.+Kuangauthor=M.+Sechiauthor=N.+Neamati&title=Mechanisms+underlying+the+cytotoxicity+of+a+novel+quinazolinedione-based+redox+modulator%2C+QD232%2C+in+pancreatic+cancer+cells&doi=10.1111%2Fbph.12855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells</span></div><div class="casAuthors">Pathania, Divya; Kuang, Yuting; Sechi, Mario; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-63</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Pancreatic cancer is characterized by alterations in several key signalling proteins, including increased expression and activity of the Src tyrosine kinase and focal adhesion kinase (FAK), which have been linked to its chemoresistance.  Sustained Src inhibition reactivates survival pathways regulated by the transcription factor STAT3, also leading to resistance.  Therefore, simultaneously targeting Src/FAK and STAT3 signalling could provide an important strategy for treating pancreatic cancer.  Recently, we described novel quinazolinediones that increased generation of reactive oxygen species (ROS) and were cytotoxic in pancreatic cancer cells.  Here, we have investigated effects of our lead compd., QD232, on Src/FAK and STAT3 signalling.  Exptl. Approach : The major signalling pathways affected by QD232 in pancreatic cancer cell lines were identified by Kinexus proteomic anal.  Changes in key signalling proteins were confirmed by Western blotting.  Cell migration was assessed by Boyden chamber and wound healing assays.  Direct inhibition of kinase activity in vitro was assayed with a panel of 92 oncogenic kinases.  Safety and efficacy of QD232 were detd. in a xenograft mouse model of pancreatic cancer.  Key Results : QD232 potently inhibited Src/FAK and STAT3 phosphorylation, decreasing pancreatic cancer cell viability and migration.  Furthermore, QD232 arrested cell cycle progression and induced apoptosis in these cells at low micromolar concns.  Effects of QD232 on Src/FAK and STAT3 phosphorylation were blocked by N-acetylcysteine or glutathione.  Conclusions and Implications : QD232 is a novel compd. with a unique, ROS-dependent mechanism, effective in drug-resistant cancer cell lines.  This compd. shows potential as therapy for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT3-x-z_lL3rVg90H21EOLACvtfcHk0lgSc9ln6f0glQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWlsLvK&md5=6471c264193699d9d78bd0f2c596008b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fbph.12855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12855%26sid%3Dliteratum%253Aachs%26aulast%3DPathania%26aufirst%3DD.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DMechanisms%2520underlying%2520the%2520cytotoxicity%2520of%2520a%2520novel%2520quinazolinedione-based%2520redox%2520modulator%252C%2520QD232%252C%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D50%26epage%3D63%26doi%3D10.1111%2Fbph.12855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Pathania, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palomba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrettini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1840</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2013.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.bbagen.2013.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23954204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOls77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1840&publication_year=2014&pages=332-343&author=D.+Pathaniaauthor=M.+Sechiauthor=M.+Palombaauthor=V.+Sannaauthor=F.+Berrettiniauthor=A.+Siasauthor=L.+Taheriauthor=N.+Neamati&title=Design+and+discovery+of+novel+quinazolinedione-based+redox+modulators+as+therapies+for+pancreatic+cancer&doi=10.1016%2Fj.bbagen.2013.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer</span></div><div class="casAuthors">Pathania, Divya; Sechi, Mario; Palomba, Michele; Sanna, Vanna; Berrettini, Francesco; Sias, Angela; Taheri, Laleh; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1840</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">332-343</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Altered cellular bioenergetics and oxidative stress are emerging hallmarks of most cancers including pancreatic cancer.  Elevated levels of intrinsic reactive oxygen species (ROS) in tumors make them more susceptible to exogenously induced oxidative stress.  Excessive oxidative insults overwhelm their adaptive antioxidant capacity and trigger ROS-mediated cell death.  Recently, we have discovered a novel class of quinazolinediones that exert their cytotoxic effects by modulating ROS-mediated signaling.  Cytotoxic potential was detd. by colorimetric and colony formation assays.  An XF24 Extracellular Flux Analyzer, and colorimetric and fluorescent techniques were used to assess the bioenergetics and oxidative stress effects, resp.  Mechanism was detd. by Western blots.  Compd. 3a (6-[(2-acetylphenyl)amino]quinazoline-5,8-dione) was identified through a medium throughput screen of ∼ 1000 highly diverse inhouse compds. and chemotherapeutic agents for their ability to alter cellular bioenergetics.  Further structural optimizations led to the discovery of a more potent analog, 3b (6-[(3-acetylphenyl)amino]quinazoline-5,8-dione) that displayed anti-proliferative activities in low micromolar range in both drug-sensitive and drug-resistant cancer cells.  Treatment with 3b causes Akt activation resulting in increased cellular oxygen consumption and oxidative stress in pancreatic cancer cells.  Moreover, oxidative stress induced by 3b promoted activation of stress kinases (p38/JNK) resulting in cancer cell death.  Treatment with antioxidants was able to reduce cell death confirming ROS-mediated cytotoxicity.  In conclusion, our novel quinazolinediones are promising lead compds. that selectively induce ROS-mediated cell death in cancer cells and warrant further preclin. studies.  Since 3b (6-[(3-acetylphenyl)amino]quinazoline-5,8-dione) exerts Akt-dependent ROS-mediated cell death, it might provide potential therapeutic options for chemoresistant and Akt-overexpressing cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtv5xHFya9e7Vg90H21EOLACvtfcHk0lgSc9ln6f0glQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOls77E&md5=cbbcaca46c9dab2968538df71746ee0d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DPathania%26aufirst%3DD.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DPalomba%26aufirst%3DM.%26aulast%3DSanna%26aufirst%3DV.%26aulast%3DBerrettini%26aufirst%3DF.%26aulast%3DSias%26aufirst%3DA.%26aulast%3DTaheri%26aufirst%3DL.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%2520and%2520discovery%2520of%2520novel%2520quinazolinedione-based%2520redox%2520modulators%2520as%2520therapies%2520for%2520pancreatic%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2014%26volume%3D1840%26spage%3D332%26epage%3D343%26doi%3D10.1016%2Fj.bbagen.2013.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Madak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Membrane permeable lipophilic cations as mitochondrial directing groups</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span><span class="refDoi"> DOI: 10.2174/1568026615666150302105622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.2174%2F1568026615666150302105622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25732791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1ymt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=745-766&author=J.+T.+Madakauthor=N.+Neamati&title=Membrane+permeable+lipophilic+cations+as+mitochondrial+directing+groups&doi=10.2174%2F1568026615666150302105622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups</span></div><div class="casAuthors">Madak, Joseph T.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">745-766</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The mitochondrion's neg. charged membrane potential has been well documented to drive the accumulation of membrane permeable delocalized lipophilic cations (DLC).  DLC attachments to known bioactive compds. can direct organelle localization and improve drug exposure to targets within the mitochondria.  Due to the mitochondria's essential function and its regulation of cell death, DLC targeted therapies are the focus of drug discovery projects altering cellular fate via mitochondrial targets.  This review provides an update on recent developments for the two main applications of DLCs: cytoprotective therapies aimed at reducing oxidative stress and cytotoxic therapies aimed at initiating cell death for the treatment of various cancers.  Both approaches have produced significant improvements using DLC conjugated compds. that include improved potency, pharmacokinetic properties, and the potential to overcome resistance mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEWZte-rFLrrVg90H21EOLACvtfcHk0lj5p8j3zMkosg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1ymt7c%253D&md5=ebd8c0db998ac0c106c40d6a6e55e372</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150302105622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150302105622%26sid%3Dliteratum%253Aachs%26aulast%3DMadak%26aufirst%3DJ.%2BT.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DMembrane%2520permeable%2520lipophilic%2520cations%2520as%2520mitochondrial%2520directing%2520groups%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D745%26epage%3D766%26doi%3D10.2174%2F1568026615666150302105622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Millard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olenyuk, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9170</span><span class="NLM_x">–</span> <span class="NLM_lpage">9179</span><span class="refDoi"> DOI: 10.1021/jm4012438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KktLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9170-9179&author=M.+Millardauthor=J.+D.+Gallagherauthor=B.+Z.+Olenyukauthor=N.+Neamati&title=A+selective+mitochondrial-targeted+chlorambucil+with+remarkable+cytotoxicity+in+breast+and+pancreatic+cancers&doi=10.1021%2Fjm4012438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Selective Mitochondrial-Targeted Chlorambucil with Remarkable Cytotoxicity in Breast and Pancreatic Cancers</span></div><div class="casAuthors">Millard, Melissa; Gallagher, John D.; Olenyuk, Bogdan Z.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9170-9179</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nitrogen mustards, widely used as chemotherapeutics, have limited safety and efficacy.  Mitochondria lack a functional nucleotide excision repair mechanism to repair DNA adducts and are sensitive to alkylating agents.  Importantly, cancer cells have higher intrinsic mitochondrial membrane potential (Δψmt) than normal cells.  Therefore, selectively targeting nitrogen mustards to cancer cell mitochondria based on Δψmt could overcome those limitations.  Herein, the authors describe the design, synthesis, and evaluation of Mito-Chlor, a triphenylphosphonium deriv. of the nitrogen mustard chlorambucil.  The authors show that Mito-Chlor localizes to cancer cell mitochondria where it acts on mtDNA to arrest cell cycle and induce cell death, resulting in a 80-fold enhancement of cell kill in a panel of breast and pancreatic cancer cell lines that are insensitive to the parent drug.  Significantly, Mito-Chlor delayed tumor progression in a mouse xenograft model of human pancreatic cancer.  This is a first example of re-purposing chlorambucil, a drug not used in breast and pancreatic cancer treatment, as a novel drug candidate for these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiXDnBfpvYybVg90H21EOLACvtfcHk0lj5p8j3zMkosg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KktLvI&md5=433d093d02a482a570ea77e3b32629a3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm4012438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012438%26sid%3Dliteratum%253Aachs%26aulast%3DMillard%26aufirst%3DM.%26aulast%3DGallagher%26aufirst%3DJ.%2BD.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DA%2520selective%2520mitochondrial-targeted%2520chlorambucil%2520with%2520remarkable%2520cytotoxicity%2520in%2520breast%2520and%2520pancreatic%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9170%26epage%3D9179%26doi%3D10.1021%2Fjm4012438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Madak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuthbertson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of brequinar conjugates as probes to study DHODH inhibition</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">13875</span><span class="NLM_x">–</span> <span class="NLM_lpage">13878</span><span class="refDoi"> DOI: 10.1002/chem.201702999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1002%2Fchem.201702999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28833638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOjsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=13875-13878&author=J.+T.+Madakauthor=C.+R.+Cuthbertsonauthor=W.+Chenauthor=H.+D.+Showalterauthor=N.+Neamati&title=Design%2C+synthesis%2C+and+characterization+of+brequinar+conjugates+as+probes+to+study+DHODH+inhibition&doi=10.1002%2Fchem.201702999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition</span></div><div class="casAuthors">Madak, Joseph T.; Cuthbertson, Christine R.; Chen, Wenmin; Showalter, Hollis D.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">56</span>),
    <span class="NLM_cas:pages">13875-13878</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Brequinar, a potent dihydroorotate dehydrogenase (DHODH) inhibitor, has been evaluated in multiple clin. trials as a potential treatment for cancer.  To further understand brequinar-based DHODH inhibition and DHODH's therapeutic relevance in cancer, we have developed novel brequinar-based probes.  We disclose a 16-step convergent synthesis of the first brequinar-PROTAC and a four-step approach towards the first mitochondrial-directed brequinar probe.  A PROTAC and mitochondria-directed probe of brequinar both possess cytotoxicity that is superior to brequinar in a colony formation assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCbV9IRIwXRLVg90H21EOLACvtfcHk0lj5p8j3zMkosg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOjsrrI&md5=30252ea9945fb5ed9265f505ff71395a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fchem.201702999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201702999%26sid%3Dliteratum%253Aachs%26aulast%3DMadak%26aufirst%3DJ.%2BT.%26aulast%3DCuthbertson%26aufirst%3DC.%2BR.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520brequinar%2520conjugates%2520as%2520probes%2520to%2520study%2520DHODH%2520inhibition%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D13875%26epage%3D13878%26doi%3D10.1002%2Fchem.201702999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almhanna, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, F. H.</span><span> </span><span class="NLM_article-title">Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer</span> <span class="citation_source-journal">Am. J. Transl Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=21139804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fis1GitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=28-47&author=S.+Aliauthor=K.+Almhannaauthor=W.+Chenauthor=P.+A.+Philipauthor=F.+H.+Sarkar&title=Differentially+expressed+miRNAs+in+the+plasma+may+provide+a+molecular+signature+for+aggressive+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer</span></div><div class="casAuthors">Ali Shadan; Almhanna Khaldoun; Chen Wei; Philip Philip A; Sarkar Fazlul H</div><div class="citationInfo"><span class="NLM_cas:title">American journal of translational research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic cancer (PC) has the poorest overall survival rate among all human cancers because of late diagnosis and absence of screening tools.  We compared the expression profile of microRNAs (miRNAs) in the plasma of patients diagnosed with PC (n=50) with healthy volunteers (n=10).  Data was further validated by quantitative realtime PCR and cell-based assays.  Thirty-seven miRNAs were down-regulated and 54 were up-regulated in plasma from patients with PC.  The expression of miR-21 was significantly higher, and the expression of let-7 family (especially let-7d) and miR-146a was significantly lower in PC.  Most interestingly, the expression of miR-21 was correlated with worse survival, and the expression of let-7 was inversely correlated with survival in this pilot study with mixed patient population.  Moreover, we found that miR-21 family was markedly over-expressed in chemo-resistant PC cell lines, which was consistent with the plasma data from PC patients.  Our previous studies have shown increased expression of miR-21 with concomitant loss of PTEN expression in PC cells, which is consistent with our current findings showing the loss of three additional targets of miR-21 (PDCD4, Maspin and TPM1).  These results suggest that identifying and validating the expression of miRNAs in newly diagnosed patients could serve as potential biomarker for tumor aggressiveness, and such miRNAs could be useful for the screening of high-risk patients, and may also serve as targets for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHSIKFKiXr0jQLBVDQn4bCfW6udTcc2eY7FZRcSVsHY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fis1GitA%253D%253D&md5=19763319038963cda07c4f56bee729c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DAlmhanna%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DPhilip%26aufirst%3DP.%2BA.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DDifferentially%2520expressed%2520miRNAs%2520in%2520the%2520plasma%2520may%2520provide%2520a%2520molecular%2520signature%2520for%2520aggressive%2520pancreatic%2520cancer%26jtitle%3DAm.%2520J.%2520Transl%2520Res.%26date%3D2010%26volume%3D3%26spage%3D28%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ouyang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaskova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M. S.</span><span> </span><span class="NLM_article-title">Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">1623</span><span class="NLM_x">–</span> <span class="NLM_lpage">1631</span><span class="refDoi"> DOI: 10.1016/S0002-9440(10)64800-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS0002-9440%2810%2964800-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=11073822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosFyhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2000&pages=1623-1631&author=H.+Ouyangauthor=L.+Mouauthor=C.+Lukauthor=N.+Liuauthor=J.+Karaskovaauthor=J.+Squireauthor=M.+S.+Tsao&title=Immortal+human+pancreatic+duct+epithelial+cell+lines+with+near+normal+genotype+and+phenotype&doi=10.1016%2FS0002-9440%2810%2964800-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype</span></div><div class="casAuthors">Ouyang, Hong; Mou, Lun-jun; Luk, Catherine; Liu, Ni; Karaskova, Jana; Squire, Jeremy; Tsao, Ming-Sound</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1623-1631</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Immortal epithelial cell lines were previously established after transduction of the HPV16-E6E7 genes into primary cultures of normal pancreatic duct epithelial cells.  Single clones were isolated that demonstrated near normal genotype and phenotype.  The proliferation of HPDE6-E6E7c7 and c11 cells is anchorage-dependent, and they were nontumorigenic in SCID mice.  The cell lines demonstrated many phenotypes of normal pancreatic duct epithelium, including mRNA expression of carbonic anhydrase II, MUC-1, and cytokeratins 7, 8, 18, and 19.  These cells have normal Ki-ras, p53, c-myc, and p16INK4A genotypes.  Cytogenetic studies demonstrated losses of 3p, 10p12, and 13q14, the latter included the Rb1 gene.  The wild-type p53 protein was detectable at very low levels consistent with the presence of E6 gene product, and the lack of functional p53 pathway was confirmed by the inability for γ-irradn. to up-regulate p53 and p21waf1/cip1 protein.  The p110/Rb protein level was also not detectable consistent with the expression of E7 protein and haploid loss of Rb1 gene.  Despite this, the proliferation of both c7 and c11 cells were markedly inhibited by transforming growth factor-β1.  This was assocd. with up-regulation of p21cip1/waf1 but not p27kip1.  Further studies showed that p130/Rb2 and cyclin D3 were expressed, suggesting that p130/Rb2 may have partially assumed the maintenance of G1 cell cycle checkpoint regulation.  These results indicate that except for the loss of p53 functional pathway, the two clones of HPDE6-E6E7 cells demonstrated a near normal genotype and phenotype of pancreatic duct epithelial cells.  These cell lines will be useful for future studies on the mol. basis of pancreatic duct cell carcinogenesis and islet cell differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonb3YiFRqHUbVg90H21EOLACvtfcHk0lhFXS3zibHKqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosFyhs7o%253D&md5=83d3a13ec1606550fc46ea0965990dc0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2964800-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252964800-6%26sid%3Dliteratum%253Aachs%26aulast%3DOuyang%26aufirst%3DH.%26aulast%3DMou%26aufirst%3DL.%26aulast%3DLuk%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DKaraskova%26aufirst%3DJ.%26aulast%3DSquire%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26atitle%3DImmortal%2520human%2520pancreatic%2520duct%2520epithelial%2520cell%2520lines%2520with%2520near%2520normal%2520genotype%2520and%2520phenotype%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2000%26volume%3D157%26spage%3D1623%26epage%3D1631%26doi%3D10.1016%2FS0002-9440%2810%2964800-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Paulsen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veloso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungman, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungman, M.</span><span> </span><span class="NLM_article-title">Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1016/j.ymeth.2013.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.ymeth.2013.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23973811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeksbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=45-54&author=M.+T.+Paulsenauthor=A.+Velosoauthor=J.+Prasadauthor=K.+Bediauthor=E.+A.+Ljungmanauthor=B.+Magnusonauthor=T.+E.+Wilsonauthor=M.+Ljungman&title=Use+of+Bru-Seq+and+BruChase-Seq+for+genome-wide+assessment+of+the+synthesis+and+stability+of+RNA&doi=10.1016%2Fj.ymeth.2013.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA</span></div><div class="casAuthors">Paulsen, Michelle T.; Veloso, Artur; Prasad, Jayendra; Bedi, Karan; Ljungman, Emily A.; Magnuson, Brian; Wilson, Thomas E.; Ljungman, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gene expression studies commonly examine total cellular RNA, which only provides information about its steady-state pool of RNA.  It remains unclear whether differences in the steady-state reflects variable rates of transcription or RNA degrdn.  To specifically monitor RNA synthesis and degrdn. genome-wide, we developed Bru-Seq and BruChase-Seq.  These assays are based on metabolic pulse-chase labeling of RNA using bromouridine (Bru).  In Bru-Seq, recently labeled RNAs are sequenced to reveal spans of nascent transcription in the genome.  In BruChase-Seq, cells are chased in uridine for different periods of time following Bru-labeling, allowing for the isolation of RNA populations of specific ages.  Here we describe these methodologies in detail and highlight their usefulness in assessing RNA synthesis and stability as well as splicing kinetics with examples of specific genes from different human cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkhkyBLXrRWrVg90H21EOLACvtfcHk0lgPOiPqDdrM7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeksbvN&md5=a18ef08d32830fe03bf5024aa7246fb9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2013.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2013.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DPaulsen%26aufirst%3DM.%2BT.%26aulast%3DVeloso%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DK.%26aulast%3DLjungman%26aufirst%3DE.%2BA.%26aulast%3DMagnuson%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DT.%2BE.%26aulast%3DLjungman%26aufirst%3DM.%26atitle%3DUse%2520of%2520Bru-Seq%2520and%2520BruChase-Seq%2520for%2520genome-wide%2520assessment%2520of%2520the%2520synthesis%2520and%2520stability%2520of%2520RNA%26jtitle%3DMethods%26date%3D2014%26volume%3D67%26spage%3D45%26epage%3D54%26doi%3D10.1016%2Fj.ymeth.2013.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Paulsen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veloso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungman, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsan, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Sinha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungman, M.</span><span> </span><span class="NLM_article-title">Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">2240</span><span class="NLM_x">–</span> <span class="NLM_lpage">2245</span><span class="refDoi"> DOI: 10.1073/pnas.1219192110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1073%2Fpnas.1219192110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23345452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVersLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=2240-2245&author=M.+T.+Paulsenauthor=A.+Velosoauthor=J.+Prasadauthor=K.+Bediauthor=E.+A.+Ljungmanauthor=Y.+C.+Tsanauthor=C.+W.+Changauthor=B.+Tarrierauthor=J.+G.+Washburnauthor=R.+Lyonsauthor=D.+R.+Robinsonauthor=C.+Kumar-Sinhaauthor=T.+E.+Wilsonauthor=M.+Ljungman&title=Coordinated+regulation+of+synthesis+and+stability+of+RNA+during+the+acute+TNF-induced+proinflammatory+response&doi=10.1073%2Fpnas.1219192110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response</span></div><div class="casAuthors">Paulsen, Michelle T.; Veloso, Artur; Prasad, Jayendra; Bedi, Karan; Ljungman, Emily A.; Tsan, Ya-Chun; Chang, Ching-Wei; Tarrier, Brendan; Washburn, Joseph G.; Lyons, Robert; Robinson, Daniel R.; Kumar-Sinha, Chandan; Wilson, Thomas E.; Ljungman, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2240-2245, S2240/1-S2240/347</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Steady-state gene expression is a coordination of synthesis and decay of RNA through epigenetic regulation, transcription factors, micro RNAs (miRNAs), and RNA-binding proteins.  Here, we present bromouride labeling and sequencing (Bru-Seq) and bromouridine pulse-chase and sequencing (BruChase-Seq) to assess genome-wide changes to RNA synthesis and stability in human fibroblasts at homeostasis and after exposure to the proinflammatory tumor necrosis factor (TNF).  The inflammatory response in human cells involves rapid and dramatic changes in gene expression, and the Bru-Seq and BruChase-Seq techniques revealed a coordinated and complex regulation of gene expression both at the transcriptional and posttranscriptional levels.  The combinatory anal. of both RNA synthesis and stability using Bru-Seq and BruChase-Seq allows for a much deeper understanding of mechanisms of gene regulation than afforded by the anal. of steady-state total RNA and should be useful in many biol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfuRwriMUd77Vg90H21EOLACvtfcHk0lgPOiPqDdrM7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVersLY%253D&md5=74e41864b9379692b3265cb7a806e7ca</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219192110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219192110%26sid%3Dliteratum%253Aachs%26aulast%3DPaulsen%26aufirst%3DM.%2BT.%26aulast%3DVeloso%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DK.%26aulast%3DLjungman%26aufirst%3DE.%2BA.%26aulast%3DTsan%26aufirst%3DY.%2BC.%26aulast%3DChang%26aufirst%3DC.%2BW.%26aulast%3DTarrier%26aufirst%3DB.%26aulast%3DWashburn%26aufirst%3DJ.%2BG.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DT.%2BE.%26aulast%3DLjungman%26aufirst%3DM.%26atitle%3DCoordinated%2520regulation%2520of%2520synthesis%2520and%2520stability%2520of%2520RNA%2520during%2520the%2520acute%2520TNF-induced%2520proinflammatory%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D2240%26epage%3D2245%26doi%3D10.1073%2Fpnas.1219192110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Jaiswal, A. K.</span><span> </span><span class="NLM_article-title">Nrf2 signaling in coordinated activation of antioxidant gene expression</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1207</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2004.02.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.freeradbiomed.2004.02.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15110384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVelsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=1199-1207&author=A.+K.+Jaiswal&title=Nrf2+signaling+in+coordinated+activation+of+antioxidant+gene+expression&doi=10.1016%2Fj.freeradbiomed.2004.02.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 signaling in coordinated activation of antioxidant gene expression</span></div><div class="casAuthors">Jaiswal, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1199-1207</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Antioxidant response element (ARE)-mediated expression and coordinated induction of antioxidant enzymes is a crit. mechanism of protection against chem. induced oxidative/electrophilic stress.  NF-E2-related nuclear factors (Nrf1 and Nrf2) bind to ARE and regulate ARE-mediated gene expression and induction.  Nrf2 is more potent than Nrf1 in activation of ARE-regulated gene expression.  Nrf2 is retained in the cytoplasm by an inhibitor INrf2.  Nrf2 binding to INrf2 leads to proteasomal degrdn. of Nrf2.  An increase in oxidative/electrophilic stress, due to chem. exposure, leads to the activation of protein kinase C (PKC) and other cytosolic factors.  PKC phosphorylation of Nrf2 at serine 40 results in the escape or release of Nrf2 from INrf2.  Nrf2 translocates to the nucleus, forms heterodimers with its unknown partner proteins, and binds to the ARE.  This leads to the coordinated activation of ARE-regulated genes.  Addnl. nuclear factor including small Mafs (MafG and MafK), large Maf (c-Maf), c-Fos, and Fra1, also bind to ARE and neg. regulate ARE-mediated gene expression.  This is presumably to keep the expression of antioxidant enzymes "in check" to maintain the cellular defenses active and/or to rapidly restore induced enzymes to normal levels.  Future investigations are expected to reveal that a balance between pos. and neg. factors regulates ARE-mediated gene expression and induction.  The future studies should also reveal a complete mechanism of signal transduction from antioxidants and xenobiotics to the transcription factors, such as Nrf2, that bind to ARE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdlKKCeHST27Vg90H21EOLACvtfcHk0lgbM_BlQgX6Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVelsL4%253D&md5=0ab1c4c25a8e063ad9db1939428ecd7f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2004.02.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2004.02.074%26sid%3Dliteratum%253Aachs%26aulast%3DJaiswal%26aufirst%3DA.%2BK.%26atitle%3DNrf2%2520signaling%2520in%2520coordinated%2520activation%2520of%2520antioxidant%2520gene%2520expression%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2004%26volume%3D36%26spage%3D1199%26epage%3D1207%26doi%3D10.1016%2Fj.freeradbiomed.2004.02.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Dinkova-Kostova, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzclaw, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talalay, P.</span><span> </span><span class="NLM_article-title">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">11908</span><span class="NLM_x">–</span> <span class="NLM_lpage">11913</span><span class="refDoi"> DOI: 10.1073/pnas.172398899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1073%2Fpnas.172398899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=12193649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11908-11913&author=A.+T.+Dinkova-Kostovaauthor=W.+D.+Holtzclawauthor=R.+N.+Coleauthor=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=M.+Yamamotoauthor=P.+Talalay&title=Direct+evidence+that+sulfhydryl+groups+of+Keap1+are+the+sensors+regulating+induction+of+phase+2+enzymes+that+protect+against+carcinogens+and+oxidants&doi=10.1073%2Fpnas.172398899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Holtzclaw, W. David; Cole, Robert N.; Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Yamamoto, Masayuki; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11908-11913</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Coordinate induction of phase 2 proteins and elevation of glutathione protect cells against the toxic and carcinogenic effects of electrophiles and oxidants.  All inducers react covalently with thiols at rates that are closely related to their potencies.  Inducers disrupt the cytoplasmic complex between the actin-bound protein Keap1 and the transcription factor Nrf2, thereby releasing Nrf2 to migrate to the nucleus where it activates the antioxidant response element (ARE) of phase 2 genes and accelerates their transcription.  We cloned, overexpressed, and purified murine Keap1 and demonstrated on native gels the formation of complexes of Keap1 with the Neh2 domain of Nrf2 and their concn.-dependent disruption by inducers such as sulforaphane and bis(2-hydroxybenzylidene)acetone.  The kinetics, stoichiometry, and order of reactivities of the most reactive of the 25 cysteine thiol groups of Keap1 have been detd. by tritium incorporation from [3H]dexamethasone mesylate (an inducer and irreversible modifier of thiols) and by UV spectroscopy with sulforaphane, 2,2'-dipyridyl disulfide and 4,4'-dipyridyl disulfide (titrants of thiol groups), and two closely related Michael reaction acceptors [bis(2- and 4-hydroxybenzylidene)acetones] that differ 100-fold in inducer potency and the UV spectra of which are bleached by thiol addn.  With large excesses of these reagents nearly all thiols of Keap1 react, but sequential reaction with three successive single equiv. (per cysteine residue) of dipyridyl disulfides revealed excellent agreement with pseudo-first order kinetics, rapid successive declines in reaction velocity, and the stoichiometric formation of two equiv. of thiopyridone per reacted cysteine.  This finding suggests that reaction of cysteine thiols is followed by rapid formation of protein disulfide linkages.  The most reactive residues of Keap1 (C257, C273, C288, and C297) were identified by mapping the dexamethasone-modified cysteines by mass spectrometry of tryptic peptides.  These residues are located in the intervening region between BTB and Kelch repeat domains of Keap1 and probably are the direct sensors of inducers of the phase 2 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAg7V1wdZgxLVg90H21EOLACvtfcHk0lgbM_BlQgX6Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D&md5=83a3b1b0549cf21153805e9c04f36620</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172398899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172398899%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DCole%26aufirst%3DR.%2BN.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DDirect%2520evidence%2520that%2520sulfhydryl%2520groups%2520of%2520Keap1%2520are%2520the%2520sensors%2520regulating%2520induction%2520of%2520phase%25202%2520enzymes%2520that%2520protect%2520against%2520carcinogens%2520and%2520oxidants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D11908%26epage%3D11913%26doi%3D10.1073%2Fpnas.172398899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Zhang, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannink, M.</span><span> </span><span class="NLM_article-title">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">8137</span><span class="NLM_x">–</span> <span class="NLM_lpage">8151</span><span class="refDoi"> DOI: 10.1128/MCB.23.22.8137-8151.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1128%2FMCB.23.22.8137-8151.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=14585973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8137-8151&author=D.+D.+Zhangauthor=M.+Hannink&title=Distinct+cysteine+residues+in+Keap1+are+required+for+Keap1-dependent+ubiquitination+of+Nrf2+and+for+stabilization+of+Nrf2+by+chemopreventive+agents+and+oxidative+stress&doi=10.1128%2FMCB.23.22.8137-8151.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span></div><div class="casAuthors">Zhang, Donna D.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8137-8151</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A common feature of diverse chemopreventive agents is the ability to activate expression of a genetic program that protects cells from reactive chem. species that if left unchecked would cause mutagenic DNA damage.  The bZIP transcription factor Nrf2 has emerged as a key regulator of this cancer-preventive genetic program.  Nrf2 is normally sequestered in the cytoplasm by a protein known as Keap1.  Chemopreventive agents allow Nrf2 to escape from Keap1-mediated repression, although the mol. mechanism(s) responsible for activation of Nrf2 is not understood.  In this report, we demonstrate that Keap1 does not passively sequester Nrf2 in the cytoplasm but actively targets Nrf2 for ubiquitination and degrdn. by the proteasome under basal culture conditions.  We have identified two crit. cysteine residues in Keap1, C273 and C288, that are required for Keap1-dependent ubiquitination of Nrf2.  Both sulforaphane, a chemopreventive isothiocyanate, and oxidative stress enable Nrf2 to escape Keap1-dependent degrdn., leading to stabilization of Nrf2, increased nuclear localization of Nrf2, and activation of Nrf2-dependent cancer-protective genes.  We have identified a third cysteine residue in Keap1, C151, that is uniquely required for inhibition of Keap1-dependent degrdn. of Nrf2 by sulforaphane and oxidative stress.  This cysteine residue is also required for a novel posttranslational modification to Keap1 that is induced by oxidative stress.  We propose that Keap1 is a component of a novel E3 ubiquitin ligase complex that is specifically targeted for inhibition by both chemopreventive agents and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqys54qQ6MlRLVg90H21EOLACvtfcHk0lhpuPzcmZnutA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D&md5=9287849578d0a6b7a6d52b67e3c65190</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.22.8137-8151.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.22.8137-8151.2003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DDistinct%2520cysteine%2520residues%2520in%2520Keap1%2520are%2520required%2520for%2520Keap1-dependent%2520ubiquitination%2520of%2520Nrf2%2520and%2520for%2520stabilization%2520of%2520Nrf2%2520by%2520chemopreventive%2520agents%2520and%2520oxidative%2520stress%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D8137%26epage%3D8151%26doi%3D10.1128%2FMCB.23.22.8137-8151.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Alam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touchard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boinapally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. L.</span><span> </span><span class="NLM_article-title">Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">26071</span><span class="NLM_x">–</span> <span class="NLM_lpage">26078</span><span class="refDoi"> DOI: 10.1074/jbc.274.37.26071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1074%2Fjbc.274.37.26071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=26071-26078&author=J.+Alamauthor=D.+Stewartauthor=C.+Touchardauthor=S.+Boinapallyauthor=A.+M.+Choiauthor=J.+L.+Cook&title=Nrf2%2C+a+Cap%E2%80%99n%E2%80%99Collar+transcription+factor%2C+regulates+induction+of+the+heme+oxygenase-1+gene&doi=10.1074%2Fjbc.274.37.26071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.37.26071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.37.26071%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DD.%26aulast%3DTouchard%26aufirst%3DC.%26aulast%3DBoinapally%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DA.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BL.%26atitle%3DNrf2%252C%2520a%2520Cap%25E2%2580%2599n%25E2%2580%2599Collar%2520transcription%2520factor%252C%2520regulates%2520induction%2520of%2520the%2520heme%2520oxygenase-1%2520gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D26071%26epage%3D26078%26doi%3D10.1074%2Fjbc.274.37.26071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Nioi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, J. D.</span><span> </span><span class="NLM_article-title">Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1042/bj20030754</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1042%2Fbj20030754" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=337-348&author=P.+Nioiauthor=M.+McMahonauthor=K.+Itohauthor=M.+Yamamotoauthor=J.+D.+Hayes&title=Identification+of+a+novel+Nrf2-regulated+antioxidant+response+element+%28ARE%29+in+the+mouse+NAD%28P%29H%3Aquinone+oxidoreductase+1+gene%3A+reassessment+of+the+ARE+consensus+sequence&doi=10.1042%2Fbj20030754"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1042%2Fbj20030754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20030754%26sid%3Dliteratum%253Aachs%26aulast%3DNioi%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520a%2520novel%2520Nrf2-regulated%2520antioxidant%2520response%2520element%2520%2528ARE%2529%2520in%2520the%2520mouse%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520gene%253A%2520reassessment%2520of%2520the%2520ARE%2520consensus%2520sequence%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D374%26spage%3D337%26epage%3D348%26doi%3D10.1042%2Fbj20030754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ross, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepa, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beall, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1016/S0009-2797(00)00199-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS0009-2797%2800%2900199-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=11154736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=77-97&author=D.+Rossauthor=J.+K.+Kepaauthor=S.+L.+Winskiauthor=H.+D.+Beallauthor=A.+Anwarauthor=D.+Siegel&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29%3A+chemoprotection%2C+bioactivation%2C+gene+regulation+and+genetic+polymorphisms&doi=10.1016%2FS0009-2797%2800%2900199-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms</span></div><div class="casAuthors">Ross, D.; Kepa, J. K.; Winski, S. L.; Beall, H. D.; Anwar, A.; Siegel, D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">77-97</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review, with 155 refs.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is an obligate two-electron reductase that is involved in chemoprotection and can also bioactivate certain antitumor quinones.  This review focuses on detoxification reactions catalyzed by NQO1 and its role in antioxidant defense via the generation of antioxidant forms of ubiquinone and vitamin E.  Bioactivation reactions catalyzed by NQO1 are also summarized and the development of new antitumor agents for the therapy of solid tumors with marked NQO1 content is reviewed.  NQO1 gene regulation and the role of the antioxidant response element and the xenobiotic response element in transcriptional regulation is summarized.  An overview of genetic polymorphisms in NQO1 is presented and biol. significance for chemoprotection, cancer susceptibility and antitumor drug action is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXdLgkTvlewbVg90H21EOLACvtfcHk0lhpuPzcmZnutA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlOntQ%253D%253D&md5=800e91c28ad691db2ab9cd749011f8c2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900199-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900199-X%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DAnwar%26aufirst%3DA.%26aulast%3DSiegel%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%253A%2520chemoprotection%252C%2520bioactivation%252C%2520gene%2520regulation%2520and%2520genetic%2520polymorphisms%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D129%26spage%3D77%26epage%3D97%26doi%3D10.1016%2FS0009-2797%2800%2900199-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Dinkova-Kostova, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talalay, P.</span><span> </span><span class="NLM_article-title">Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1016/S0891-5849(00)00300-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS0891-5849%2800%2900300-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=11035251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=231-240&author=A.+T.+Dinkova-Kostovaauthor=P.+Talalay&title=Persuasive+evidence+that+quinone+reductase+type+1+%28DT+diaphorase%29+protects+cells+against+the+toxicity+of+electrophiles+and+reactive+forms+of+oxygen&doi=10.1016%2FS0891-5849%2800%2900300-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">231-240</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 101 refs.  An extensive body of evidence supports the conclusion that by catalyzing obligatory two-electron redns. of quinones to hydroquinones, NAD(P)H:quinone reductase (QR1) protects cells against the deleterious effects of redox cycling of quinones, their ability to deplete glutathione, and to produce neoplasia.  The effects of elevation of QR1 levels by various enzyme inducers, inhibition of the enzyme by dicumarol, and genetic deletion of the enzyme (knockout mouse) are all consistent with the proposed protective functions.  Measurement of QR1 activity in murine hepatoma cells grown in 96-well microtiter plates has provided a rapid and quant. for detecting inducer activity and detg. inducer potency.  This constitutes a strategy for the identification of potential chemoprotectors against cancer.  Epidemiol. studies show that humans who are genetically deficient in QR1 are more susceptible to the hematol. toxicity and carcinogenicity of benzene exposure, and may be more susceptible to the development of a no. of malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Pc6HOOW7CrVg90H21EOLACvtfcHk0lhU4wUqjdLVOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrs%253D&md5=120350b82bb1779144d0e52557132f6c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900300-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900300-2%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DPersuasive%2520evidence%2520that%2520quinone%2520reductase%2520type%25201%2520%2528DT%2520diaphorase%2529%2520protects%2520cells%2520against%2520the%2520toxicity%2520of%2520electrophiles%2520and%2520reactive%2520forms%2520of%2520oxygen%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26spage%3D231%26epage%3D240%26doi%3D10.1016%2FS0891-5849%2800%2900300-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Choi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, J.</span><span> </span><span class="NLM_article-title">Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1165/ajrcmb.15.1.8679227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1165%2Fajrcmb.15.1.8679227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=8679227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADyaK28Xktl2rtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=9-19&author=A.+M.+Choiauthor=J.+Alam&title=Heme+oxygenase-1%3A+function%2C+regulation%2C+and+implication+of+a+novel+stress-inducible+protein+in+oxidant-induced+lung+injury&doi=10.1165%2Fajrcmb.15.1.8679227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury</span></div><div class="casAuthors">Choi, Augustine M. K.; Alam, Jawed</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-19</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Lung Association</span>)
        </div><div class="casAbstract">A review, with 58 refs.  Accumulating evidence suggests that oxidative stress plays a central role in the pathogenesis of many pulmonary diseases including adult respiratory distress syndrome, emphysema, asthma, bronchopulmonary dysplasia, and interstitial pulmonary fibrosis.  The morbidity and mortality of these diseases remain high even with optimal medical management.  In our attempts to devise new therapies for these disorders, it is crucial to improve our understanding of the basic mechanism(s) of oxidant-induced lung injury.  A major line of investigation seeks to characterize the cellular and mol. responses of the lung to oxidant insults.  Much progress has been made in our understanding of the role of the "classic" antioxidant enzymes (e.e., superoxide dismutase, catalase, glutathione peroxidase) in mediating the lung's resistance against oxidant lung injury.  However, it is becoming clear that other oxidant-induced gene products may also play vital roles in the lung's adaptive and/or protective response to oxidative stress.  One such stress-response protein is heme oxygenase-1, HO-1.  Since the identification of HO-1 in 1968, many of the studies involving this enzyme were understandably focused on the regulation and function of HO-1 in heme metab.  This emphasis is self-evident as HO-1 catalyzes the first and rate-limiting step in heme degrdn.  Interestingly, however, evidence accumulated over the past 25 yr demonstrates that HO-1 is induced not only by the substrate heme but also by a variety of non-heme inducers such as heavy metals, endotoxin, heat shock, inflammatory cytokines, and prostaglandins.  The chem. diversity of HO-1 inducers led to the speculation that HO-1, besides its role in heme degrdn., may also play a vital function in maintaining cellular homeostasis.  Further support for this hypothesis was provided by Tyrrell and colleagues who showed in 1989 that HO-1 is also highly induced by a variety of agents causing oxidative stress.  Subsequently, many investigators have focused their attention on the function and regulation of HO-1 in various in vitro and in vivo models of oxidant-mediated cellular and tissue injury.  The magnitude of HO-1 induction after oxidative stress and the wide distribution of this enzyme in systemic tissues coupled with the intriguing biol. activities of the catalytic byproducts, carbon monoxide, iron, and bilirubin, makes HO-1 a highly attractive and interesting candidate stress-response protein which may play key role(s) in mediating protection against oxidant-mediated lung injury.  This review will focus on the current understanding of the physiol. significance of HO-1 induction and the mol. regulation of HO-1 gene expression in response to oxidative stress.  We hope that this discussion will stimulate interest and investigations into a field which is still largely uncharted in the pulmonary research community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB2BigA_UOO7Vg90H21EOLACvtfcHk0lhU4wUqjdLVOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xktl2rtrk%253D&md5=0713375357221c282c34f3ef481703a8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.15.1.8679227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.15.1.8679227%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DA.%2BM.%26aulast%3DAlam%26aufirst%3DJ.%26atitle%3DHeme%2520oxygenase-1%253A%2520function%252C%2520regulation%252C%2520and%2520implication%2520of%2520a%2520novel%2520stress-inducible%2520protein%2520in%2520oxidant-induced%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1996%26volume%3D15%26spage%3D9%26epage%3D19%26doi%3D10.1165%2Fajrcmb.15.1.8679227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Shamu, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, P.</span><span> </span><span class="NLM_article-title">Oligomerization and phosphorylation of the Ire1p kinase during intracellular signaling from the endoplasmic reticulum to the nucleus</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1002%2Fj.1460-2075.1996.tb00666.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=8670804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADyaK28XjvFCgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=3028-3039&author=C.+E.+Shamuauthor=P.+Walter&title=Oligomerization+and+phosphorylation+of+the+Ire1p+kinase+during+intracellular+signaling+from+the+endoplasmic+reticulum+to+the+nucleus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomerization and phosphorylation of the Ire1p kinase during intracellular signaling from the endoplasmic reticulum to the nucleus</span></div><div class="casAuthors">Shamu, Caroline E.; Walter, Peter</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3028-3039</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The transmembrane kinase Ire1p is required for activation of the unfolded protein response (URP), the increase in transcription of genes encoding endoplasmic reticulum (ER) resident proteins that occurs in response to the accumulation of unfolded proteins in the ER.  Ire1p spans the ER membrane (or the nuclear membrane with which the ER is continuous), with its kinase domain localized in the cytoplasm or in the nucleus.  Consistent with this arrangement, it has been proposed that Ire1p senses the accumulation of unfolded proteins in the ER and transmits the signal across the membrane toward the transcription machinery, possibly by phosphorylating downstream components of the UPR pathway.  Mol. genetic and biochem. studies described here suggest that, as in the case of growth factor receptors of higher eukaryotic cells, Ire1p oligomerizes in response to the accumulation of unfolded proteins in the ER and is phosphorylated in trans by other Ire1p mols. as a result of oligomerization.  In addn. to its kinase domain, a C-terminal tail domain of Ire1p is required for induction of the UPR.  The role of the tail is probably to bind other proteins that transmit the unfolded protein signal to the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOYAh9Wp61orVg90H21EOLACvtfcHk0ljIzr7BW93mFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFCgsLY%253D&md5=74919a4457aef594c1d932cc7a49b334</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1996.tb00666.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1996.tb00666.x%26sid%3Dliteratum%253Aachs%26aulast%3DShamu%26aufirst%3DC.%2BE.%26aulast%3DWalter%26aufirst%3DP.%26atitle%3DOligomerization%2520and%2520phosphorylation%2520of%2520the%2520Ire1p%2520kinase%2520during%2520intracellular%2520signaling%2520from%2520the%2520endoplasmic%2520reticulum%2520to%2520the%2520nucleus%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D3028%26epage%3D3039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Harding, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertolotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ron, D.</span><span> </span><span class="NLM_article-title">Perk is essential for translational regulation and cell survival during the unfolded protein response</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1016/S1097-2765(00)80330-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS1097-2765%2800%2980330-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=897-904&author=H.+P.+Hardingauthor=Y.+Zhangauthor=A.+Bertolottiauthor=H.+Zengauthor=D.+Ron&title=Perk+is+essential+for+translational+regulation+and+cell+survival+during+the+unfolded+protein+response&doi=10.1016%2FS1097-2765%2800%2980330-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980330-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980330-5%26sid%3Dliteratum%253Aachs%26aulast%3DHarding%26aufirst%3DH.%2BP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBertolotti%26aufirst%3DA.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DRon%26aufirst%3DD.%26atitle%3DPerk%2520is%2520essential%2520for%2520translational%2520regulation%2520and%2520cell%2520survival%2520during%2520the%2520unfolded%2520protein%2520response%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D5%26spage%3D897%26epage%3D904%26doi%3D10.1016%2FS1097-2765%2800%2980330-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Haze, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span> </span><span class="NLM_article-title">Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3787</span><span class="NLM_x">–</span> <span class="NLM_lpage">3799</span><span class="refDoi"> DOI: 10.1091/mbc.10.11.3787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1091%2Fmbc.10.11.3787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10564271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADyaK1MXntlyrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=3787-3799&author=K.+Hazeauthor=H.+Yoshidaauthor=H.+Yanagiauthor=T.+Yuraauthor=K.+Mori&title=Mammalian+transcription+factor+ATF6+is+synthesized+as+a+transmembrane+protein+and+activated+by+proteolysis+in+response+to+endoplasmic+reticulum+stress&doi=10.1091%2Fmbc.10.11.3787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress</span></div><div class="casAuthors">Haze, Kyosuke; Yoshida, Hiderou; Yanagi, Hideki; Yura, Takashi; Mori, Kazutoshi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3787-3799</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The unfolded protein response (UPR) controls the levels of mol. chaperones and enzymes involved in protein folding in the endoplasmic reticulum (ER).  We recently isolated ATF6 as a candidate for mammalian UPR-specific transcription factor.  We report here that ATF6 constitutively expressed as a 90-kDa protein (p90ATF6) is directly converted to a 50-kDa protein (p50ATF6) in ER-stressed cells.  Furthermore, we showed that the most important consequence of this conversion was altered subcellular localization; p90ATF6 is embedded in the ER, whereas p50ATF6 is a nuclear protein.  P90ATF6 is a type II transmembrane glycoprotein with a hydrophobic stretch in the middle of the mol.  Thus, the N-terminal half contg. a basic leucine zipper motif is oriented facing the cytoplasm.  Full-length ATF6 as well as its C-terminal deletion mutant carrying the transmembrane domain is localized in the ER when transfected.  In contrast, mutant ATF6 representing the cytoplasmic region translocates into the nucleus and activates transcription of the endogenous GRP78/BiP gene.  We propose that ER stress-induced proteolysis of membrane-bound p90ATF6 releases sol. p50ATF6, leading to induced transcription in the nucleus.  Unlike yeast UPR, mammalian UPR appears to use a system similar to that reported for cholesterol homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk6OQE9Nxup7Vg90H21EOLACvtfcHk0ljIzr7BW93mFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlyrsLs%253D&md5=544de37cda67e33a415700db02a46d9d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1091%2Fmbc.10.11.3787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.10.11.3787%26sid%3Dliteratum%253Aachs%26aulast%3DHaze%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DYanagi%26aufirst%3DH.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DK.%26atitle%3DMammalian%2520transcription%2520factor%2520ATF6%2520is%2520synthesized%2520as%2520a%2520transmembrane%2520protein%2520and%2520activated%2520by%2520proteolysis%2520in%2520response%2520to%2520endoplasmic%2520reticulum%2520stress%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D1999%26volume%3D10%26spage%3D3787%26epage%3D3799%26doi%3D10.1091%2Fmbc.10.11.3787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Hetz, C.</span><span> </span><span class="NLM_article-title">The unfolded protein response: controlling cell fate decisions under ER stress and beyond</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span><span class="refDoi"> DOI: 10.1038/nrm3270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fnrm3270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=22251901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=89-102&author=C.+Hetz&title=The+unfolded+protein+response%3A+controlling+cell+fate+decisions+under+ER+stress+and+beyond&doi=10.1038%2Fnrm3270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The unfolded protein response: controlling cell fate decisions under ER stress and beyond</span></div><div class="casAuthors">Hetz, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-102</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-folding stress at the endoplasmic reticulum (ER) is a salient feature of specialized secretory cells and is also involved in the pathogenesis of many human diseases.  ER stress is buffered by the activation of the unfolded protein response (UPR), a homeostatic signaling network that orchestrates the recovery of ER function, and failure to adapt to ER stress results in apoptosis.  Progress in the field has provided insight into the regulatory mechanisms and signaling crosstalk of the 3 branches of the UPR, which are initiated by the stress sensors protein kinase RNA-like ER kinase (PERK), inositol-requiring protein 1α (IRE1α) and activating transcription factor 6 (ATF6).  In addn., novel physiol. outcomes of the UPR that are not directly related to protein-folding stress, such as innate immunity, metab. and cell differentiation, have been revealed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoytTsGjkDMDbVg90H21EOLACvtfcHk0lgRxN0c4TNAnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVeltQ%253D%253D&md5=8ed19fba32eee7eb893693d348f22e3f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnrm3270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3270%26sid%3Dliteratum%253Aachs%26aulast%3DHetz%26aufirst%3DC.%26atitle%3DThe%2520unfolded%2520protein%2520response%253A%2520controlling%2520cell%2520fate%2520decisions%2520under%2520ER%2520stress%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D89%26epage%3D102%26doi%3D10.1038%2Fnrm3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, S.</span><span> </span><span class="NLM_article-title">Role of the unfolded protein response in cell death</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1007/s10495-005-3088-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1007%2Fs10495-005-3088-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=5-13&author=R.+Kimauthor=M.+Emiauthor=K.+Tanabeauthor=S.+Murakami&title=Role+of+the+unfolded+protein+response+in+cell+death&doi=10.1007%2Fs10495-005-3088-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs10495-005-3088-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-005-3088-0%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DR.%26aulast%3DEmi%26aufirst%3DM.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DMurakami%26aufirst%3DS.%26atitle%3DRole%2520of%2520the%2520unfolded%2520protein%2520response%2520in%2520cell%2520death%26jtitle%3DApoptosis%26date%3D2006%26volume%3D11%26spage%3D5%26epage%3D13%26doi%3D10.1007%2Fs10495-005-3088-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Verfaillie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostinis, P.</span><span> </span><span class="NLM_article-title">Targeting ER stress induced apoptosis and inflammation in cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.1016/j.canlet.2010.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.canlet.2010.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=20732741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVWitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2013&pages=249-264&author=T.+Verfaillieauthor=A.+D.+Gargauthor=P.+Agostinis&title=Targeting+ER+stress+induced+apoptosis+and+inflammation+in+cancer&doi=10.1016%2Fj.canlet.2010.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting ER stress induced apoptosis and inflammation in cancer</span></div><div class="casAuthors">Verfaillie, Tom; Garg, Abhishek D.; Agostinis, Patrizia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-264</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Disturbance in the folding capacity of the endoplasmic reticulum (ER), caused by a variety of endogenous and exogenous insults, prompts a cellular stress condition known as ER stress.  ER stress is initially shaped to re-establish ER homeostasis through the activation of an integrated intracellular signal transduction pathway termed as unfolded protein response (UPR).  However, when ER stress is too severe or prolonged, the pro-survival function of the UPR turns into a toxic signal, which is predominantly executed by mitochondrial apoptosis.  Moreover, accumulating evidence implicates ER stress pathways in the activation of various classical' inflammatory processes in and around the tumor microenvironment.  In fact, ER stress pathways evoked by certain conventional or exptl. anticancer modalities have been found to promote anti-tumor immunity by enhancing immunogenicity of dying cancer cells.  Thus, the ER functions as an essential sensing organelle capable of coordinating stress pathways crucially involved in maintaining the cross-talk between the cancer cell's intracellular and extracellular environment.  In this review we discuss the emerging link between ER stress, cell fate decisions and immunomodulation and the potential therapeutic benefit of targeting this multifaceted signaling pathway in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpAzGvYM83BLVg90H21EOLACvtfcHk0lgRxN0c4TNAnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVWitLk%253D&md5=d38020e0a259ab9003d405074c5fe6ab</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2010.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2010.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaillie%26aufirst%3DT.%26aulast%3DGarg%26aufirst%3DA.%2BD.%26aulast%3DAgostinis%26aufirst%3DP.%26atitle%3DTargeting%2520ER%2520stress%2520induced%2520apoptosis%2520and%2520inflammation%2520in%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D332%26spage%3D249%26epage%3D264%26doi%3D10.1016%2Fj.canlet.2010.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Nishitoh, H.</span><span> </span><span class="NLM_article-title">CHOP is a multifunctional transcription factor in the ER stress response</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1093/jb/mvr143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1093%2Fjb%2Fmvr143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=22210905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlKksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2012&pages=217-219&author=H.+Nishitoh&title=CHOP+is+a+multifunctional+transcription+factor+in+the+ER+stress+response&doi=10.1093%2Fjb%2Fmvr143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">CHOP is a multifunctional transcription factor in the ER stress response</span></div><div class="casAuthors">Nishitoh, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-219</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The accumulation of unfolded proteins in the endoplasmic reticulum (ER) induces ER stress.  To restore ER homeostasis, cells possess a highly specific ER quality-control system called the unfold protein response (UPR).  In the case of prolonged ER stress or UPR malfunction, apoptosis signaling is activated.  This ER stress-induced apoptosis has been implicated in the pathogenesis of several conformational diseases.  CCAAT-enhancer-binding protein homologous protein (CHOP) is induced by ER stress and mediates apoptosis.  Recent studies by the Gotoh group have shown that the CHOP pathway is also involved in ER stress-induced cytokine prodn. in macrophages.  The multifunctional roles of CHOP in the ER stress response are discussed below.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRCLxqlVNdQ7Vg90H21EOLACvtfcHk0lijVS-3QxKkbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlKksL8%253D&md5=85d59d11b346c9a223ee4f0ba8766edd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvr143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvr143%26sid%3Dliteratum%253Aachs%26aulast%3DNishitoh%26aufirst%3DH.%26atitle%3DCHOP%2520is%2520a%2520multifunctional%2520transcription%2520factor%2520in%2520the%2520ER%2520stress%2520response%26jtitle%3DJ.%2520Biochem.%26date%3D2012%26volume%3D151%26spage%3D217%26epage%3D219%26doi%3D10.1093%2Fjb%2Fmvr143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Oyadomari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span> </span><span class="NLM_article-title">Roles of CHOP/GADD153 in endoplasmic reticulum stress</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4401373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fsj.cdd.4401373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=14685163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2cXit12ntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=381-389&author=S.+Oyadomariauthor=M.+Mori&title=Roles+of+CHOP%2FGADD153+in+endoplasmic+reticulum+stress&doi=10.1038%2Fsj.cdd.4401373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of CHOP/GADD153 in endoplasmic reticulum stress</span></div><div class="casAuthors">Oyadomari, S.; Mori, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-389</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Endoplasmic reticulum (ER) is the site of synthesis and folding of secretory proteins.  Perturbations of ER homeostasis affect protein folding and cause ER stress.  ER can sense the stress and respond to it through translational attenuation, upregulation of the genes for ER chaperones and related proteins, and degrdn. of unfolded proteins by a quality-control system.  However, when the ER function is severely impaired, the organelle elicits apoptotic signals.  ER stress has been implicated in a variety of common diseases such as diabetes, ischemia and neurodegenerative disorders.  One of the components of the ER stress-mediated apoptosis pathway is C/EBP homologous protein (CHOP), also known as growth arrest- and DNA damage-inducible gene 153 (GADD153).  Here, we summarize the current understanding of the roles of CHOP/GADD153 in ER stress-mediated apoptosis and in diseases including diabetes, brain ischemia and neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8UJrt59E87Vg90H21EOLACvtfcHk0lijVS-3QxKkbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXit12ntbc%253D&md5=2a4e6231233086bd7cf30c51dfe923d8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401373%26sid%3Dliteratum%253Aachs%26aulast%3DOyadomari%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DM.%26atitle%3DRoles%2520of%2520CHOP%252FGADD153%2520in%2520endoplasmic%2520reticulum%2520stress%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2004%26volume%3D11%26spage%3D381%26epage%3D389%26doi%3D10.1038%2Fsj.cdd.4401373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Ghosh, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klocke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestas, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, K. A.</span><span> </span><span class="NLM_article-title">CHOP potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stress</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e39586</span><span class="refDoi"> DOI: 10.1371/journal.pone.0039586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1371%2Fjournal.pone.0039586" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e39586&author=A.+P.+Ghoshauthor=B.+J.+Klockeauthor=M.+E.+Ballestasauthor=K.+A.+Roth&title=CHOP+potentially+co-operates+with+FOXO3a+in+neuronal+cells+to+regulate+PUMA+and+BIM+expression+in+response+to+ER+stress&doi=10.1371%2Fjournal.pone.0039586"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039586%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BP.%26aulast%3DKlocke%26aufirst%3DB.%2BJ.%26aulast%3DBallestas%26aufirst%3DM.%2BE.%26aulast%3DRoth%26aufirst%3DK.%2BA.%26atitle%3DCHOP%2520potentially%2520co-operates%2520with%2520FOXO3a%2520in%2520neuronal%2520cells%2520to%2520regulate%2520PUMA%2520and%2520BIM%2520expression%2520in%2520response%2520to%2520ER%2520stress%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De39586%26doi%3D10.1371%2Fjournal.pone.0039586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadalapaka, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">25332</span><span class="NLM_x">–</span> <span class="NLM_lpage">25344</span><span class="refDoi"> DOI: 10.1074/jbc.M109.095240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1074%2Fjbc.M109.095240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=25332-25344&author=I.+Jutooruauthor=G.+Chadalapakaauthor=P.+Leiauthor=S.+Safe&title=Inhibition+of+NFkappaB+and+pancreatic+cancer+cell+and+tumor+growth+by+curcumin+is+dependent+on+specificity+protein+down-regulation&doi=10.1074%2Fjbc.M109.095240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.095240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.095240%26sid%3Dliteratum%253Aachs%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DChadalapaka%26aufirst%3DG.%26aulast%3DLei%26aufirst%3DP.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520NFkappaB%2520and%2520pancreatic%2520cancer%2520cell%2520and%2520tumor%2520growth%2520by%2520curcumin%2520is%2520dependent%2520on%2520specificity%2520protein%2520down-regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D25332%26epage%3D25344%26doi%3D10.1074%2Fjbc.M109.095240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Kasiappan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Benzyl isothiocyanate (BITC) induces reactive oxygen species-dependent repression of STAT3 protein by down-regulation of specificity proteins in pancreatic cancer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">27122</span><span class="NLM_x">–</span> <span class="NLM_lpage">27133</span><span class="refDoi"> DOI: 10.1074/jbc.M116.746339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1074%2Fjbc.M116.746339" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=27122-27133&author=R.+Kasiappanauthor=I.+Jutooruauthor=K.+Karkiauthor=E.+Hedrickauthor=S.+Safe&title=Benzyl+isothiocyanate+%28BITC%29+induces+reactive+oxygen+species-dependent+repression+of+STAT3+protein+by+down-regulation+of+specificity+proteins+in+pancreatic+cancer&doi=10.1074%2Fjbc.M116.746339"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.746339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.746339%26sid%3Dliteratum%253Aachs%26aulast%3DKasiappan%26aufirst%3DR.%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DHedrick%26aufirst%3DE.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DBenzyl%2520isothiocyanate%2520%2528BITC%2529%2520induces%2520reactive%2520oxygen%2520species-dependent%2520repression%2520of%2520STAT3%2520protein%2520by%2520down-regulation%2520of%2520specificity%2520proteins%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D27122%26epage%3D27133%26doi%3D10.1074%2Fjbc.M116.746339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadalapaka, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghardt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2382</span><span class="NLM_x">–</span> <span class="NLM_lpage">2395</span><span class="refDoi"> DOI: 10.1128/MCB.01602-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1128%2FMCB.01602-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=24732804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGrsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=2382-2395&author=I.+Jutooruauthor=A.+S.+Guthrieauthor=G.+Chadalapakaauthor=S.+Pathiauthor=K.+Kimauthor=R.+Burghardtauthor=U.+H.+Jinauthor=S.+Safe&title=Mechanism+of+action+of+phenethylisothiocyanate+and+other+reactive+oxygen+species-inducing+anticancer+agents&doi=10.1128%2FMCB.01602-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents</span></div><div class="casAuthors">Jutooru, Indira; Guthrie, Aaron S.; Chadalapaka, Gayathri; Pathi, Satya; Kim, KyoungHyun; Burghardt, Robert; Jin, Un-Ho; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2382-2395, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS)-inducing anticancer agents such as phenethylisothiocyanate (PEITC) activate stress pathways for killing cancer cells.  Here we demonstrate that PEITC-induced ROS decreased expression of microRNA 27a (miR-27a)/miR-20a:miR-17-5p and induced miR-regulated ZBTB10/ZBTB4 and ZBTB34 transcriptional repressors, which, in turn, downregulate specificity protein (Sp) transcription factors (TFs) Sp1, Sp3, and Sp4 in pancreatic cancer cells.  Decreased expression of miR-27a/miR-20a:miR-17-5p by PEITC-induced ROS is a key step in triggering the miR-ZBTB Sp cascade leading to downregulation of Sp TFs, and this is due to ROS-dependent epigenetic effects assocd. with genome-wide shifts in repressor complexes, resulting in decreased expression of Myc and the Myc-regulated miRs.  Knockdown of Sp1 alone by RNA interference also induced apoptosis and decreased pancreatic cancer cell growth and invasion, indicating that downregulation of Sp transcription factors is an important common mechanism of action for PEITC and other ROS-inducing anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrJFKj-FYedLVg90H21EOLACvtfcHk0li2tGOQ7CMBEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGrsbjI&md5=65e5082c1df292b751afd551b1d4ccb6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FMCB.01602-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01602-13%26sid%3Dliteratum%253Aachs%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DGuthrie%26aufirst%3DA.%2BS.%26aulast%3DChadalapaka%26aufirst%3DG.%26aulast%3DPathi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DBurghardt%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DU.%2BH.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DMechanism%2520of%2520action%2520of%2520phenethylisothiocyanate%2520and%2520other%2520reactive%2520oxygen%2520species-inducing%2520anticancer%2520agents%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2014%26volume%3D34%26spage%3D2382%26epage%3D2395%26doi%3D10.1128%2FMCB.01602-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Guleng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meling, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognum, T. O.</span><span> </span><span class="NLM_article-title">Mitochondrial microsatellite instability in colorectal carcinomas--frequency and association with nuclear microsatellite instability</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1016/j.canlet.2004.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.canlet.2004.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15694669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=2005&pages=97-103&author=G.+Gulengauthor=T.+Lovigauthor=G.+I.+Melingauthor=S.+N.+Andersenauthor=T.+O.+Rognum&title=Mitochondrial+microsatellite+instability+in+colorectal+carcinomas%2D%2Dfrequency+and+association+with+nuclear+microsatellite+instability&doi=10.1016%2Fj.canlet.2004.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial microsatellite instability in colorectal carcinomas-frequency and association with nuclear microsatellite instability</span></div><div class="casAuthors">Guleng, Guttorm; Lovig, Tone; Meling, Gunn Iren; Andersen, Solveig Norheim; Rognum, Torleiv Ole</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The D310 mononucleotide repeat in the D-loop region in mitochondrial DNA has been identified as a hotspot for alterations in primary tumors.  We examd. D310 alterations as well as repeats in the ND1 and ND5 genes, in 95 colorectal carcinomas and in 95 controls without known gastrointestinal malignancy.  D310 alterations were found in 32 (34%) of the carcinomas, in contrast to two persons (2%) in the control group.  Thus, when frequency is concerned, D310 seems to be a hotspot for alterations in colorectal cancer.  No mutations were found in the ND1 and ND5 genes.  D310 instability was not assocd. with nuclear microsatellite instability, indicating different mechanisms of occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTahyWz9PAbVg90H21EOLACvtfcHk0li2tGOQ7CMBEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqsL0%253D&md5=7e5d2b28868ebc842c5bb17677f70b38</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DGuleng%26aufirst%3DG.%26aulast%3DLovig%26aufirst%3DT.%26aulast%3DMeling%26aufirst%3DG.%2BI.%26aulast%3DAndersen%26aufirst%3DS.%2BN.%26aulast%3DRognum%26aufirst%3DT.%2BO.%26atitle%3DMitochondrial%2520microsatellite%2520instability%2520in%2520colorectal%2520carcinomas--frequency%2520and%2520association%2520with%2520nuclear%2520microsatellite%2520instability%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D219%26spage%3D97%26epage%3D103%26doi%3D10.1016%2Fj.canlet.2004.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kabekkodu, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarenhas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushtagi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangaraj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopinath, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamoorthy, K.</span><span> </span><span class="NLM_article-title">Mitochondrial DNA variation analysis in cervical cancer</span> <span class="citation_source-journal">Mitochondrion</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1016/j.mito.2013.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.mito.2013.07.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=73-82&author=S.+P.+Kabekkoduauthor=S.+Bhatauthor=R.+Mascarenhasauthor=S.+Mallyaauthor=M.+Bhatauthor=D.+Pandeyauthor=P.+Kushtagiauthor=K.+Thangarajauthor=P.+M.+Gopinathauthor=K.+Satyamoorthy&title=Mitochondrial+DNA+variation+analysis+in+cervical+cancer&doi=10.1016%2Fj.mito.2013.07.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.mito.2013.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mito.2013.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DKabekkodu%26aufirst%3DS.%2BP.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DMascarenhas%26aufirst%3DR.%26aulast%3DMallya%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DD.%26aulast%3DKushtagi%26aufirst%3DP.%26aulast%3DThangaraj%26aufirst%3DK.%26aulast%3DGopinath%26aufirst%3DP.%2BM.%26aulast%3DSatyamoorthy%26aufirst%3DK.%26atitle%3DMitochondrial%2520DNA%2520variation%2520analysis%2520in%2520cervical%2520cancer%26jtitle%3DMitochondrion%26date%3D2014%26volume%3D16%26spage%3D73%26epage%3D82%26doi%3D10.1016%2Fj.mito.2013.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekele, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span> </span><span class="NLM_article-title">Alterations in the mitochondrial displacement loop in lung cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">5636</span><span class="NLM_x">–</span> <span class="NLM_lpage">5641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=14654546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVejurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=5636-5641&author=M.+Suzukiauthor=S.+Toyookaauthor=K.+Miyajimaauthor=T.+Iizasaauthor=T.+Fujisawaauthor=N.+B.+Bekeleauthor=A.+F.+Gazdar&title=Alterations+in+the+mitochondrial+displacement+loop+in+lung+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations in the mitochondrial displacement loop in lung cancers</span></div><div class="casAuthors">Suzuki, Makoto; Toyooka, Shinichi; Miyajima, Kuniharu; Iizasa, Toshihiko; Fujisawa, Takehiko; Bekele, Nebiyou B.; Gazdar, Adi F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5636-5641</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Alterations of the noncoding displacement (D) loop of mitochondrial DNA are present in many cancers.  These alterations include numerical changes in a homopolymeric C tract (PCT) at positions 303-309 and single base substitutions (SBS).  The authors detd. the frequency of D-loop alterations in lung cancer cell lines and tumors, and related them to clinicopathol. features.  The authors sequenced the entire D-loop of 28 lung cancer cell lines [12 small cell lung cancer (SCLC) and 16 non-small cell lung cancer (NSCLC)] and matched B-lymphoblastoid cell lines.  In 55 resected NSCLCs and corresponding nonmalignant lungs they detd. the length of the PCT.  In nonmalignant cell lines and tissues the most frequent PCT repeat no. was seven (36 of 83; 43%) with a range of six to nine.  Alterations, often multiple, were present in 17 of 28 (61%) of the cell lines, including 8 of 12 SCLC (67%) and 9 of 16 NSCLC (56%) lines.  They consisted of SBS in 8 of 28 lines (29%), all of which were homoplasmic, and PCT changes in 14 of 28 (50%) lines, 8 of which were homoplasmic.  Of interest, 95% (40 of 42) of the SBS were present within the two hypervariable regions in the D-loop.  Because SBS were more frequent if PCT changes were present, only the PCT no. was detd. in resected samples.  PCT changes were present in 11 of 55 (20%) of the NSCLC tumors.  Changes were never noted in tumors when the PCT no. in the nonmalignant tissue was seven, and only two tumor cell lines had changes when the PCT no. in the matched lymphoblastoid cell line was seven.  These changes were higher in squamous cell carcinomas (8 of 25; 32%) than in adenocarcinomas (3 of 30; 10%; P = 0.04) and in large tumors (T3 and T4; 7 of 20; 35%) compared with smaller tumors (T1 and T2; 4 of 35; 11%; P = 0.04).  Smoking history, gender, age, and stage were not related to frequency of PCT change.  These findings indicate that D-loop alterations are frequent in lung cancers and their cell lines, and that these changes are weakly assocd. with certain clin. parameters.  In tumors PCT changes were only present when the corresponding nonmalignant lung demonstrated a variation from the most common repeat no. of seven.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm29G4zStGurVg90H21EOLACvtfcHk0lhYVC1o-Wq5ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVejurw%253D&md5=b249e144ecd7e1f8ba4a1ac86d5d0123</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DToyooka%26aufirst%3DS.%26aulast%3DMiyajima%26aufirst%3DK.%26aulast%3DIizasa%26aufirst%3DT.%26aulast%3DFujisawa%26aufirst%3DT.%26aulast%3DBekele%26aufirst%3DN.%2BB.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26atitle%3DAlterations%2520in%2520the%2520mitochondrial%2520displacement%2520loop%2520in%2520lung%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D5636%26epage%3D5641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Wheelhouse, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigmore, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, D. J.</span><span> </span><span class="NLM_article-title">Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1272</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6602496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fsj.bjc.6602496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15785740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFWltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=1268-1272&author=N.+M.+Wheelhouseauthor=P.+B.+Laiauthor=S.+J.+Wigmoreauthor=J.+A.+Rossauthor=D.+J.+Harrison&title=Mitochondrial+D-loop+mutations+and+deletion+profiles+of+cancerous+and+noncancerous+liver+tissue+in+hepatitis+B+virus-infected+liver&doi=10.1038%2Fsj.bjc.6602496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver</span></div><div class="casAuthors">Wheelhouse, N. M.; Lai, P. B. S.; Wigmore, S. J.; Ross, J. A.; Harrison, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1268-1272</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The largest single underlying cause of hepatocellular carcinoma (HCC) worldwide is hepatitis B virus (HBV) infection.  Hepatitis B virus increases cellular oxidative stress and the development of HCC occurs after a long latency period.  The study was carried out to det. whether mitochondrial DNA abnormalities were assocd. with HCC in individuals with HBV.  The frequency of mutation and deletion of specific areas of the mitochondrial genome in tumor and matched normal tissue of patients with HBV infection was investigated in the current study.  The percentage of control subjects harboring D-loop mutations was 11%, which was significantly lower than that obsd. in both the noncancerous (49%, P=0.033) and tumor tissue (59%, P=0.014) of patients with HCC.  In contrast, the no. of cases in which the common 4977 bp deletion of the mitochondrial genome was detected was significantly greater in control liver and noncancerous liver tissue of subjects with HCC (100 and 95%, resp.) than in cancerous liver tissue (28%, P<0.001).  These observations suggest that the inflammatory process contributes to the rate of mitochondrial mutations.  However, the lower frequency of the large deletion in cancerous tissue suggests that there is selection against either mitochondria, which harbor large deletions, or against cells that contain these mitochondria during hepatocarcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqloGI3of97abVg90H21EOLACvtfcHk0lhYVC1o-Wq5ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFWltL0%253D&md5=b2522e5478dde9d431e3246a6a8e8ecc</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602496%26sid%3Dliteratum%253Aachs%26aulast%3DWheelhouse%26aufirst%3DN.%2BM.%26aulast%3DLai%26aufirst%3DP.%2BB.%26aulast%3DWigmore%26aufirst%3DS.%2BJ.%26aulast%3DRoss%26aufirst%3DJ.%2BA.%26aulast%3DHarrison%26aufirst%3DD.%2BJ.%26atitle%3DMitochondrial%2520D-loop%2520mutations%2520and%2520deletion%2520profiles%2520of%2520cancerous%2520and%2520noncancerous%2520liver%2520tissue%2520in%2520hepatitis%2520B%2520virus-infected%2520liver%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2005%26volume%3D92%26spage%3D1268%26epage%3D1272%26doi%3D10.1038%2Fsj.bjc.6602496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Lievre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapusot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinzindohoue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roignot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnould, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaune, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faivre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent-Puig, P.</span><span> </span><span class="NLM_article-title">Clinical value of mitochondrial mutations in colorectal cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3525</span><span class="refDoi"> DOI: 10.1200/JCO.2005.07.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1200%2FJCO.2005.07.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15908662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVyhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=3517-3525&author=A.+Lievreauthor=C.+Chapusotauthor=A.+M.+Bouvierauthor=F.+Zinzindohoueauthor=F.+Piardauthor=P.+Roignotauthor=L.+Arnouldauthor=P.+Beauneauthor=J.+Faivreauthor=P.+Laurent-Puig&title=Clinical+value+of+mitochondrial+mutations+in+colorectal+cancer&doi=10.1200%2FJCO.2005.07.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical value of mitochondrial mutations in colorectal cancer</span></div><div class="casAuthors">Lievre, Astrid; Chapusot, Caroline; Bouvier, Anne-Marie; Zinzindohoue, Franck; Piard, Francoise; Roignot, Patrick; Arnould, Laurent; Beaune, Philippe; Faivre, Jean; Laurent-Puig, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3517-3525</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Prognostic factors that could select high-risk recurrence colorectal cancer patients and predict chemosensitivity are needed.  Since mutations of mitochondrial DNA (mtDNA) have been described in different types of cancers and since they may play a role in response to anticancer agents, we investigated in a population-based series of colorectal cancer patients the clin. value of mtDNA mutations.  Patients and Methods: The displacement loop (D-loop) region of mtDNA was sequenced on a series of 365 patients recorded in the Digestive Cancer Registry of Cote-d'Or (France) between 1998 and 2000.  Clinicopathol. characteristics were correlated to the presence of a D-loop mutation.  Survival rates were compared with the log-rank test.  A multivariate survival anal. was performed.  Results: D-loop mutations were found in 38.3% of the tumors.  The 3-yr survival rate was 53.5% in patients with D-loop mutation vs. 62.1% in patients without (P = .05).  After adjustment for age, stage, and microsatellite instability status, the relative risk of death in patients with D-loop mutation was 1.40 (95% Cl, 1.02 to 1.93; P = .034) as compared with those without.  In stage III colon cancers, adjuvant chemotherapy was beneficial only for patients without D-loop mutation (3-yr survival, 78.3% v 45.4%, P < .02).  In those with D-loop mutation who received adjuvant chemotherapy, the relative risk of death was 4.30 (95% Cl, 1.23 to 15.00; P < .02).  Conclusion: The D-loop region is a hotspot for somatic mutations in colorectal tumors.  Moreover, presence of tumor D-loop mutation appears to be a factor of poor prognosis in colorectal patients and a factor of resistance to fluorouracil-based adjuvant chemotherapy in stage III colon cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozsFpjs65JB7Vg90H21EOLACvtfcHk0lhpRrEorXFlww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVyhsrk%253D&md5=7b8a1ff5d3711524bf9f1f6caecc5ddd</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.07.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.07.044%26sid%3Dliteratum%253Aachs%26aulast%3DLievre%26aufirst%3DA.%26aulast%3DChapusot%26aufirst%3DC.%26aulast%3DBouvier%26aufirst%3DA.%2BM.%26aulast%3DZinzindohoue%26aufirst%3DF.%26aulast%3DPiard%26aufirst%3DF.%26aulast%3DRoignot%26aufirst%3DP.%26aulast%3DArnould%26aufirst%3DL.%26aulast%3DBeaune%26aufirst%3DP.%26aulast%3DFaivre%26aufirst%3DJ.%26aulast%3DLaurent-Puig%26aufirst%3DP.%26atitle%3DClinical%2520value%2520of%2520mitochondrial%2520mutations%2520in%2520colorectal%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D3517%26epage%3D3525%26doi%3D10.1200%2FJCO.2005.07.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Ye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keinan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z.</span><span> </span><span class="NLM_article-title">Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">10654</span><span class="NLM_x">–</span> <span class="NLM_lpage">10659</span><span class="refDoi"> DOI: 10.1073/pnas.1403521111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1073%2Fpnas.1403521111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=10654-10659&author=K.+Yeauthor=J.+Luauthor=F.+Maauthor=A.+Keinanauthor=Z.+Gu&title=Extensive+pathogenicity+of+mitochondrial+heteroplasmy+in+healthy+human+individuals&doi=10.1073%2Fpnas.1403521111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1403521111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1403521111%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DF.%26aulast%3DKeinan%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DZ.%26atitle%3DExtensive%2520pathogenicity%2520of%2520mitochondrial%2520heteroplasmy%2520in%2520healthy%2520human%2520individuals%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D10654%26epage%3D10659%26doi%3D10.1073%2Fpnas.1403521111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Na, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surh, Y. J.</span><span> </span><span class="NLM_article-title">Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2013.10.819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.freeradbiomed.2013.10.819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=24200599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitleru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=353-365&author=H.+K.+Naauthor=Y.+J.+Surh&title=Oncogenic+potential+of+Nrf2+and+its+principal+target+protein+heme+oxygenase-1&doi=10.1016%2Fj.freeradbiomed.2013.10.819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1</span></div><div class="casAuthors">Na, Hye-Kyung; Surh, Young-Joon</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">353-365</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor erythroid 2-related factor 2 (Nrf2) is an essential component of cellular defense against a vast variety of endogenous and exogenous insults, including oxidative stress.  Nrf2 acts as a master switch in the circuits upregulating the expression of various stress-response proteins, esp. heme oxygenase-1 (HO-1).  Paradoxically, however, recent studies have demonstrated oncogenic functions of Nrf2 and its major target protein HO-1.  Levels of Nrf2 and HO-1 are elevated in many different types of human malignancies, which may facilitate the remodeling of the tumor microenvironment making it advantageous for the autonomic growth of cancer cells, metastasis, angiogenesis, and tolerance to chemotherapeutic agents and radiation and photodynamic therapy.  In this context, the cellular stress response or cytoprotective signaling mediated via the Nrf2-HO-1 axis is hijacked by cancer cells for their growth advantage and survival of anticancer treatment.  Therefore, Nrf2 and HO-1 may represent potential therapeutic targets in the management of cancer.  This review highlights the roles of Nrf2 and HO-1 in proliferation of cancer cells, their tolerance/resistance to anticancer treatments, and metastasis or angiogenesis in tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaE3XQc3Q1DLVg90H21EOLACvtfcHk0lhpRrEorXFlww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitleru70%253D&md5=fed50e791bb78e27585cdb07fcf80a5b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.10.819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.10.819%26sid%3Dliteratum%253Aachs%26aulast%3DNa%26aufirst%3DH.%2BK.%26aulast%3DSurh%26aufirst%3DY.%2BJ.%26atitle%3DOncogenic%2520potential%2520of%2520Nrf2%2520and%2520its%2520principal%2520target%2520protein%2520heme%2520oxygenase-1%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D67%26spage%3D353%26epage%3D365%26doi%3D10.1016%2Fj.freeradbiomed.2013.10.819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Moon, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccia, A.</span><span> </span><span class="NLM_article-title">Dual roles of NRF2 in tumor prevention and progression: Possible implications in cancer treatment</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.freeradbiomed.2014.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25458917" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=292-299&author=E.+J.+Moonauthor=A.+Giaccia&title=Dual+roles+of+NRF2+in+tumor+prevention+and+progression%3A+Possible+implications+in+cancer+treatment&doi=10.1016%2Fj.freeradbiomed.2014.11.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DGiaccia%26aufirst%3DA.%26atitle%3DDual%2520roles%2520of%2520NRF2%2520in%2520tumor%2520prevention%2520and%2520progression%253A%2520Possible%2520implications%2520in%2520cancer%2520treatment%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D79%26spage%3D292%26epage%3D299%26doi%3D10.1016%2Fj.freeradbiomed.2014.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Hayes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, M.</span><span> </span><span class="NLM_article-title">NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1016/j.tibs.2008.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.tibs.2008.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=19321346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVSkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=176-188&author=J.+D.+Hayesauthor=M.+McMahon&title=NRF2+and+KEAP1+mutations%3A+permanent+activation+of+an+adaptive+response+in+cancer&doi=10.1016%2Fj.tibs.2008.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer</span></div><div class="casAuthors">Hayes, John D.; McMahon, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">176-188</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Transcription factor nuclear factor-erythroid 2-related factor 2 (NRF2) controls cellular adaptation to oxidants and electrophiles by inducing antioxidant and detoxification genes in response to redox stress.  NRF2 is neg. regulated by Kelch-like ECH-assocd. protein 1 (KEAP1).  Tumors from ∼15% of patients with lung cancer harbor somatic mutations in KEAP1 that prevent effective NRF2 repression.  Recently, two NRF2 mutation hot-spots' were identified in ∼10% of patients with lung cancer, enabling the transcription factor to evade KEAP1-mediated repression.  Somatic mutations in KEAP1 and NRF2 provide an insight into the mol. mechanisms by which NRF2 is regulated.  Moreover, constitutive NRF2 activation might cause drug resistance in tumors, and an understanding of how the transcription factor is regulated indicates ways in which this could be overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfEHw_HJuBmbVg90H21EOLACvtfcHk0li3EImRZ7FBLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVSkt7k%253D&md5=a1440f372f38737be500a8795e7a97d0</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2008.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2008.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DMcMahon%26aufirst%3DM.%26atitle%3DNRF2%2520and%2520KEAP1%2520mutations%253A%2520permanent%2520activation%2520of%2520an%2520adaptive%2520response%2520in%2520cancer%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2009%26volume%3D34%26spage%3D176%26epage%3D188%26doi%3D10.1016%2Fj.tibs.2008.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Lister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedjadi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitteringham, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copple, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neoptolemos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldring, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. K.</span><span> </span><span class="NLM_article-title">Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/1476-4598-10-37</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1186%2F1476-4598-10-37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=21489257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltV2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=37&author=A.+Listerauthor=T.+Nedjadiauthor=N.+R.+Kitteringhamauthor=F.+Campbellauthor=E.+Costelloauthor=B.+Lloydauthor=I.+M.+Coppleauthor=S.+Williamsauthor=A.+Owenauthor=J.+P.+Neoptolemosauthor=C.+E.+Goldringauthor=B.+K.+Park&title=Nrf2+is+overexpressed+in+pancreatic+cancer%3A+implications+for+cell+proliferation+and+therapy&doi=10.1186%2F1476-4598-10-37"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy</span></div><div class="casAuthors">Lister, Adam; Nedjadi, Taoufik; Kitteringham, Neil R.; Campbell, Fiona; Costello, Eithne; Lloyd, Bryony; Copple, Ian M.; Williams, Samantha; Owen, Andrew; Neoptolemos, John P.; Goldring, Chris E.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Nrf2 is a key transcriptional regulator of a battery of genes that facilitate phase II/III drug metab. and defense against oxidative stress.  Nrf2 is largely regulated by Keap1, which directs Nrf2 for proteasomal degrdn.  The Nrf2/Keap1 system is dysregulated in lung, head and neck, and breast cancers and this affects cellular proliferation and response to therapy.  Here, we have investigated the integrity of the Nrf2/Keap1 system in pancreatic cancer.  Results: Keap1, Nrf2 and the Nrf2 target genes AKR1c1 and GCLC were detected in a panel of five pancreatic cancer cell lines.  Mutation anal. of NRF2 exon 2 and KEAP1 exons 2-6 in these cell lines identified no mutations in NRF2 and only synonomous mutations in KEAP1.  RNAi depletion of Nrf2 caused a decrease in the proliferation of Suit-2, MiaPaca-2 and FAMPAC cells and enhanced sensitivity to gemcitabine (Suit-2), 5-flurouracil (FAMPAC), cisplatin (Suit-2 and FAMPAC) and gamma radiation (Suit-2).  The expression of Nrf2 and Keap1 was also analyzed in pancreatic ductal adenocarcinomas (n = 66 and 57, resp.) and matching normal benign epithelium (n = 21 cases).  While no significant correlation was seen between the expression levels of Keap1 and Nrf2 in the tumors, interestingly, Nrf2 staining was significantly greater in the cytoplasm of tumors compared to benign ducts (P<0.001).  Conclusions Expression of Nrf2 is up-regulated in pancreatic cancer cell lines and ductal adenocarcinomas.  This may reflect a greater intrinsic capacity of these cells to respond to stress signals and resist chemotherapeutic interventions.  Nrf2 also appears to support proliferation in certain pancreatic adenocarinomas.  Therefore, strategies to pharmacol. manipulate the levels and/or activity of Nrf2 may have the potential to reduce pancreatic tumor growth, and increase sensitivity to therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreSsAuu7vbI7Vg90H21EOLACvtfcHk0li3EImRZ7FBLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltV2ntL4%253D&md5=a0a1c733c9e2144650d6ed21f30340e5</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-10-37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-10-37%26sid%3Dliteratum%253Aachs%26aulast%3DLister%26aufirst%3DA.%26aulast%3DNedjadi%26aufirst%3DT.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DCampbell%26aufirst%3DF.%26aulast%3DCostello%26aufirst%3DE.%26aulast%3DLloyd%26aufirst%3DB.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DOwen%26aufirst%3DA.%26aulast%3DNeoptolemos%26aufirst%3DJ.%2BP.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DNrf2%2520is%2520overexpressed%2520in%2520pancreatic%2520cancer%253A%2520implications%2520for%2520cell%2520proliferation%2520and%2520therapy%26jtitle%3DMol.%2520Cancer%26date%3D2011%26volume%3D10%26spage%3D37%26doi%3D10.1186%2F1476-4598-10-37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Arlt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geismann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, H.</span><span> </span><span class="NLM_article-title">Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">4825</span><span class="NLM_x">–</span> <span class="NLM_lpage">4835</span><span class="refDoi"> DOI: 10.1038/onc.2012.493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fonc.2012.493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23108405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyjsrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=4825-4835&author=A.+Arltauthor=S.+Sebensauthor=S.+Krebsauthor=C.+Geismannauthor=M.+Grossmannauthor=M.+L.+Kruseauthor=S.+Schreiberauthor=H.+Schafer&title=Inhibition+of+the+Nrf2+transcription+factor+by+the+alkaloid+trigonelline+renders+pancreatic+cancer+cells+more+susceptible+to+apoptosis+through+decreased+proteasomal+gene+expression+and+proteasome+activity&doi=10.1038%2Fonc.2012.493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity</span></div><div class="casAuthors">Arlt, A.; Sebens, S.; Krebs, S.; Geismann, C.; Grossmann, M.; Kruse, M-L.; Schreiber, S.; Schaefer, H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">4825-4835</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Evidence accumulates that the transcription factor nuclear factor E2-related factor 2 (Nrf2) has an essential role in cancer development and chemoresistance, thus pointing to its potential as an anticancer target and undermining its suitability in chemoprevention.  Through the induction of cytoprotective and proteasomal genes, Nrf2 confers apoptosis protection in tumor cells, and inhibiting Nrf2 would therefore be an efficient strategy in anticancer therapy.  In the present study, pancreatic carcinoma cell lines (Panc1, Colo357 and MiaPaca2) and H6c7 pancreatic duct cells were analyzed for the Nrf2-inhibitory effect of the coffee alkaloid trigonelline (trig), as well as for its impact on Nrf2-dependent proteasome activity and resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and anticancer drug-induced apoptosis.  Chemoresistant Panc1 and Colo357 cells exhibit high constitutive Nrf2 activity, whereas chemosensitive MiaPaca2 and H6c7 cells display little basal but strong tert-butylhydroquinone (tBHQ)-inducible Nrf2 activity and drug resistance.  Trig efficiently decreased basal and tBHQ-induced Nrf2 activity in all cell lines, an effect relying on a reduced nuclear accumulation of the Nrf2 protein.  Along with Nrf2 inhibition, trig blocked the Nrf2-dependent expression of proteasomal genes (for example, s5a/psmd4 and α5/psma5) and reduced proteasome activity in all cell lines tested.  These blocking effects were absent after treatment with Nrf2 siRNA, a condition in which proteasomal gene expression and proteasome activity were already decreased, whereas siRNA against the related transcription factor Nrf1 did not affect proteasome activity and the inhibitory effect of trig.  Depending on both Nrf2 and proteasomal gene expression, the sensitivity of all cell lines to anticancer drugs and TRAIL-induced apoptosis was enhanced by trig.  Moreover, greater antitumor responses toward anticancer drug treatment were obsd. in tumor-bearing mice when receiving trig.  In conclusion, representing an efficient Nrf2 inhibitor capable of blocking Nrf2-dependent proteasome activity and thereby apoptosis protection in pancreatic cancer cells, trig might be beneficial in improving anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1uD5vWn0aALVg90H21EOLACvtfcHk0lhxf-5w4h7_2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyjsrbL&md5=3fb3a122c1cabe14251448dbdc0d7ec4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.493%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DA.%26aulast%3DSebens%26aufirst%3DS.%26aulast%3DKrebs%26aufirst%3DS.%26aulast%3DGeismann%26aufirst%3DC.%26aulast%3DGrossmann%26aufirst%3DM.%26aulast%3DKruse%26aufirst%3DM.%2BL.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DSchafer%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520the%2520Nrf2%2520transcription%2520factor%2520by%2520the%2520alkaloid%2520trigonelline%2520renders%2520pancreatic%2520cancer%2520cells%2520more%2520susceptible%2520to%2520apoptosis%2520through%2520decreased%2520proteasomal%2520gene%2520expression%2520and%2520proteasome%2520activity%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D4825%26epage%3D4835%26doi%3D10.1038%2Fonc.2012.493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Dhillon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chikara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindl, K. M.</span><span> </span><span class="NLM_article-title">Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage</span> <span class="citation_source-journal">Toxicol Rep</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span><span class="refDoi"> DOI: 10.1016/j.toxrep.2014.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.toxrep.2014.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25530945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFWktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=309-318&author=H.+Dhillonauthor=S.+Chikaraauthor=K.+M.+Reindl&title=Piperlongumine+induces+pancreatic+cancer+cell+death+by+enhancing+reactive+oxygen+species+and+DNA+damage&doi=10.1016%2Fj.toxrep.2014.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage</span></div><div class="casAuthors">Dhillon, Harsharan; Chikara, Shireen; Reindl, Katie M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">309-318</span>CODEN:
                <span class="NLM_cas:coden">TROEF9</span>;
        ISSN:<span class="NLM_cas:issn">2214-7500</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pancreatic cancer is one of the most deadly cancers with a nearly 95% mortality rate.  The poor response of pancreatic cancer to currently available therapies and the extremely low survival rate of pancreatic cancer patients point to a crit. need for alternative therapeutic strategies.  The use of reactive oxygen species (ROS)-inducing agents has emerged as an innovative and effective strategy to treat various cancers.  In this study, we investigated the potential of a known ROS inducer, piperlongumine (PPLGM), a bioactive agent found in long peppers, to induce pancreatic cancer cell death in cell culture and animal models.  We found that PPLGM inhibited the growth of pancreatic cancer cell cultures by elevating ROS levels and causing DNA damage.  PPLGM-induced DNA damage and pancreatic cancer cell death was reversed by treating the cells with an exogenous antioxidant.  Similar to the in vitro studies, PPLGM caused a redn. in tumor growth in a xenograft mouse model of human pancreatic cancer.  Tumors from the PPLGM-treated animals showed decreased Ki-67 and increased 8-OHdG expression, suggesting PPLGM inhibited tumor cell proliferation and enhanced oxidative stress.  Taken together, our results show that PPLGM is an effective inhibitor for in vitro and in vivo growth of pancreatic cancer cells, and that it works through a ROS-mediated DNA damage pathway.  These findings suggest that PPLGM has the potential to be used for treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-34z6fNJ5fLVg90H21EOLACvtfcHk0lhxf-5w4h7_2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFWktr8%253D&md5=b309c470b101793c55ab0e36e7916512</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.toxrep.2014.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxrep.2014.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DH.%26aulast%3DChikara%26aufirst%3DS.%26aulast%3DReindl%26aufirst%3DK.%2BM.%26atitle%3DPiperlongumine%2520induces%2520pancreatic%2520cancer%2520cell%2520death%2520by%2520enhancing%2520reactive%2520oxygen%2520species%2520and%2520DNA%2520damage%26jtitle%3DToxicol%2520Rep%26date%3D2014%26volume%3D1%26spage%3D309%26epage%3D318%26doi%3D10.1016%2Fj.toxrep.2014.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Dorr, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landowski, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, S.</span><span> </span><span class="NLM_article-title">Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines</span> <span class="citation_source-journal">Int. J. Gastrointest. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">015</span><span class="NLM_x">–</span> <span class="NLM_lpage">028</span><span class="refDoi"> DOI: 10.1385/IJGC:36:1:015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1385%2FIJGC%3A36%3A1%3A015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=16227632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1eiu7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2005&pages=015-028&author=R.+T.+Dorrauthor=M.+A.+Raymondauthor=T.+H.+Landowskiauthor=N.+O.+Romanauthor=S.+Fukushima&title=Induction+of+apoptosis+and+cell+cycle+arrest+by+imexon+in+human+pancreatic+cancer+cell+lines&doi=10.1385%2FIJGC%3A36%3A1%3A015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines</span></div><div class="casAuthors">Dorr, Robert T.; Raymond, Mary Ann; Landowski, Terry H.; Roman, Nicholas O.; Fukushima, Shoji</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Gastrointestinal Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-28</span>CODEN:
                <span class="NLM_cas:coden">IJGCAJ</span>;
        ISSN:<span class="NLM_cas:issn">1537-3649</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Imexon is an aziridine-contg. small mol. currently in Phase I clin. trials.  This agent has been shown to bind to thiols and increase intracellular oxidants, inducing apoptosis in hematol. cancer cells.  Pancreatic cancers are known to be sensitive to oxidn., suggesting this disease may be an appropriate target for this agent.  The current report examines the activity of imexon in pancreatic cells.  Imexon induced concn.-dependent and time-dependent apoptosis in a panel of six human pancreatic carcinoma cell (PCC) lines.  The mean IC50 for growth inhibition by the SRB assay was 200 (101) μM for a 48 h exposure with a range of 64-358 μM.  Cell killing was schedule-dependent, favoring exposure times ≥48 h.  Imexon-treated MiaPaCa-2 cells underwent non-lethal growth arrest following exposure to concns. ≤200 μM for 48 h.  When concns. were increased to 300 μM for ≥48 h, the MiaPaCa-2 cells arrested in G2 phase and activated caspases 3, 8, and 9 were detected.  After a 72 h exposure to the IC80 concn. of imexon, cells exhibited a loss of mitochondrial membrane potential detected by CMXRos staining.  However, there was no loss of reduced cellular thiols unless very high concns. of ≥400 μM were used.  In contrast, reactive oxygen species (ROS) were elevated in a dose-dependent fashion, starting at very low imexon concns.  Imexon also significantly inhibited MiaPaCa-2 tumor growth in SCID mice at 100 mg/kg/d for 9 d.  The tumor growth inhibition (% T/C) was 27% of control, and the tumor growth delay was 21 d, indicating an active agent by NCI stds.  The levels of imexon that are cytotoxic in human PCC's are achievable based on the preliminary results of the ongoing Phase I trial.  Imexon appears to be active against PCCs in vitro and has an entirely novel mechanism of action involving G2 arrest, accumulation of ROS, and the induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8OKBkKs3l3rVg90H21EOLACvtfcHk0lhpLSZR7ZuJdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1eiu7bJ&md5=0913fe235123502be25ede9b0b6629b8</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1385%2FIJGC%3A36%3A1%3A015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FIJGC%253A36%253A1%253A015%26sid%3Dliteratum%253Aachs%26aulast%3DDorr%26aufirst%3DR.%2BT.%26aulast%3DRaymond%26aufirst%3DM.%2BA.%26aulast%3DLandowski%26aufirst%3DT.%2BH.%26aulast%3DRoman%26aufirst%3DN.%2BO.%26aulast%3DFukushima%26aufirst%3DS.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520imexon%2520in%2520human%2520pancreatic%2520cancer%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Gastrointest.%2520Cancer%26date%3D2005%26volume%3D36%26spage%3D015%26epage%3D028%26doi%3D10.1385%2FIJGC%3A36%3A1%3A015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Cohen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalupski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modiano, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conkling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorr, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boytim, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersh, E. M.</span><span> </span><span class="NLM_article-title">A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1007/s00280-009-1162-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1007%2Fs00280-009-1162-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=19855966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1alsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=287-294&author=S.+J.+Cohenauthor=M.+M.+Zalupskiauthor=M.+R.+Modianoauthor=P.+Conklingauthor=Y.+Z.+Pattauthor=P.+Davisauthor=R.+T.+Dorrauthor=M.+L.+Boytimauthor=E.+M.+Hersh&title=A+phase+I+study+of+imexon+plus+gemcitabine+as+first-line+therapy+for+advanced+pancreatic+cancer&doi=10.1007%2Fs00280-009-1162-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer</span></div><div class="casAuthors">Cohen, Steven J.; Zalupski, Mark M.; Modiano, Manuel R.; Conkling, Paul; Patt, Yehuda Z.; Davis, Peg; Dorr, Robert T.; Boytim, Michelle L.; Hersh, Evan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Imexon is an aziridine-derived iminopyrrolidone which has synergy with gemcitabine in pancreatic cancer cell lines.  Gemcitabine is a std. therapy for pancreatic cancer.  We performed a phase I trial of imexon and gemcitabine to evaluate safety, dose-limiting toxicity (DLT), and max. tolerated dose (MTD) in patients with advanced pancreatic cancer.  Patients with untreated locally advanced or metastatic pancreatic adenocarcinoma received therapy in sequential cohorts on regimen A (n = 19; imexon 200 or 280 mg/m2 i.v. over 30 min days 1-5, 15-19 and gemcitabine 800 or 1000 mg/m2 i.v. over 30 min on days 1, 8, 15, every 28 days) or regimen B (n = 86; imexon 280-1,300 mg/m2 i.v. over 30-60 min days 1, 8, and 15 and gemcitabine 1000 mg/m2 i.v. over 30 min on days 1, 8, and 15 every 28 days).  105 Patients received 340 treatment cycles (median 2, range 1-16).  Patient characteristics: median age 63, 61% male, ECOG PS 0/1 50%/50%, 93% metastatic.  DLT was abdominal cramping and pain, often with transient, acute diarrhea.  Best response was confirmed partial response (PR) in 11.4%, 8.9% unconfirmed PR, and 48.1% with stable disease.  There was a dose proportional increase in imexon AUC across the doses tested with terminal half life 69 min at the MTD and no alteration of gemcitabine pharmacokinetics.  The recommended phase II dose of imexon is 875 mg/m2 with gemcitabine 1000 mg/m2.  DLT was acute abdominal pain and cramping.  Encouraging antitumor responses support further evaluation of this combination in advanced pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMSm8oSO2R3LVg90H21EOLACvtfcHk0lhpLSZR7ZuJdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1alsL8%253D&md5=5630161aab6bea628dd8eb5047bc9c4f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2Fs00280-009-1162-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-009-1162-y%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DZalupski%26aufirst%3DM.%2BM.%26aulast%3DModiano%26aufirst%3DM.%2BR.%26aulast%3DConkling%26aufirst%3DP.%26aulast%3DPatt%26aufirst%3DY.%2BZ.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DDorr%26aufirst%3DR.%2BT.%26aulast%3DBoytim%26aufirst%3DM.%2BL.%26aulast%3DHersh%26aufirst%3DE.%2BM.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520imexon%2520plus%2520gemcitabine%2520as%2520first-line%2520therapy%2520for%2520advanced%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D66%26spage%3D287%26epage%3D294%26doi%3D10.1007%2Fs00280-009-1162-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Malhotra, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, R. J.</span><span> </span><span class="NLM_article-title">Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2277</span><span class="NLM_x">–</span> <span class="NLM_lpage">2293</span><span class="refDoi"> DOI: 10.1089/ars.2007.1782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1089%2Fars.2007.1782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=17979528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1GrsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=2277-2293&author=J.+D.+Malhotraauthor=R.+J.+Kaufman&title=Endoplasmic+reticulum+stress+and+oxidative+stress%3A+a+vicious+cycle+or+a+double-edged+sword%3F&doi=10.1089%2Fars.2007.1782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?</span></div><div class="casAuthors">Malhotra, Jyoti D.; Kaufman, Randal J.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2277-2294</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The endoplasmic reticulum (ER) is a well-orchestrated protein-folding machine composed of protein chaperones, proteins that catalyze protein folding, and sensors that detect the presence of misfolded or unfolded proteins.  A sensitive surveillance mechanism exists to prevent misfolded proteins from transiting the secretory pathway and ensures that persistently misfolded proteins are directed toward a degradative pathway.  The unfolded protein response (UPR) is an intracellular signaling pathway that coordinates ER protein-folding demand with protein-folding capacity and is essential to adapt to homeostatic alterations that cause protein misfolding.  These include changes in intraluminal calcium, altered glycosylation, nutrient deprivation, pathogen infection, expression of folding-defective proteins, and changes in redox status.  The ER provides a unique oxidizing folding-environment that favors the formation of the disulfide bonds.  Accumulating evidence suggests that protein folding and generation of reactive oxygen species (ROS) as a byproduct of protein oxidn. in the ER are closely linked events.  It has also become apparent that activation of the UPR on exposure to oxidative stress is an adaptive mechanism to preserve cell function and survival.  Persistent oxidative stress and protein misfolding initiate apoptotic cascades and are now known to play predominant roles in the pathogenesis of multiple human diseases including diabetes, atherosclerosis, and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpesElrZ8K6fbVg90H21EOLACvtfcHk0liA-hqxTXdNcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1GrsLzL&md5=3a36ff2200b23ec16ce6d02717149210</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1782%26sid%3Dliteratum%253Aachs%26aulast%3DMalhotra%26aufirst%3DJ.%2BD.%26aulast%3DKaufman%26aufirst%3DR.%2BJ.%26atitle%3DEndoplasmic%2520reticulum%2520stress%2520and%2520oxidative%2520stress%253A%2520a%2520vicious%2520cycle%2520or%2520a%2520double-edged%2520sword%253F%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D2277%26epage%3D2293%26doi%3D10.1089%2Fars.2007.1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Falkenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, C. M.</span><span> </span><span class="NLM_article-title">DNA replication and transcription in mammalian mitochondria</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.76.060305.152028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1146%2Fannurev.biochem.76.060305.152028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=17408359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=679-699&author=M.+Falkenbergauthor=N.+G.+Larssonauthor=C.+M.+Gustafsson&title=DNA+replication+and+transcription+in+mammalian+mitochondria&doi=10.1146%2Fannurev.biochem.76.060305.152028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">DNA replication and transcription in mammalian mitochondria</span></div><div class="casAuthors">Falkenberg, Maria; Larsson, Nils-Goeran; Gustafsson, Claes M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">679-699</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The mitochondrion was originally a free-living prokaryotic organism, which explains the presence of a compact mammalian mitochondrial DNA (mtDNA) in contemporary mammalian cells.  The genome encodes for key subunits of the electron transport chain and RNA components needed for mitochondrial translation.  Nuclear genes encode the enzyme systems responsible for mtDNA replication and transcription.  Several of the key components of these systems are related to proteins replicating and transcribing DNA in phages.  This observation has led to the proposition that some genes required for DNA replication and transcription were acquired together from a phage early in the evolution of the eukaryotic cell, already at the time of the mitochondrial endosymbiosis.  Recent years have seen a rapid development in the mol. understanding of these machineries, but many aspects still remain unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWW_PjZM-qTrVg90H21EOLACvtfcHk0lji7xoH0YR7oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehtbzK&md5=107375dbb12d81d6ce398be43d732c3d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.76.060305.152028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.76.060305.152028%26sid%3Dliteratum%253Aachs%26aulast%3DFalkenberg%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DN.%2BG.%26aulast%3DGustafsson%26aufirst%3DC.%2BM.%26atitle%3DDNA%2520replication%2520and%2520transcription%2520in%2520mammalian%2520mitochondria%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2007%26volume%3D76%26spage%3D679%26epage%3D699%26doi%3D10.1146%2Fannurev.biochem.76.060305.152028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Montoya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardi, G.</span><span> </span><span class="NLM_article-title">The pattern of transcription of the human mitochondrial rRNA genes reveals two overlapping transcription units</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1016/0092-8674(83)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2F0092-8674%2883%2990145-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1983&pages=151-9&author=J.+Montoyaauthor=G.+L.+Gainesauthor=G.+Attardi&title=The+pattern+of+transcription+of+the+human+mitochondrial+rRNA+genes+reveals+two+overlapping+transcription+units&doi=10.1016%2F0092-8674%2883%2990145-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2883%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252883%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DJ.%26aulast%3DGaines%26aufirst%3DG.%2BL.%26aulast%3DAttardi%26aufirst%3DG.%26atitle%3DThe%2520pattern%2520of%2520transcription%2520of%2520the%2520human%2520mitochondrial%2520rRNA%2520genes%2520reveals%2520two%2520overlapping%2520transcription%2520units%26jtitle%3DCell%26date%3D1983%26volume%3D34%26spage%3D151%26epage%3D9%26doi%3D10.1016%2F0092-8674%2883%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Ojala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardi, G.</span><span> </span><span class="NLM_article-title">tRNA punctuation model of RNA processing in human mitochondria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1038/290470a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2F290470a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1981&pages=470-474&author=D.+Ojalaauthor=J.+Montoyaauthor=G.+Attardi&title=tRNA+punctuation+model+of+RNA+processing+in+human+mitochondria&doi=10.1038%2F290470a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2F290470a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F290470a0%26sid%3Dliteratum%253Aachs%26aulast%3DOjala%26aufirst%3DD.%26aulast%3DMontoya%26aufirst%3DJ.%26aulast%3DAttardi%26aufirst%3DG.%26atitle%3DtRNA%2520punctuation%2520model%2520of%2520RNA%2520processing%2520in%2520human%2520mitochondria%26jtitle%3DNature%26date%3D1981%26volume%3D290%26spage%3D470%26epage%3D474%26doi%3D10.1038%2F290470a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Subramanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mootha, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomeroy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesirov, J. P.</span><span> </span><span class="NLM_article-title">Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">15545</span><span class="NLM_x">–</span> <span class="NLM_lpage">15550</span><span class="refDoi"> DOI: 10.1073/pnas.0506580102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1073%2Fpnas.0506580102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=16199517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=15545-15550&author=A.+Subramanianauthor=P.+Tamayoauthor=V.+K.+Moothaauthor=S.+Mukherjeeauthor=B.+L.+Ebertauthor=M.+A.+Gilletteauthor=A.+Paulovichauthor=S.+L.+Pomeroyauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=J.+P.+Mesirov&title=Gene+set+enrichment+analysis%3A+a+knowledge-based+approach+for+interpreting+genome-wide+expression+profiles&doi=10.1073%2Fpnas.0506580102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</span></div><div class="casAuthors">Subramanian, Aravind; Tamayo, Pablo; Mootha, Vamsi K.; Mukherjee, Sayan; Ebert, Benjamin L.; Gillette, Michael A.; Paulovich, Amanda; Pomeroy, Scott L.; Golub, Todd R.; Lander, Eric S.; Mesirov, Jill P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15545-15550</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although genomewide RNA expression anal. has become a routine tool in biomedical research, extg. biol. insight from such information remains a major challenge.  Here, we describe a powerful anal. method called Gene Set Enrichment Anal. (GSEA) for interpreting gene expression data.  The method derives its power by focusing on gene sets, i.e., groups of genes that share common biol. function, chromosomal location, or regulation.  We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer.  Notably, where single-gene anal. finds little similarity between two independent studies of patients survival in lung cancer, GSEA reveals many biol. pathways in common.  The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biol. defined gene sets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH2_E6gWd0yrVg90H21EOLACvtfcHk0lj8hghXeOTjKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO&md5=ca2eb221010f20379199e6442c65fc2e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506580102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506580102%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGillette%26aufirst%3DM.%2BA.%26aulast%3DPaulovich%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26atitle%3DGene%2520set%2520enrichment%2520analysis%253A%2520a%2520knowledge-based%2520approach%2520for%2520interpreting%2520genome-wide%2520expression%2520profiles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D15545%26epage%3D15550%26doi%3D10.1073%2Fpnas.0506580102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Mootha, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sihag, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puigserver, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridderstrale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurila, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houstis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesirov, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegelman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschhorn, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altshuler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groop, L. C.</span><span> </span><span class="NLM_article-title">PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1038/ng1180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fng1180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=12808457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFSrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=267-273&author=V.+K.+Moothaauthor=C.+M.+Lindgrenauthor=K.+F.+Erikssonauthor=A.+Subramanianauthor=S.+Sihagauthor=J.+Leharauthor=P.+Puigserverauthor=E.+Carlssonauthor=M.+Ridderstraleauthor=E.+Laurilaauthor=N.+Houstisauthor=M.+J.+Dalyauthor=N.+Pattersonauthor=J.+P.+Mesirovauthor=T.+R.+Golubauthor=P.+Tamayoauthor=B.+Spiegelmanauthor=E.+S.+Landerauthor=J.+N.+Hirschhornauthor=D.+Altshulerauthor=L.+C.+Groop&title=PGC-1alpha-responsive+genes+involved+in+oxidative+phosphorylation+are+coordinately+downregulated+in+human+diabetes&doi=10.1038%2Fng1180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</span></div><div class="casAuthors">Mootha, Vamsi K.; Lindgren, Cecilia M.; Eriksson, Karl-Fredrik; Subramanian, Aravind; Sihag, Smita; Lehar, Joseph; Puigserver, Pere; Carlsson, Emma; Ridderstrale, Martin; Laurila, Esa; Houstis, Nicholas; Daly, Mark J.; Patterson, Nick; Mesirov, Jill P.; Golub, Todd R.; Tamayo, Pablo; Spiegelman, Bruce; Lander, Eric S.; Hirschhorn, Joel N.; Altshuler, David; Groop, Leif C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">DNA microarrays can be used to identify gene expression changes characteristic of human disease.  This is challenging, however, when relevant differences are subtle at the level of individual genes.  We introduce an anal. strategy, Gene Set Enrichment Anal., designed to detect modest but coordinate changes in the expression of groups of functionally related genes.  Using this approach, we identify a set of genes involved in oxidative phosphorylation whose expression is coordinately decreased in human diabetic muscle.  Expression of these genes is high at sites of insulin-mediated glucose disposal, activated by PGC-1α and correlated with total-body aerobic capacity.  Our results assoc. this gene set with clin. important variation in human metab. and illustrate the value of pathway relationships in the anal. of genomic profiling expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6DlqdMV1i-rVg90H21EOLACvtfcHk0ljuW1Wd60orHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFSrs7o%253D&md5=98e5a8107603527d570829235359f0a7</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fng1180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1180%26sid%3Dliteratum%253Aachs%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DLindgren%26aufirst%3DC.%2BM.%26aulast%3DEriksson%26aufirst%3DK.%2BF.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DSihag%26aufirst%3DS.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DPuigserver%26aufirst%3DP.%26aulast%3DCarlsson%26aufirst%3DE.%26aulast%3DRidderstrale%26aufirst%3DM.%26aulast%3DLaurila%26aufirst%3DE.%26aulast%3DHoustis%26aufirst%3DN.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DPatterson%26aufirst%3DN.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DSpiegelman%26aufirst%3DB.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DHirschhorn%26aufirst%3DJ.%2BN.%26aulast%3DAltshuler%26aufirst%3DD.%26aulast%3DGroop%26aufirst%3DL.%2BC.%26atitle%3DPGC-1alpha-responsive%2520genes%2520involved%2520in%2520oxidative%2520phosphorylation%2520are%2520coordinately%2520downregulated%2520in%2520human%2520diabetes%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D267%26epage%3D273%26doi%3D10.1038%2Fng1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Akash S. Ubale, Moseen A. Shaikh, <span class="NLM_string-name hlFld-ContribAuthor">Boopathy Gnanaprakasam</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential Oxidative Fragmentation and Skeletal Rearrangement of Peroxides for the Synthesis of Quinazolinone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (14)
                                     , 9621-9636. <a href="https://doi.org/10.1021/acs.joc.1c00889" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00889</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00889%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSequential%252BOxidative%252BFragmentation%252Band%252BSkeletal%252BRearrangement%252Bof%252BPeroxides%252Bfor%252Bthe%252BSynthesis%252Bof%252BQuinazolinone%252BDerivatives%26aulast%3DUbale%26aufirst%3DAkash%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D17042021%26date%3D07072021%26volume%3D86%26issue%3D14%26spage%3D9621%26epage%3D9636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yi Gou, MeiRong Chen, Shanhe Li, JunGang Deng, Jinlong Li, GuiHua Fang, Feng Yang, <span class="NLM_string-name hlFld-ContribAuthor">GuoJin Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5485-5499. <a href="https://doi.org/10.1021/acs.jmedchem.0c01936" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01936</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01936%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDithiocarbazate-Copper%252BComplexes%252Bfor%252BBioimaging%252Band%252BTreatment%252Bof%252BPancreatic%252BCancer%26aulast%3DGou%26aufirst%3DYi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D08112020%26date%3D16042021%26volume%3D64%26issue%3D9%26spage%3D5485%26epage%3D5499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chaitanya A. Kulkarni, Brian D. Fink, Bettine E. Gibbs, Pratik R. Chheda, Meng Wu, William I. Sivitz, <span class="NLM_string-name hlFld-ContribAuthor">Robert J. Kerns</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Triphenylphosphonium Carrier to Target Mitochondria without Uncoupling Oxidative Phosphorylation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 662-676. <a href="https://doi.org/10.1021/acs.jmedchem.0c01671" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01671%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BTriphenylphosphonium%252BCarrier%252Bto%252BTarget%252BMitochondria%252Bwithout%252BUncoupling%252BOxidative%252BPhosphorylation%26aulast%3DKulkarni%26aufirst%3DChaitanya%2BA.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D23092020%26date%3D04012021%26volume%3D64%26issue%3D1%26spage%3D662%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shuai Hu, Mario Sechi, Pankaj Kumar Singh, Lipeng Dai, Sean McCann, Duxin Sun, Mats Ljungman, <span class="NLM_string-name hlFld-ContribAuthor">Nouri Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9838-9855. <a href="https://doi.org/10.1021/acs.jmedchem.0c01016" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BRedox%252BModulator%252BInduces%252Ba%252BGPX4-Mediated%252BCell%252BDeath%252BThat%252BIs%252BDependent%252Bon%252BIron%252Band%252BReactive%252BOxygen%252BSpecies%26aulast%3DHu%26aufirst%3DShuai%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15062020%26date%3D28082020%26date%3D18082020%26volume%3D63%26issue%3D17%26spage%3D9838%26epage%3D9855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hui Chen, Peng Li, Rongfei Qin, Hong Yan, Gang Li, <span class="NLM_string-name hlFld-ContribAuthor">Haihong Huang</span>. </span><span class="cited-content_cbyCitation_article-title">DMAP-Catalyzed One-Pot Synthesis of Quinazoline-2,4-diones from 2-Aminobenzamides and Di-tert-butyl Dicarbonate. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (16)
                                     , 9614-9623. <a href="https://doi.org/10.1021/acsomega.0c01104" title="DOI URL">https://doi.org/10.1021/acsomega.0c01104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c01104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c01104%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDMAP-Catalyzed%252BOne-Pot%252BSynthesis%252Bof%252BQuinazoline-2%25252C4-diones%252Bfrom%252B2-Aminobenzamides%252Band%252BDi-tert-butyl%252BDicarbonate%26aulast%3DChen%26aufirst%3DHui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12032020%26date%3D09042020%26date%3D16042020%26volume%3D5%26issue%3D16%26spage%3D9614%26epage%3D9623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xingsen Wu, Xiang Li, Zhihong Li, Yancheng Yu, Qidong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (24)
                                     , 11280-11297. <a href="https://doi.org/10.1021/acs.jmedchem.8b01424" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01424</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01424%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNonquinone%252BSubstrates%252Bfor%252BNAD%252528P%252529H%25253A%252BQuinone%252BOxidoreductase%252B1%252B%252528NQO1%252529%252Bas%252BEffective%252BIntracellular%252BROS%252BGenerators%252Bfor%252Bthe%252BTreatment%252Bof%252BDrug-Resistant%252BNon-Small-Cell%252BLung%252BCancer%26aulast%3DWu%26aufirst%3DXingsen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13092018%26date%3D10122018%26date%3D03122018%26volume%3D61%26issue%3D24%26spage%3D11280%26epage%3D11297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiying  Zhang</span>, <span class="hlFld-ContribAuthor ">Shujing  Xu</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of quinones as a privileged structure in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113632. <a href="https://doi.org/10.1016/j.ejmech.2021.113632" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113632%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bof%252Bquinones%252Bas%252Ba%252Bprivileged%252Bstructure%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZhang%26aufirst%3DLi%26date%3D2021%26volume%3D223%26spage%3D113632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pelin  Telkoparan-Akillilar</span>, <span class="hlFld-ContribAuthor ">Emiliano  Panieri</span>, <span class="hlFld-ContribAuthor ">Dilek  Cevik</span>, <span class="hlFld-ContribAuthor ">Sibel  Suzen</span>, <span class="hlFld-ContribAuthor ">Luciano  Saso</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (5)
                                     , 1417. <a href="https://doi.org/10.3390/molecules26051417" title="DOI URL">https://doi.org/10.3390/molecules26051417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26051417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26051417%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTherapeutic%252BTargeting%252Bof%252Bthe%252BNRF2%252BSignaling%252BPathway%252Bin%252BCancer%26aulast%3DTelkoparan-Akillilar%26aufirst%3DPelin%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D5%26spage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadine  Abdel Hadi</span>, <span class="hlFld-ContribAuthor ">Gabriela  Reyes-Castellanos</span>, <span class="hlFld-ContribAuthor ">Alice  Carrier</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Redox Metabolism in Pancreatic Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (4)
                                     , 1534. <a href="https://doi.org/10.3390/ijms22041534" title="DOI URL">https://doi.org/10.3390/ijms22041534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22041534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22041534%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTargeting%252BRedox%252BMetabolism%252Bin%252BPancreatic%252BCancer%26aulast%3DAbdel%2BHadi%26aufirst%3DNadine%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D4%26spage%3D1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elvira  Gonzalez de Mejia</span>, <span class="hlFld-ContribAuthor ">Miguel  Rebollo-Hernanz</span>, <span class="hlFld-ContribAuthor ">Yolanda  Aguilera</span>, <span class="hlFld-ContribAuthor ">Maria A.  Martín-Cabrejas</span>. </span><span class="cited-content_cbyCitation_article-title">Role of anthocyanins in oxidative stress and the prevention of cancer in the digestive system. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 265-280. <a href="https://doi.org/10.1016/B978-0-12-819547-5.00024-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-819547-5.00024-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819547-5.00024-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819547-5.00024-9%26sid%3Dliteratum%253Aachs%26atitle%3DRole%252Bof%252Banthocyanins%252Bin%252Boxidative%252Bstress%252Band%252Bthe%252Bprevention%252Bof%252Bcancer%252Bin%252Bthe%252Bdigestive%252Bsystem%26aulast%3DGonzalez%2Bde%2BMejia%26aufirst%3DElvira%26date%3D2021%26spage%3D265%26epage%3D280%26pub%3DElsevier%26atitle%3DCancer%26date%3D2021%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daisuke  Uchida</span>, <span class="hlFld-ContribAuthor ">Akinobu  Takaki</span>, <span class="hlFld-ContribAuthor ">Atsushi  Oyama</span>, <span class="hlFld-ContribAuthor ">Takuya  Adachi</span>, <span class="hlFld-ContribAuthor ">Nozomu  Wada</span>, <span class="hlFld-ContribAuthor ">Hideki  Onishi</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Okada</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Nutrients</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1576. <a href="https://doi.org/10.3390/nu12061576" title="DOI URL">https://doi.org/10.3390/nu12061576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/nu12061576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fnu12061576%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrients%26atitle%3DOxidative%252BStress%252BManagement%252Bin%252BChronic%252BLiver%252BDiseases%252Band%252BHepatocellular%252BCarcinoma%26aulast%3DUchida%26aufirst%3DDaisuke%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang-Jiang  Qin</span>, <span class="hlFld-ContribAuthor ">Xiang-Dong  Cheng</span>, <span class="hlFld-ContribAuthor ">Jia  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei-Dong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review. </span><span class="cited-content_cbyCitation_journal-name">Cell Communication and Signaling</span><span> <strong>2019,</strong> <em>17 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12964-019-0435-2" title="DOI URL">https://doi.org/10.1186/s12964-019-0435-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12964-019-0435-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12964-019-0435-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Communication%2520and%2520Signaling%26atitle%3DDual%252Broles%252Band%252Btherapeutic%252Bpotential%252Bof%252BKeap1-Nrf2%252Bpathway%252Bin%252Bpancreatic%252Bcancer%25253A%252Ba%252Bsystematic%252Breview%26aulast%3DQin%26aufirst%3DJiang-Jiang%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akinobu  Takaki</span>, <span class="hlFld-ContribAuthor ">Seiji  Kawano</span>, <span class="hlFld-ContribAuthor ">Daisuke  Uchida</span>, <span class="hlFld-ContribAuthor ">Masahiro  Takahara</span>, <span class="hlFld-ContribAuthor ">Sakiko  Hiraoka</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Okada</span>. </span><span class="cited-content_cbyCitation_article-title">Paradoxical Roles of Oxidative Stress Response in the Digestive System before and after Carcinogenesis. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (2)
                                     , 213. <a href="https://doi.org/10.3390/cancers11020213" title="DOI URL">https://doi.org/10.3390/cancers11020213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11020213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11020213%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DParadoxical%252BRoles%252Bof%252BOxidative%252BStress%252BResponse%252Bin%252Bthe%252BDigestive%252BSystem%252Bbefore%252Band%252Bafter%252BCarcinogenesis%26aulast%3DTakaki%26aufirst%3DAkinobu%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D2%26spage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai  Hu</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Yanghan  Liu</span>, <span class="hlFld-ContribAuthor ">Mats  Ljungman</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 884-895. <a href="https://doi.org/10.1016/j.ejmech.2018.09.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bmechanistic%252Bstudies%252Bof%252Bquinolin-chlorobenzothioate%252Bderivatives%252Bwith%252Bproteasome%252Binhibitory%252Bactivity%252Bin%252Bpancreatic%252Bcancer%252Bcell%252Blines%26aulast%3DHu%26aufirst%3DShuai%26date%3D2018%26volume%3D158%26spage%3D884%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Han</span>, <span class="hlFld-ContribAuthor ">Yanli  An</span>, <span class="hlFld-ContribAuthor ">Gang  Jia</span>, <span class="hlFld-ContribAuthor ">Xihui  Wang</span>, <span class="hlFld-ContribAuthor ">Chen  He</span>, <span class="hlFld-ContribAuthor ">Yinan  Ding</span>, <span class="hlFld-ContribAuthor ">Qiusha  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Theranostic micelles based on upconversion nanoparticles for dual-modality imaging and photodynamic therapy in hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Nanoscale</span><span> <strong>2018,</strong> <em>10 </em>
                                    (14)
                                     , 6511-6523. <a href="https://doi.org/10.1039/C7NR09717D" title="DOI URL">https://doi.org/10.1039/C7NR09717D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7NR09717D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7NR09717D%26sid%3Dliteratum%253Aachs%26jtitle%3DNanoscale%26atitle%3DTheranostic%252Bmicelles%252Bbased%252Bon%252Bupconversion%252Bnanoparticles%252Bfor%252Bdual-modality%252Bimaging%252Band%252Bphotodynamic%252Btherapy%252Bin%252Bhepatocellular%252Bcarcinoma%26aulast%3DHan%26aufirst%3DYong%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D14%26spage%3D6511%26epage%3D6523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Select Examples of Drugs Containing Quinone or a Michael Acceptor That Are FDA-Approved or under Clinical Investigations for Various Diseases</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Structure of Lead Compound <b>QD232</b> and Design of Title Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for the Preparation of the Key Intermediate <b>QD323</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) conc. HNO<sub>3</sub>, (CH<sub>3</sub>CO)<sub>2</sub>O, 0 °C, 1.5 h; (<i>ii</i>) H<sub>2</sub>NCHO, HCl<sub>(g)</sub> from 40 to 80 °C, 1h; (<i>iii</i>) glacial CH<sub>3</sub>COOH, Zn, 0 °C for 2 h, rt for 4 h; (<i>iv</i>) (NH<sub>4</sub>)<sub>2</sub>Ce(NO<sub>3</sub>)<sub>6</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O, 0 °C, 20 min.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compounds <b>QD324</b>–<b>338</b>, <b>353</b>–<b>355</b>, <b>357</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) CeCl<sub>3</sub>·7H<sub>2</sub>O, abs EtOH, rt, 1–6 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of <b>QD356</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) CeCl<sub>3</sub>·7H<sub>2</sub>O, abs EtOH, rt, 2 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <b>QD339</b>, <b>340</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) MeCN, reflux, 16 h; (<i>ii</i>) 4-aminobenzoic acid, DIPEA, HBtU, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h; (<i>iii</i>) CeCl<sub>3</sub>·7H<sub>2</sub>O, abs EtOH, rt, 2 h.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of <b>QD358, 359</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (<i>i</i>) MeCN, reflux, 16 h; (<i>ii</i>) 3-aminobenzoic acid, DIPEA, HBtU, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h; (<i>iii</i>) CeCl<sub>3</sub>·7H<sub>2</sub>O, abs EtOH, rt, 1.5 h.</p></p></figure><figure data-id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cytotoxicity of the QD compounds is reduced by NAC in MIA PaCa-2 cells. (A) The parental compound <b>QD232</b> induces ROS accumulation in a dose- and time-dependent manner. The new analogues <b>QD325</b> and <b>QD326</b> induced a stronger and more rapid ROS accumulation in MIA PaCa-2 cells than the parental <b>QD232</b> compound. Compounds were tested at 10, 3.3, or 1.1 μM. DMSO was used as a negative control to determine the basal signal of the assay (DMSO). Cells without preloaded H2DCFDA were treated with compounds at 10 μM at the same conditions to determine the endogenous fluorescence of the compounds (no stain). Data points represent mean ± SD from duplicates. Graphs are representatives of three independent experiments. (B) ROS induction by <b>QD232</b>, <b>325</b>, and <b>326</b> was inhibited by NAC pretreatment (5 mM for 30 min). Data points represent mean ± SD from duplicates. Graphs are representatives of three independent experiments. (C) Presence of NAC at 5 mM decreased the cytotoxicity of the <b>QD232</b>, <b>QD325</b>, and <b>QD326</b> compounds. Cytotoxicity was determined by the MTT assay after a 72 h treatment. Data points represent mean ± SD from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. QD compounds induce oxidative stress and the unfolded protein response. (A) Top 15 canonical pathways induced by <b>QD232</b> or <b>QD325</b> treatment as revealed by IPA analysis of Bru-seq data. MIA PaCa-2 cells were treated with <b>QD232</b> (at 1, 2, or 3 times IC<sub>50</sub>) or <b>QD325</b> (at 1, 2, or 5 times IC<sub>50</sub>) for 4 h. Nascent RNA was labeled with 2 mM bromouridine during the last 30 min of treatment, immunocaptured, converted to cDNA libraries and deep sequenced. (B) Transcription of oxidative stress responsive genes <i>NQO1</i> and <i>HMOX1</i> was upregulated by <b>QD232</b> or <b>QD325</b> treatment in MIA PaCa-2 cells in a dose-dependent manner. (C) Transcription of unfolded protein response target genes <i>DDIT3</i> and <i>HSPA5</i> was upregulated by <b>QD232</b> or <b>QD325</b> treatment in MIA PaCa-2 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. QD compounds induce protein expression of target genes for oxidative stress and unfolded protein response. Expression levels of oxidative stress responsive proteins NQO1, HO-1, and unfolded protein response target proteins CHOP and GRP78 were regulated to different extents by <b>QD232</b> or <b>QD325</b> treatment time dependently in (A) MIA PaCa-2, (B) Panc-1, and (C) BxPC-3 cells. Protein levels were quantified by ImageJ and normalized to respective loading controls. Data on quantification plots represent mean ± SD from three independent experiments. <i>p</i> values were calculated using student’s <i>t</i> test. *, <i>p</i> < 0.05; **, <i>p</i> < 0.01, ***, <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. QD compounds show selective inhibition of transcription from the mitochondrial genome. (A) Nascent mitochondrial RNA synthesis was inhibited following a 4-h treatment with <b>QD232</b> (at 6.9 μM) or <b>QD325</b> (at 5.0 μM) in MIA PaCa-2 cells. Top forward arrows represent transcripts from the heavy strand. While the shorter arrow represents the shorter rRNA transcript regulated by the HSP1 promoter, the longer arrow represents transcript regulated by the HSP2 promoter that covers the full length of the heavy strand of the mitochondrial genome. Bottom reverse arrow represents the light strand transcript regulated by the LSP promoter. Transcription signals from DMSO-treated control cells are shown in yellow, while transcription signals from the <b>QD232</b>-treated cells are shown in blue, and signals from the <b>QD325</b>-treated cells are shown in red. The full-length transcripts from both heavy and light strands are further processed into functional tRNA, rRNA and mRNA molecules, whose corresponding genes are shown at the bottom of the panel. (B) Protein (COXIII) expression levels of the mitochondrial gene <i>COIII</i> were decreased by treatment of the QD compounds in MIA PaCa-2 cells. Protein levels were quantified by ImageJ and normalized to respective loading controls. Data on quantification plots represent mean ± SD from three independent experiments. <i>p</i> values were calculated using student’s <i>t</i> test. *, <i>p</i> < 0.05; **, <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>QD325</b> inhibits tumor growth of MIA PaCa-2 xenograft without systemic toxicity. (A) MIA PaCa-2 engrafted NOD/SCID mice were randomized into vehicle control (<i>n</i> = 5) or <b>QD325</b> treatment (<i>n</i> = 5) group when tumor size reached 65 mm<sup>3</sup>. <b>QD325</b> was given at 5 mg/kg five times a week until day 44. (B) Body weight of engrafted mice was not affected by <b>QD325</b> treatment at 5 mg/kg five times a week until day 44. Data points represent mean ± SEM. (C) Representative micrographs of hematoxylin and eosin (H&E)-stained organ sections. Images were taken with an Olympus IX83 inverted microscope at 20× magnification. Histopathology inspection showed no major microscopic changes in major organs after <b>QD325</b> treatment at 5 mg/kg five times a week until day 44. (D) Representative immunohistochemistry images for Ki67 staining of MIA PaCa-2 xenograft sections. <b>QD325</b> decreased Ki67 index (percentage of Ki67 positive cells in the field) of treated tumors. Data represents mean ± SD (<i>n</i> = 9, 3 tumors from each group, 3 images of each tumor section). <i>p</i> values were calculated using student’s <i>t</i> test. (E) NQO1, HO-1, CHOP, GRP78 protein levels in vehicle or <b>QD325</b>-treated MIA PaCa-2 xenografts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/medium/jm-2017-01463b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>QD325</b> inhibits tumor growth of MIA PaCa-2 xenograft. (A) <b>QD325</b> treatment at 5 mg/kg inhibits growth of MIA PaCa-2 xenograft in NOD/SCID mice. MIA PaCa-2 engrafted mice were randomized into vehicle control (<i>n</i> = 5) or <b>QD325</b> treatment (<i>n</i> = 5) group when tumor size reached 65 mm<sup>3</sup>. <b>QD325</b> was given at 5 mg/kg five times a week until day 44. Three mice from each group were euthanized for tissue analysis. Two mice remained in each group after day 44 and <b>QD325</b> dose was increased from 5 mg/kg to 20 mg/kg until day 67. (B) Body weight of engrafted mice was not affected by <b>QD325</b> treatment from 5 to 20 mg/kg. Error bars indicate mean ± SEM. (C) Gemcitabine treatment at 15 mg/kg inhibits growth of MIA PaCa-2 xenograft in NOD/SCID mice. MIA PaCa-2 engrafted mice were randomized into vehicle control (<i>n</i> = 4), gemcitabine treatment 1 (<i>n</i> = 3), gemcitabine treatment 2 (<i>n</i> = 4) groups when tumor size reached 75 mm<sup>3</sup>. In treatment 1, gemcitabine was given at 15 mg/kg once a week for 48 days; in treatment 2, gemcitabine was given at 15 mg/kg twice a week for 15 days. Data points represent mean ± SEM. (D) Body weight of engrafted mice is not affected by gemcitabine treatment in either dosing frequency. (E) <b>QD325</b> treatment at 5 mg/kg inhibits growth of MIA PaCa-2 xenograft in NOD/SCID mice. MIA PaCa-2 engrafted mice were randomized into vehicle control (<i>n</i> = 4), gemcitabine treatment (<i>n</i> = 3), <b>QD325</b> treatment (<i>n</i> = 3) and combination treatment groups (<i>n</i> = 3) when tumor size reached 75 mm<sup>3</sup>. <b>QD325</b> was given at 5 mg/kg five times a week and gemcitabine was given at 15 mg/kg once a week. Data points represent mean ± SEM. (F) Body weight of engrafted mice was not affected by gemcitabine or <b>QD325</b> treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01463/20180215/images/large/jm-2017-01463b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01463&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 77 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Siegel, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer statistics, 2017</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.3322/caac.21387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.3322%2Fcaac.21387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28055103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC1c7isFWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2017&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2017&doi=10.3322%2Fcaac.21387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Statistics, 2017</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2017, 1,688,780 new cancer cases and 600,920 cancer deaths are projected to occur in the United States.  For all sites combined, the cancer incidence rate is 20% higher in men than in women, while the cancer death rate is 40% higher.  However, sex disparities vary by cancer type.  For example, thyroid cancer incidence rates are 3-fold higher in women than in men (21 vs 7 per 100,000 population), despite equivalent death rates (0.5 per 100,000 population), largely reflecting sex differences in the "epidemic of diagnosis." Over the past decade of available data, the overall cancer incidence rate (2004-2013) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2005-2014) declined by about 1.5% annually in both men and women.  From 1991 to 2014, the overall cancer death rate dropped 25%, translating to approximately 2,143,200 fewer cancer deaths than would have been expected if death rates had remained at their peak.  Although the cancer death rate was 15% higher in blacks than in whites in 2014, increasing access to care as a result of the Patient Protection and Affordable Care Act may expedite the narrowing racial gap; from 2010 to 2015, the proportion of blacks who were uninsured halved, from 21% to 11%, as it did for Hispanics (31% to 16%).  Gains in coverage for traditionally underserved Americans will facilitate the broader application of existing cancer control knowledge across every segment of the population.  CA Cancer J Clin 2017;67:7-30. © 2017 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB4oj7vNRTIb5oR8RchjrrfW6udTcc2eaORH5BQ4vLpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7isFWgtA%253D%253D&md5=e439f3424d5a773e4ae289c392236ad6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21387%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202017%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2017%26volume%3D67%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Sohal, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangu, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khorana, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uronis, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engebretson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggiero, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copur, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laheru, D.</span><span> </span><span class="NLM_article-title">Metastatic pancreatic cancer: American Society of Clinical Oncology clinical practice guideline</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2784</span><span class="NLM_x">–</span> <span class="NLM_lpage">2796</span><span class="refDoi"> DOI: 10.1200/JCO.2016.67.1412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1200%2FJCO.2016.67.1412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27247222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fltl2qtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=2784-2796&author=D.+P.+Sohalauthor=P.+B.+Manguauthor=A.+A.+Khoranaauthor=M.+A.+Shahauthor=P.+A.+Philipauthor=E.+M.+O%E2%80%99Reillyauthor=H.+E.+Uronisauthor=R.+K.+Ramanathanauthor=C.+H.+Craneauthor=A.+Engebretsonauthor=J.+T.+Ruggieroauthor=M.+S.+Copurauthor=M.+Lauauthor=S.+Urbaauthor=D.+Laheru&title=Metastatic+pancreatic+cancer%3A+American+Society+of+Clinical+Oncology+clinical+practice+guideline&doi=10.1200%2FJCO.2016.67.1412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline</span></div><div class="casAuthors">Sohal Davendra P S; Mangu Pamela B; Khorana Alok A; Shah Manish A; Philip Philip A; O'Reilly Eileen M; Uronis Hope E; Ramanathan Ramesh K; Crane Christopher H; Engebretson Anitra; Ruggiero Joseph T; Copur Mehmet S; Lau Michelle; Urba Susan; Laheru Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2784-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To provide evidence-based recommendations to oncologists and others for the treatment of patients with metastatic pancreatic cancer.  METHODS:  American Society of Clinical Oncology convened an Expert Panel of medical oncology, radiation oncology, surgical oncology, gastroenterology, palliative care, and advocacy experts to conduct a systematic review of the literature from April 2004 to June 2015.  Outcomes were overall survival, disease-free survival, progression-free survival, and adverse events.  RESULTS:  Twenty-four randomized controlled trials met the systematic review criteria.  RECOMMENDATIONS:  A multiphase computed tomography scan of the chest, abdomen, and pelvis should be performed.  Baseline performance status and comorbidity profile should be evaluated.  Goals of care, patient preferences, treatment response, psychological status, support systems, and symptom burden should guide decisions for treatments.  A palliative care referral should occur at first visit.  FOLFIRINOX (leucovorin, fluorouracil, irinotecan, and oxaliplatin; favorable comorbidity profile) or gemcitabine plus nanoparticle albumin-bound (NAB) -paclitaxel (adequate comorbidity profile) should be offered to patients with Eastern Cooperative Oncology Group performance status (ECOG PS) 0 to 1 based on patient preference and support system available.  Gemcitabine alone is recommended for patients with ECOG PS 2 or with a comorbidity profile that precludes other regimens; the addition of capecitabine or erlotinib may be offered.  Patients with an ECOG PS ≥ 3 and poorly controlled comorbid conditions should be offered cancer-directed therapy only on a case-by-case basis; supportive care should be emphasized.  For second-line therapy, gemcitabine plus NAB-paclitaxel should be offered to patients with first-line treatment with FOLFIRINOX, an ECOG PS 0 to 1, and a favorable comorbidity profile; fluorouracil plus oxaliplatin, irinotecan, or nanoliposomal irinotecan should be offered to patients with first-line treatment with gemcitabine plus NAB-paclitaxel, ECOG PS 0 to 1, and favorable comorbidity profile, and gemcitabine or fluorouracil should be offered to patients with either an ECOG PS 2 or a comorbidity profile that precludes other regimens.  Additional information is available at www.asco.org/guidelines/MetPC and www.asco.org/guidelineswiki.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJv2riehYPOZQHPYJuLg8TfW6udTcc2eaORH5BQ4vLpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fltl2qtg%253D%253D&md5=ac8fe5f540eff233a3010d69d93960bd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2016.67.1412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2016.67.1412%26sid%3Dliteratum%253Aachs%26aulast%3DSohal%26aufirst%3DD.%2BP.%26aulast%3DMangu%26aufirst%3DP.%2BB.%26aulast%3DKhorana%26aufirst%3DA.%2BA.%26aulast%3DShah%26aufirst%3DM.%2BA.%26aulast%3DPhilip%26aufirst%3DP.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DE.%2BM.%26aulast%3DUronis%26aufirst%3DH.%2BE.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DCrane%26aufirst%3DC.%2BH.%26aulast%3DEngebretson%26aufirst%3DA.%26aulast%3DRuggiero%26aufirst%3DJ.%2BT.%26aulast%3DCopur%26aufirst%3DM.%2BS.%26aulast%3DLau%26aufirst%3DM.%26aulast%3DUrba%26aufirst%3DS.%26aulast%3DLaheru%26aufirst%3DD.%26atitle%3DMetastatic%2520pancreatic%2520cancer%253A%2520American%2520Society%2520of%2520Clinical%2520Oncology%2520clinical%2520practice%2520guideline%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D34%26spage%3D2784%26epage%3D2796%26doi%3D10.1200%2FJCO.2016.67.1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ryan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardeesy, N.</span><span> </span><span class="NLM_article-title">Pancreatic adenocarcinoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1049</span><span class="refDoi"> DOI: 10.1056/NEJMra1404198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1056%2FNEJMra1404198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25207767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Olt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=1039-1049&author=D.+P.+Ryanauthor=T.+S.+Hongauthor=N.+Bardeesy&title=Pancreatic+adenocarcinoma&doi=10.1056%2FNEJMra1404198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic adenocarcinoma</span></div><div class="casAuthors">Ryan, David P.; Hong, Theodore S.; Bardeesy, Nabeel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1049, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ1-TPh2I8RbVg90H21EOLACvtfcHk0lhLZn8Z5MpzrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Olt7rK&md5=c916814b3ce1e14f3a93b9a0b05cd286</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1404198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1404198%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DD.%2BP.%26aulast%3DHong%26aufirst%3DT.%2BS.%26aulast%3DBardeesy%26aufirst%3DN.%26atitle%3DPancreatic%2520adenocarcinoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D1039%26epage%3D1049%26doi%3D10.1056%2FNEJMra1404198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ervin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arena, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiorean, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seay, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjulandin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleh, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowden, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laheru, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahary, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cutsem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iglesias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renschler, M. F.</span><span> </span><span class="NLM_article-title">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">–</span> <span class="NLM_lpage">1703</span><span class="refDoi"> DOI: 10.1056/NEJMoa1304369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1056%2FNEJMoa1304369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=24131140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=1691-1703&author=D.+D.+Von+Hoffauthor=T.+Ervinauthor=F.+P.+Arenaauthor=E.+G.+Chioreanauthor=J.+Infanteauthor=M.+Mooreauthor=T.+Seayauthor=S.+A.+Tjulandinauthor=W.+W.+Maauthor=M.+N.+Salehauthor=M.+Harrisauthor=M.+Reniauthor=S.+Dowdenauthor=D.+Laheruauthor=N.+Baharyauthor=R.+K.+Ramanathanauthor=J.+Taberneroauthor=M.+Hidalgoauthor=D.+Goldsteinauthor=E.+Van+Cutsemauthor=X.+Weiauthor=J.+Iglesiasauthor=M.+F.+Renschler&title=Increased+survival+in+pancreatic+cancer+with+nab-paclitaxel+plus+gemcitabine&doi=10.1056%2FNEJMoa1304369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine</span></div><div class="casAuthors">Von Hoff, Daniel D.; Ervin, Thomas; Arena, Francis P.; Chiorean, E. Gabriela; Infante, Jeffrey; Moore, Malcolm; Seay, Thomas; Tjulandin, Sergei A.; Ma, Wen Wee; Saleh, Mansoor N.; Harris, Marion; Reni, Michele; Dowden, Scot; Laheru, Daniel; Bahary, Nathan; Ramanathan, Ramesh K.; Tabernero, Josep; Hidalgo, Manuel; Goldstein, David; Van Cutsem, Eric; Wei, Xinyu; Iglesias, Jose; Renschler, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: In a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clin. activity was noted in patients with advanced pancreatic cancer.  We conducted a phase 3 study of the efficacy and safety of the combination vs. gemcitabine monotherapy in patients with metastatic pancreatic cancer.  METHODS: We randomly assigned patients with a Karnofsky performance-status score of 70 or more (on a scale from 0 to 100, with higher scores indicating better performance status) to nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 wk or gemcitabine monotherapy (1000 mg per square meter) weekly for 7 of 8 wk (cycle 1) and then on days 1, 8, and 15 every 4 wk (cycle 2 and subsequent cycles).  Patients received the study treatment until disease progression.  The primary end point was overall survival; secondary end points were progression-free survival and overall response rate.  RESULTS: A total of 861 patients were randomly assigned to nab-paclitaxel plus gemcitabine (431 patients) or gemcitabine (430).  The median overall survival was 8.5 mo in the nab-paclitaxel-gemcitabine group as compared with 6.7 mo in the gemcitabine group (hazard ratio for death, 0.72; 95% confidence interval [CI], 0.62 to 0.83; P<0.001).  The survival rate was 35% in the nab-paclitaxel-gemcitabine group vs. 22% in the gemcitabine group at 1 yr, and 9% vs. 4% at 2 years.  The median progression-free survival was 5.5 mo in the nab-paclitaxel-gemcitabine group, as compared with 3.7 mo in the gemcitabine group (hazard ratio for disease progression or death, 0.69; 95% CI, 0.58 to 0.82; P<0.001); the response rate according to independent review was 23% vs. 7% in the two groups (P<0.001).  The most common adverse events of grade 3 or higher were neutropenia (38% in the nab-paclitaxel-gemcitabine group vs. 27% in the gemcitabine group), fatigue (17% vs. 7%), and neuropathy (17% vs. 1%).  Febrile neutropenia occurred in 3% vs. 1% of the patients in the two groups.  In the nab-paclitaxel-gemcitabine group, neuropathy of grade 3 or higher improved to grade 1 or lower in a median of 29 days.  CONCLUSIONS: In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCXpODbQZ6dLVg90H21EOLACvtfcHk0lhLZn8Z5MpzrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjsb7I&md5=b1169c7e9879c08061dd9e9389dc36fe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1304369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1304369%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DArena%26aufirst%3DF.%2BP.%26aulast%3DChiorean%26aufirst%3DE.%2BG.%26aulast%3DInfante%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DSeay%26aufirst%3DT.%26aulast%3DTjulandin%26aufirst%3DS.%2BA.%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DSaleh%26aufirst%3DM.%2BN.%26aulast%3DHarris%26aufirst%3DM.%26aulast%3DReni%26aufirst%3DM.%26aulast%3DDowden%26aufirst%3DS.%26aulast%3DLaheru%26aufirst%3DD.%26aulast%3DBahary%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DIglesias%26aufirst%3DJ.%26aulast%3DRenschler%26aufirst%3DM.%2BF.%26atitle%3DIncreased%2520survival%2520in%2520pancreatic%2520cancer%2520with%2520nab-paclitaxel%2520plus%2520gemcitabine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1304369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Conroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desseigne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ychou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouche, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimbaud, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becouarn, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adenis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raoul, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourgou-Bourgade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Fouchardiere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennouna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachet, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khemissa-Akouz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pere-Verge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbaldo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assenat, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauffert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoto-Grillot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducreux, M.</span><span> </span><span class="NLM_article-title">Groupe Tumeurs Digestives of, U.; Intergroup, P. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1825</span><span class="refDoi"> DOI: 10.1056/NEJMoa1011923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1056%2FNEJMoa1011923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=21561347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1817-1825&author=T.+Conroyauthor=F.+Desseigneauthor=M.+Ychouauthor=O.+Boucheauthor=R.+Guimbaudauthor=Y.+Becouarnauthor=A.+Adenisauthor=J.+L.+Raoulauthor=S.+Gourgou-Bourgadeauthor=C.+de+la+Fouchardiereauthor=J.+Bennounaauthor=J.+B.+Bachetauthor=F.+Khemissa-Akouzauthor=D.+Pere-Vergeauthor=C.+Delbaldoauthor=E.+Assenatauthor=B.+Chauffertauthor=P.+Michelauthor=C.+Montoto-Grillotauthor=M.+Ducreux&title=Groupe+Tumeurs+Digestives+of%2C+U.%3B+Intergroup%2C+P.+FOLFIRINOX+versus+gemcitabine+for+metastatic+pancreatic+cancer&doi=10.1056%2FNEJMoa1011923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FOLFIRINOX versus gemcitabine or metastatic pancreatic cancer</span></div><div class="casAuthors">Conroy, Thierry; Desseigne, Francoise; Ychou, Marc; Bouche, Olivier; Guimbaud, Rosine; Becouarn, Yves; Adenis, Antoine; Raoul, Jean-Luc; Gourgou-Bourgade, Sophie; de la Fouchardiere, Christelle; Bennouna, Jaafar; Bachet, Jean-Baptiste; Khemissa-Akouz, Faiza; Pere-Verge, Denis; Delbaldo, Catherine; Assenat, Eric; Chauffert, Bruno; Michel, Pierre; Montoto-Grillot, Christine; Ducreux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1817-1825</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.  METHODS We randomly assigned 342 patients with an Eastern Cooperative Oncol. Group performance status score of 0 or 1 (on a scale of 0 to 5, with higher scores indicating a greater severity of illness) to receive FOLFIRINOX (oxaliplatin, 85 mg per square meter of body-surface area; irinotecan, 180 mg per square meter; leucovorin, 400 mg per square meter; and fluorouracil, 400 mg per square meter given as a bolus followed by 2400 mg per square meter given as a 46-h continuous infusion, every 2 wk) or gemcitabine at a dose of 1000 mg per square meter weekly for 7 of 8 wk and then weekly for 3 of 4 wk.  Six months of chemotherapy were recommended in both groups in patients who had a response.  The primary end point was overall survival.  RESULTS The median overall survival was 11.1 mo in the FOLFIRINOX group as compared with 6.8 mo in the gemcitabine group (hazard ratio for death, 0.57; 95% confidence interval [CI], 0.45 to 0.73; P < 0.001).  Median progression-free survival was 6.4 mo in the FOLFIRINOX group and 3.3 mo in the gemcitabine group (hazard ratio for disease progression, 0.47; 95% CI, 0.37 to 0.59; P < 0.001).  The objective response rate was 31.60% in the FOLFIRINOX group vs. 9.4% in the gemcitabine group (P < 0.001).  More adverse events were noted in the FOLFIRINOX group; 5.4% of patients in this group had febrile neutropenia.  At 6 mo, 31% of the patients in the FOLFIRINOX group had a definitive degrdn. of the quality of life vs. 66% in the gemcitabine group (hazard ratio, 0.47; 95% CI, 0.30 to 0.70; P < 0.001).  CONCLUSIONS As compared with gemcitabine, FOLFIRINOX was assocd. with a survival advantage and had increased toxicity.  FOLFIRINOX is an option for the treatment of patients with metastatic pancreatic cancer and good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyDR85GUgOrVg90H21EOLACvtfcHk0lhDushRWZPbFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvF2jsrw%253D&md5=a1a7135a6c97c4dc47233465ce0defd5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1011923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1011923%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DDesseigne%26aufirst%3DF.%26aulast%3DYchou%26aufirst%3DM.%26aulast%3DBouche%26aufirst%3DO.%26aulast%3DGuimbaud%26aufirst%3DR.%26aulast%3DBecouarn%26aufirst%3DY.%26aulast%3DAdenis%26aufirst%3DA.%26aulast%3DRaoul%26aufirst%3DJ.%2BL.%26aulast%3DGourgou-Bourgade%26aufirst%3DS.%26aulast%3Dde%2Bla%2BFouchardiere%26aufirst%3DC.%26aulast%3DBennouna%26aufirst%3DJ.%26aulast%3DBachet%26aufirst%3DJ.%2BB.%26aulast%3DKhemissa-Akouz%26aufirst%3DF.%26aulast%3DPere-Verge%26aufirst%3DD.%26aulast%3DDelbaldo%26aufirst%3DC.%26aulast%3DAssenat%26aufirst%3DE.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DP.%26aulast%3DMontoto-Grillot%26aufirst%3DC.%26aulast%3DDucreux%26aufirst%3DM.%26atitle%3DGroupe%2520Tumeurs%2520Digestives%2520of%252C%2520U.%253B%2520Intergroup%252C%2520P.%2520FOLFIRINOX%2520versus%2520gemcitabine%2520for%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1817%26epage%3D1825%26doi%3D10.1056%2FNEJMoa1011923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kamisawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaori, K.</span><span> </span><span class="NLM_article-title">Pancreatic cancer</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1016/S0140-6736(16)00141-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS0140-6736%2816%2900141-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=26830752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=73-85&author=T.+Kamisawaauthor=L.+D.+Woodauthor=T.+Itoiauthor=K.+Takaori&title=Pancreatic+cancer&doi=10.1016%2FS0140-6736%2816%2900141-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer</span></div><div class="casAuthors">Kamisawa, Terumi; Wood, Laura D.; Itoi, Takao; Takaori, Kyoichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10039</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence.  Most patients with pancreatic cancer remain asymptomatic until the disease reaches an advanced stage.  There is no std. program for screening patients at high risk of pancreatic cancer (eg, those with a family history of pancreatic cancer and chronic pancreatitis).  Most pancreatic cancers arise from microscopic non-invasive epithelial proliferations within the pancreatic ducts, referred to as pancreatic intraepithelial neoplasias.  There are four major driver genes for pancreatic cancer: KRAS, CDKN2A, TP53, and SMAD4.  KRAS mutation and alterations in CDKN2A are early events in pancreatic tumorigenesis.  Endoscopic ultrasonog. and endoscopic ultrasonog.-guided fine-needle aspiration offer high diagnostic ability for pancreatic cancer.  Surgical resection is regarded as the only potentially curative treatment, and adjuvant chemotherapy with gemcitabine or S-1, an oral fluoropyrimidine deriv., is given after surgery.  FOLFIRINOX (fluorouracil, folinic acid [leucovorin], irinotecan, and oxaliplatin) and gemcitabine plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) are the treatments of choice for patients who are not surgical candidates but have good performance status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowv4Kc18l117Vg90H21EOLACvtfcHk0lhDushRWZPbFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2mtb8%253D&md5=008fad5f1be8c3c6f3534c5bc3c3ea3a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2900141-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252900141-0%26sid%3Dliteratum%253Aachs%26aulast%3DKamisawa%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DL.%2BD.%26aulast%3DItoi%26aufirst%3DT.%26aulast%3DTakaori%26aufirst%3DK.%26atitle%3DPancreatic%2520cancer%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D73%26epage%3D85%26doi%3D10.1016%2FS0140-6736%2816%2900141-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Suker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beumer, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marthey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faris, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellon, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Rayes, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang-Gillam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosein, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorcraft, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taieb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shridhar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eijck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerkamp, B. G.</span><span> </span><span class="NLM_article-title">FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span><span class="refDoi"> DOI: 10.1016/S1470-2045(16)00172-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS1470-2045%2816%2900172-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27160474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVChtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=801-810&author=M.+Sukerauthor=B.+R.+Beumerauthor=E.+Sadotauthor=L.+Martheyauthor=J.+E.+Farisauthor=E.+A.+Mellonauthor=B.+F.+El-Rayesauthor=A.+Wang-Gillamauthor=J.+Lacyauthor=P.+J.+Hoseinauthor=S.+Y.+Moorcraftauthor=T.+Conroyauthor=F.+Hohlaauthor=P.+Allenauthor=J.+Taiebauthor=T.+S.+Hongauthor=R.+Shridharauthor=I.+Chauauthor=C.+H.+van+Eijckauthor=B.+G.+Koerkamp&title=FOLFIRINOX+for+locally+advanced+pancreatic+cancer%3A+a+systematic+review+and+patient-level+meta-analysis&doi=10.1016%2FS1470-2045%2816%2900172-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis</span></div><div class="casAuthors">Suker, Mustafa; Beumer, Berend R.; Sadot, Eran; Marthey, Lysiane; Faris, Jason E.; Mellon, Eric A.; El-Rayes, Bassel F.; Wang-Gillam, Andrea; Lacy, Jill; Hosein, Peter J.; Moorcraft, Sing Yu; Conroy, Thierry; Hohla, Florian; Allen, Peter; Taieb, Julien; Hong, Theodore S.; Shridhar, Ravi; Chau, Ian; van Eijck, Casper H.; Koerkamp, Bas Groot</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">801-810</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">35% Of patients with pancreatic cancer have unresectable locally advanced disease at diagnosis.  Several studies have examd. systemic chemotherapy with FOLFIRINOX (leucovorin and fluorouracil plus irinotecan and oxaliplatin) in patients with locally advanced pancreatic cancer.  We aimed to assess the effectiveness of FOLFIRINOX as first-line treatment in this patient population.  We systematically searched Embase, MEDLINE (OvidSP), Web of Science, Scopus, PubMed Publisher, Cochrane, and Google Scholar from July 1, 1994, to July 2, 2015, for studies of treatment-naive patients of any age who received FOLFIRINOX as first-line treatment of locally advanced pancreatic cancer.  Our primary outcome was overall survival.  Secondary outcomes were progression-free survival; rates of grade 3 or 4 adverse events; and the proportion of patients who underwent radiotherapy or chemoradiotherapy, surgical resection after FOLFIRINOX, and R0 resection.  We evaluated survival outcomes with the Kaplan-Meier method with patient-level data.  Grade 3 or 4 adverse events, and the proportion of patients who underwent subsequent radiotherapy or chemoradiotherapy or resection, were pooled in a random-effects model.  We included 13 studies comprising 689 patients, of whom 355 (52%) patients had locally advanced pancreatic cancer. 11 studies, comprising 315 patients with locally advanced disease, reported survival outcomes and were eligible for patient-level meta-anal.  Median overall survival from the start of FOLFIRINOX ranged from 10·0 mo (95% CI 4·0-16·0) to 32·7 mo (23·1-42·3) across studies with a pooled patient-level median overall survival of 24·2 mo (95% CI 21·7-26·8).  Median progression-free survival ranged from 3·0 mo (95% CI not calculable) to 20·4 mo (6·5-34·3) across studies with a patient-level median progression-free survival of 15·0 mo (95% 13·8-16·2).  In ten studies comprising 490 patients, 296 grade 3 or 4 adverse events were reported (60·4 events per 100 patients).  No deaths were attributed to FOLFIRINOX toxicity.  The proportion of patients who underwent radiotherapy or chemoradiotherapy ranged from 31% to 100% across studies.  In eight studies, 154 (57%) of 271 patients received radiotherapy or chemoradiotherapy after FOLFIRINOX.  The pooled proportion of patients who received any radiotherapy treatment was 63·5% (95% CI 43·3-81·6, I2 90%).  The proportion of patients who underwent surgical resection for locally advanced pancreatic cancer ranged from 0% to 43%.  The proportion of patients who had R0 resection of those who underwent resection ranged from 50% to 100% across studies.  In 12 studies, 91 (28%) of 325 patients underwent resection after FOLFIRINOX.  The pooled proportion of patients who had resection was 25·9% (95% CI 20·2-31·9, I2 24%).  R0 resection was reported in 60 (74%) of 81 patients.  The pooled proportion of patients who had R0 resection was 78·4% (95% CI 60·2-92·2, I2 64%).  Patients with locally advanced pancreatic cancer treated with FOLFIRINOX had a median overall survival of 24·2 mo-longer than that reported with gemcitabine (6-13 mo).  Future research should assess these promising results in a randomized controlled trial, and should establish which patients might benefit from radiotherapy or chemoradiotherapy or resection after FOLFIRINOX.None.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDWNhn2_V6LbVg90H21EOLACvtfcHk0lhgio8SxV3btQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVChtbc%253D&md5=65d6114f17bcebe3d620379281b2ecbb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2816%2900172-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252816%252900172-8%26sid%3Dliteratum%253Aachs%26aulast%3DSuker%26aufirst%3DM.%26aulast%3DBeumer%26aufirst%3DB.%2BR.%26aulast%3DSadot%26aufirst%3DE.%26aulast%3DMarthey%26aufirst%3DL.%26aulast%3DFaris%26aufirst%3DJ.%2BE.%26aulast%3DMellon%26aufirst%3DE.%2BA.%26aulast%3DEl-Rayes%26aufirst%3DB.%2BF.%26aulast%3DWang-Gillam%26aufirst%3DA.%26aulast%3DLacy%26aufirst%3DJ.%26aulast%3DHosein%26aufirst%3DP.%2BJ.%26aulast%3DMoorcraft%26aufirst%3DS.%2BY.%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DHohla%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DP.%26aulast%3DTaieb%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DT.%2BS.%26aulast%3DShridhar%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DI.%26aulast%3Dvan%2BEijck%26aufirst%3DC.%2BH.%26aulast%3DKoerkamp%26aufirst%3DB.%2BG.%26atitle%3DFOLFIRINOX%2520for%2520locally%2520advanced%2520pancreatic%2520cancer%253A%2520a%2520systematic%2520review%2520and%2520patient-level%2520meta-analysis%26jtitle%3DLancet%2520Oncol.%26date%3D2016%26volume%3D17%26spage%3D801%26epage%3D810%26doi%3D10.1016%2FS1470-2045%2816%2900172-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Conroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachet, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huguet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caramella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laethem, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducreux, M.</span><span> </span><span class="NLM_article-title">Current standards and new innovative approaches for treatment of pancreatic cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.ejca.2015.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.ejca.2015.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=26851397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC28not1aiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=10-22&author=T.+Conroyauthor=J.+B.+Bachetauthor=A.+Ayavauthor=F.+Huguetauthor=A.+Lambertauthor=C.+Caramellaauthor=R.+Marechalauthor=J.+L.+Van+Laethemauthor=M.+Ducreux&title=Current+standards+and+new+innovative+approaches+for+treatment+of+pancreatic+cancer&doi=10.1016%2Fj.ejca.2015.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Current standards and new innovative approaches for treatment of pancreatic cancer</span></div><div class="casAuthors">Conroy Thierry; Bachet Jean-Baptiste; Ayav Ahmet; Huguet Florence; Lambert Aurelien; Caramella Caroline; Ducreux Michel; Marechal Raphael; Van Laethem Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cancer (Oxford, England : 1990)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic adenocarcinoma remains a devastating disease with a 5-year survival rate not exceeding 6%.  Treatment of this disease remains a major challenge.  This article reviews the state-of-the-art in the management of this disease and the new innovative approaches that may help to accelerate progress in treating its victims.  After careful pre-therapeutic evaluation, only 15-20% of patients diagnosed with a pancreatic cancer (PC) are eligible for upfront radical surgery.  After R0 or R1 resection in such patients, evidence suggests a significantly positive impact on survival of adjuvant chemotherapy comprising 6 months of gemcitabine or fluorouracil/folinic acid.  Delayed adjuvant chemoradiation is considered as an option in cases of positive margins.  Borderline resectable pancreatic cancer (BRPC) is defined as a tumour involving the mesenteric vasculature to a limited extend.  Resection of these tumours is technically feasible, yet runs the high risk of a R1 resection.  Neoadjuvant treatment probably offers the best chance of achieving successful R0 resection and long-term survival, but the best treatment options should be determined in prospective randomised studies.  Gemcitabine has for 15 years been the only validated therapy for advanced PC.  Following decades of negative phase III studies, increasing evidence now suggests that further significant improvements to overall survival can be achieved via either Folfirinox or gemcitabine + nab-paclitaxel regimens.  Progress in systemic therapy may improve the chances of resection in borderline resectable pancreatic cancer (BRPC) or locally advanced PC.  This requires first enhancing knowledge of the genetic events driving carcinogenesis, which may then be translated into clinical studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREoImV5nSKf_6BottYdIAWfW6udTcc2eabOfyGGQVMtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28not1aiuw%253D%253D&md5=d336a90b16ee93020e64a1481858df55</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2015.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2015.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DBachet%26aufirst%3DJ.%2BB.%26aulast%3DAyav%26aufirst%3DA.%26aulast%3DHuguet%26aufirst%3DF.%26aulast%3DLambert%26aufirst%3DA.%26aulast%3DCaramella%26aufirst%3DC.%26aulast%3DMarechal%26aufirst%3DR.%26aulast%3DVan%2BLaethem%26aufirst%3DJ.%2BL.%26aulast%3DDucreux%26aufirst%3DM.%26atitle%3DCurrent%2520standards%2520and%2520new%2520innovative%2520approaches%2520for%2520treatment%2520of%2520pancreatic%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2016%26volume%3D57%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.ejca.2015.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Fogel, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandrasegaran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easler, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagleson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zyromski, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">House, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Hajj, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakeeb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, S.</span><span> </span><span class="NLM_article-title">A multidisciplinary approach to pancreas cancer in 2016: A review</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span><span class="refDoi"> DOI: 10.1038/ajg.2016.610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fajg.2016.610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28139655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC1c3gvFGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2017&pages=537-554&author=E.+L.+Fogelauthor=S.+Shahdaauthor=K.+Sandrasegaranauthor=J.+DeWittauthor=J.+J.+Easlerauthor=D.+M.+Agarwalauthor=M.+Eaglesonauthor=N.+J.+Zyromskiauthor=M.+G.+Houseauthor=S.+Ellsworthauthor=I.+El+Hajjauthor=B.+H.+O%E2%80%99Neilauthor=A.+Nakeebauthor=S.+Sherman&title=A+multidisciplinary+approach+to+pancreas+cancer+in+2016%3A+A+review&doi=10.1038%2Fajg.2016.610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review</span></div><div class="casAuthors">Fogel Evan L; Shahda Safi; DeWitt John; Easler Jeffrey J; Ellsworth Susannah; El Hajj Ihab; O'Neil Bert H; Sherman Stuart; Sandrasegaran Kumar; Agarwal David M; Eagleson Mackenzie; Zyromski Nicholas J; House Michael G; Nakeeb Attila</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">537-554</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In this article, we review our multidisciplinary approach for patients with pancreatic cancer.  Specifically, we review the epidemiology, diagnosis and staging, biliary drainage techniques, selection of patients for surgery, chemotherapy, radiation therapy, and discuss other palliative interventions.  The areas of active research investigation and where our knowledge is limited are emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRH3FF2fu0tB0wlCcfExbvbfW6udTcc2ebHtFM4H0kEPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3gvFGktg%253D%253D&md5=fa28cd98c222f298baf369bd7f261cee</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fajg.2016.610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2016.610%26sid%3Dliteratum%253Aachs%26aulast%3DFogel%26aufirst%3DE.%2BL.%26aulast%3DShahda%26aufirst%3DS.%26aulast%3DSandrasegaran%26aufirst%3DK.%26aulast%3DDeWitt%26aufirst%3DJ.%26aulast%3DEasler%26aufirst%3DJ.%2BJ.%26aulast%3DAgarwal%26aufirst%3DD.%2BM.%26aulast%3DEagleson%26aufirst%3DM.%26aulast%3DZyromski%26aufirst%3DN.%2BJ.%26aulast%3DHouse%26aufirst%3DM.%2BG.%26aulast%3DEllsworth%26aufirst%3DS.%26aulast%3DEl%2BHajj%26aufirst%3DI.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%2BH.%26aulast%3DNakeeb%26aufirst%3DA.%26aulast%3DSherman%26aufirst%3DS.%26atitle%3DA%2520multidisciplinary%2520approach%2520to%2520pancreas%2520cancer%2520in%25202016%253A%2520A%2520review%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2017%26volume%3D112%26spage%3D537%26epage%3D554%26doi%3D10.1038%2Fajg.2016.610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Falasca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casari, I.</span><span> </span><span class="NLM_article-title">Pancreatic cancer: Current research and future directions</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1865</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1016/j.bbcan.2016.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.bbcan.2016.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=26794394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1865&publication_year=2016&pages=123-132&author=M.+Falascaauthor=M.+Kimauthor=I.+Casari&title=Pancreatic+cancer%3A+Current+research+and+future+directions&doi=10.1016%2Fj.bbcan.2016.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer: Current research and future directions</span></div><div class="casAuthors">Falasca, Marco; Kim, Minkyoung; Casari, Ilaria</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1865</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-132</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite the survival rate advancements in different types of cancer in the last 40 years, the perspective for pancreatic cancer patients has seen no substantial changes.  Indeed, the five year survival rate remains around 5%.  Nevertheless, in the last decade we have witnessed an increased interest in pancreatic cancer biol. and this has produced a substantial increment in our knowledge on pancreatic cancer progression.  The big challenge is now to translate this knowledge in better outcomes for patients.  The aim of this review is to describe the latest discoveries and advancements in pancreatic cancer research and to discuss future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8OJHrOiLVYbVg90H21EOLACvtfcHk0ljrJhmb4Tu67Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVajsw%253D%253D&md5=8632fdedacfb4992e4a59fb712899790</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2016.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2016.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DFalasca%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DCasari%26aufirst%3DI.%26atitle%3DPancreatic%2520cancer%253A%2520Current%2520research%2520and%2520future%2520directions%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2016%26volume%3D1865%26spage%3D123%26epage%3D132%26doi%3D10.1016%2Fj.bbcan.2016.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mukherjee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parianos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer</span> <span class="citation_source-journal">Cancer Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span><span class="refDoi"> DOI: 10.1016/j.cancergen.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.cancergen.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27613576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC2szptFygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2016&pages=582-591&author=I.+Mukherjeeauthor=B.+Powellauthor=M.+Parianosauthor=D.+Downsauthor=S.+B.+Ross&title=Available+technologies+and+clinical+applications+of+targeted+chemotherapy+in+pancreatic+cancer&doi=10.1016%2Fj.cancergen.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer</span></div><div class="casAuthors">Mukherjee Indraneil; Powell Brett; Parianos Mary; Downs Darrell; Ross Sharona B</div><div class="citationInfo"><span class="NLM_cas:title">Cancer genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">582-591</span>
        ISSN:<span class="NLM_cas:issn">2210-7762</span>.
    </div><div class="casAbstract">The incidence of pancreatic cancer, the fourth leading cause of cancer death in United States, is increasing worldwide.  Even though the cure rate has doubled in 40 years, it is abysmally poor at 6-7%.  As surgical resection remains the only curative treatment and less than 20% of the newly diagnosed cancers are resectable, the major burden of disease management lies in early diagnosis, good prognostication, and proper neo-adjuvant and/or adjuvant therapy.  With advancing technologies and their ease of availability, researchers have better tools to understand pancreatic cancer.  In the post-genetic era, proteomic, phosphoproteomic, metabolomic, and more have brought us to a multi-omics era.  These newer avenues bring promises of better screening modalities, less invasive diagnostics and monitoring, subtyping of pancreatic cancer, and fine tuning the treatment modalities not only to the right stage of tumor but also to the right tumor biology.  As the multitudes of technologies are generating extensive amounts of incongruous data, they are giving clinicians a lot of non-actionable information.  In this paper, we wish to encompass the newer technologies, sub-classifications, and future treatment modalities in personalized care of patients with pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReZY61VS1T9nRxY89Cm6SyfW6udTcc2eZemHUTB02olbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szptFygtg%253D%253D&md5=716782d8540d2770e57d084edcb5b301</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cancergen.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cancergen.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DParianos%26aufirst%3DM.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DAvailable%2520technologies%2520and%2520clinical%2520applications%2520of%2520targeted%2520chemotherapy%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Genet.%26date%3D2016%26volume%3D209%26spage%3D582%26epage%3D591%26doi%3D10.1016%2Fj.cancergen.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Martinez-Useros, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabeza-Morales, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Foncillas, J.</span><span> </span><span class="NLM_article-title">Oxidative stress: A new target for pancreatic cancer prognosis and treatment</span> <span class="citation_source-journal">J. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="refDoi"> DOI: 10.3390/jcm6030029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.3390%2Fjcm6030029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKgs7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=29&author=J.+Martinez-Userosauthor=W.+Liauthor=M.+Cabeza-Moralesauthor=J.+Garcia-Foncillas&title=Oxidative+stress%3A+A+new+target+for+pancreatic+cancer+prognosis+and+treatment&doi=10.3390%2Fjcm6030029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress: a new target for pancreatic cancer prognosis and treatment</span></div><div class="casAuthors">Martinez-Useros, Javier; Li, Weiyao; Cabeza-Morales, Marticela; Garcia-Foncillas, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">29/1-29/16</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of tumors, and its incidence is rising worldwide.  Survival can be improved when tumors are detected at an early stage; however, this cancer is usually asymptomatic, and the disease only becomes apparent after metastasis.  Several risk factors are assocd. to this disease.  Chronic pancreatitis, diabetes, and some infectious disease are the most relevant risk factors.  Incidence of PDAC has increased in the last decades.  It is hypothesized it could be due to other acquired risk habits, like smoking, high alc. intake, and obesity.  Indeed, adipose tissue is a dynamic endocrine organ that secretes different pro-inflammatory cytokines, enzymes, and other factors that activate oxidative stress.  Reactive oxygen species caused by oxidative stress, damage DNA, proteins, and lipids, and produce several toxic and high mutagenic metabolites that could modify tumor behavior, turning it into a malignant phenotype.  Anti-oxidant compds., like vitamins, are considered protective factors against cancer.  Here, we review the literature on oxidative stress, the mol. pathways that activate or counteract oxidative stress, and potential treatment strategies that target reactive oxygen species suitable for this kind of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMFm6vrD8mZLVg90H21EOLACvtfcHk0lgqvi59s-TRZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKgs7zN&md5=164c1c2f59446cde147e0da0e308de42</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fjcm6030029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm6030029%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Useros%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DCabeza-Morales%26aufirst%3DM.%26aulast%3DGarcia-Foncillas%26aufirst%3DJ.%26atitle%3DOxidative%2520stress%253A%2520A%2520new%2520target%2520for%2520pancreatic%2520cancer%2520prognosis%2520and%2520treatment%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2017%26volume%3D6%26spage%3D29%26doi%3D10.3390%2Fjcm6030029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Trachootham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span> </span><span class="NLM_article-title">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span><span class="refDoi"> DOI: 10.1038/nrd2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fnrd2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=19478820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=579-591&author=D.+Trachoothamauthor=J.+Alexandreauthor=P.+Huang&title=Targeting+cancer+cells+by+ROS-mediated+mechanisms%3A+a+radical+therapeutic+approach%3F&doi=10.1038%2Fnrd2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span></div><div class="casAuthors">Trachootham, Dunyaporn; Alexandre, Jerome; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increased generation of reactive oxygen species (ROS) and an altered redox status have long been obsd. in cancer cells, and recent studies suggest that this biochem. property of cancer cells can be exploited for therapeutic benefits.  Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacol. ROS insults.  However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance.  Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications.  We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgIa2fgBPBrVg90H21EOLACvtfcHk0lgqvi59s-TRZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D&md5=d50931b8de8bcab62d376becc768a71c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2803%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DAlexandre%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DTargeting%2520cancer%2520cells%2520by%2520ROS-mediated%2520mechanisms%253A%2520a%2520radical%2520therapeutic%2520approach%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D579%26epage%3D591%26doi%3D10.1038%2Fnrd2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Moloney, J. N.; Cotter, T. G.</span><span> </span><span class="NLM_article-title">ROS signalling in the biology of cancer</span>.  <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span>. DOI: <span class="refDoi"> DOI: 10.1016/j.semcdb.2017.05.023</span> . Published Online: June 3, 2017.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.semcdb.2017.05.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+N.+Moloney&author=T.+G.+Cotter&title=ROS+signalling+in+the+biology+of+cancer&doi=10.1016%2Fj.semcdb.2017.05.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2017.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2017.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DMoloney%26aufirst%3DJ.%2BN.%26atitle%3DROS%2520signalling%2520in%2520the%2520biology%2520of%2520cancer%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2017%26doi%3D10.1016%2Fj.semcdb.2017.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Idelchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melendez, J. A.</span><span> </span><span class="NLM_article-title">Mitochondrial ROS control of cancer</span> <span class="citation_source-journal">Semin. Cancer Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1016/j.semcancer.2017.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.semcancer.2017.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28445781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFCnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=57-66&author=M.+Idelchikauthor=U.+Begleyauthor=T.+J.+Begleyauthor=J.+A.+Melendez&title=Mitochondrial+ROS+control+of+cancer&doi=10.1016%2Fj.semcancer.2017.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial ROS control of cancer</span></div><div class="casAuthors">Idelchik, Maria del Pilar Sosa; Begley, Ulrike; Begley, Thomas J.; Melendez, J. Andres</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-66</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mitochondria serves a primary role in energy maintenance but also function to govern levels of mitochondria-derived reactive oxygen species (mROS).  ROS have long been established to play a crit. role in tumorigenesis and are now considered to be integral to the regulation of diverse signaling networks that drive proliferation, tumor cell survival and malignant progression. mROS can damage DNA, activate oncogenes, block the function of tumor suppressors and drive migratory signaling.  The mitochondrion's oxidant scavenging systems including SOD2, Grx2, GPrx, Trx and TrxR are key of the cellular redox tone.  These mitochondrial antioxidant systems serve to tightly control the levels of the primary ROS signaling species, H2O2.  The coordinated control of mROS levels is also coupled to the activity of the primary H2O2 consuming enzymes of the mitochondria which are reliant on the epitranscriptomic control of selenocysteine incorporation.  This review highlights the interplay between these many oncogenic signaling networks, mROS and the H2O2 emitting and consuming capacity of the mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobMZDqsgiyr7Vg90H21EOLACvtfcHk0lhyJm8fCoJ0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFCnsb0%253D&md5=faf124b5a300a215c8d85a41f1c8a904</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DIdelchik%26aufirst%3DM.%26aulast%3DBegley%26aufirst%3DU.%26aulast%3DBegley%26aufirst%3DT.%2BJ.%26aulast%3DMelendez%26aufirst%3DJ.%2BA.%26atitle%3DMitochondrial%2520ROS%2520control%2520of%2520cancer%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D47%26spage%3D57%26epage%3D66%26doi%3D10.1016%2Fj.semcancer.2017.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Dharmaraja, A. T.</span><span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3221</span><span class="NLM_x">–</span> <span class="NLM_lpage">3240</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3221-3240&author=A.+T.+Dharmaraja&title=Role+of+reactive+oxygen+species+%28ROS%29+in+therapeutics+and+drug+resistance+in+cancer+and+bacteria&doi=10.1021%2Facs.jmedchem.6b01243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria</span></div><div class="casAuthors">Dharmaraja, Allimuthu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3221-3240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Evading persistent drug resistance in cancer and bacteria to most of the com. used drugs is necessary to restore the human health settings.  A distinct property of cancer phenotype is enhanced glucose metab. and oxidative stress from normal cells.  Reactive oxygen species (ROS) are metabolic byproducts of aerobic respiration and are responsible for maintaining redox homeostasis in cells.  Maintaining the redox balance in cancerous cells are found to be crit. for their survival, which is modulated by reduced thiols and reducing cofactors NAD(P)H.  Thus altering the levels reducing equiv. were found to enhance intracellular ROS and sensitize cancer cells to therapeutics.  Similarly, Escherichia coli and life threatening infectious pathogens such as Staphylococcus aureus and Mycobacterium tuberculosis were found to be more sensitive to modulation of intracellular oxidative environment.  Combination drug strategies were successfully employed in attenuating the effects of drug resistant cancer and bacterial.  Here, a collection of some ROS modulation based cancer and bacterial therapeutics is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoshDBtCrwl5LVg90H21EOLACvtfcHk0lhyJm8fCoJ0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D&md5=71bfb8f37ab75364fedcb07de262fc2c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01243%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520therapeutics%2520and%2520drug%2520resistance%2520in%2520cancer%2520and%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3221%26epage%3D3240%26doi%3D10.1021%2Facs.jmedchem.6b01243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Panieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M. M.</span><span> </span><span class="NLM_article-title">ROS homeostasis and metabolism: a dangerous liason in cancer cells</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2253</span><span class="refDoi"> DOI: 10.1038/cddis.2016.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fcddis.2016.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27277675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFChsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=e2253&author=E.+Panieriauthor=M.+M.+Santoro&title=ROS+homeostasis+and+metabolism%3A+a+dangerous+liason+in+cancer+cells&doi=10.1038%2Fcddis.2016.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">ROS homeostasis and metabolism: a dangerous liason in cancer cells</span></div><div class="casAuthors">Panieri, E.; Santoro, M. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e2253</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor cells harbor genetic alterations that promote a continuous and elevated prodn. of reactive oxygen species.  Whereas such oxidative stress conditions would be harmful to normal cells, they facilitate tumor growth in multiple ways by causing DNA damage and genomic instability, and ultimately, by reprogramming cancer cell metab.  This review outlines the metabolic-dependent mechanisms that tumors engage in when faced with oxidative stress conditions that are crit. for cancer progression by producing redox cofactors.  In particular, we describe how the mitochondria has a key role in regulating the interplay between redox homeostasis and metab. within tumor cells.  Last, we will discuss the potential therapeutic use of agents that directly or indirectly block metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRB6mlouZWDrVg90H21EOLACvtfcHk0lidwzd_4RpYOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFChsLo%253D&md5=44483b7ad16d4c5212b9329d0c7811f9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.105%26sid%3Dliteratum%253Aachs%26aulast%3DPanieri%26aufirst%3DE.%26aulast%3DSantoro%26aufirst%3DM.%2BM.%26atitle%3DROS%2520homeostasis%2520and%2520metabolism%253A%2520a%2520dangerous%2520liason%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2016%26volume%3D7%26spage%3De2253%26doi%3D10.1038%2Fcddis.2016.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Diebold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandel, N. S.</span><span> </span><span class="NLM_article-title">Mitochondrial ROS regulation of proliferating cells</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2016.04.198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.freeradbiomed.2016.04.198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27154978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvV2rsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2016&pages=86-93&author=L.+Dieboldauthor=N.+S.+Chandel&title=Mitochondrial+ROS+regulation+of+proliferating+cells&doi=10.1016%2Fj.freeradbiomed.2016.04.198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial ROS regulation of proliferating cells</span></div><div class="casAuthors">Diebold, Lauren; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86-93</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Once thought of exclusively as damaging mols., reactive oxygen species (ROS) are becoming increasingly appreciated for the role they play in cellular signaling through redox biol.  Notably, mitochondria are a major source of ROS within a cell (mROS).  Mounting evidence now clearly shows that mROS are crit. for intracellular redox signaling by which they contribute to a plethora of cellular processes such as proliferation. mROS are essential for physiol. cell proliferation, particularly by the regulation of hypoxia inducible factors (HIFs) under hypoxia. mROS are also vital mediators of growth factor signaling cascades such as angiotensin II (Ang II) and T-cell receptor (TCR) signaling.  Pathol. proliferative diseases such as cancer utilize mROS to their advantage, aberrantly activating growth factor signaling cascades and perpetuating angiogenesis under hypoxia.  This review discusses how mROS pos. regulate mitogenic cellular signaling through redox biol., which is crit. for both physiol. and pathol. proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjlm-SYjhpnbVg90H21EOLACvtfcHk0lidwzd_4RpYOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvV2rsbc%253D&md5=eb952b7d486db48c650cbe13bed2ae14</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2016.04.198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2016.04.198%26sid%3Dliteratum%253Aachs%26aulast%3DDiebold%26aufirst%3DL.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DMitochondrial%2520ROS%2520regulation%2520of%2520proliferating%2520cells%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2016%26volume%3D100%26spage%3D86%26epage%3D93%26doi%3D10.1016%2Fj.freeradbiomed.2016.04.198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. F.</span><span> </span><span class="NLM_article-title">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span> <span class="citation_source-journal">J. Hematol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="refDoi"> DOI: 10.1186/1756-8722-6-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1186%2F1756-8722-6-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23442817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=19&author=X.+Liauthor=P.+Fangauthor=J.+Maiauthor=E.+T.+Choiauthor=H.+Wangauthor=X.+F.+Yang&title=Targeting+mitochondrial+reactive+oxygen+species+as+novel+therapy+for+inflammatory+diseases+and+cancers&doi=10.1186%2F1756-8722-6-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span></div><div class="casAuthors">Li, Xinyuan; Fang, Pu; Mai, Jietang; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  There are multiple sources of reactive oxygen species (ROS) in the cell.  As a major site of ROS prodn., mitochondria have drawn considerable interest because it was recently discovered that mitochondrial ROS (mtROS) directly stimulate the prodn. of proinflammatory cytokines and pathol. conditions as diverse as malignancies, autoimmune diseases, and cardiovascular diseases all share common phenotype of increased mtROS prodn. above basal levels.  Several excellent reviews on this topic have been published, but ever-changing new discoveries mandated a more up-to-date and comprehensive review on this topic.  Therefore, we update recent understanding of how mitochondria generate and regulate the prodn. of mtROS and the function of mtROS both in physiol. and pathol. conditions.  In addn., we describe newly developed methods to probe or scavenge mtROS and compare these methods in detail.  Thorough understanding of this topic and the application of mtROS-targeting drugs in the research is significant towards development of better therapies to combat inflammatory diseases and inflammatory malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdw7mjnRfUbVg90H21EOLACvtfcHk0lidwzd_4RpYOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D&md5=d041a496a1ede846460023f0cc54885a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-19%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%2BF.%26atitle%3DTargeting%2520mitochondrial%2520reactive%2520oxygen%2520species%2520as%2520novel%2520therapy%2520for%2520inflammatory%2520diseases%2520and%2520cancers%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D19%26doi%3D10.1186%2F1756-8722-6-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Chio, I. I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span> </span><span class="NLM_article-title">ROS in cancer: The burning question</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span><span class="refDoi"> DOI: 10.1016/j.molmed.2017.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.molmed.2017.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28427863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1WiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=411-429&author=I.+I.+C.+Chioauthor=D.+A.+Tuveson&title=ROS+in+cancer%3A+The+burning+question&doi=10.1016%2Fj.molmed.2017.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ROS in Cancer: The Burning Question</span></div><div class="casAuthors">Chio, Iok In Christine; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-429</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An unanswered question in human health is whether antioxidn. prevents or promotes cancer.  Antioxidn. has historically been viewed as chemopreventive, but emerging evidence suggests that antioxidants may be supportive of neoplasia.  We posit this contention to be rooted in the fact that ROS do not operate as one single biochem. entity, but as diverse secondary messengers in cancer cells.  This cautions against therapeutic strategies to increase ROS at a global level.  To leverage redox alterations towards the development of effective therapies necessitates the application of biophys. and biochem. approaches to define redox dynamics and to functionally elucidate specific oxidative modifications in cancer vs. normal cells.  An improved understanding of the sophisticated workings of redox biol. is imperative to defeating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0BkT0gWhumrVg90H21EOLACvtfcHk0ligQfF05BN9KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1WiurY%253D&md5=74ce7fb3d8db3718d6c97b9030deb0da</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2017.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2017.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DI.%2BI.%2BC.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DROS%2520in%2520cancer%253A%2520The%2520burning%2520question%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D411%26epage%3D429%26doi%3D10.1016%2Fj.molmed.2017.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Fruehauf, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyskens, F. L.,  Jr.</span><span> </span><span class="NLM_article-title">Reactive oxygen species: a breath of life or death?</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1158%2F1078-0432.CCR-06-2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=17289868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=789-794&author=J.+P.+Fruehaufauthor=F.+L.+Meyskens&title=Reactive+oxygen+species%3A+a+breath+of+life+or+death%3F&doi=10.1158%2F1078-0432.CCR-06-2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species: A Breath of Life or Death?</span></div><div class="casAuthors">Fruehauf, John P.; Meyskens, Frank L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-794</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  New insights into cancer cell-specific biol. pathways are urgently needed to promote development of rationally targeted therapeutics.  Reactive oxygen species (ROS) and their role in cancer cell response to growth factor signaling and hypoxia are emerging as verdant areas of exploration on the road to discovering cancer's Achilles heel.  One of the distinguishing and near-universal hallmarks of cancer growth is hypoxia.  Unregulated cellular proliferation leads to formation of cellular masses that extend beyond the resting vasculature, resulting in oxygen and nutrient deprivation.  The resulting hypoxia triggers a no. of crit. adaptations that enable cancer cell survival, including apoptosis suppression, altered glucose metab., and an angiogenic phenotype.  Ironically, recent investigations suggest that oxygen depletion stimulates mitochondria to elaborate increased ROS, with subsequent activation of signaling pathways, such as hypoxia inducible factor 1α, that promote cancer cell survival and tumor growth.  Because mitochondria are key organelles involved in chemotherapy-induced apoptosis induction, the relationship between mitochondria, ROS signaling, and activation of survival pathways under hypoxic conditions has been the subject of increased study.  Insights into mechanisms involved in ROS signaling may offer novel avenues to facilitate discovery of cancer-specific therapies.  Preclin. and clin. evaluation of agents that modify ROS signaling in cancer offers a novel avenue for intervention.  This review will cover recent work in ROS-mediated signaling in cancer cells and its potential as a target for developmental therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquetAH3cZLGrVg90H21EOLACvtfcHk0ligQfF05BN9KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyrsrs%253D&md5=1a31e4373a08496e74a631af5f532b0b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2082%26sid%3Dliteratum%253Aachs%26aulast%3DFruehauf%26aufirst%3DJ.%2BP.%26aulast%3DMeyskens%26aufirst%3DF.%2BL.%26atitle%3DReactive%2520oxygen%2520species%253A%2520a%2520breath%2520of%2520life%2520or%2520death%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D789%26epage%3D794%26doi%3D10.1158%2F1078-0432.CCR-06-2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">DeNicola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karreth, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humpton, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopinathan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frese, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calhoun, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrimieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruban, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacobuzio-Donahue, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span> </span><span class="NLM_article-title">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">475</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span><span class="refDoi"> DOI: 10.1038/nature10189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fnature10189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=21734707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=106-109&author=G.+M.+DeNicolaauthor=F.+A.+Karrethauthor=T.+J.+Humptonauthor=A.+Gopinathanauthor=C.+Weiauthor=K.+Freseauthor=D.+Mangalauthor=K.+H.+Yuauthor=C.+J.+Yeoauthor=E.+S.+Calhounauthor=F.+Scrimieriauthor=J.+M.+Winterauthor=R.+H.+Hrubanauthor=C.+Iacobuzio-Donahueauthor=S.+E.+Kernauthor=I.+A.+Blairauthor=D.+A.+Tuveson&title=Oncogene-induced+Nrf2+transcription+promotes+ROS+detoxification+and+tumorigenesis&doi=10.1038%2Fnature10189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span></div><div class="casAuthors">DeNicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Wei, Cong; Frese, Kristopher; Mangal, Dipti; Yu, Kenneth H.; Yeo, Charles J.; Calhoun, Eric S.; Scrimieri, Francesca; Winter, Jordan M.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.; Blair, Ian A.; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">106-109</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer.  Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly regulated by the transcription factor Nrf2 (also known as Nfe2l2) and its repressor protein Keap1 (refs. 2-5).  In contrast to the acute physiol. regulation of Nrf2, in neoplasia there is evidence for increased basal activation of Nrf2.  Indeed, somatic mutations that disrupt the Nrf2-Keap1 interaction to stabilize Nrf2 and increase the constitutive transcription of Nrf2 target genes were recently identified, indicating that enhanced ROS detoxification and addnl. Nrf2 functions may in fact be pro-tumorigenic.  Here, we investigated ROS metab. in primary murine cells following the expression of endogenous oncogenic alleles of Kras, Braf and Myc, and found that ROS are actively suppressed by these oncogenes.  K-RasG12D, B-RafV619E and MycERT2 each increased the transcription of Nrf2 to stably elevate the basal Nrf2 antioxidant program and thereby lower intracellular ROS and confer a more reduced intracellular environment.  Oncogene-directed increased expression of Nrf2 is a new mechanism for the activation of the Nrf2 antioxidant program, and is evident in primary cells and tissues of mice expressing K-RasG12D and B-RafV619E, and in human pancreatic cancer.  Furthermore, genetic targeting of the Nrf2 pathway impairs K-RasG12D-induced proliferation and tumorigenesis in vivo.  Thus, the Nrf2 antioxidant and cellular detoxification program represents a previously unappreciated mediator of oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFpMbvjw2msLVg90H21EOLACvtfcHk0lj374CYqCdSaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D&md5=54d0e0b5940672a96bde0f8cfd9e7ff9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnature10189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10189%26sid%3Dliteratum%253Aachs%26aulast%3DDeNicola%26aufirst%3DG.%2BM.%26aulast%3DKarreth%26aufirst%3DF.%2BA.%26aulast%3DHumpton%26aufirst%3DT.%2BJ.%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DFrese%26aufirst%3DK.%26aulast%3DMangal%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DCalhoun%26aufirst%3DE.%2BS.%26aulast%3DScrimieri%26aufirst%3DF.%26aulast%3DWinter%26aufirst%3DJ.%2BM.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DBlair%26aufirst%3DI.%2BA.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DOncogene-induced%2520Nrf2%2520transcription%2520promotes%2520ROS%2520detoxification%2520and%2520tumorigenesis%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D106%26epage%3D109%26doi%3D10.1038%2Fnature10189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erkan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalski, C. W.</span><span> </span><span class="NLM_article-title">Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels</span> <span class="citation_source-journal">Front. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="refDoi"> DOI: 10.3389/fphys.2013.00246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.3389%2Ffphys.2013.00246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=24062691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC2cflt1ylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=246&author=B.+Kongauthor=C.+Qiaauthor=M.+Erkanauthor=J.+Kleeffauthor=C.+W.+Michalski&title=Overview+on+how+oncogenic+Kras+promotes+pancreatic+carcinogenesis+by+inducing+low+intracellular+ROS+levels&doi=10.3389%2Ffphys.2013.00246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels</span></div><div class="casAuthors">Kong Bo; Qia Chengjia; Erkan Mert; Kleeff Jorg; Michalski Christoph W</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">246</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease without clearly known disease causes.  Recent epidemiological and animal studies suggest that the supplementation of dietary antioxidants (e.g., vitamins C and E) decreases cancer risk, implying that increased reactive oxygen species (ROS) may play a role in pancreatic carcinogenesis.  However, oncogenic Kras mutations (e.g., Kras(G12D)), which are present in more than 90% of PDAC, have been proven to foster low intracellular ROS levels.  Here, oncogenic Kras activates expression of a series of anti-oxidant genes via Nrf2 (nuclear factor, erythroid derived 2, like 2) and also mediates an unusual metabolic pathway of glutamine to generate NADPH.  This can then be used as the reducing power for ROS detoxification, leading collectively to low ROS levels in pancreatic pre-neoplastic cells and in cancer cells.  In adult stem cells and cancer stem cells, low ROS levels have been associated with the formation of a proliferation-permissive intracellular environment and with perseverance of self-renewal capacities.  Therefore, it is conceivable that low intracellular ROS levels may contribute significantly to oncogenic Kras-mediated PDAC formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4U-tZwxXjRY2y4bB4mnvYfW6udTcc2ea7Dxf4lzx4k7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflt1ylsg%253D%253D&md5=02f78da404b5d0367cb3776c32f91bf2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2013.00246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2013.00246%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DB.%26aulast%3DQia%26aufirst%3DC.%26aulast%3DErkan%26aufirst%3DM.%26aulast%3DKleeff%26aufirst%3DJ.%26aulast%3DMichalski%26aufirst%3DC.%2BW.%26atitle%3DOverview%2520on%2520how%2520oncogenic%2520Kras%2520promotes%2520pancreatic%2520carcinogenesis%2520by%2520inducing%2520low%2520intracellular%2520ROS%2520levels%26jtitle%3DFront.%2520Physiol.%26date%3D2013%26volume%3D4%26spage%3D246%26doi%3D10.3389%2Ffphys.2013.00246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">KRas, ROS and the initiation of pancreatic cancer</span> <span class="citation_source-journal">Small GTPases</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1080/21541248.2016.1192714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1080%2F21541248.2016.1192714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27215184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtValtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=38-42&author=P.+Storz&title=KRas%2C+ROS+and+the+initiation+of+pancreatic+cancer&doi=10.1080%2F21541248.2016.1192714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">KRas, ROS and the initiation of pancreatic cancer</span></div><div class="casAuthors">Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Small GTPases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-42</span>CODEN:
                <span class="NLM_cas:coden">SGMTBK</span>;
        ISSN:<span class="NLM_cas:issn">2154-1256</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Oncogenic mutations of KRAS are the most frequent driver mutations in pancreatic cancer.  Expression of an oncogenic allele of KRAS leads to metabolic changes and altered cellular signaling that both can increase the prodn. of intracellular reactive oxygen species (ROS).  Increases in ROS have been shown to drive the formation and progression of pancreatic precancerous lesions by upregulating survival and growth factor signaling.  A key issue for precancerous and cancer cells is to keep ROS at levels where they are beneficial for tumor development and progression, but below the threshold that leads to induction of senescence or cell death.  In KRas-driven neoplasia aberrantly increased ROS levels are therefore balanced by an upregulation of antioxidant genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeeejFcCf6r7Vg90H21EOLACvtfcHk0lj374CYqCdSaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtValtL3J&md5=d1fa43521389b67fe2c99e966391f930</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1080%2F21541248.2016.1192714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21541248.2016.1192714%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DKRas%252C%2520ROS%2520and%2520the%2520initiation%2520of%2520pancreatic%2520cancer%26jtitle%3DSmall%2520GTPases%26date%3D2017%26volume%3D8%26spage%3D38%26epage%3D42%26doi%3D10.1080%2F21541248.2016.1192714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span> </span><span class="NLM_article-title">The relevance of Nrf2 pathway and autophagy in pancreatic cancer cells upon stimulation of reactive oxygen species</span> <span class="citation_source-journal">Oxid. Med. Cell. Longevity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">3897250</span><span class="refDoi"> DOI: 10.1155/2016/3897250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1155%2F2016%2F3897250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=26682003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC28risl2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=3897250&author=L.+Zhangauthor=J.+Liauthor=J.+Maauthor=X.+Chenauthor=K.+Chenauthor=Z.+Jiangauthor=L.+Zongauthor=S.+Yuauthor=X.+Liauthor=Q.+Xuauthor=J.+Leiauthor=W.+Duanauthor=W.+Liauthor=T.+Shanauthor=Q.+Maauthor=X.+Shen&title=The+relevance+of+Nrf2+pathway+and+autophagy+in+pancreatic+cancer+cells+upon+stimulation+of+reactive+oxygen+species&doi=10.1155%2F2016%2F3897250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species</span></div><div class="casAuthors">Zhang Lun; Li Jiahui; Chen Xin; Chen Ke; Jiang Zhengdong; Zong Liang; Xu Qinhong; Lei Jianjun; Duan Wanxing; Li Wei; Ma Qingyong; Ma Jiguang; Yu Shuo; Shan Tao; Li Xuqi; Shen Xin</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3897250</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nrf2 (NF-E2-related factor 2) pathway and autophagy both can respond to oxidative stress to promote cancer cells to survive in the tumor microenvironment.  We, therefore, explored the relevance between Nrf2 pathway and autophagy in pancreatic cancer cells upon stimulation of reactive oxygen species (ROS).  Pancreatic cancer cells were cultured under controlled ROS stressing condition or basal condition.  Different inhibitors were used to prevent autophagy at particular stages.  Nrf2 siRNA was used to inhibit Nrf2 pathway activation.  Ad-mRFP-GFP-LC3 infection was used to monitor autophagic flux.  The result shows that a small amount of exogenous hydrogen peroxide (H2O2) can significantly improve the level of intracellular ROS.  Moreover, our findings indicate that ROS promotes the activation of both Nrf2 pathway and autophagy in pancreatic cancer cells.  Moreover, our data demonstrate that suppression of autophagic activity at particular stages results in an increased promotion of Nrf2 pathway activation upon ROS stimulation.  Furthermore, we found that silencing of Nrf2 promotes autophagy upon ROS stimulation.  In addition, Nrf2 interference effectively promotes autophagic flux upon ROS stimulation.  In summary, our findings suggest that Nrf2 pathway and autophagy have a negative interaction with each other upon ROS stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyYNpHHtF1I_69nzq6467DfW6udTcc2eby9CpWZmP0Vrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28risl2lsA%253D%253D&md5=f277f5c57372b27af3cb2e9ff006d707</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1155%2F2016%2F3897250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F3897250%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DZong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DShan%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DX.%26atitle%3DThe%2520relevance%2520of%2520Nrf2%2520pathway%2520and%2520autophagy%2520in%2520pancreatic%2520cancer%2520cells%2520upon%2520stimulation%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2016%26volume%3D2016%26spage%3D3897250%26doi%3D10.1155%2F2016%2F3897250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Pelicano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span> </span><span class="NLM_article-title">ROS stress in cancer cells and therapeutic implications</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1016/j.drup.2004.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.drup.2004.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15158766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Wquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=97-110&author=H.+Pelicanoauthor=D.+Carneyauthor=P.+Huang&title=ROS+stress+in+cancer+cells+and+therapeutic+implications&doi=10.1016%2Fj.drup.2004.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ROS stress in cancer cells and therapeutic implications</span></div><div class="casAuthors">Pelicano, Helene; Carney, Dennis; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-110</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are constantly generated and eliminated in the biol. system, and play important roles in a variety of normal biochem. functions and abnormal pathol. processes.  Growing evidence suggests that cancer cells exhibit increased intrinsic ROS stress, due in part to oncogenic stimulation, increased metabolic activity, and mitochondrial malfunction.  Since the mitochondrial respiratory chain (electron transport complexes) is a major source of ROS generation in the cells, the vulnerability of the mitochondrial DNA to ROS-mediated damage appears to be a mechanism to amplify ROS stress in cancer cells.  The escalated ROS generation in cancer cells serves as an endogenous source of DNA-damaging agents that promote genetic instability and development of drug resistance.  Malfunction of mitochondria also alters cellular apoptotic response to anticancer agents.  Despite the neg. impacts of increased ROS in cancer cells, it is possible to exploit this biochem. feature and develop novel therapeutic strategies to preferentially kill cancer cells through ROS-mediated mechanisms.  This article reviews ROS stress in cancer cells, its underlying mechanisms and relationship with mitochondrial malfunction and alteration in drug sensitivity, and suggests new therapeutic strategies that take advantage of increased ROS in cancer cells to enhance therapeutic activity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2pkSeKlxObVg90H21EOLACvtfcHk0lgnymqS0nsGYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Wquro%253D&md5=80f41fc45cd1e43971bb118a238e2196</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2004.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2004.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPelicano%26aufirst%3DH.%26aulast%3DCarney%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DROS%2520stress%2520in%2520cancer%2520cells%2520and%2520therapeutic%2520implications%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2004%26volume%3D7%26spage%3D97%26epage%3D110%26doi%3D10.1016%2Fj.drup.2004.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sabharwal, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacker, P. T.</span><span> </span><span class="NLM_article-title">Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span><span class="refDoi"> DOI: 10.1038/nrc3803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fnrc3803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25342630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSmtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=709-721&author=S.+S.+Sabharwalauthor=P.+T.+Schumacker&title=Mitochondrial+ROS+in+cancer%3A+initiators%2C+amplifiers+or+an+Achilles%E2%80%99+heel%3F&doi=10.1038%2Fnrc3803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?</span></div><div class="casAuthors">Sabharwal, Simran S.; Schumacker, Paul T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">709-721</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mitochondria cooperate with their host cells by contributing to bioenergetics, metab., biosynthesis, and cell death or survival functions.  Reactive oxygen species (ROS) generated by mitochondria participate in stress signalling in normal cells but also contribute to the initiation of nuclear or mitochondrial DNA mutations that promote neoplastic transformation.  In cancer cells, mitochondrial ROS amplify the tumorigenic phenotype and accelerate the accumulation of addnl. mutations that lead to metastatic behavior.  As mitochondria carry out important functions in normal cells, disabling their function is not a feasible therapy for cancer.  However, ROS signalling contributes to proliferation and survival in many cancers, so the targeted disruption of mitochondria-to-cell redox communication represents a promising avenue for future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNrCJgdvCMg7Vg90H21EOLACvtfcHk0lic7kuj-pitVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSmtLbO&md5=96707798e33043d755b569fd089d8617</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrc3803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3803%26sid%3Dliteratum%253Aachs%26aulast%3DSabharwal%26aufirst%3DS.%2BS.%26aulast%3DSchumacker%26aufirst%3DP.%2BT.%26atitle%3DMitochondrial%2520ROS%2520in%2520cancer%253A%2520initiators%252C%2520amplifiers%2520or%2520an%2520Achilles%25E2%2580%2599%2520heel%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D709%26epage%3D721%26doi%3D10.1038%2Fnrc3803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Durand, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">Targeting reactive oxygen species in development and progression of pancreatic cancer</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1080/14737140.2017.1261017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1080%2F14737140.2017.1261017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=27841037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCgtbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=19-31&author=N.+Durandauthor=P.+Storz&title=Targeting+reactive+oxygen+species+in+development+and+progression+of+pancreatic+cancer&doi=10.1080%2F14737140.2017.1261017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting reactive oxygen species in development and progression of pancreatic cancer</span></div><div class="casAuthors">Durand, Nisha; Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-31</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDA) is characterized by expression of oncogenic KRas which drives all aspects of tumorigenesis.  Oncogenic KRas induces the formation of reactive oxygen species (ROS) which have been implicated in initiation and progression of PDA.  To facilitate tumor promoting levels and to avoid oncogene-induced senescence or cytotoxicity, ROS homeostasis in PDA cells is balanced by addnl. up-regulation of antioxidant systems.  We examine the sources of ROS in PDA, the mechanisms by which ROS homeostasis is maintained, and the biol. consequences of ROS in PDA.  Addnl., we discuss the potential mechanisms for targeting ROS homoeostasis as a point of therapeutic intervention.  An extensive review of the relevant literature as it relates to the topic was conducted using PubMed. Even though oncogenic mutations in the KRAS gene have been detected in over 95% of human pancreatic adenocarcinoma, targeting its gene product, KRas, has been difficult.  The dependency of PDA cells on balancing ROS homeostasis could be an angle for new prevention or treatment strategies.  These include use of antioxidants to prevent formation or progression of precancerous lesions, or methods to increase ROS in tumor cells to toxic levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGcAyB4qAqGbVg90H21EOLACvtfcHk0lic7kuj-pitVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCgtbfO&md5=dd51ffe392d672754074fc7afa8ec44e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F14737140.2017.1261017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14737140.2017.1261017%26sid%3Dliteratum%253Aachs%26aulast%3DDurand%26aufirst%3DN.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DTargeting%2520reactive%2520oxygen%2520species%2520in%2520development%2520and%2520progression%2520of%2520pancreatic%2520cancer%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2017%26volume%3D17%26spage%3D19%26epage%3D31%26doi%3D10.1080%2F14737140.2017.1261017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pathania, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1111/bph.12855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1111%2Fbph.12855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25047070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWlsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=50-63&author=D.+Pathaniaauthor=Y.+Kuangauthor=M.+Sechiauthor=N.+Neamati&title=Mechanisms+underlying+the+cytotoxicity+of+a+novel+quinazolinedione-based+redox+modulator%2C+QD232%2C+in+pancreatic+cancer+cells&doi=10.1111%2Fbph.12855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells</span></div><div class="casAuthors">Pathania, Divya; Kuang, Yuting; Sechi, Mario; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-63</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Pancreatic cancer is characterized by alterations in several key signalling proteins, including increased expression and activity of the Src tyrosine kinase and focal adhesion kinase (FAK), which have been linked to its chemoresistance.  Sustained Src inhibition reactivates survival pathways regulated by the transcription factor STAT3, also leading to resistance.  Therefore, simultaneously targeting Src/FAK and STAT3 signalling could provide an important strategy for treating pancreatic cancer.  Recently, we described novel quinazolinediones that increased generation of reactive oxygen species (ROS) and were cytotoxic in pancreatic cancer cells.  Here, we have investigated effects of our lead compd., QD232, on Src/FAK and STAT3 signalling.  Exptl. Approach : The major signalling pathways affected by QD232 in pancreatic cancer cell lines were identified by Kinexus proteomic anal.  Changes in key signalling proteins were confirmed by Western blotting.  Cell migration was assessed by Boyden chamber and wound healing assays.  Direct inhibition of kinase activity in vitro was assayed with a panel of 92 oncogenic kinases.  Safety and efficacy of QD232 were detd. in a xenograft mouse model of pancreatic cancer.  Key Results : QD232 potently inhibited Src/FAK and STAT3 phosphorylation, decreasing pancreatic cancer cell viability and migration.  Furthermore, QD232 arrested cell cycle progression and induced apoptosis in these cells at low micromolar concns.  Effects of QD232 on Src/FAK and STAT3 phosphorylation were blocked by N-acetylcysteine or glutathione.  Conclusions and Implications : QD232 is a novel compd. with a unique, ROS-dependent mechanism, effective in drug-resistant cancer cell lines.  This compd. shows potential as therapy for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT3-x-z_lL3rVg90H21EOLACvtfcHk0lic7kuj-pitVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWlsLvK&md5=6471c264193699d9d78bd0f2c596008b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fbph.12855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12855%26sid%3Dliteratum%253Aachs%26aulast%3DPathania%26aufirst%3DD.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DMechanisms%2520underlying%2520the%2520cytotoxicity%2520of%2520a%2520novel%2520quinazolinedione-based%2520redox%2520modulator%252C%2520QD232%252C%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D50%26epage%3D63%26doi%3D10.1111%2Fbph.12855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Pathania, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palomba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrettini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1840</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2013.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.bbagen.2013.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23954204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOls77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1840&publication_year=2014&pages=332-343&author=D.+Pathaniaauthor=M.+Sechiauthor=M.+Palombaauthor=V.+Sannaauthor=F.+Berrettiniauthor=A.+Siasauthor=L.+Taheriauthor=N.+Neamati&title=Design+and+discovery+of+novel+quinazolinedione-based+redox+modulators+as+therapies+for+pancreatic+cancer&doi=10.1016%2Fj.bbagen.2013.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer</span></div><div class="casAuthors">Pathania, Divya; Sechi, Mario; Palomba, Michele; Sanna, Vanna; Berrettini, Francesco; Sias, Angela; Taheri, Laleh; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1840</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">332-343</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Altered cellular bioenergetics and oxidative stress are emerging hallmarks of most cancers including pancreatic cancer.  Elevated levels of intrinsic reactive oxygen species (ROS) in tumors make them more susceptible to exogenously induced oxidative stress.  Excessive oxidative insults overwhelm their adaptive antioxidant capacity and trigger ROS-mediated cell death.  Recently, we have discovered a novel class of quinazolinediones that exert their cytotoxic effects by modulating ROS-mediated signaling.  Cytotoxic potential was detd. by colorimetric and colony formation assays.  An XF24 Extracellular Flux Analyzer, and colorimetric and fluorescent techniques were used to assess the bioenergetics and oxidative stress effects, resp.  Mechanism was detd. by Western blots.  Compd. 3a (6-[(2-acetylphenyl)amino]quinazoline-5,8-dione) was identified through a medium throughput screen of ∼ 1000 highly diverse inhouse compds. and chemotherapeutic agents for their ability to alter cellular bioenergetics.  Further structural optimizations led to the discovery of a more potent analog, 3b (6-[(3-acetylphenyl)amino]quinazoline-5,8-dione) that displayed anti-proliferative activities in low micromolar range in both drug-sensitive and drug-resistant cancer cells.  Treatment with 3b causes Akt activation resulting in increased cellular oxygen consumption and oxidative stress in pancreatic cancer cells.  Moreover, oxidative stress induced by 3b promoted activation of stress kinases (p38/JNK) resulting in cancer cell death.  Treatment with antioxidants was able to reduce cell death confirming ROS-mediated cytotoxicity.  In conclusion, our novel quinazolinediones are promising lead compds. that selectively induce ROS-mediated cell death in cancer cells and warrant further preclin. studies.  Since 3b (6-[(3-acetylphenyl)amino]quinazoline-5,8-dione) exerts Akt-dependent ROS-mediated cell death, it might provide potential therapeutic options for chemoresistant and Akt-overexpressing cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtv5xHFya9e7Vg90H21EOLACvtfcHk0lhzX6VfCmYT0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOls77E&md5=cbbcaca46c9dab2968538df71746ee0d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DPathania%26aufirst%3DD.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DPalomba%26aufirst%3DM.%26aulast%3DSanna%26aufirst%3DV.%26aulast%3DBerrettini%26aufirst%3DF.%26aulast%3DSias%26aufirst%3DA.%26aulast%3DTaheri%26aufirst%3DL.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%2520and%2520discovery%2520of%2520novel%2520quinazolinedione-based%2520redox%2520modulators%2520as%2520therapies%2520for%2520pancreatic%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2014%26volume%3D1840%26spage%3D332%26epage%3D343%26doi%3D10.1016%2Fj.bbagen.2013.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Madak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Membrane permeable lipophilic cations as mitochondrial directing groups</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span><span class="refDoi"> DOI: 10.2174/1568026615666150302105622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.2174%2F1568026615666150302105622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25732791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1ymt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=745-766&author=J.+T.+Madakauthor=N.+Neamati&title=Membrane+permeable+lipophilic+cations+as+mitochondrial+directing+groups&doi=10.2174%2F1568026615666150302105622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups</span></div><div class="casAuthors">Madak, Joseph T.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">745-766</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The mitochondrion's neg. charged membrane potential has been well documented to drive the accumulation of membrane permeable delocalized lipophilic cations (DLC).  DLC attachments to known bioactive compds. can direct organelle localization and improve drug exposure to targets within the mitochondria.  Due to the mitochondria's essential function and its regulation of cell death, DLC targeted therapies are the focus of drug discovery projects altering cellular fate via mitochondrial targets.  This review provides an update on recent developments for the two main applications of DLCs: cytoprotective therapies aimed at reducing oxidative stress and cytotoxic therapies aimed at initiating cell death for the treatment of various cancers.  Both approaches have produced significant improvements using DLC conjugated compds. that include improved potency, pharmacokinetic properties, and the potential to overcome resistance mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEWZte-rFLrrVg90H21EOLACvtfcHk0lhzX6VfCmYT0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1ymt7c%253D&md5=ebd8c0db998ac0c106c40d6a6e55e372</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150302105622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150302105622%26sid%3Dliteratum%253Aachs%26aulast%3DMadak%26aufirst%3DJ.%2BT.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DMembrane%2520permeable%2520lipophilic%2520cations%2520as%2520mitochondrial%2520directing%2520groups%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D745%26epage%3D766%26doi%3D10.2174%2F1568026615666150302105622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Millard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olenyuk, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9170</span><span class="NLM_x">–</span> <span class="NLM_lpage">9179</span><span class="refDoi"> DOI: 10.1021/jm4012438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KktLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9170-9179&author=M.+Millardauthor=J.+D.+Gallagherauthor=B.+Z.+Olenyukauthor=N.+Neamati&title=A+selective+mitochondrial-targeted+chlorambucil+with+remarkable+cytotoxicity+in+breast+and+pancreatic+cancers&doi=10.1021%2Fjm4012438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Selective Mitochondrial-Targeted Chlorambucil with Remarkable Cytotoxicity in Breast and Pancreatic Cancers</span></div><div class="casAuthors">Millard, Melissa; Gallagher, John D.; Olenyuk, Bogdan Z.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9170-9179</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nitrogen mustards, widely used as chemotherapeutics, have limited safety and efficacy.  Mitochondria lack a functional nucleotide excision repair mechanism to repair DNA adducts and are sensitive to alkylating agents.  Importantly, cancer cells have higher intrinsic mitochondrial membrane potential (Δψmt) than normal cells.  Therefore, selectively targeting nitrogen mustards to cancer cell mitochondria based on Δψmt could overcome those limitations.  Herein, the authors describe the design, synthesis, and evaluation of Mito-Chlor, a triphenylphosphonium deriv. of the nitrogen mustard chlorambucil.  The authors show that Mito-Chlor localizes to cancer cell mitochondria where it acts on mtDNA to arrest cell cycle and induce cell death, resulting in a 80-fold enhancement of cell kill in a panel of breast and pancreatic cancer cell lines that are insensitive to the parent drug.  Significantly, Mito-Chlor delayed tumor progression in a mouse xenograft model of human pancreatic cancer.  This is a first example of re-purposing chlorambucil, a drug not used in breast and pancreatic cancer treatment, as a novel drug candidate for these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiXDnBfpvYybVg90H21EOLACvtfcHk0lh4SleZDGHDtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KktLvI&md5=433d093d02a482a570ea77e3b32629a3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm4012438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012438%26sid%3Dliteratum%253Aachs%26aulast%3DMillard%26aufirst%3DM.%26aulast%3DGallagher%26aufirst%3DJ.%2BD.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DA%2520selective%2520mitochondrial-targeted%2520chlorambucil%2520with%2520remarkable%2520cytotoxicity%2520in%2520breast%2520and%2520pancreatic%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9170%26epage%3D9179%26doi%3D10.1021%2Fjm4012438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Madak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuthbertson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of brequinar conjugates as probes to study DHODH inhibition</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">13875</span><span class="NLM_x">–</span> <span class="NLM_lpage">13878</span><span class="refDoi"> DOI: 10.1002/chem.201702999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1002%2Fchem.201702999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=28833638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOjsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=13875-13878&author=J.+T.+Madakauthor=C.+R.+Cuthbertsonauthor=W.+Chenauthor=H.+D.+Showalterauthor=N.+Neamati&title=Design%2C+synthesis%2C+and+characterization+of+brequinar+conjugates+as+probes+to+study+DHODH+inhibition&doi=10.1002%2Fchem.201702999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition</span></div><div class="casAuthors">Madak, Joseph T.; Cuthbertson, Christine R.; Chen, Wenmin; Showalter, Hollis D.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">56</span>),
    <span class="NLM_cas:pages">13875-13878</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Brequinar, a potent dihydroorotate dehydrogenase (DHODH) inhibitor, has been evaluated in multiple clin. trials as a potential treatment for cancer.  To further understand brequinar-based DHODH inhibition and DHODH's therapeutic relevance in cancer, we have developed novel brequinar-based probes.  We disclose a 16-step convergent synthesis of the first brequinar-PROTAC and a four-step approach towards the first mitochondrial-directed brequinar probe.  A PROTAC and mitochondria-directed probe of brequinar both possess cytotoxicity that is superior to brequinar in a colony formation assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCbV9IRIwXRLVg90H21EOLACvtfcHk0lh4SleZDGHDtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOjsrrI&md5=30252ea9945fb5ed9265f505ff71395a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fchem.201702999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201702999%26sid%3Dliteratum%253Aachs%26aulast%3DMadak%26aufirst%3DJ.%2BT.%26aulast%3DCuthbertson%26aufirst%3DC.%2BR.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520brequinar%2520conjugates%2520as%2520probes%2520to%2520study%2520DHODH%2520inhibition%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D13875%26epage%3D13878%26doi%3D10.1002%2Fchem.201702999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almhanna, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, F. H.</span><span> </span><span class="NLM_article-title">Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer</span> <span class="citation_source-journal">Am. J. Transl Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=21139804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fis1GitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=28-47&author=S.+Aliauthor=K.+Almhannaauthor=W.+Chenauthor=P.+A.+Philipauthor=F.+H.+Sarkar&title=Differentially+expressed+miRNAs+in+the+plasma+may+provide+a+molecular+signature+for+aggressive+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer</span></div><div class="casAuthors">Ali Shadan; Almhanna Khaldoun; Chen Wei; Philip Philip A; Sarkar Fazlul H</div><div class="citationInfo"><span class="NLM_cas:title">American journal of translational research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic cancer (PC) has the poorest overall survival rate among all human cancers because of late diagnosis and absence of screening tools.  We compared the expression profile of microRNAs (miRNAs) in the plasma of patients diagnosed with PC (n=50) with healthy volunteers (n=10).  Data was further validated by quantitative realtime PCR and cell-based assays.  Thirty-seven miRNAs were down-regulated and 54 were up-regulated in plasma from patients with PC.  The expression of miR-21 was significantly higher, and the expression of let-7 family (especially let-7d) and miR-146a was significantly lower in PC.  Most interestingly, the expression of miR-21 was correlated with worse survival, and the expression of let-7 was inversely correlated with survival in this pilot study with mixed patient population.  Moreover, we found that miR-21 family was markedly over-expressed in chemo-resistant PC cell lines, which was consistent with the plasma data from PC patients.  Our previous studies have shown increased expression of miR-21 with concomitant loss of PTEN expression in PC cells, which is consistent with our current findings showing the loss of three additional targets of miR-21 (PDCD4, Maspin and TPM1).  These results suggest that identifying and validating the expression of miRNAs in newly diagnosed patients could serve as potential biomarker for tumor aggressiveness, and such miRNAs could be useful for the screening of high-risk patients, and may also serve as targets for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHSIKFKiXr0jQLBVDQn4bCfW6udTcc2eaus7N5M5AV07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fis1GitA%253D%253D&md5=19763319038963cda07c4f56bee729c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DAlmhanna%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DPhilip%26aufirst%3DP.%2BA.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DDifferentially%2520expressed%2520miRNAs%2520in%2520the%2520plasma%2520may%2520provide%2520a%2520molecular%2520signature%2520for%2520aggressive%2520pancreatic%2520cancer%26jtitle%3DAm.%2520J.%2520Transl%2520Res.%26date%3D2010%26volume%3D3%26spage%3D28%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ouyang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaskova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squire, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M. S.</span><span> </span><span class="NLM_article-title">Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">1623</span><span class="NLM_x">–</span> <span class="NLM_lpage">1631</span><span class="refDoi"> DOI: 10.1016/S0002-9440(10)64800-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS0002-9440%2810%2964800-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=11073822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosFyhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2000&pages=1623-1631&author=H.+Ouyangauthor=L.+Mouauthor=C.+Lukauthor=N.+Liuauthor=J.+Karaskovaauthor=J.+Squireauthor=M.+S.+Tsao&title=Immortal+human+pancreatic+duct+epithelial+cell+lines+with+near+normal+genotype+and+phenotype&doi=10.1016%2FS0002-9440%2810%2964800-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype</span></div><div class="casAuthors">Ouyang, Hong; Mou, Lun-jun; Luk, Catherine; Liu, Ni; Karaskova, Jana; Squire, Jeremy; Tsao, Ming-Sound</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1623-1631</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Immortal epithelial cell lines were previously established after transduction of the HPV16-E6E7 genes into primary cultures of normal pancreatic duct epithelial cells.  Single clones were isolated that demonstrated near normal genotype and phenotype.  The proliferation of HPDE6-E6E7c7 and c11 cells is anchorage-dependent, and they were nontumorigenic in SCID mice.  The cell lines demonstrated many phenotypes of normal pancreatic duct epithelium, including mRNA expression of carbonic anhydrase II, MUC-1, and cytokeratins 7, 8, 18, and 19.  These cells have normal Ki-ras, p53, c-myc, and p16INK4A genotypes.  Cytogenetic studies demonstrated losses of 3p, 10p12, and 13q14, the latter included the Rb1 gene.  The wild-type p53 protein was detectable at very low levels consistent with the presence of E6 gene product, and the lack of functional p53 pathway was confirmed by the inability for γ-irradn. to up-regulate p53 and p21waf1/cip1 protein.  The p110/Rb protein level was also not detectable consistent with the expression of E7 protein and haploid loss of Rb1 gene.  Despite this, the proliferation of both c7 and c11 cells were markedly inhibited by transforming growth factor-β1.  This was assocd. with up-regulation of p21cip1/waf1 but not p27kip1.  Further studies showed that p130/Rb2 and cyclin D3 were expressed, suggesting that p130/Rb2 may have partially assumed the maintenance of G1 cell cycle checkpoint regulation.  These results indicate that except for the loss of p53 functional pathway, the two clones of HPDE6-E6E7 cells demonstrated a near normal genotype and phenotype of pancreatic duct epithelial cells.  These cell lines will be useful for future studies on the mol. basis of pancreatic duct cell carcinogenesis and islet cell differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonb3YiFRqHUbVg90H21EOLACvtfcHk0lh2018C297JkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosFyhs7o%253D&md5=83d3a13ec1606550fc46ea0965990dc0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2964800-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252964800-6%26sid%3Dliteratum%253Aachs%26aulast%3DOuyang%26aufirst%3DH.%26aulast%3DMou%26aufirst%3DL.%26aulast%3DLuk%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DKaraskova%26aufirst%3DJ.%26aulast%3DSquire%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26atitle%3DImmortal%2520human%2520pancreatic%2520duct%2520epithelial%2520cell%2520lines%2520with%2520near%2520normal%2520genotype%2520and%2520phenotype%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2000%26volume%3D157%26spage%3D1623%26epage%3D1631%26doi%3D10.1016%2FS0002-9440%2810%2964800-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Paulsen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veloso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungman, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungman, M.</span><span> </span><span class="NLM_article-title">Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1016/j.ymeth.2013.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.ymeth.2013.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23973811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeksbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=45-54&author=M.+T.+Paulsenauthor=A.+Velosoauthor=J.+Prasadauthor=K.+Bediauthor=E.+A.+Ljungmanauthor=B.+Magnusonauthor=T.+E.+Wilsonauthor=M.+Ljungman&title=Use+of+Bru-Seq+and+BruChase-Seq+for+genome-wide+assessment+of+the+synthesis+and+stability+of+RNA&doi=10.1016%2Fj.ymeth.2013.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA</span></div><div class="casAuthors">Paulsen, Michelle T.; Veloso, Artur; Prasad, Jayendra; Bedi, Karan; Ljungman, Emily A.; Magnuson, Brian; Wilson, Thomas E.; Ljungman, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gene expression studies commonly examine total cellular RNA, which only provides information about its steady-state pool of RNA.  It remains unclear whether differences in the steady-state reflects variable rates of transcription or RNA degrdn.  To specifically monitor RNA synthesis and degrdn. genome-wide, we developed Bru-Seq and BruChase-Seq.  These assays are based on metabolic pulse-chase labeling of RNA using bromouridine (Bru).  In Bru-Seq, recently labeled RNAs are sequenced to reveal spans of nascent transcription in the genome.  In BruChase-Seq, cells are chased in uridine for different periods of time following Bru-labeling, allowing for the isolation of RNA populations of specific ages.  Here we describe these methodologies in detail and highlight their usefulness in assessing RNA synthesis and stability as well as splicing kinetics with examples of specific genes from different human cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkhkyBLXrRWrVg90H21EOLACvtfcHk0lh2018C297JkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeksbvN&md5=a18ef08d32830fe03bf5024aa7246fb9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2013.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2013.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DPaulsen%26aufirst%3DM.%2BT.%26aulast%3DVeloso%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DK.%26aulast%3DLjungman%26aufirst%3DE.%2BA.%26aulast%3DMagnuson%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DT.%2BE.%26aulast%3DLjungman%26aufirst%3DM.%26atitle%3DUse%2520of%2520Bru-Seq%2520and%2520BruChase-Seq%2520for%2520genome-wide%2520assessment%2520of%2520the%2520synthesis%2520and%2520stability%2520of%2520RNA%26jtitle%3DMethods%26date%3D2014%26volume%3D67%26spage%3D45%26epage%3D54%26doi%3D10.1016%2Fj.ymeth.2013.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Paulsen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veloso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungman, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsan, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Sinha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungman, M.</span><span> </span><span class="NLM_article-title">Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">2240</span><span class="NLM_x">–</span> <span class="NLM_lpage">2245</span><span class="refDoi"> DOI: 10.1073/pnas.1219192110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1073%2Fpnas.1219192110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23345452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVersLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=2240-2245&author=M.+T.+Paulsenauthor=A.+Velosoauthor=J.+Prasadauthor=K.+Bediauthor=E.+A.+Ljungmanauthor=Y.+C.+Tsanauthor=C.+W.+Changauthor=B.+Tarrierauthor=J.+G.+Washburnauthor=R.+Lyonsauthor=D.+R.+Robinsonauthor=C.+Kumar-Sinhaauthor=T.+E.+Wilsonauthor=M.+Ljungman&title=Coordinated+regulation+of+synthesis+and+stability+of+RNA+during+the+acute+TNF-induced+proinflammatory+response&doi=10.1073%2Fpnas.1219192110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response</span></div><div class="casAuthors">Paulsen, Michelle T.; Veloso, Artur; Prasad, Jayendra; Bedi, Karan; Ljungman, Emily A.; Tsan, Ya-Chun; Chang, Ching-Wei; Tarrier, Brendan; Washburn, Joseph G.; Lyons, Robert; Robinson, Daniel R.; Kumar-Sinha, Chandan; Wilson, Thomas E.; Ljungman, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2240-2245, S2240/1-S2240/347</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Steady-state gene expression is a coordination of synthesis and decay of RNA through epigenetic regulation, transcription factors, micro RNAs (miRNAs), and RNA-binding proteins.  Here, we present bromouride labeling and sequencing (Bru-Seq) and bromouridine pulse-chase and sequencing (BruChase-Seq) to assess genome-wide changes to RNA synthesis and stability in human fibroblasts at homeostasis and after exposure to the proinflammatory tumor necrosis factor (TNF).  The inflammatory response in human cells involves rapid and dramatic changes in gene expression, and the Bru-Seq and BruChase-Seq techniques revealed a coordinated and complex regulation of gene expression both at the transcriptional and posttranscriptional levels.  The combinatory anal. of both RNA synthesis and stability using Bru-Seq and BruChase-Seq allows for a much deeper understanding of mechanisms of gene regulation than afforded by the anal. of steady-state total RNA and should be useful in many biol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfuRwriMUd77Vg90H21EOLACvtfcHk0lgq9UbAXSmtDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVersLY%253D&md5=74e41864b9379692b3265cb7a806e7ca</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219192110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219192110%26sid%3Dliteratum%253Aachs%26aulast%3DPaulsen%26aufirst%3DM.%2BT.%26aulast%3DVeloso%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DK.%26aulast%3DLjungman%26aufirst%3DE.%2BA.%26aulast%3DTsan%26aufirst%3DY.%2BC.%26aulast%3DChang%26aufirst%3DC.%2BW.%26aulast%3DTarrier%26aufirst%3DB.%26aulast%3DWashburn%26aufirst%3DJ.%2BG.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DT.%2BE.%26aulast%3DLjungman%26aufirst%3DM.%26atitle%3DCoordinated%2520regulation%2520of%2520synthesis%2520and%2520stability%2520of%2520RNA%2520during%2520the%2520acute%2520TNF-induced%2520proinflammatory%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D2240%26epage%3D2245%26doi%3D10.1073%2Fpnas.1219192110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Jaiswal, A. K.</span><span> </span><span class="NLM_article-title">Nrf2 signaling in coordinated activation of antioxidant gene expression</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1207</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2004.02.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.freeradbiomed.2004.02.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15110384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVelsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=1199-1207&author=A.+K.+Jaiswal&title=Nrf2+signaling+in+coordinated+activation+of+antioxidant+gene+expression&doi=10.1016%2Fj.freeradbiomed.2004.02.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 signaling in coordinated activation of antioxidant gene expression</span></div><div class="casAuthors">Jaiswal, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1199-1207</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Antioxidant response element (ARE)-mediated expression and coordinated induction of antioxidant enzymes is a crit. mechanism of protection against chem. induced oxidative/electrophilic stress.  NF-E2-related nuclear factors (Nrf1 and Nrf2) bind to ARE and regulate ARE-mediated gene expression and induction.  Nrf2 is more potent than Nrf1 in activation of ARE-regulated gene expression.  Nrf2 is retained in the cytoplasm by an inhibitor INrf2.  Nrf2 binding to INrf2 leads to proteasomal degrdn. of Nrf2.  An increase in oxidative/electrophilic stress, due to chem. exposure, leads to the activation of protein kinase C (PKC) and other cytosolic factors.  PKC phosphorylation of Nrf2 at serine 40 results in the escape or release of Nrf2 from INrf2.  Nrf2 translocates to the nucleus, forms heterodimers with its unknown partner proteins, and binds to the ARE.  This leads to the coordinated activation of ARE-regulated genes.  Addnl. nuclear factor including small Mafs (MafG and MafK), large Maf (c-Maf), c-Fos, and Fra1, also bind to ARE and neg. regulate ARE-mediated gene expression.  This is presumably to keep the expression of antioxidant enzymes "in check" to maintain the cellular defenses active and/or to rapidly restore induced enzymes to normal levels.  Future investigations are expected to reveal that a balance between pos. and neg. factors regulates ARE-mediated gene expression and induction.  The future studies should also reveal a complete mechanism of signal transduction from antioxidants and xenobiotics to the transcription factors, such as Nrf2, that bind to ARE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdlKKCeHST27Vg90H21EOLACvtfcHk0lgq9UbAXSmtDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVelsL4%253D&md5=0ab1c4c25a8e063ad9db1939428ecd7f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2004.02.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2004.02.074%26sid%3Dliteratum%253Aachs%26aulast%3DJaiswal%26aufirst%3DA.%2BK.%26atitle%3DNrf2%2520signaling%2520in%2520coordinated%2520activation%2520of%2520antioxidant%2520gene%2520expression%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2004%26volume%3D36%26spage%3D1199%26epage%3D1207%26doi%3D10.1016%2Fj.freeradbiomed.2004.02.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Dinkova-Kostova, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzclaw, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talalay, P.</span><span> </span><span class="NLM_article-title">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">11908</span><span class="NLM_x">–</span> <span class="NLM_lpage">11913</span><span class="refDoi"> DOI: 10.1073/pnas.172398899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1073%2Fpnas.172398899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=12193649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11908-11913&author=A.+T.+Dinkova-Kostovaauthor=W.+D.+Holtzclawauthor=R.+N.+Coleauthor=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=M.+Yamamotoauthor=P.+Talalay&title=Direct+evidence+that+sulfhydryl+groups+of+Keap1+are+the+sensors+regulating+induction+of+phase+2+enzymes+that+protect+against+carcinogens+and+oxidants&doi=10.1073%2Fpnas.172398899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Holtzclaw, W. David; Cole, Robert N.; Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Yamamoto, Masayuki; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11908-11913</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Coordinate induction of phase 2 proteins and elevation of glutathione protect cells against the toxic and carcinogenic effects of electrophiles and oxidants.  All inducers react covalently with thiols at rates that are closely related to their potencies.  Inducers disrupt the cytoplasmic complex between the actin-bound protein Keap1 and the transcription factor Nrf2, thereby releasing Nrf2 to migrate to the nucleus where it activates the antioxidant response element (ARE) of phase 2 genes and accelerates their transcription.  We cloned, overexpressed, and purified murine Keap1 and demonstrated on native gels the formation of complexes of Keap1 with the Neh2 domain of Nrf2 and their concn.-dependent disruption by inducers such as sulforaphane and bis(2-hydroxybenzylidene)acetone.  The kinetics, stoichiometry, and order of reactivities of the most reactive of the 25 cysteine thiol groups of Keap1 have been detd. by tritium incorporation from [3H]dexamethasone mesylate (an inducer and irreversible modifier of thiols) and by UV spectroscopy with sulforaphane, 2,2'-dipyridyl disulfide and 4,4'-dipyridyl disulfide (titrants of thiol groups), and two closely related Michael reaction acceptors [bis(2- and 4-hydroxybenzylidene)acetones] that differ 100-fold in inducer potency and the UV spectra of which are bleached by thiol addn.  With large excesses of these reagents nearly all thiols of Keap1 react, but sequential reaction with three successive single equiv. (per cysteine residue) of dipyridyl disulfides revealed excellent agreement with pseudo-first order kinetics, rapid successive declines in reaction velocity, and the stoichiometric formation of two equiv. of thiopyridone per reacted cysteine.  This finding suggests that reaction of cysteine thiols is followed by rapid formation of protein disulfide linkages.  The most reactive residues of Keap1 (C257, C273, C288, and C297) were identified by mapping the dexamethasone-modified cysteines by mass spectrometry of tryptic peptides.  These residues are located in the intervening region between BTB and Kelch repeat domains of Keap1 and probably are the direct sensors of inducers of the phase 2 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAg7V1wdZgxLVg90H21EOLACvtfcHk0ljID6j5P5WBuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D&md5=83a3b1b0549cf21153805e9c04f36620</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172398899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172398899%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DCole%26aufirst%3DR.%2BN.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DDirect%2520evidence%2520that%2520sulfhydryl%2520groups%2520of%2520Keap1%2520are%2520the%2520sensors%2520regulating%2520induction%2520of%2520phase%25202%2520enzymes%2520that%2520protect%2520against%2520carcinogens%2520and%2520oxidants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D11908%26epage%3D11913%26doi%3D10.1073%2Fpnas.172398899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Zhang, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannink, M.</span><span> </span><span class="NLM_article-title">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">8137</span><span class="NLM_x">–</span> <span class="NLM_lpage">8151</span><span class="refDoi"> DOI: 10.1128/MCB.23.22.8137-8151.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1128%2FMCB.23.22.8137-8151.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=14585973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8137-8151&author=D.+D.+Zhangauthor=M.+Hannink&title=Distinct+cysteine+residues+in+Keap1+are+required+for+Keap1-dependent+ubiquitination+of+Nrf2+and+for+stabilization+of+Nrf2+by+chemopreventive+agents+and+oxidative+stress&doi=10.1128%2FMCB.23.22.8137-8151.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span></div><div class="casAuthors">Zhang, Donna D.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8137-8151</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A common feature of diverse chemopreventive agents is the ability to activate expression of a genetic program that protects cells from reactive chem. species that if left unchecked would cause mutagenic DNA damage.  The bZIP transcription factor Nrf2 has emerged as a key regulator of this cancer-preventive genetic program.  Nrf2 is normally sequestered in the cytoplasm by a protein known as Keap1.  Chemopreventive agents allow Nrf2 to escape from Keap1-mediated repression, although the mol. mechanism(s) responsible for activation of Nrf2 is not understood.  In this report, we demonstrate that Keap1 does not passively sequester Nrf2 in the cytoplasm but actively targets Nrf2 for ubiquitination and degrdn. by the proteasome under basal culture conditions.  We have identified two crit. cysteine residues in Keap1, C273 and C288, that are required for Keap1-dependent ubiquitination of Nrf2.  Both sulforaphane, a chemopreventive isothiocyanate, and oxidative stress enable Nrf2 to escape Keap1-dependent degrdn., leading to stabilization of Nrf2, increased nuclear localization of Nrf2, and activation of Nrf2-dependent cancer-protective genes.  We have identified a third cysteine residue in Keap1, C151, that is uniquely required for inhibition of Keap1-dependent degrdn. of Nrf2 by sulforaphane and oxidative stress.  This cysteine residue is also required for a novel posttranslational modification to Keap1 that is induced by oxidative stress.  We propose that Keap1 is a component of a novel E3 ubiquitin ligase complex that is specifically targeted for inhibition by both chemopreventive agents and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqys54qQ6MlRLVg90H21EOLACvtfcHk0ljID6j5P5WBuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D&md5=9287849578d0a6b7a6d52b67e3c65190</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.22.8137-8151.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.22.8137-8151.2003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DDistinct%2520cysteine%2520residues%2520in%2520Keap1%2520are%2520required%2520for%2520Keap1-dependent%2520ubiquitination%2520of%2520Nrf2%2520and%2520for%2520stabilization%2520of%2520Nrf2%2520by%2520chemopreventive%2520agents%2520and%2520oxidative%2520stress%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D8137%26epage%3D8151%26doi%3D10.1128%2FMCB.23.22.8137-8151.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Alam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touchard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boinapally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. L.</span><span> </span><span class="NLM_article-title">Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">26071</span><span class="NLM_x">–</span> <span class="NLM_lpage">26078</span><span class="refDoi"> DOI: 10.1074/jbc.274.37.26071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1074%2Fjbc.274.37.26071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=26071-26078&author=J.+Alamauthor=D.+Stewartauthor=C.+Touchardauthor=S.+Boinapallyauthor=A.+M.+Choiauthor=J.+L.+Cook&title=Nrf2%2C+a+Cap%E2%80%99n%E2%80%99Collar+transcription+factor%2C+regulates+induction+of+the+heme+oxygenase-1+gene&doi=10.1074%2Fjbc.274.37.26071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.37.26071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.37.26071%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DD.%26aulast%3DTouchard%26aufirst%3DC.%26aulast%3DBoinapally%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DA.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BL.%26atitle%3DNrf2%252C%2520a%2520Cap%25E2%2580%2599n%25E2%2580%2599Collar%2520transcription%2520factor%252C%2520regulates%2520induction%2520of%2520the%2520heme%2520oxygenase-1%2520gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D26071%26epage%3D26078%26doi%3D10.1074%2Fjbc.274.37.26071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Nioi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, J. D.</span><span> </span><span class="NLM_article-title">Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1042/bj20030754</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1042%2Fbj20030754" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=337-348&author=P.+Nioiauthor=M.+McMahonauthor=K.+Itohauthor=M.+Yamamotoauthor=J.+D.+Hayes&title=Identification+of+a+novel+Nrf2-regulated+antioxidant+response+element+%28ARE%29+in+the+mouse+NAD%28P%29H%3Aquinone+oxidoreductase+1+gene%3A+reassessment+of+the+ARE+consensus+sequence&doi=10.1042%2Fbj20030754"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1042%2Fbj20030754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20030754%26sid%3Dliteratum%253Aachs%26aulast%3DNioi%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520a%2520novel%2520Nrf2-regulated%2520antioxidant%2520response%2520element%2520%2528ARE%2529%2520in%2520the%2520mouse%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520gene%253A%2520reassessment%2520of%2520the%2520ARE%2520consensus%2520sequence%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D374%26spage%3D337%26epage%3D348%26doi%3D10.1042%2Fbj20030754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ross, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepa, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beall, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1016/S0009-2797(00)00199-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS0009-2797%2800%2900199-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=11154736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=77-97&author=D.+Rossauthor=J.+K.+Kepaauthor=S.+L.+Winskiauthor=H.+D.+Beallauthor=A.+Anwarauthor=D.+Siegel&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29%3A+chemoprotection%2C+bioactivation%2C+gene+regulation+and+genetic+polymorphisms&doi=10.1016%2FS0009-2797%2800%2900199-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms</span></div><div class="casAuthors">Ross, D.; Kepa, J. K.; Winski, S. L.; Beall, H. D.; Anwar, A.; Siegel, D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">77-97</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review, with 155 refs.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is an obligate two-electron reductase that is involved in chemoprotection and can also bioactivate certain antitumor quinones.  This review focuses on detoxification reactions catalyzed by NQO1 and its role in antioxidant defense via the generation of antioxidant forms of ubiquinone and vitamin E.  Bioactivation reactions catalyzed by NQO1 are also summarized and the development of new antitumor agents for the therapy of solid tumors with marked NQO1 content is reviewed.  NQO1 gene regulation and the role of the antioxidant response element and the xenobiotic response element in transcriptional regulation is summarized.  An overview of genetic polymorphisms in NQO1 is presented and biol. significance for chemoprotection, cancer susceptibility and antitumor drug action is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXdLgkTvlewbVg90H21EOLACvtfcHk0ljDc0-5Mtx5JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlOntQ%253D%253D&md5=800e91c28ad691db2ab9cd749011f8c2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900199-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900199-X%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DAnwar%26aufirst%3DA.%26aulast%3DSiegel%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%253A%2520chemoprotection%252C%2520bioactivation%252C%2520gene%2520regulation%2520and%2520genetic%2520polymorphisms%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D129%26spage%3D77%26epage%3D97%26doi%3D10.1016%2FS0009-2797%2800%2900199-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Dinkova-Kostova, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talalay, P.</span><span> </span><span class="NLM_article-title">Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1016/S0891-5849(00)00300-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS0891-5849%2800%2900300-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=11035251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=231-240&author=A.+T.+Dinkova-Kostovaauthor=P.+Talalay&title=Persuasive+evidence+that+quinone+reductase+type+1+%28DT+diaphorase%29+protects+cells+against+the+toxicity+of+electrophiles+and+reactive+forms+of+oxygen&doi=10.1016%2FS0891-5849%2800%2900300-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">231-240</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 101 refs.  An extensive body of evidence supports the conclusion that by catalyzing obligatory two-electron redns. of quinones to hydroquinones, NAD(P)H:quinone reductase (QR1) protects cells against the deleterious effects of redox cycling of quinones, their ability to deplete glutathione, and to produce neoplasia.  The effects of elevation of QR1 levels by various enzyme inducers, inhibition of the enzyme by dicumarol, and genetic deletion of the enzyme (knockout mouse) are all consistent with the proposed protective functions.  Measurement of QR1 activity in murine hepatoma cells grown in 96-well microtiter plates has provided a rapid and quant. for detecting inducer activity and detg. inducer potency.  This constitutes a strategy for the identification of potential chemoprotectors against cancer.  Epidemiol. studies show that humans who are genetically deficient in QR1 are more susceptible to the hematol. toxicity and carcinogenicity of benzene exposure, and may be more susceptible to the development of a no. of malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Pc6HOOW7CrVg90H21EOLACvtfcHk0ljDc0-5Mtx5JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrs%253D&md5=120350b82bb1779144d0e52557132f6c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900300-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900300-2%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DPersuasive%2520evidence%2520that%2520quinone%2520reductase%2520type%25201%2520%2528DT%2520diaphorase%2529%2520protects%2520cells%2520against%2520the%2520toxicity%2520of%2520electrophiles%2520and%2520reactive%2520forms%2520of%2520oxygen%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26spage%3D231%26epage%3D240%26doi%3D10.1016%2FS0891-5849%2800%2900300-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Choi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, J.</span><span> </span><span class="NLM_article-title">Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1165/ajrcmb.15.1.8679227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1165%2Fajrcmb.15.1.8679227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=8679227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADyaK28Xktl2rtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=9-19&author=A.+M.+Choiauthor=J.+Alam&title=Heme+oxygenase-1%3A+function%2C+regulation%2C+and+implication+of+a+novel+stress-inducible+protein+in+oxidant-induced+lung+injury&doi=10.1165%2Fajrcmb.15.1.8679227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury</span></div><div class="casAuthors">Choi, Augustine M. K.; Alam, Jawed</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-19</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Lung Association</span>)
        </div><div class="casAbstract">A review, with 58 refs.  Accumulating evidence suggests that oxidative stress plays a central role in the pathogenesis of many pulmonary diseases including adult respiratory distress syndrome, emphysema, asthma, bronchopulmonary dysplasia, and interstitial pulmonary fibrosis.  The morbidity and mortality of these diseases remain high even with optimal medical management.  In our attempts to devise new therapies for these disorders, it is crucial to improve our understanding of the basic mechanism(s) of oxidant-induced lung injury.  A major line of investigation seeks to characterize the cellular and mol. responses of the lung to oxidant insults.  Much progress has been made in our understanding of the role of the "classic" antioxidant enzymes (e.e., superoxide dismutase, catalase, glutathione peroxidase) in mediating the lung's resistance against oxidant lung injury.  However, it is becoming clear that other oxidant-induced gene products may also play vital roles in the lung's adaptive and/or protective response to oxidative stress.  One such stress-response protein is heme oxygenase-1, HO-1.  Since the identification of HO-1 in 1968, many of the studies involving this enzyme were understandably focused on the regulation and function of HO-1 in heme metab.  This emphasis is self-evident as HO-1 catalyzes the first and rate-limiting step in heme degrdn.  Interestingly, however, evidence accumulated over the past 25 yr demonstrates that HO-1 is induced not only by the substrate heme but also by a variety of non-heme inducers such as heavy metals, endotoxin, heat shock, inflammatory cytokines, and prostaglandins.  The chem. diversity of HO-1 inducers led to the speculation that HO-1, besides its role in heme degrdn., may also play a vital function in maintaining cellular homeostasis.  Further support for this hypothesis was provided by Tyrrell and colleagues who showed in 1989 that HO-1 is also highly induced by a variety of agents causing oxidative stress.  Subsequently, many investigators have focused their attention on the function and regulation of HO-1 in various in vitro and in vivo models of oxidant-mediated cellular and tissue injury.  The magnitude of HO-1 induction after oxidative stress and the wide distribution of this enzyme in systemic tissues coupled with the intriguing biol. activities of the catalytic byproducts, carbon monoxide, iron, and bilirubin, makes HO-1 a highly attractive and interesting candidate stress-response protein which may play key role(s) in mediating protection against oxidant-mediated lung injury.  This review will focus on the current understanding of the physiol. significance of HO-1 induction and the mol. regulation of HO-1 gene expression in response to oxidative stress.  We hope that this discussion will stimulate interest and investigations into a field which is still largely uncharted in the pulmonary research community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB2BigA_UOO7Vg90H21EOLACvtfcHk0lhwxB4rejdINg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xktl2rtrk%253D&md5=0713375357221c282c34f3ef481703a8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.15.1.8679227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.15.1.8679227%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DA.%2BM.%26aulast%3DAlam%26aufirst%3DJ.%26atitle%3DHeme%2520oxygenase-1%253A%2520function%252C%2520regulation%252C%2520and%2520implication%2520of%2520a%2520novel%2520stress-inducible%2520protein%2520in%2520oxidant-induced%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1996%26volume%3D15%26spage%3D9%26epage%3D19%26doi%3D10.1165%2Fajrcmb.15.1.8679227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Shamu, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, P.</span><span> </span><span class="NLM_article-title">Oligomerization and phosphorylation of the Ire1p kinase during intracellular signaling from the endoplasmic reticulum to the nucleus</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1002%2Fj.1460-2075.1996.tb00666.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=8670804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADyaK28XjvFCgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=3028-3039&author=C.+E.+Shamuauthor=P.+Walter&title=Oligomerization+and+phosphorylation+of+the+Ire1p+kinase+during+intracellular+signaling+from+the+endoplasmic+reticulum+to+the+nucleus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomerization and phosphorylation of the Ire1p kinase during intracellular signaling from the endoplasmic reticulum to the nucleus</span></div><div class="casAuthors">Shamu, Caroline E.; Walter, Peter</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3028-3039</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The transmembrane kinase Ire1p is required for activation of the unfolded protein response (URP), the increase in transcription of genes encoding endoplasmic reticulum (ER) resident proteins that occurs in response to the accumulation of unfolded proteins in the ER.  Ire1p spans the ER membrane (or the nuclear membrane with which the ER is continuous), with its kinase domain localized in the cytoplasm or in the nucleus.  Consistent with this arrangement, it has been proposed that Ire1p senses the accumulation of unfolded proteins in the ER and transmits the signal across the membrane toward the transcription machinery, possibly by phosphorylating downstream components of the UPR pathway.  Mol. genetic and biochem. studies described here suggest that, as in the case of growth factor receptors of higher eukaryotic cells, Ire1p oligomerizes in response to the accumulation of unfolded proteins in the ER and is phosphorylated in trans by other Ire1p mols. as a result of oligomerization.  In addn. to its kinase domain, a C-terminal tail domain of Ire1p is required for induction of the UPR.  The role of the tail is probably to bind other proteins that transmit the unfolded protein signal to the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOYAh9Wp61orVg90H21EOLACvtfcHk0lhwxB4rejdINg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFCgsLY%253D&md5=74919a4457aef594c1d932cc7a49b334</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1996.tb00666.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1996.tb00666.x%26sid%3Dliteratum%253Aachs%26aulast%3DShamu%26aufirst%3DC.%2BE.%26aulast%3DWalter%26aufirst%3DP.%26atitle%3DOligomerization%2520and%2520phosphorylation%2520of%2520the%2520Ire1p%2520kinase%2520during%2520intracellular%2520signaling%2520from%2520the%2520endoplasmic%2520reticulum%2520to%2520the%2520nucleus%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D3028%26epage%3D3039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Harding, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertolotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ron, D.</span><span> </span><span class="NLM_article-title">Perk is essential for translational regulation and cell survival during the unfolded protein response</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1016/S1097-2765(00)80330-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2FS1097-2765%2800%2980330-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=897-904&author=H.+P.+Hardingauthor=Y.+Zhangauthor=A.+Bertolottiauthor=H.+Zengauthor=D.+Ron&title=Perk+is+essential+for+translational+regulation+and+cell+survival+during+the+unfolded+protein+response&doi=10.1016%2FS1097-2765%2800%2980330-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980330-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980330-5%26sid%3Dliteratum%253Aachs%26aulast%3DHarding%26aufirst%3DH.%2BP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBertolotti%26aufirst%3DA.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DRon%26aufirst%3DD.%26atitle%3DPerk%2520is%2520essential%2520for%2520translational%2520regulation%2520and%2520cell%2520survival%2520during%2520the%2520unfolded%2520protein%2520response%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D5%26spage%3D897%26epage%3D904%26doi%3D10.1016%2FS1097-2765%2800%2980330-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Haze, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span> </span><span class="NLM_article-title">Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3787</span><span class="NLM_x">–</span> <span class="NLM_lpage">3799</span><span class="refDoi"> DOI: 10.1091/mbc.10.11.3787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1091%2Fmbc.10.11.3787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10564271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADyaK1MXntlyrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=3787-3799&author=K.+Hazeauthor=H.+Yoshidaauthor=H.+Yanagiauthor=T.+Yuraauthor=K.+Mori&title=Mammalian+transcription+factor+ATF6+is+synthesized+as+a+transmembrane+protein+and+activated+by+proteolysis+in+response+to+endoplasmic+reticulum+stress&doi=10.1091%2Fmbc.10.11.3787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress</span></div><div class="casAuthors">Haze, Kyosuke; Yoshida, Hiderou; Yanagi, Hideki; Yura, Takashi; Mori, Kazutoshi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3787-3799</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The unfolded protein response (UPR) controls the levels of mol. chaperones and enzymes involved in protein folding in the endoplasmic reticulum (ER).  We recently isolated ATF6 as a candidate for mammalian UPR-specific transcription factor.  We report here that ATF6 constitutively expressed as a 90-kDa protein (p90ATF6) is directly converted to a 50-kDa protein (p50ATF6) in ER-stressed cells.  Furthermore, we showed that the most important consequence of this conversion was altered subcellular localization; p90ATF6 is embedded in the ER, whereas p50ATF6 is a nuclear protein.  P90ATF6 is a type II transmembrane glycoprotein with a hydrophobic stretch in the middle of the mol.  Thus, the N-terminal half contg. a basic leucine zipper motif is oriented facing the cytoplasm.  Full-length ATF6 as well as its C-terminal deletion mutant carrying the transmembrane domain is localized in the ER when transfected.  In contrast, mutant ATF6 representing the cytoplasmic region translocates into the nucleus and activates transcription of the endogenous GRP78/BiP gene.  We propose that ER stress-induced proteolysis of membrane-bound p90ATF6 releases sol. p50ATF6, leading to induced transcription in the nucleus.  Unlike yeast UPR, mammalian UPR appears to use a system similar to that reported for cholesterol homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk6OQE9Nxup7Vg90H21EOLACvtfcHk0lgii5l0EUjoOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlyrsLs%253D&md5=544de37cda67e33a415700db02a46d9d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1091%2Fmbc.10.11.3787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.10.11.3787%26sid%3Dliteratum%253Aachs%26aulast%3DHaze%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DYanagi%26aufirst%3DH.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DK.%26atitle%3DMammalian%2520transcription%2520factor%2520ATF6%2520is%2520synthesized%2520as%2520a%2520transmembrane%2520protein%2520and%2520activated%2520by%2520proteolysis%2520in%2520response%2520to%2520endoplasmic%2520reticulum%2520stress%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D1999%26volume%3D10%26spage%3D3787%26epage%3D3799%26doi%3D10.1091%2Fmbc.10.11.3787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Hetz, C.</span><span> </span><span class="NLM_article-title">The unfolded protein response: controlling cell fate decisions under ER stress and beyond</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span><span class="refDoi"> DOI: 10.1038/nrm3270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fnrm3270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=22251901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=89-102&author=C.+Hetz&title=The+unfolded+protein+response%3A+controlling+cell+fate+decisions+under+ER+stress+and+beyond&doi=10.1038%2Fnrm3270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The unfolded protein response: controlling cell fate decisions under ER stress and beyond</span></div><div class="casAuthors">Hetz, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-102</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-folding stress at the endoplasmic reticulum (ER) is a salient feature of specialized secretory cells and is also involved in the pathogenesis of many human diseases.  ER stress is buffered by the activation of the unfolded protein response (UPR), a homeostatic signaling network that orchestrates the recovery of ER function, and failure to adapt to ER stress results in apoptosis.  Progress in the field has provided insight into the regulatory mechanisms and signaling crosstalk of the 3 branches of the UPR, which are initiated by the stress sensors protein kinase RNA-like ER kinase (PERK), inositol-requiring protein 1α (IRE1α) and activating transcription factor 6 (ATF6).  In addn., novel physiol. outcomes of the UPR that are not directly related to protein-folding stress, such as innate immunity, metab. and cell differentiation, have been revealed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoytTsGjkDMDbVg90H21EOLACvtfcHk0lgii5l0EUjoOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVeltQ%253D%253D&md5=8ed19fba32eee7eb893693d348f22e3f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnrm3270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3270%26sid%3Dliteratum%253Aachs%26aulast%3DHetz%26aufirst%3DC.%26atitle%3DThe%2520unfolded%2520protein%2520response%253A%2520controlling%2520cell%2520fate%2520decisions%2520under%2520ER%2520stress%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D89%26epage%3D102%26doi%3D10.1038%2Fnrm3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, S.</span><span> </span><span class="NLM_article-title">Role of the unfolded protein response in cell death</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1007/s10495-005-3088-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1007%2Fs10495-005-3088-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=5-13&author=R.+Kimauthor=M.+Emiauthor=K.+Tanabeauthor=S.+Murakami&title=Role+of+the+unfolded+protein+response+in+cell+death&doi=10.1007%2Fs10495-005-3088-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs10495-005-3088-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-005-3088-0%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DR.%26aulast%3DEmi%26aufirst%3DM.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DMurakami%26aufirst%3DS.%26atitle%3DRole%2520of%2520the%2520unfolded%2520protein%2520response%2520in%2520cell%2520death%26jtitle%3DApoptosis%26date%3D2006%26volume%3D11%26spage%3D5%26epage%3D13%26doi%3D10.1007%2Fs10495-005-3088-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Verfaillie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostinis, P.</span><span> </span><span class="NLM_article-title">Targeting ER stress induced apoptosis and inflammation in cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.1016/j.canlet.2010.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.canlet.2010.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=20732741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVWitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2013&pages=249-264&author=T.+Verfaillieauthor=A.+D.+Gargauthor=P.+Agostinis&title=Targeting+ER+stress+induced+apoptosis+and+inflammation+in+cancer&doi=10.1016%2Fj.canlet.2010.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting ER stress induced apoptosis and inflammation in cancer</span></div><div class="casAuthors">Verfaillie, Tom; Garg, Abhishek D.; Agostinis, Patrizia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-264</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Disturbance in the folding capacity of the endoplasmic reticulum (ER), caused by a variety of endogenous and exogenous insults, prompts a cellular stress condition known as ER stress.  ER stress is initially shaped to re-establish ER homeostasis through the activation of an integrated intracellular signal transduction pathway termed as unfolded protein response (UPR).  However, when ER stress is too severe or prolonged, the pro-survival function of the UPR turns into a toxic signal, which is predominantly executed by mitochondrial apoptosis.  Moreover, accumulating evidence implicates ER stress pathways in the activation of various classical' inflammatory processes in and around the tumor microenvironment.  In fact, ER stress pathways evoked by certain conventional or exptl. anticancer modalities have been found to promote anti-tumor immunity by enhancing immunogenicity of dying cancer cells.  Thus, the ER functions as an essential sensing organelle capable of coordinating stress pathways crucially involved in maintaining the cross-talk between the cancer cell's intracellular and extracellular environment.  In this review we discuss the emerging link between ER stress, cell fate decisions and immunomodulation and the potential therapeutic benefit of targeting this multifaceted signaling pathway in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpAzGvYM83BLVg90H21EOLACvtfcHk0lhx7XStGqiLSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVWitLk%253D&md5=d38020e0a259ab9003d405074c5fe6ab</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2010.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2010.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DVerfaillie%26aufirst%3DT.%26aulast%3DGarg%26aufirst%3DA.%2BD.%26aulast%3DAgostinis%26aufirst%3DP.%26atitle%3DTargeting%2520ER%2520stress%2520induced%2520apoptosis%2520and%2520inflammation%2520in%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D332%26spage%3D249%26epage%3D264%26doi%3D10.1016%2Fj.canlet.2010.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Nishitoh, H.</span><span> </span><span class="NLM_article-title">CHOP is a multifunctional transcription factor in the ER stress response</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1093/jb/mvr143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1093%2Fjb%2Fmvr143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=22210905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlKksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2012&pages=217-219&author=H.+Nishitoh&title=CHOP+is+a+multifunctional+transcription+factor+in+the+ER+stress+response&doi=10.1093%2Fjb%2Fmvr143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">CHOP is a multifunctional transcription factor in the ER stress response</span></div><div class="casAuthors">Nishitoh, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-219</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The accumulation of unfolded proteins in the endoplasmic reticulum (ER) induces ER stress.  To restore ER homeostasis, cells possess a highly specific ER quality-control system called the unfold protein response (UPR).  In the case of prolonged ER stress or UPR malfunction, apoptosis signaling is activated.  This ER stress-induced apoptosis has been implicated in the pathogenesis of several conformational diseases.  CCAAT-enhancer-binding protein homologous protein (CHOP) is induced by ER stress and mediates apoptosis.  Recent studies by the Gotoh group have shown that the CHOP pathway is also involved in ER stress-induced cytokine prodn. in macrophages.  The multifunctional roles of CHOP in the ER stress response are discussed below.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRCLxqlVNdQ7Vg90H21EOLACvtfcHk0lhx7XStGqiLSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlKksL8%253D&md5=85d59d11b346c9a223ee4f0ba8766edd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvr143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvr143%26sid%3Dliteratum%253Aachs%26aulast%3DNishitoh%26aufirst%3DH.%26atitle%3DCHOP%2520is%2520a%2520multifunctional%2520transcription%2520factor%2520in%2520the%2520ER%2520stress%2520response%26jtitle%3DJ.%2520Biochem.%26date%3D2012%26volume%3D151%26spage%3D217%26epage%3D219%26doi%3D10.1093%2Fjb%2Fmvr143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Oyadomari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span> </span><span class="NLM_article-title">Roles of CHOP/GADD153 in endoplasmic reticulum stress</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1038/sj.cdd.4401373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fsj.cdd.4401373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=14685163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2cXit12ntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=381-389&author=S.+Oyadomariauthor=M.+Mori&title=Roles+of+CHOP%2FGADD153+in+endoplasmic+reticulum+stress&doi=10.1038%2Fsj.cdd.4401373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of CHOP/GADD153 in endoplasmic reticulum stress</span></div><div class="casAuthors">Oyadomari, S.; Mori, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-389</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Endoplasmic reticulum (ER) is the site of synthesis and folding of secretory proteins.  Perturbations of ER homeostasis affect protein folding and cause ER stress.  ER can sense the stress and respond to it through translational attenuation, upregulation of the genes for ER chaperones and related proteins, and degrdn. of unfolded proteins by a quality-control system.  However, when the ER function is severely impaired, the organelle elicits apoptotic signals.  ER stress has been implicated in a variety of common diseases such as diabetes, ischemia and neurodegenerative disorders.  One of the components of the ER stress-mediated apoptosis pathway is C/EBP homologous protein (CHOP), also known as growth arrest- and DNA damage-inducible gene 153 (GADD153).  Here, we summarize the current understanding of the roles of CHOP/GADD153 in ER stress-mediated apoptosis and in diseases including diabetes, brain ischemia and neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8UJrt59E87Vg90H21EOLACvtfcHk0lhx7XStGqiLSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXit12ntbc%253D&md5=2a4e6231233086bd7cf30c51dfe923d8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401373%26sid%3Dliteratum%253Aachs%26aulast%3DOyadomari%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DM.%26atitle%3DRoles%2520of%2520CHOP%252FGADD153%2520in%2520endoplasmic%2520reticulum%2520stress%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2004%26volume%3D11%26spage%3D381%26epage%3D389%26doi%3D10.1038%2Fsj.cdd.4401373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Ghosh, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klocke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestas, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, K. A.</span><span> </span><span class="NLM_article-title">CHOP potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stress</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e39586</span><span class="refDoi"> DOI: 10.1371/journal.pone.0039586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1371%2Fjournal.pone.0039586" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e39586&author=A.+P.+Ghoshauthor=B.+J.+Klockeauthor=M.+E.+Ballestasauthor=K.+A.+Roth&title=CHOP+potentially+co-operates+with+FOXO3a+in+neuronal+cells+to+regulate+PUMA+and+BIM+expression+in+response+to+ER+stress&doi=10.1371%2Fjournal.pone.0039586"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039586%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BP.%26aulast%3DKlocke%26aufirst%3DB.%2BJ.%26aulast%3DBallestas%26aufirst%3DM.%2BE.%26aulast%3DRoth%26aufirst%3DK.%2BA.%26atitle%3DCHOP%2520potentially%2520co-operates%2520with%2520FOXO3a%2520in%2520neuronal%2520cells%2520to%2520regulate%2520PUMA%2520and%2520BIM%2520expression%2520in%2520response%2520to%2520ER%2520stress%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De39586%26doi%3D10.1371%2Fjournal.pone.0039586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadalapaka, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">25332</span><span class="NLM_x">–</span> <span class="NLM_lpage">25344</span><span class="refDoi"> DOI: 10.1074/jbc.M109.095240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1074%2Fjbc.M109.095240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=25332-25344&author=I.+Jutooruauthor=G.+Chadalapakaauthor=P.+Leiauthor=S.+Safe&title=Inhibition+of+NFkappaB+and+pancreatic+cancer+cell+and+tumor+growth+by+curcumin+is+dependent+on+specificity+protein+down-regulation&doi=10.1074%2Fjbc.M109.095240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.095240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.095240%26sid%3Dliteratum%253Aachs%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DChadalapaka%26aufirst%3DG.%26aulast%3DLei%26aufirst%3DP.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520NFkappaB%2520and%2520pancreatic%2520cancer%2520cell%2520and%2520tumor%2520growth%2520by%2520curcumin%2520is%2520dependent%2520on%2520specificity%2520protein%2520down-regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D25332%26epage%3D25344%26doi%3D10.1074%2Fjbc.M109.095240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Kasiappan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Benzyl isothiocyanate (BITC) induces reactive oxygen species-dependent repression of STAT3 protein by down-regulation of specificity proteins in pancreatic cancer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">27122</span><span class="NLM_x">–</span> <span class="NLM_lpage">27133</span><span class="refDoi"> DOI: 10.1074/jbc.M116.746339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1074%2Fjbc.M116.746339" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=27122-27133&author=R.+Kasiappanauthor=I.+Jutooruauthor=K.+Karkiauthor=E.+Hedrickauthor=S.+Safe&title=Benzyl+isothiocyanate+%28BITC%29+induces+reactive+oxygen+species-dependent+repression+of+STAT3+protein+by+down-regulation+of+specificity+proteins+in+pancreatic+cancer&doi=10.1074%2Fjbc.M116.746339"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.746339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.746339%26sid%3Dliteratum%253Aachs%26aulast%3DKasiappan%26aufirst%3DR.%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DHedrick%26aufirst%3DE.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DBenzyl%2520isothiocyanate%2520%2528BITC%2529%2520induces%2520reactive%2520oxygen%2520species-dependent%2520repression%2520of%2520STAT3%2520protein%2520by%2520down-regulation%2520of%2520specificity%2520proteins%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D27122%26epage%3D27133%26doi%3D10.1074%2Fjbc.M116.746339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Jutooru, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadalapaka, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghardt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safe, S.</span><span> </span><span class="NLM_article-title">Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2382</span><span class="NLM_x">–</span> <span class="NLM_lpage">2395</span><span class="refDoi"> DOI: 10.1128/MCB.01602-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1128%2FMCB.01602-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=24732804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGrsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=2382-2395&author=I.+Jutooruauthor=A.+S.+Guthrieauthor=G.+Chadalapakaauthor=S.+Pathiauthor=K.+Kimauthor=R.+Burghardtauthor=U.+H.+Jinauthor=S.+Safe&title=Mechanism+of+action+of+phenethylisothiocyanate+and+other+reactive+oxygen+species-inducing+anticancer+agents&doi=10.1128%2FMCB.01602-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents</span></div><div class="casAuthors">Jutooru, Indira; Guthrie, Aaron S.; Chadalapaka, Gayathri; Pathi, Satya; Kim, KyoungHyun; Burghardt, Robert; Jin, Un-Ho; Safe, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2382-2395, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS)-inducing anticancer agents such as phenethylisothiocyanate (PEITC) activate stress pathways for killing cancer cells.  Here we demonstrate that PEITC-induced ROS decreased expression of microRNA 27a (miR-27a)/miR-20a:miR-17-5p and induced miR-regulated ZBTB10/ZBTB4 and ZBTB34 transcriptional repressors, which, in turn, downregulate specificity protein (Sp) transcription factors (TFs) Sp1, Sp3, and Sp4 in pancreatic cancer cells.  Decreased expression of miR-27a/miR-20a:miR-17-5p by PEITC-induced ROS is a key step in triggering the miR-ZBTB Sp cascade leading to downregulation of Sp TFs, and this is due to ROS-dependent epigenetic effects assocd. with genome-wide shifts in repressor complexes, resulting in decreased expression of Myc and the Myc-regulated miRs.  Knockdown of Sp1 alone by RNA interference also induced apoptosis and decreased pancreatic cancer cell growth and invasion, indicating that downregulation of Sp transcription factors is an important common mechanism of action for PEITC and other ROS-inducing anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrJFKj-FYedLVg90H21EOLACvtfcHk0ljkG0SA68ckxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGrsbjI&md5=65e5082c1df292b751afd551b1d4ccb6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FMCB.01602-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01602-13%26sid%3Dliteratum%253Aachs%26aulast%3DJutooru%26aufirst%3DI.%26aulast%3DGuthrie%26aufirst%3DA.%2BS.%26aulast%3DChadalapaka%26aufirst%3DG.%26aulast%3DPathi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DBurghardt%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DU.%2BH.%26aulast%3DSafe%26aufirst%3DS.%26atitle%3DMechanism%2520of%2520action%2520of%2520phenethylisothiocyanate%2520and%2520other%2520reactive%2520oxygen%2520species-inducing%2520anticancer%2520agents%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2014%26volume%3D34%26spage%3D2382%26epage%3D2395%26doi%3D10.1128%2FMCB.01602-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Guleng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meling, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognum, T. O.</span><span> </span><span class="NLM_article-title">Mitochondrial microsatellite instability in colorectal carcinomas--frequency and association with nuclear microsatellite instability</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1016/j.canlet.2004.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.canlet.2004.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15694669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=2005&pages=97-103&author=G.+Gulengauthor=T.+Lovigauthor=G.+I.+Melingauthor=S.+N.+Andersenauthor=T.+O.+Rognum&title=Mitochondrial+microsatellite+instability+in+colorectal+carcinomas%2D%2Dfrequency+and+association+with+nuclear+microsatellite+instability&doi=10.1016%2Fj.canlet.2004.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial microsatellite instability in colorectal carcinomas-frequency and association with nuclear microsatellite instability</span></div><div class="casAuthors">Guleng, Guttorm; Lovig, Tone; Meling, Gunn Iren; Andersen, Solveig Norheim; Rognum, Torleiv Ole</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The D310 mononucleotide repeat in the D-loop region in mitochondrial DNA has been identified as a hotspot for alterations in primary tumors.  We examd. D310 alterations as well as repeats in the ND1 and ND5 genes, in 95 colorectal carcinomas and in 95 controls without known gastrointestinal malignancy.  D310 alterations were found in 32 (34%) of the carcinomas, in contrast to two persons (2%) in the control group.  Thus, when frequency is concerned, D310 seems to be a hotspot for alterations in colorectal cancer.  No mutations were found in the ND1 and ND5 genes.  D310 instability was not assocd. with nuclear microsatellite instability, indicating different mechanisms of occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTahyWz9PAbVg90H21EOLACvtfcHk0ljkG0SA68ckxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqsL0%253D&md5=7e5d2b28868ebc842c5bb17677f70b38</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DGuleng%26aufirst%3DG.%26aulast%3DLovig%26aufirst%3DT.%26aulast%3DMeling%26aufirst%3DG.%2BI.%26aulast%3DAndersen%26aufirst%3DS.%2BN.%26aulast%3DRognum%26aufirst%3DT.%2BO.%26atitle%3DMitochondrial%2520microsatellite%2520instability%2520in%2520colorectal%2520carcinomas--frequency%2520and%2520association%2520with%2520nuclear%2520microsatellite%2520instability%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D219%26spage%3D97%26epage%3D103%26doi%3D10.1016%2Fj.canlet.2004.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kabekkodu, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarenhas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushtagi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangaraj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopinath, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamoorthy, K.</span><span> </span><span class="NLM_article-title">Mitochondrial DNA variation analysis in cervical cancer</span> <span class="citation_source-journal">Mitochondrion</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1016/j.mito.2013.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.mito.2013.07.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=73-82&author=S.+P.+Kabekkoduauthor=S.+Bhatauthor=R.+Mascarenhasauthor=S.+Mallyaauthor=M.+Bhatauthor=D.+Pandeyauthor=P.+Kushtagiauthor=K.+Thangarajauthor=P.+M.+Gopinathauthor=K.+Satyamoorthy&title=Mitochondrial+DNA+variation+analysis+in+cervical+cancer&doi=10.1016%2Fj.mito.2013.07.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.mito.2013.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mito.2013.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DKabekkodu%26aufirst%3DS.%2BP.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DMascarenhas%26aufirst%3DR.%26aulast%3DMallya%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DD.%26aulast%3DKushtagi%26aufirst%3DP.%26aulast%3DThangaraj%26aufirst%3DK.%26aulast%3DGopinath%26aufirst%3DP.%2BM.%26aulast%3DSatyamoorthy%26aufirst%3DK.%26atitle%3DMitochondrial%2520DNA%2520variation%2520analysis%2520in%2520cervical%2520cancer%26jtitle%3DMitochondrion%26date%3D2014%26volume%3D16%26spage%3D73%26epage%3D82%26doi%3D10.1016%2Fj.mito.2013.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekele, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span> </span><span class="NLM_article-title">Alterations in the mitochondrial displacement loop in lung cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">5636</span><span class="NLM_x">–</span> <span class="NLM_lpage">5641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=14654546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVejurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=5636-5641&author=M.+Suzukiauthor=S.+Toyookaauthor=K.+Miyajimaauthor=T.+Iizasaauthor=T.+Fujisawaauthor=N.+B.+Bekeleauthor=A.+F.+Gazdar&title=Alterations+in+the+mitochondrial+displacement+loop+in+lung+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations in the mitochondrial displacement loop in lung cancers</span></div><div class="casAuthors">Suzuki, Makoto; Toyooka, Shinichi; Miyajima, Kuniharu; Iizasa, Toshihiko; Fujisawa, Takehiko; Bekele, Nebiyou B.; Gazdar, Adi F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5636-5641</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Alterations of the noncoding displacement (D) loop of mitochondrial DNA are present in many cancers.  These alterations include numerical changes in a homopolymeric C tract (PCT) at positions 303-309 and single base substitutions (SBS).  The authors detd. the frequency of D-loop alterations in lung cancer cell lines and tumors, and related them to clinicopathol. features.  The authors sequenced the entire D-loop of 28 lung cancer cell lines [12 small cell lung cancer (SCLC) and 16 non-small cell lung cancer (NSCLC)] and matched B-lymphoblastoid cell lines.  In 55 resected NSCLCs and corresponding nonmalignant lungs they detd. the length of the PCT.  In nonmalignant cell lines and tissues the most frequent PCT repeat no. was seven (36 of 83; 43%) with a range of six to nine.  Alterations, often multiple, were present in 17 of 28 (61%) of the cell lines, including 8 of 12 SCLC (67%) and 9 of 16 NSCLC (56%) lines.  They consisted of SBS in 8 of 28 lines (29%), all of which were homoplasmic, and PCT changes in 14 of 28 (50%) lines, 8 of which were homoplasmic.  Of interest, 95% (40 of 42) of the SBS were present within the two hypervariable regions in the D-loop.  Because SBS were more frequent if PCT changes were present, only the PCT no. was detd. in resected samples.  PCT changes were present in 11 of 55 (20%) of the NSCLC tumors.  Changes were never noted in tumors when the PCT no. in the nonmalignant tissue was seven, and only two tumor cell lines had changes when the PCT no. in the matched lymphoblastoid cell line was seven.  These changes were higher in squamous cell carcinomas (8 of 25; 32%) than in adenocarcinomas (3 of 30; 10%; P = 0.04) and in large tumors (T3 and T4; 7 of 20; 35%) compared with smaller tumors (T1 and T2; 4 of 35; 11%; P = 0.04).  Smoking history, gender, age, and stage were not related to frequency of PCT change.  These findings indicate that D-loop alterations are frequent in lung cancers and their cell lines, and that these changes are weakly assocd. with certain clin. parameters.  In tumors PCT changes were only present when the corresponding nonmalignant lung demonstrated a variation from the most common repeat no. of seven.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm29G4zStGurVg90H21EOLACvtfcHk0ljhBcpu0CC4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVejurw%253D&md5=b249e144ecd7e1f8ba4a1ac86d5d0123</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DToyooka%26aufirst%3DS.%26aulast%3DMiyajima%26aufirst%3DK.%26aulast%3DIizasa%26aufirst%3DT.%26aulast%3DFujisawa%26aufirst%3DT.%26aulast%3DBekele%26aufirst%3DN.%2BB.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26atitle%3DAlterations%2520in%2520the%2520mitochondrial%2520displacement%2520loop%2520in%2520lung%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D5636%26epage%3D5641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Wheelhouse, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigmore, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, D. J.</span><span> </span><span class="NLM_article-title">Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1272</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6602496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fsj.bjc.6602496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15785740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFWltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=1268-1272&author=N.+M.+Wheelhouseauthor=P.+B.+Laiauthor=S.+J.+Wigmoreauthor=J.+A.+Rossauthor=D.+J.+Harrison&title=Mitochondrial+D-loop+mutations+and+deletion+profiles+of+cancerous+and+noncancerous+liver+tissue+in+hepatitis+B+virus-infected+liver&doi=10.1038%2Fsj.bjc.6602496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver</span></div><div class="casAuthors">Wheelhouse, N. M.; Lai, P. B. S.; Wigmore, S. J.; Ross, J. A.; Harrison, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1268-1272</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The largest single underlying cause of hepatocellular carcinoma (HCC) worldwide is hepatitis B virus (HBV) infection.  Hepatitis B virus increases cellular oxidative stress and the development of HCC occurs after a long latency period.  The study was carried out to det. whether mitochondrial DNA abnormalities were assocd. with HCC in individuals with HBV.  The frequency of mutation and deletion of specific areas of the mitochondrial genome in tumor and matched normal tissue of patients with HBV infection was investigated in the current study.  The percentage of control subjects harboring D-loop mutations was 11%, which was significantly lower than that obsd. in both the noncancerous (49%, P=0.033) and tumor tissue (59%, P=0.014) of patients with HCC.  In contrast, the no. of cases in which the common 4977 bp deletion of the mitochondrial genome was detected was significantly greater in control liver and noncancerous liver tissue of subjects with HCC (100 and 95%, resp.) than in cancerous liver tissue (28%, P<0.001).  These observations suggest that the inflammatory process contributes to the rate of mitochondrial mutations.  However, the lower frequency of the large deletion in cancerous tissue suggests that there is selection against either mitochondria, which harbor large deletions, or against cells that contain these mitochondria during hepatocarcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqloGI3of97abVg90H21EOLACvtfcHk0ljhBcpu0CC4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFWltL0%253D&md5=b2522e5478dde9d431e3246a6a8e8ecc</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602496%26sid%3Dliteratum%253Aachs%26aulast%3DWheelhouse%26aufirst%3DN.%2BM.%26aulast%3DLai%26aufirst%3DP.%2BB.%26aulast%3DWigmore%26aufirst%3DS.%2BJ.%26aulast%3DRoss%26aufirst%3DJ.%2BA.%26aulast%3DHarrison%26aufirst%3DD.%2BJ.%26atitle%3DMitochondrial%2520D-loop%2520mutations%2520and%2520deletion%2520profiles%2520of%2520cancerous%2520and%2520noncancerous%2520liver%2520tissue%2520in%2520hepatitis%2520B%2520virus-infected%2520liver%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2005%26volume%3D92%26spage%3D1268%26epage%3D1272%26doi%3D10.1038%2Fsj.bjc.6602496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Lievre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapusot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinzindohoue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roignot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnould, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaune, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faivre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent-Puig, P.</span><span> </span><span class="NLM_article-title">Clinical value of mitochondrial mutations in colorectal cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3525</span><span class="refDoi"> DOI: 10.1200/JCO.2005.07.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1200%2FJCO.2005.07.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=15908662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVyhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=3517-3525&author=A.+Lievreauthor=C.+Chapusotauthor=A.+M.+Bouvierauthor=F.+Zinzindohoueauthor=F.+Piardauthor=P.+Roignotauthor=L.+Arnouldauthor=P.+Beauneauthor=J.+Faivreauthor=P.+Laurent-Puig&title=Clinical+value+of+mitochondrial+mutations+in+colorectal+cancer&doi=10.1200%2FJCO.2005.07.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical value of mitochondrial mutations in colorectal cancer</span></div><div class="casAuthors">Lievre, Astrid; Chapusot, Caroline; Bouvier, Anne-Marie; Zinzindohoue, Franck; Piard, Francoise; Roignot, Patrick; Arnould, Laurent; Beaune, Philippe; Faivre, Jean; Laurent-Puig, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3517-3525</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Prognostic factors that could select high-risk recurrence colorectal cancer patients and predict chemosensitivity are needed.  Since mutations of mitochondrial DNA (mtDNA) have been described in different types of cancers and since they may play a role in response to anticancer agents, we investigated in a population-based series of colorectal cancer patients the clin. value of mtDNA mutations.  Patients and Methods: The displacement loop (D-loop) region of mtDNA was sequenced on a series of 365 patients recorded in the Digestive Cancer Registry of Cote-d'Or (France) between 1998 and 2000.  Clinicopathol. characteristics were correlated to the presence of a D-loop mutation.  Survival rates were compared with the log-rank test.  A multivariate survival anal. was performed.  Results: D-loop mutations were found in 38.3% of the tumors.  The 3-yr survival rate was 53.5% in patients with D-loop mutation vs. 62.1% in patients without (P = .05).  After adjustment for age, stage, and microsatellite instability status, the relative risk of death in patients with D-loop mutation was 1.40 (95% Cl, 1.02 to 1.93; P = .034) as compared with those without.  In stage III colon cancers, adjuvant chemotherapy was beneficial only for patients without D-loop mutation (3-yr survival, 78.3% v 45.4%, P < .02).  In those with D-loop mutation who received adjuvant chemotherapy, the relative risk of death was 4.30 (95% Cl, 1.23 to 15.00; P < .02).  Conclusion: The D-loop region is a hotspot for somatic mutations in colorectal tumors.  Moreover, presence of tumor D-loop mutation appears to be a factor of poor prognosis in colorectal patients and a factor of resistance to fluorouracil-based adjuvant chemotherapy in stage III colon cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozsFpjs65JB7Vg90H21EOLACvtfcHk0ljhBcpu0CC4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVyhsrk%253D&md5=7b8a1ff5d3711524bf9f1f6caecc5ddd</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.07.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.07.044%26sid%3Dliteratum%253Aachs%26aulast%3DLievre%26aufirst%3DA.%26aulast%3DChapusot%26aufirst%3DC.%26aulast%3DBouvier%26aufirst%3DA.%2BM.%26aulast%3DZinzindohoue%26aufirst%3DF.%26aulast%3DPiard%26aufirst%3DF.%26aulast%3DRoignot%26aufirst%3DP.%26aulast%3DArnould%26aufirst%3DL.%26aulast%3DBeaune%26aufirst%3DP.%26aulast%3DFaivre%26aufirst%3DJ.%26aulast%3DLaurent-Puig%26aufirst%3DP.%26atitle%3DClinical%2520value%2520of%2520mitochondrial%2520mutations%2520in%2520colorectal%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D3517%26epage%3D3525%26doi%3D10.1200%2FJCO.2005.07.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Ye, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keinan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z.</span><span> </span><span class="NLM_article-title">Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">10654</span><span class="NLM_x">–</span> <span class="NLM_lpage">10659</span><span class="refDoi"> DOI: 10.1073/pnas.1403521111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1073%2Fpnas.1403521111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=10654-10659&author=K.+Yeauthor=J.+Luauthor=F.+Maauthor=A.+Keinanauthor=Z.+Gu&title=Extensive+pathogenicity+of+mitochondrial+heteroplasmy+in+healthy+human+individuals&doi=10.1073%2Fpnas.1403521111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1403521111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1403521111%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DF.%26aulast%3DKeinan%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DZ.%26atitle%3DExtensive%2520pathogenicity%2520of%2520mitochondrial%2520heteroplasmy%2520in%2520healthy%2520human%2520individuals%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D10654%26epage%3D10659%26doi%3D10.1073%2Fpnas.1403521111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Na, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surh, Y. J.</span><span> </span><span class="NLM_article-title">Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2013.10.819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.freeradbiomed.2013.10.819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=24200599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitleru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=353-365&author=H.+K.+Naauthor=Y.+J.+Surh&title=Oncogenic+potential+of+Nrf2+and+its+principal+target+protein+heme+oxygenase-1&doi=10.1016%2Fj.freeradbiomed.2013.10.819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1</span></div><div class="casAuthors">Na, Hye-Kyung; Surh, Young-Joon</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">353-365</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nuclear factor erythroid 2-related factor 2 (Nrf2) is an essential component of cellular defense against a vast variety of endogenous and exogenous insults, including oxidative stress.  Nrf2 acts as a master switch in the circuits upregulating the expression of various stress-response proteins, esp. heme oxygenase-1 (HO-1).  Paradoxically, however, recent studies have demonstrated oncogenic functions of Nrf2 and its major target protein HO-1.  Levels of Nrf2 and HO-1 are elevated in many different types of human malignancies, which may facilitate the remodeling of the tumor microenvironment making it advantageous for the autonomic growth of cancer cells, metastasis, angiogenesis, and tolerance to chemotherapeutic agents and radiation and photodynamic therapy.  In this context, the cellular stress response or cytoprotective signaling mediated via the Nrf2-HO-1 axis is hijacked by cancer cells for their growth advantage and survival of anticancer treatment.  Therefore, Nrf2 and HO-1 may represent potential therapeutic targets in the management of cancer.  This review highlights the roles of Nrf2 and HO-1 in proliferation of cancer cells, their tolerance/resistance to anticancer treatments, and metastasis or angiogenesis in tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaE3XQc3Q1DLVg90H21EOLACvtfcHk0lhl1eEmwLCHJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitleru70%253D&md5=fed50e791bb78e27585cdb07fcf80a5b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.10.819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.10.819%26sid%3Dliteratum%253Aachs%26aulast%3DNa%26aufirst%3DH.%2BK.%26aulast%3DSurh%26aufirst%3DY.%2BJ.%26atitle%3DOncogenic%2520potential%2520of%2520Nrf2%2520and%2520its%2520principal%2520target%2520protein%2520heme%2520oxygenase-1%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D67%26spage%3D353%26epage%3D365%26doi%3D10.1016%2Fj.freeradbiomed.2013.10.819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Moon, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccia, A.</span><span> </span><span class="NLM_article-title">Dual roles of NRF2 in tumor prevention and progression: Possible implications in cancer treatment</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.freeradbiomed.2014.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25458917" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=292-299&author=E.+J.+Moonauthor=A.+Giaccia&title=Dual+roles+of+NRF2+in+tumor+prevention+and+progression%3A+Possible+implications+in+cancer+treatment&doi=10.1016%2Fj.freeradbiomed.2014.11.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DGiaccia%26aufirst%3DA.%26atitle%3DDual%2520roles%2520of%2520NRF2%2520in%2520tumor%2520prevention%2520and%2520progression%253A%2520Possible%2520implications%2520in%2520cancer%2520treatment%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D79%26spage%3D292%26epage%3D299%26doi%3D10.1016%2Fj.freeradbiomed.2014.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Hayes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, M.</span><span> </span><span class="NLM_article-title">NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1016/j.tibs.2008.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.tibs.2008.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=19321346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVSkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=176-188&author=J.+D.+Hayesauthor=M.+McMahon&title=NRF2+and+KEAP1+mutations%3A+permanent+activation+of+an+adaptive+response+in+cancer&doi=10.1016%2Fj.tibs.2008.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer</span></div><div class="casAuthors">Hayes, John D.; McMahon, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">176-188</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Transcription factor nuclear factor-erythroid 2-related factor 2 (NRF2) controls cellular adaptation to oxidants and electrophiles by inducing antioxidant and detoxification genes in response to redox stress.  NRF2 is neg. regulated by Kelch-like ECH-assocd. protein 1 (KEAP1).  Tumors from ∼15% of patients with lung cancer harbor somatic mutations in KEAP1 that prevent effective NRF2 repression.  Recently, two NRF2 mutation hot-spots' were identified in ∼10% of patients with lung cancer, enabling the transcription factor to evade KEAP1-mediated repression.  Somatic mutations in KEAP1 and NRF2 provide an insight into the mol. mechanisms by which NRF2 is regulated.  Moreover, constitutive NRF2 activation might cause drug resistance in tumors, and an understanding of how the transcription factor is regulated indicates ways in which this could be overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfEHw_HJuBmbVg90H21EOLACvtfcHk0lhl1eEmwLCHJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVSkt7k%253D&md5=a1440f372f38737be500a8795e7a97d0</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2008.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2008.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DMcMahon%26aufirst%3DM.%26atitle%3DNRF2%2520and%2520KEAP1%2520mutations%253A%2520permanent%2520activation%2520of%2520an%2520adaptive%2520response%2520in%2520cancer%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2009%26volume%3D34%26spage%3D176%26epage%3D188%26doi%3D10.1016%2Fj.tibs.2008.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Lister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedjadi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitteringham, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copple, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neoptolemos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldring, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. K.</span><span> </span><span class="NLM_article-title">Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/1476-4598-10-37</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1186%2F1476-4598-10-37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=21489257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltV2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=37&author=A.+Listerauthor=T.+Nedjadiauthor=N.+R.+Kitteringhamauthor=F.+Campbellauthor=E.+Costelloauthor=B.+Lloydauthor=I.+M.+Coppleauthor=S.+Williamsauthor=A.+Owenauthor=J.+P.+Neoptolemosauthor=C.+E.+Goldringauthor=B.+K.+Park&title=Nrf2+is+overexpressed+in+pancreatic+cancer%3A+implications+for+cell+proliferation+and+therapy&doi=10.1186%2F1476-4598-10-37"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy</span></div><div class="casAuthors">Lister, Adam; Nedjadi, Taoufik; Kitteringham, Neil R.; Campbell, Fiona; Costello, Eithne; Lloyd, Bryony; Copple, Ian M.; Williams, Samantha; Owen, Andrew; Neoptolemos, John P.; Goldring, Chris E.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Nrf2 is a key transcriptional regulator of a battery of genes that facilitate phase II/III drug metab. and defense against oxidative stress.  Nrf2 is largely regulated by Keap1, which directs Nrf2 for proteasomal degrdn.  The Nrf2/Keap1 system is dysregulated in lung, head and neck, and breast cancers and this affects cellular proliferation and response to therapy.  Here, we have investigated the integrity of the Nrf2/Keap1 system in pancreatic cancer.  Results: Keap1, Nrf2 and the Nrf2 target genes AKR1c1 and GCLC were detected in a panel of five pancreatic cancer cell lines.  Mutation anal. of NRF2 exon 2 and KEAP1 exons 2-6 in these cell lines identified no mutations in NRF2 and only synonomous mutations in KEAP1.  RNAi depletion of Nrf2 caused a decrease in the proliferation of Suit-2, MiaPaca-2 and FAMPAC cells and enhanced sensitivity to gemcitabine (Suit-2), 5-flurouracil (FAMPAC), cisplatin (Suit-2 and FAMPAC) and gamma radiation (Suit-2).  The expression of Nrf2 and Keap1 was also analyzed in pancreatic ductal adenocarcinomas (n = 66 and 57, resp.) and matching normal benign epithelium (n = 21 cases).  While no significant correlation was seen between the expression levels of Keap1 and Nrf2 in the tumors, interestingly, Nrf2 staining was significantly greater in the cytoplasm of tumors compared to benign ducts (P<0.001).  Conclusions Expression of Nrf2 is up-regulated in pancreatic cancer cell lines and ductal adenocarcinomas.  This may reflect a greater intrinsic capacity of these cells to respond to stress signals and resist chemotherapeutic interventions.  Nrf2 also appears to support proliferation in certain pancreatic adenocarinomas.  Therefore, strategies to pharmacol. manipulate the levels and/or activity of Nrf2 may have the potential to reduce pancreatic tumor growth, and increase sensitivity to therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreSsAuu7vbI7Vg90H21EOLACvtfcHk0ljz434lES6Jfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltV2ntL4%253D&md5=a0a1c733c9e2144650d6ed21f30340e5</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-10-37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-10-37%26sid%3Dliteratum%253Aachs%26aulast%3DLister%26aufirst%3DA.%26aulast%3DNedjadi%26aufirst%3DT.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DCampbell%26aufirst%3DF.%26aulast%3DCostello%26aufirst%3DE.%26aulast%3DLloyd%26aufirst%3DB.%26aulast%3DCopple%26aufirst%3DI.%2BM.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DOwen%26aufirst%3DA.%26aulast%3DNeoptolemos%26aufirst%3DJ.%2BP.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DNrf2%2520is%2520overexpressed%2520in%2520pancreatic%2520cancer%253A%2520implications%2520for%2520cell%2520proliferation%2520and%2520therapy%26jtitle%3DMol.%2520Cancer%26date%3D2011%26volume%3D10%26spage%3D37%26doi%3D10.1186%2F1476-4598-10-37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Arlt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geismann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, H.</span><span> </span><span class="NLM_article-title">Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">4825</span><span class="NLM_x">–</span> <span class="NLM_lpage">4835</span><span class="refDoi"> DOI: 10.1038/onc.2012.493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fonc.2012.493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=23108405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyjsrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=4825-4835&author=A.+Arltauthor=S.+Sebensauthor=S.+Krebsauthor=C.+Geismannauthor=M.+Grossmannauthor=M.+L.+Kruseauthor=S.+Schreiberauthor=H.+Schafer&title=Inhibition+of+the+Nrf2+transcription+factor+by+the+alkaloid+trigonelline+renders+pancreatic+cancer+cells+more+susceptible+to+apoptosis+through+decreased+proteasomal+gene+expression+and+proteasome+activity&doi=10.1038%2Fonc.2012.493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity</span></div><div class="casAuthors">Arlt, A.; Sebens, S.; Krebs, S.; Geismann, C.; Grossmann, M.; Kruse, M-L.; Schreiber, S.; Schaefer, H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">4825-4835</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Evidence accumulates that the transcription factor nuclear factor E2-related factor 2 (Nrf2) has an essential role in cancer development and chemoresistance, thus pointing to its potential as an anticancer target and undermining its suitability in chemoprevention.  Through the induction of cytoprotective and proteasomal genes, Nrf2 confers apoptosis protection in tumor cells, and inhibiting Nrf2 would therefore be an efficient strategy in anticancer therapy.  In the present study, pancreatic carcinoma cell lines (Panc1, Colo357 and MiaPaca2) and H6c7 pancreatic duct cells were analyzed for the Nrf2-inhibitory effect of the coffee alkaloid trigonelline (trig), as well as for its impact on Nrf2-dependent proteasome activity and resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and anticancer drug-induced apoptosis.  Chemoresistant Panc1 and Colo357 cells exhibit high constitutive Nrf2 activity, whereas chemosensitive MiaPaca2 and H6c7 cells display little basal but strong tert-butylhydroquinone (tBHQ)-inducible Nrf2 activity and drug resistance.  Trig efficiently decreased basal and tBHQ-induced Nrf2 activity in all cell lines, an effect relying on a reduced nuclear accumulation of the Nrf2 protein.  Along with Nrf2 inhibition, trig blocked the Nrf2-dependent expression of proteasomal genes (for example, s5a/psmd4 and α5/psma5) and reduced proteasome activity in all cell lines tested.  These blocking effects were absent after treatment with Nrf2 siRNA, a condition in which proteasomal gene expression and proteasome activity were already decreased, whereas siRNA against the related transcription factor Nrf1 did not affect proteasome activity and the inhibitory effect of trig.  Depending on both Nrf2 and proteasomal gene expression, the sensitivity of all cell lines to anticancer drugs and TRAIL-induced apoptosis was enhanced by trig.  Moreover, greater antitumor responses toward anticancer drug treatment were obsd. in tumor-bearing mice when receiving trig.  In conclusion, representing an efficient Nrf2 inhibitor capable of blocking Nrf2-dependent proteasome activity and thereby apoptosis protection in pancreatic cancer cells, trig might be beneficial in improving anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1uD5vWn0aALVg90H21EOLACvtfcHk0ljz434lES6Jfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyjsrbL&md5=3fb3a122c1cabe14251448dbdc0d7ec4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.493%26sid%3Dliteratum%253Aachs%26aulast%3DArlt%26aufirst%3DA.%26aulast%3DSebens%26aufirst%3DS.%26aulast%3DKrebs%26aufirst%3DS.%26aulast%3DGeismann%26aufirst%3DC.%26aulast%3DGrossmann%26aufirst%3DM.%26aulast%3DKruse%26aufirst%3DM.%2BL.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DSchafer%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520the%2520Nrf2%2520transcription%2520factor%2520by%2520the%2520alkaloid%2520trigonelline%2520renders%2520pancreatic%2520cancer%2520cells%2520more%2520susceptible%2520to%2520apoptosis%2520through%2520decreased%2520proteasomal%2520gene%2520expression%2520and%2520proteasome%2520activity%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D4825%26epage%3D4835%26doi%3D10.1038%2Fonc.2012.493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Dhillon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chikara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindl, K. M.</span><span> </span><span class="NLM_article-title">Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage</span> <span class="citation_source-journal">Toxicol Rep</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span><span class="refDoi"> DOI: 10.1016/j.toxrep.2014.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2Fj.toxrep.2014.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=25530945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFWktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=309-318&author=H.+Dhillonauthor=S.+Chikaraauthor=K.+M.+Reindl&title=Piperlongumine+induces+pancreatic+cancer+cell+death+by+enhancing+reactive+oxygen+species+and+DNA+damage&doi=10.1016%2Fj.toxrep.2014.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage</span></div><div class="casAuthors">Dhillon, Harsharan; Chikara, Shireen; Reindl, Katie M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">309-318</span>CODEN:
                <span class="NLM_cas:coden">TROEF9</span>;
        ISSN:<span class="NLM_cas:issn">2214-7500</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pancreatic cancer is one of the most deadly cancers with a nearly 95% mortality rate.  The poor response of pancreatic cancer to currently available therapies and the extremely low survival rate of pancreatic cancer patients point to a crit. need for alternative therapeutic strategies.  The use of reactive oxygen species (ROS)-inducing agents has emerged as an innovative and effective strategy to treat various cancers.  In this study, we investigated the potential of a known ROS inducer, piperlongumine (PPLGM), a bioactive agent found in long peppers, to induce pancreatic cancer cell death in cell culture and animal models.  We found that PPLGM inhibited the growth of pancreatic cancer cell cultures by elevating ROS levels and causing DNA damage.  PPLGM-induced DNA damage and pancreatic cancer cell death was reversed by treating the cells with an exogenous antioxidant.  Similar to the in vitro studies, PPLGM caused a redn. in tumor growth in a xenograft mouse model of human pancreatic cancer.  Tumors from the PPLGM-treated animals showed decreased Ki-67 and increased 8-OHdG expression, suggesting PPLGM inhibited tumor cell proliferation and enhanced oxidative stress.  Taken together, our results show that PPLGM is an effective inhibitor for in vitro and in vivo growth of pancreatic cancer cells, and that it works through a ROS-mediated DNA damage pathway.  These findings suggest that PPLGM has the potential to be used for treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-34z6fNJ5fLVg90H21EOLACvtfcHk0ljYX5YLA4ibww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFWktr8%253D&md5=b309c470b101793c55ab0e36e7916512</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.toxrep.2014.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxrep.2014.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DH.%26aulast%3DChikara%26aufirst%3DS.%26aulast%3DReindl%26aufirst%3DK.%2BM.%26atitle%3DPiperlongumine%2520induces%2520pancreatic%2520cancer%2520cell%2520death%2520by%2520enhancing%2520reactive%2520oxygen%2520species%2520and%2520DNA%2520damage%26jtitle%3DToxicol%2520Rep%26date%3D2014%26volume%3D1%26spage%3D309%26epage%3D318%26doi%3D10.1016%2Fj.toxrep.2014.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Dorr, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landowski, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, S.</span><span> </span><span class="NLM_article-title">Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines</span> <span class="citation_source-journal">Int. J. Gastrointest. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">015</span><span class="NLM_x">–</span> <span class="NLM_lpage">028</span><span class="refDoi"> DOI: 10.1385/IJGC:36:1:015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1385%2FIJGC%3A36%3A1%3A015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=16227632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1eiu7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2005&pages=015-028&author=R.+T.+Dorrauthor=M.+A.+Raymondauthor=T.+H.+Landowskiauthor=N.+O.+Romanauthor=S.+Fukushima&title=Induction+of+apoptosis+and+cell+cycle+arrest+by+imexon+in+human+pancreatic+cancer+cell+lines&doi=10.1385%2FIJGC%3A36%3A1%3A015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines</span></div><div class="casAuthors">Dorr, Robert T.; Raymond, Mary Ann; Landowski, Terry H.; Roman, Nicholas O.; Fukushima, Shoji</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Gastrointestinal Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-28</span>CODEN:
                <span class="NLM_cas:coden">IJGCAJ</span>;
        ISSN:<span class="NLM_cas:issn">1537-3649</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Imexon is an aziridine-contg. small mol. currently in Phase I clin. trials.  This agent has been shown to bind to thiols and increase intracellular oxidants, inducing apoptosis in hematol. cancer cells.  Pancreatic cancers are known to be sensitive to oxidn., suggesting this disease may be an appropriate target for this agent.  The current report examines the activity of imexon in pancreatic cells.  Imexon induced concn.-dependent and time-dependent apoptosis in a panel of six human pancreatic carcinoma cell (PCC) lines.  The mean IC50 for growth inhibition by the SRB assay was 200 (101) μM for a 48 h exposure with a range of 64-358 μM.  Cell killing was schedule-dependent, favoring exposure times ≥48 h.  Imexon-treated MiaPaCa-2 cells underwent non-lethal growth arrest following exposure to concns. ≤200 μM for 48 h.  When concns. were increased to 300 μM for ≥48 h, the MiaPaCa-2 cells arrested in G2 phase and activated caspases 3, 8, and 9 were detected.  After a 72 h exposure to the IC80 concn. of imexon, cells exhibited a loss of mitochondrial membrane potential detected by CMXRos staining.  However, there was no loss of reduced cellular thiols unless very high concns. of ≥400 μM were used.  In contrast, reactive oxygen species (ROS) were elevated in a dose-dependent fashion, starting at very low imexon concns.  Imexon also significantly inhibited MiaPaCa-2 tumor growth in SCID mice at 100 mg/kg/d for 9 d.  The tumor growth inhibition (% T/C) was 27% of control, and the tumor growth delay was 21 d, indicating an active agent by NCI stds.  The levels of imexon that are cytotoxic in human PCC's are achievable based on the preliminary results of the ongoing Phase I trial.  Imexon appears to be active against PCCs in vitro and has an entirely novel mechanism of action involving G2 arrest, accumulation of ROS, and the induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8OKBkKs3l3rVg90H21EOLACvtfcHk0ljYX5YLA4ibww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1eiu7bJ&md5=0913fe235123502be25ede9b0b6629b8</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1385%2FIJGC%3A36%3A1%3A015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FIJGC%253A36%253A1%253A015%26sid%3Dliteratum%253Aachs%26aulast%3DDorr%26aufirst%3DR.%2BT.%26aulast%3DRaymond%26aufirst%3DM.%2BA.%26aulast%3DLandowski%26aufirst%3DT.%2BH.%26aulast%3DRoman%26aufirst%3DN.%2BO.%26aulast%3DFukushima%26aufirst%3DS.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520imexon%2520in%2520human%2520pancreatic%2520cancer%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Gastrointest.%2520Cancer%26date%3D2005%26volume%3D36%26spage%3D015%26epage%3D028%26doi%3D10.1385%2FIJGC%3A36%3A1%3A015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Cohen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalupski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modiano, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conkling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorr, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boytim, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersh, E. M.</span><span> </span><span class="NLM_article-title">A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1007/s00280-009-1162-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1007%2Fs00280-009-1162-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=19855966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1alsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=287-294&author=S.+J.+Cohenauthor=M.+M.+Zalupskiauthor=M.+R.+Modianoauthor=P.+Conklingauthor=Y.+Z.+Pattauthor=P.+Davisauthor=R.+T.+Dorrauthor=M.+L.+Boytimauthor=E.+M.+Hersh&title=A+phase+I+study+of+imexon+plus+gemcitabine+as+first-line+therapy+for+advanced+pancreatic+cancer&doi=10.1007%2Fs00280-009-1162-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer</span></div><div class="casAuthors">Cohen, Steven J.; Zalupski, Mark M.; Modiano, Manuel R.; Conkling, Paul; Patt, Yehuda Z.; Davis, Peg; Dorr, Robert T.; Boytim, Michelle L.; Hersh, Evan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Imexon is an aziridine-derived iminopyrrolidone which has synergy with gemcitabine in pancreatic cancer cell lines.  Gemcitabine is a std. therapy for pancreatic cancer.  We performed a phase I trial of imexon and gemcitabine to evaluate safety, dose-limiting toxicity (DLT), and max. tolerated dose (MTD) in patients with advanced pancreatic cancer.  Patients with untreated locally advanced or metastatic pancreatic adenocarcinoma received therapy in sequential cohorts on regimen A (n = 19; imexon 200 or 280 mg/m2 i.v. over 30 min days 1-5, 15-19 and gemcitabine 800 or 1000 mg/m2 i.v. over 30 min on days 1, 8, 15, every 28 days) or regimen B (n = 86; imexon 280-1,300 mg/m2 i.v. over 30-60 min days 1, 8, and 15 and gemcitabine 1000 mg/m2 i.v. over 30 min on days 1, 8, and 15 every 28 days).  105 Patients received 340 treatment cycles (median 2, range 1-16).  Patient characteristics: median age 63, 61% male, ECOG PS 0/1 50%/50%, 93% metastatic.  DLT was abdominal cramping and pain, often with transient, acute diarrhea.  Best response was confirmed partial response (PR) in 11.4%, 8.9% unconfirmed PR, and 48.1% with stable disease.  There was a dose proportional increase in imexon AUC across the doses tested with terminal half life 69 min at the MTD and no alteration of gemcitabine pharmacokinetics.  The recommended phase II dose of imexon is 875 mg/m2 with gemcitabine 1000 mg/m2.  DLT was acute abdominal pain and cramping.  Encouraging antitumor responses support further evaluation of this combination in advanced pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMSm8oSO2R3LVg90H21EOLACvtfcHk0ljYX5YLA4ibww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1alsL8%253D&md5=5630161aab6bea628dd8eb5047bc9c4f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2Fs00280-009-1162-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-009-1162-y%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DZalupski%26aufirst%3DM.%2BM.%26aulast%3DModiano%26aufirst%3DM.%2BR.%26aulast%3DConkling%26aufirst%3DP.%26aulast%3DPatt%26aufirst%3DY.%2BZ.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DDorr%26aufirst%3DR.%2BT.%26aulast%3DBoytim%26aufirst%3DM.%2BL.%26aulast%3DHersh%26aufirst%3DE.%2BM.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520imexon%2520plus%2520gemcitabine%2520as%2520first-line%2520therapy%2520for%2520advanced%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D66%26spage%3D287%26epage%3D294%26doi%3D10.1007%2Fs00280-009-1162-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Malhotra, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, R. J.</span><span> </span><span class="NLM_article-title">Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2277</span><span class="NLM_x">–</span> <span class="NLM_lpage">2293</span><span class="refDoi"> DOI: 10.1089/ars.2007.1782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1089%2Fars.2007.1782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=17979528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1GrsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=2277-2293&author=J.+D.+Malhotraauthor=R.+J.+Kaufman&title=Endoplasmic+reticulum+stress+and+oxidative+stress%3A+a+vicious+cycle+or+a+double-edged+sword%3F&doi=10.1089%2Fars.2007.1782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?</span></div><div class="casAuthors">Malhotra, Jyoti D.; Kaufman, Randal J.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2277-2294</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The endoplasmic reticulum (ER) is a well-orchestrated protein-folding machine composed of protein chaperones, proteins that catalyze protein folding, and sensors that detect the presence of misfolded or unfolded proteins.  A sensitive surveillance mechanism exists to prevent misfolded proteins from transiting the secretory pathway and ensures that persistently misfolded proteins are directed toward a degradative pathway.  The unfolded protein response (UPR) is an intracellular signaling pathway that coordinates ER protein-folding demand with protein-folding capacity and is essential to adapt to homeostatic alterations that cause protein misfolding.  These include changes in intraluminal calcium, altered glycosylation, nutrient deprivation, pathogen infection, expression of folding-defective proteins, and changes in redox status.  The ER provides a unique oxidizing folding-environment that favors the formation of the disulfide bonds.  Accumulating evidence suggests that protein folding and generation of reactive oxygen species (ROS) as a byproduct of protein oxidn. in the ER are closely linked events.  It has also become apparent that activation of the UPR on exposure to oxidative stress is an adaptive mechanism to preserve cell function and survival.  Persistent oxidative stress and protein misfolding initiate apoptotic cascades and are now known to play predominant roles in the pathogenesis of multiple human diseases including diabetes, atherosclerosis, and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpesElrZ8K6fbVg90H21EOLACvtfcHk0lhonBYm4JuRew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1GrsLzL&md5=3a36ff2200b23ec16ce6d02717149210</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1782%26sid%3Dliteratum%253Aachs%26aulast%3DMalhotra%26aufirst%3DJ.%2BD.%26aulast%3DKaufman%26aufirst%3DR.%2BJ.%26atitle%3DEndoplasmic%2520reticulum%2520stress%2520and%2520oxidative%2520stress%253A%2520a%2520vicious%2520cycle%2520or%2520a%2520double-edged%2520sword%253F%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D2277%26epage%3D2293%26doi%3D10.1089%2Fars.2007.1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Falkenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, C. M.</span><span> </span><span class="NLM_article-title">DNA replication and transcription in mammalian mitochondria</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.76.060305.152028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1146%2Fannurev.biochem.76.060305.152028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=17408359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=679-699&author=M.+Falkenbergauthor=N.+G.+Larssonauthor=C.+M.+Gustafsson&title=DNA+replication+and+transcription+in+mammalian+mitochondria&doi=10.1146%2Fannurev.biochem.76.060305.152028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">DNA replication and transcription in mammalian mitochondria</span></div><div class="casAuthors">Falkenberg, Maria; Larsson, Nils-Goeran; Gustafsson, Claes M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">679-699</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The mitochondrion was originally a free-living prokaryotic organism, which explains the presence of a compact mammalian mitochondrial DNA (mtDNA) in contemporary mammalian cells.  The genome encodes for key subunits of the electron transport chain and RNA components needed for mitochondrial translation.  Nuclear genes encode the enzyme systems responsible for mtDNA replication and transcription.  Several of the key components of these systems are related to proteins replicating and transcribing DNA in phages.  This observation has led to the proposition that some genes required for DNA replication and transcription were acquired together from a phage early in the evolution of the eukaryotic cell, already at the time of the mitochondrial endosymbiosis.  Recent years have seen a rapid development in the mol. understanding of these machineries, but many aspects still remain unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWW_PjZM-qTrVg90H21EOLACvtfcHk0ljRDJCjRNHG7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehtbzK&md5=107375dbb12d81d6ce398be43d732c3d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.76.060305.152028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.76.060305.152028%26sid%3Dliteratum%253Aachs%26aulast%3DFalkenberg%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DN.%2BG.%26aulast%3DGustafsson%26aufirst%3DC.%2BM.%26atitle%3DDNA%2520replication%2520and%2520transcription%2520in%2520mammalian%2520mitochondria%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2007%26volume%3D76%26spage%3D679%26epage%3D699%26doi%3D10.1146%2Fannurev.biochem.76.060305.152028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Montoya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardi, G.</span><span> </span><span class="NLM_article-title">The pattern of transcription of the human mitochondrial rRNA genes reveals two overlapping transcription units</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1016/0092-8674(83)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1016%2F0092-8674%2883%2990145-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1983&pages=151-9&author=J.+Montoyaauthor=G.+L.+Gainesauthor=G.+Attardi&title=The+pattern+of+transcription+of+the+human+mitochondrial+rRNA+genes+reveals+two+overlapping+transcription+units&doi=10.1016%2F0092-8674%2883%2990145-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2883%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252883%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DJ.%26aulast%3DGaines%26aufirst%3DG.%2BL.%26aulast%3DAttardi%26aufirst%3DG.%26atitle%3DThe%2520pattern%2520of%2520transcription%2520of%2520the%2520human%2520mitochondrial%2520rRNA%2520genes%2520reveals%2520two%2520overlapping%2520transcription%2520units%26jtitle%3DCell%26date%3D1983%26volume%3D34%26spage%3D151%26epage%3D9%26doi%3D10.1016%2F0092-8674%2883%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Ojala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardi, G.</span><span> </span><span class="NLM_article-title">tRNA punctuation model of RNA processing in human mitochondria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1038/290470a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2F290470a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1981&pages=470-474&author=D.+Ojalaauthor=J.+Montoyaauthor=G.+Attardi&title=tRNA+punctuation+model+of+RNA+processing+in+human+mitochondria&doi=10.1038%2F290470a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2F290470a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F290470a0%26sid%3Dliteratum%253Aachs%26aulast%3DOjala%26aufirst%3DD.%26aulast%3DMontoya%26aufirst%3DJ.%26aulast%3DAttardi%26aufirst%3DG.%26atitle%3DtRNA%2520punctuation%2520model%2520of%2520RNA%2520processing%2520in%2520human%2520mitochondria%26jtitle%3DNature%26date%3D1981%26volume%3D290%26spage%3D470%26epage%3D474%26doi%3D10.1038%2F290470a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Subramanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mootha, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomeroy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesirov, J. P.</span><span> </span><span class="NLM_article-title">Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">15545</span><span class="NLM_x">–</span> <span class="NLM_lpage">15550</span><span class="refDoi"> DOI: 10.1073/pnas.0506580102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1073%2Fpnas.0506580102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=16199517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=15545-15550&author=A.+Subramanianauthor=P.+Tamayoauthor=V.+K.+Moothaauthor=S.+Mukherjeeauthor=B.+L.+Ebertauthor=M.+A.+Gilletteauthor=A.+Paulovichauthor=S.+L.+Pomeroyauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=J.+P.+Mesirov&title=Gene+set+enrichment+analysis%3A+a+knowledge-based+approach+for+interpreting+genome-wide+expression+profiles&doi=10.1073%2Fpnas.0506580102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</span></div><div class="casAuthors">Subramanian, Aravind; Tamayo, Pablo; Mootha, Vamsi K.; Mukherjee, Sayan; Ebert, Benjamin L.; Gillette, Michael A.; Paulovich, Amanda; Pomeroy, Scott L.; Golub, Todd R.; Lander, Eric S.; Mesirov, Jill P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15545-15550</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although genomewide RNA expression anal. has become a routine tool in biomedical research, extg. biol. insight from such information remains a major challenge.  Here, we describe a powerful anal. method called Gene Set Enrichment Anal. (GSEA) for interpreting gene expression data.  The method derives its power by focusing on gene sets, i.e., groups of genes that share common biol. function, chromosomal location, or regulation.  We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer.  Notably, where single-gene anal. finds little similarity between two independent studies of patients survival in lung cancer, GSEA reveals many biol. pathways in common.  The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biol. defined gene sets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH2_E6gWd0yrVg90H21EOLACvtfcHk0ljRDJCjRNHG7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO&md5=ca2eb221010f20379199e6442c65fc2e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506580102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506580102%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGillette%26aufirst%3DM.%2BA.%26aulast%3DPaulovich%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26atitle%3DGene%2520set%2520enrichment%2520analysis%253A%2520a%2520knowledge-based%2520approach%2520for%2520interpreting%2520genome-wide%2520expression%2520profiles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D15545%26epage%3D15550%26doi%3D10.1073%2Fpnas.0506580102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Mootha, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sihag, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puigserver, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridderstrale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurila, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houstis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesirov, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegelman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschhorn, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altshuler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groop, L. C.</span><span> </span><span class="NLM_article-title">PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1038/ng1180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=10.1038%2Fng1180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=12808457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFSrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=267-273&author=V.+K.+Moothaauthor=C.+M.+Lindgrenauthor=K.+F.+Erikssonauthor=A.+Subramanianauthor=S.+Sihagauthor=J.+Leharauthor=P.+Puigserverauthor=E.+Carlssonauthor=M.+Ridderstraleauthor=E.+Laurilaauthor=N.+Houstisauthor=M.+J.+Dalyauthor=N.+Pattersonauthor=J.+P.+Mesirovauthor=T.+R.+Golubauthor=P.+Tamayoauthor=B.+Spiegelmanauthor=E.+S.+Landerauthor=J.+N.+Hirschhornauthor=D.+Altshulerauthor=L.+C.+Groop&title=PGC-1alpha-responsive+genes+involved+in+oxidative+phosphorylation+are+coordinately+downregulated+in+human+diabetes&doi=10.1038%2Fng1180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</span></div><div class="casAuthors">Mootha, Vamsi K.; Lindgren, Cecilia M.; Eriksson, Karl-Fredrik; Subramanian, Aravind; Sihag, Smita; Lehar, Joseph; Puigserver, Pere; Carlsson, Emma; Ridderstrale, Martin; Laurila, Esa; Houstis, Nicholas; Daly, Mark J.; Patterson, Nick; Mesirov, Jill P.; Golub, Todd R.; Tamayo, Pablo; Spiegelman, Bruce; Lander, Eric S.; Hirschhorn, Joel N.; Altshuler, David; Groop, Leif C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">DNA microarrays can be used to identify gene expression changes characteristic of human disease.  This is challenging, however, when relevant differences are subtle at the level of individual genes.  We introduce an anal. strategy, Gene Set Enrichment Anal., designed to detect modest but coordinate changes in the expression of groups of functionally related genes.  Using this approach, we identify a set of genes involved in oxidative phosphorylation whose expression is coordinately decreased in human diabetic muscle.  Expression of these genes is high at sites of insulin-mediated glucose disposal, activated by PGC-1α and correlated with total-body aerobic capacity.  Our results assoc. this gene set with clin. important variation in human metab. and illustrate the value of pathway relationships in the anal. of genomic profiling expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6DlqdMV1i-rVg90H21EOLACvtfcHk0lj1hdmeOz0g2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFSrs7o%253D&md5=98e5a8107603527d570829235359f0a7</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fng1180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1180%26sid%3Dliteratum%253Aachs%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DLindgren%26aufirst%3DC.%2BM.%26aulast%3DEriksson%26aufirst%3DK.%2BF.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DSihag%26aufirst%3DS.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DPuigserver%26aufirst%3DP.%26aulast%3DCarlsson%26aufirst%3DE.%26aulast%3DRidderstrale%26aufirst%3DM.%26aulast%3DLaurila%26aufirst%3DE.%26aulast%3DHoustis%26aufirst%3DN.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DPatterson%26aufirst%3DN.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DSpiegelman%26aufirst%3DB.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DHirschhorn%26aufirst%3DJ.%2BN.%26aulast%3DAltshuler%26aufirst%3DD.%26aulast%3DGroop%26aufirst%3DL.%2BC.%26atitle%3DPGC-1alpha-responsive%2520genes%2520involved%2520in%2520oxidative%2520phosphorylation%2520are%2520coordinately%2520downregulated%2520in%2520human%2520diabetes%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D267%26epage%3D273%26doi%3D10.1038%2Fng1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i62"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01463">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_71072"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01463">10.1021/acs.jmedchem.7b01463</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Correlation of cytotoxicity of QD compounds and ROS induction (Figure S2); list of top 30 canonical pathways affected by QD compound treatments (Figures S3 and S4); list of top 50 gene sets up regulated by QD compound treatments (Figure S5); list of top 50 gene sets down regulated by QD compound treatments (Figure S6); panels showing <b>QD232</b> or <b>QD325</b> treatment that selectively inhibits synthesis of mtDNA transcripts (Figure S7); and elemental analyses for tested compounds (Table S8) <a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01463/suppl_file/jm7b01463_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Additional compound data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01463/suppl_file/jm7b01463_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01463/suppl_file/jm7b01463_si_001.pdf">jm7b01463_si_001.pdf (4.42 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01463/suppl_file/jm7b01463_si_002.csv">jm7b01463_si_002.csv (1.92 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01463&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-4%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01463%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01463" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996d83fb333c76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
